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ABSTRACT OF DISSERTATION 
FUNCTIONAL ANALYSES OF THE DNA- AND RNA-BINDING PROTEIN SPOVG 
IN BORRELIA BURGDORFERI 
Borrelia burgdorferi, the causative agent of Lyme disease, exists in a defined 
enzootic cycle involving Ixodes scapularis ticks and various vertebrates. Humans can serve 
as an accidental host, if a tick colonized with B. burgdorferi happens to feed on a human. 
B. burgdorferi are also accidental pathogens: they do not make toxins, or destroy host tissue
by other mechanisms. They merely transmit between vector and host to survive. In order
to do this, they must effectively sense their current environment, and appropriately alter
cellular processes. Understanding the regulatory mechanisms of how B. burgdorferi
manages to do this has been a focus of the Stevenson lab for many years.
Previous work identified SpoVG as a DNA-binding protein. Although a homologue 
of this protein had been implicated to serve a regulatory role in other bacteria, the 
Stevenson lab was the first to demonstrate a function for the protein, both for B. burgdorferi 
and two other bacteria. Studies contained in this body of work aim to provide insight into 
regulation of SpoVG by B. burgdorferi as well the impact that it has on gene regulation.  
By using genetic mutants, we determined that SpoVG is regulated at the levels of 
transcription and translation in culture by growth rate, temperature, and other regulatory 
factors. Additionally, we provide evidence that SpoVG regulates its own expression. 
Numerous genes are under control of SpoVG. Biochemical analyses revealed that SpoVG 
specifically interacts with DNAs and RNAs associated with genes found to be under its 
regulatory control. Finally, we provide evidence for SpoVG acting in concert with other 
known regulatory factors such as other DNA-binding proteins and the cyclic di-nucleotide 
second messengers cyclic-di-GMP and cyclic-di-AMP. 
All together, these studies provide insight into how B. burgdorferi broadly regulates 
cellular processes during different stages of the enzootic cycle. We hypothesize that 
SpoVG does this through globally manipulating the three-dimensional structure of the 
bacterial chromosome, and that exactly how SpoVG acts at any given point will be 
dependent on the other regulatory factors that are also present in the cell. 
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CHAPTER 1. INTRODUCTION 
“Happy families are all alike; every unhappy family is unhappy in its own way”  
 
 
1.1 Bacteria sense and respond to their environments 
Thus begins Tolstoy’s Anna Karenina. But what can be said of the Domain Bacteria? 
There is enormous diversity in where individuals live, the nutrients they need to survive, 
and environments within which they flourish. Thermus aquaticus was isolated from deep-
sea hot-water vents (1). Many bacteria can metabolize sulfur, and some are magnetotactic, 
by storing iron in specialized organelles (2, 3). Different bacteria can live in volcanos, soil, 
water, within various hosts, and even within other cells (4-8).  Happy bacteria are certainly 
not all alike.  
And what of unhappy bacteria? Bacteria have evolved a number of strategies to deal 
with harsh environments and toxic components in their environments. Not every bacterium 
employs every strategy, however there is remarkable conservation in the ways in which 
bacteria cope with “unhappiness”. At the core of evolutionary survival is the ability of 
bacteria to recognize when stressful factors are present, and drastically slow-down cellular 
processes that require energy, such as growth and division, transcription and translation (9-
11).  
This simple strategy essentially gives bacteria time to employ other strategies they 
may have evolved to cope with stress without dying. This has particularly relevant 
implications for how bacteria are so adept at developing resistance to antimicrobial drugs. 
Bacteria only need to survive while the drug is present, then can go on happily growing 
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afterwards (12). There are two main classes of antibacterial drugs, based on the effect that 
they have on bacteria. Bacteriostatic drugs prevent bacterial growth, and work by allowing 
human immune systems to kill the bacteria, and bactericidal drugs work by directly killing 
bacteria. The majority of antibiotics approved for human use are bacteriostatic, and these 
are far easier for bacteria to develop resistance to (12, 13) . 
Although strategies that bacteria employ to survive harsh environments evolve, and 
development of resistance to antibiotics is well documented and studied, very little is 
known about the mechanism by which bacteria distinguish a “harsh environment” or “toxic 
compounds”, and exactly how they go about reprogramming their cellular processes (14). 
Borrelia burgdorferi provides a unique model for studying how bacteria sense and respond 
to changing environments. The bacterium exists by transmitting within a rigid enzootic 
cycle that includes surviving within a tick midgut for months at a time with very few 
available nutrients.  
1.2 Borrelia burgdorferi as the causative agent of Lyme disease 
Lyme disease was first described in 1976, when a cluster of children living in Lyme 
Connecticut presented with symptoms that appeared to be consistent with rheumatoid 
arthritis (15-17). A few years later, at the NIH Rocky Mountain Laboratories, the link 
between Lyme disease and the tick-borne spirochete Borrelia burgdorferi was established 
(18-20). Although the disease has only relatively recently been named, B. burgdorferi has 
been endemic to North America for approximately 60,000 years (21).  
Lyme disease (LD) presents in patients as immunologically driven symptoms. The 
bacteria do not make any toxins, or attack host cells (22, 23). The disease is driven entirely 
3 
 
 
by immune responses that do not efficiently target B. burgdorferi, and instead damage host 
tissue. The most visibly obvious symptom is the “bulls-eye” rash. Approximately 70% of 
people infected with B. burgdorferi present with a round rash expanding from the tick bite 
site (24-26). Other common symptoms include facial palsy and arthritis (27).  It is 
estimated that approximately 60% of LD patients who are not treated in the early stages of 
infection with antibiotics develop arthritis in one or more large joints after several months 
(17).  
There have been no reported cases of antibiotic resistant B. burgdorferi in an infected 
human (16, 28-31). The majority of Lyme disease patients who receive antibiotic therapy 
in a timely manner recover with no long-term side effects. A small sub-set of treated 
patients (less than 10%) suffer from refractory Lyme arthritis, a condition that is caused by 
continued immunological responses in the previously infected tissues (32-35).  
There is no evidence to support claims that B. burgdorferi forms persister cells, or 
that patient’s symptoms are dependent on the presence of live, uncleared bacteria (36, 37). 
The details of the mechanism of what causes persistent symptoms in this sub-population 
of patients remain to be fully examined. A recent study, however, demonstrated that B. 
burgdorferi peptidoglycan can be detected in human synovial tissue long after bacteria are 
cleared (38). B. burgdorferi peptidoglycan is constructed in a unique manner, and is highly 
immunogenic on its own (38, 39). Additionally, B. burgdorferi lacks any pathway to 
recycle peptidoglycan (23). During the process of cell growth and cell wall remodeling, B. 
burgdorferi peptidoglycan accumulates in its environment (38, 39).  
4 
 
 
1.3  Enzootic transmission cycle of B. burgdorferi 
Borrelia burgdorferi exists in nature by transmitting between Ixodes spp. ticks and 
vertebrates (Figure 1.1). The bacterium cannot survive outside of a host, and does not live 
intracellularly within eukaryotic cells. B. burgdorferi is not transmitted transovarially 
within the tick, meaning the bacteria cannot infect the eggs. After hatching, the larvae take 
a blood meal. If a larva feeds on an animal that has been infected with B. burgdorferi, some 
of those bacteria can be transmitted to the tick. While the blood meal is digested, B. 
burgdorferi reduces its growth and replication rate, and attaches to the cells of the tick mid-
gut (40-43). The larva will then over-winter, molt into a nymph, and take a blood meal. 
Once the blood begins to come in, B. burgdorferi detaches from the mid-gut, traverses 
through the hemolymph, and into the salivary glands where they can transmit into the host 
that the tick is feeding on (44, 45). The nymph is the stage most likely to transmit B. 
burgdorferi to humans. They are very tiny--about the size of a sesame seed--which makes 
them exceptionally difficult to detect (46-50). 
There is an important distinction to be made for Ixodes, the genus of ticks that carry 
B. burgdorferi. There are two main classifications of ticks: soft-bodied and hard-bodied 
(51). The group which Ixodes belongs to are hard-bodied. One of the most important 
distinctions between these two groups, and essential for understanding B. burgdorferi 
survival and transmission, is how these two groups of ticks feed. Soft-bodied ticks feed 
often and very quickly. They can take blood-meals as often as once every few weeks, but 
they only feed for about 15 minutes at a time. Hard-bodied ticks, however, take only one 
blood meal per life cycle stage, and can take up to seven days to complete a feeding (51-
53). A larva takes one blood meal then molts into a nymph. The nymph takes one blood 
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meal, then molts into either a female or male adult. Only the female adult will take a blood 
meal, although males at this stage will attach to vertebrates as well, in order to mate with 
the females. After the female has taken her blood meal, she uses all of her resources to 
develop a clutch of eggs, and dies in the process (51-55).  
The range of vertebrate hosts that can be infected with, and transmit B. burgdorferi 
is quite wide, ranging from birds to rodents such as mice and squirrels to reptiles such as 
lizards (40, 56-59). Ticks do not fly or jump, but rather lie in-wait for their victim to brush 
past. The vertebrate animal most likely to serve as host in this cycle is largely dependent 
on geographic location, and the preferred “blood buffet” for the tick species in that region. 
For example, in the southern United States, Ixodes scapularis ticks exhibit a very different 
questing behavior than ticks in the North Eastern states, and tend to feed on reptiles rather 
than small mammals. Rather than climbing as high as possible on blades of grass, for 
instance, the southern Ixodes prefer to remain low in the leaf litter (57, 60, 61). On the 
western coast, Ixodes pacificus can feed on humans, but the percentage of I. pacificus 
infected by B. burgdorferi is much lower than the percentage of I. scapularis that is infected 
in endemic areas. Whereas up to 30% of I. scapularis nymphs are infected with B. 
burgdorferi, only about 3% of I. pacificus ticks are. (62-66). 
1.4 Distribution of Ixodes scapularis ticks and Lyme Disease 
Although there is a smattering of Lyme disease cases throughout the U.S., 
particularly in California, the majority of cases reported are concentrated on the East coast 
and in the Midwest in Minnesota, Wisconsin and Illinois. The CDC began recording 
reported cases in 1997. That year, there were 12,801 confirmed cases. For 2017, the most 
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recent year with available data, there were 29,513 confirmed cases, and an additional 
13,320 probable cases were reported. The CDC estimates that up to 300,000 people 
contract Lyme disease each year, but that the majority of cases go undiagnosed and 
unreported. The increase in reported cases is due to a number of factors, including an 
increasing awareness, diagnosis, and reporting of Lyme disease cases (67, 68).  
The most significant impact on the increase in Lyme disease is due to expanding tick 
populations (57, 69). There could be two contributing factors to this: 1) the percentage of 
ticks within a population that harbors B. burgdorferi could increase, and 2) the tick 
population itself could increase, and its geographical footprint could expand. Even in areas 
where I. scapularis ticks and Lyme disease are endemic, about 30% of the total tick 
population carries B. burgdorferi, and this percentage has been fairly consistent since these 
ecological studies were first conducted (61, 70-73). The  Ixodes scapularis population has 
been expanding, in part due to climate change (44, 61, 74).  
1.5 Borrelia burgdorferi physiology  
Borrelia burgdorferi is a spirochete, a group of bacteria easily identified by their 
distinctive corkscrew-like shape. These bacteria are very thin (approximately 200 nm) and 
very long (approximately 20 µm). B. burgdorferi is classified as a gram-negative bacterium 
due to the fact that it has an outer membrane, however, many of its proteins are more 
closely related to those found in gram-positive bacteria, and it has no lipopolysaccharide 
(LPS) as other gram-negative bacteria do (23, 75, 76). The corkscrew shape of Borrelia 
spp. comes from the periplasmic flagella that are present at each end of the cell. The motors 
are anchored in the inner membrane of the cell, and the flagella wrap around the body of 
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the cell, within the periplasmic space between the outer and inner membranes. The rotation 
of flagella are the source of the corkscrew shape (77-81).  
B. burgdorferi also posseses an unusual genome that is both reduced and highly 
segmented. The entire genome is about 1.5 million base pairs in total. Approximately 900 
KB is located on the main, linear chromosome, while the remaining 6 KB is distributed 
across as many as two dozen circular and linear plasmids of varying sizes (76, 82-89). 
Cultured B. burgdorferi loses plasmids over the course of laboratory passages, however B. 
burgdorferi in the wild maintain approximately two dozen (85, 90-92). Some plasmids 
contain genes that are necessary for survival within the tick, such as lp45. This plasmid 
encodes two genes ospA and ospB, which encode outersurface lipoproteins that interact 
with TROSPA/B receptors on the cells lining the tick mid-gut (93). This enables B. 
burgdorferi  to attach to the mid-gut of the tick during digestion and molting.  Some 
plasmids contain genes necessary for survival within vertebrates, such as the group of cp32 
plasmids, which are prophages and contain the erp genes which code for outersurface 
lipoproteins that bind to complement inhibitor protein factor H (94). Finally, some 
plasmids are always faithfully maintained, because they harbor genes that code for essential 
proteins. For example, cp26 contains the gene resT, which codes for the telomere resolvase 
protein, which is necessary for replication of all linear DNA elements in B. burgdorferi, 
including the main chromosome (93, 95-98). B. burgdorferi that is serially passaged in 
culture lose plasmids over time, therefore individual strains are noted as either high-
passage non-infectious (such as B31-e2) or low-passage, infectious (such as B31-A3). B31-
e2 is non-infectious, grows more quickly, and is more easily transformable because it has 
lost most plasmids not necessary for survival in culture. These include lp28-1 which carries 
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the vlsE locus, and lp25 which carries the locus for one of the two restriction modification 
systems. 
1.6 Motility and Chemotaxis 
B. burgodrferi is highly motile. Seven to eleven falgellar motors are positioned in 
the inner membrane on both ends of the cell (99). The flagellelar filaments extend from the 
motors into the periplasmic space between the peptidoglycan and the outer membrane, and 
wrap back around the body of the cell. The motion of the flagella turning give the 
charactaristic corkscrew shape to the bacterium (77, 79, 100, 101).  
 B. burgdorferi maintains chemotactic systems that allow the bacteria to very 
quickly and efficiently detect incoming signals (77, 79, 102-105). The process of 
transmitting from a tick to a vertebrate or from a vertebrate to a tick is an active one. When 
the blood meal comes into a tick, B. burgdorferi must detach from the midgut, enter the 
hemolymph, travel to the salivary glands, and out into the vertebrate. Likewise, when a tick 
feeds on a vertebrate, B. burgdorferi  actively migrates to the tick bite site to be taken up 
with the blood meal. Although it is unknown exactly what molecules B. burgdorferi 
migrates towards, bacteria deficient in the chemotactic proteins CheX, CheY3 and CheA2 
are unable to transmit between tick and vertebrate in either direction (106-109). 
1.7 Tick and vertebrate interfaces 
Numerous studies have demonstrated that B. burgdorferi drastically alters its 
transcriptome and proteome, depending on whether it is transmitting from a tick to a 
vertebrate, establishing an infection within a vertebrate, transmitting to a tick, or colonizing 
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the tick after the blood meal has been digested by the tick (110-116). B. burgdorferi 
expresses different outer surface proteins at different points. OspA and OspB interact with 
TROSPA/B receptors on cells in the tick mid-gut, allowing B. burgdorferi to effectly 
adhere onto the lining of the midgut (117) (118-122).  
Other outer surface proteins are expressed when B. burgdorferi  is in the vertebrate 
which binds to extracellular matrix material such as fibronectin and laminin. This has the 
effect of “coating” the bacteria and appearing as “self” to the host immune cells (123-129). 
“Erp” and CRASP outer surface proteins encoded on the cp32 prophages bind Factor H, 
and thus prevent killing by the complement pathway (94, 130-137). VlsE is only expressed 
in vertebrates, and although it is highly immunogenic, it undergoes antigenic variation by 
a mechanism that remains to be defined (138-141).  
1.8 B. burgdorferi regulatory factors 
Although some bacteria have evolved hundreds of regulatory factors, B. 
burgdorferi encodes surprisingly few. This may be in part due to the fact that B. burgdorferi 
has evolved to exist in a very defined enzootic cycle. Where B. burgdorferi has been 
informs the bacteria of its current environment, the current environment informs the 
bacteria of what is coming next. In contrast to bacteria that have evolved to survive in a 
wide variety of environments (think Pseudomonas spp), B. burgdorferi has evolved to be 
prepared for a defined set of niches.  
B. burgdorferi has two two-componant systems (not including those in the 
chemotaxis pathway), termed Hk1-Rrp1 and Hk2-Rrp2 (23). When phosphorylated, Rrp1 
synthesizes the small molecule c-di-GMP (142). C-di-GMP, is essential for survival in the 
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tick, although it is dispensible for survival in mice (143), and controls gene expression 
likely through its interaction with PlzA (144-148). Rrp2 is the alternative sigma factor 
RpoN, which together with the DNA-binding protein BosR, stimulates expression of the 
only other alternative sigma factor, RpoS (149-151). Together, Rrp2 and RpoS govern gene 
expression of proteins necessary for transmission from a tick to a vertebrate, and for 
establishing vertebrate infection (110, 152-154).  
The Stevenson lab has long been interested in identifying and characterizing novel 
factors that regulate these processes. Previous work from the lab has identified BpuR, a 
DNA/RNA-binding protein unique to Spirochetes and eukaryotes, and EbfC, a DNA-
binding protein found in all bacteria, as well as ascribed a role for plasmid BpaB proteins 
in gene regulation (38, 155-163). Most recently, SpoVG, which is conserved across many 
gram-positive bacteria, was identified as a DNA binding protein in B. burgodorferi, 
Listeria monocytogenes and Staphyloccocus aureus (164). 
1.9 Initial studies on SpoVG 
SpoVG was initially identified in 1981 (165, 166) in Bacillus subtilis, and was so 
named because it was determined to have some role in stage five of sporulation. Cells that 
lacked SpoVG were far less likely to complete sporulation(165, 167, 168). It was noted, 
however, that the few spores that did form were fully functional--they were resistant to 
sodium dodecyl sulfate (SDS) and could regenerate into active cells. The early studies 
noted that spoVG was transcribed during stage one of sporulation, and there appeared to be 
some evidence for self-regulation (165, 166, 168). Later in the 1990s, SpoVG was 
identified in a suppressor screen. The transcriptional regulator SpoIIB inhibits sporulation 
11 
 
 
at stage two. Sporulation was restored in a DspoIIB B. subtilis strain in which a non-sense 
mutation arose in spoVG (167, 169).  
In the 2000s, SpoVG was identified as having some role in the regulation of capsule 
gene esxA in Staphylococcus aureus, although the mechanism of action remained unclear 
(170-173). While this work was in progress, two studies provided further insight into the 
mechanism of how SpoVG regulates gene expression. One study demonstrated that S. 
aureus SpoVG bound to DNA with a higher affinity when phosphorylated (174). Another 
study demonstrated that L. monocytogenes SpoVG bound to RNA with a higher affinity 
than either double-stranded or single-stranded RNA (175). 
Studies from the Stevenson lab on the regulation of the outer surface protein VlsE 
identified SpoVG as binding to DNA. This was the first time a function had been ascribed 
to any SpoVG homologue. The same study demonstrated that SpoVG from Listeria 
monocytogenes and S. aureus also bind DNA (164). We hypothesized that SpoVG acts as 
a regulator in B. burgdorferi, and that SpoVG itself is regulated. The studies in this work 
aim to understand regulation of SpoVG by B. burgdorferi as well as what impact SpoVG 
has on the cell. 
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Figure 1.1 Enzootic cycle of Borrelia burgdorferi 
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CHAPTER 2. MATERIALS AND METHODS 
2.1 Media and Stock Solutions 
BSK-II     1L 
ddH2O      750 ml 
CMRL (w/o glutamine) ThermoFisher 9.7 g 
Neopeptone     4.18 g 
Probumin     41.7 g 
 
*Let stir to dissolve Probumin/Neopeptone (~20 min) 
 
HEPES     5.0 g 
Sodium Citrate    0.575 g  
Glucose     4.175 g 
Tc yeastolate (BD Biosciences)  1.68 g 
Pyruvic acid     0.668 g 
N-acetyl-D-glucosamine   0.333 g 
Sodium bicarbonate    1.833 g 
 
Add to media, let stir 20 min. pH to 7.6, QS to 1 L with ddH2O. Filter through 0.45 µm, 
fitted with extra filter. Filter through 0.2 µm filter. Move into hood, aliquot 94 ml into 100 
ml sterile glass bottles. Store at -20° C until needed. When ready to use, thaw one 94 ml 
bottle of BSK, and add 6 ml rabbit serum (Gibco) (final concentration 6% vol/vol). This is 
complete BSK. 
 
BSK-II 1.5x for plates    1 L 
Probumin     83.25 g 
CMRL      14.6 g 
Neopeptone     8.33 g 
HEPES     9.99 g 
Citrate, Sodium    1.22 g 
Glucose     8.33 g 
Pyruvic acid     1.33 g 
N-acetyl-glucosamine (NAG)   0.67 g 
Sodium Bicarbonate    3.66 g 
TC yeastolate     4.23 g 
 
Adjust pH to 7.5 with NaOH (takes a lot) stir slowly for minimum 3 hours 
Filter sterilize through 0.45 µm then 0.2 µm filter. Aliquot 100 ml into a 400 ml bottle. 
Store at -20° C.   
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LB Broth     500 ml 
Tryptone     5.0 g 
Yeast extract     2.5 g 
NaCl      5.0 g 
** QS to 500 ml with ddH2O, autoclave 
 
 
LB Agar     500 ml 
Tryptone     5 g 
Yeast extract     2.5 g 
NaCl      5 g 
Agar (1.5% w/vol)    7.5 g 
**QS to 500 ml with ddH2O, autoclave, cool to 55° C in water bath, add antibiotic, mix by 
swirling. Pour plates, allow to dry for 24 hours upright, in a single layer, store at 4° C.  
 
 
Super Broth (SB)    1 L 
Tryptone     32 g 
Yeast      20 g 
NaCl      5 g 
** QS to 1 L with ddH2O, autoclave 
 
 
SOC      200 ml 
Bacto-Tryptone    4 g 
Bacto-Yeast     1 g 
NaCl      0.117 g 
KCl      0.037 g 
** QS to 200 ml with ddH2O, autoclave 
 
 
Antibiotics  Stock conc.  Working/c. E. coli  W/c B.b 
Ampicillin  10 mg/ml  50 µg/ml      
Carbenicillin  10 mg/ml  50 µg/ml 
Chloramphenicol 34 mg/ml  34 µg/ml 
Gentamicin  3 mg/ml  15 µg/ml   150 µg/ml 
Kanamycin  10 mg/ml  50 µg/ml   20 µg/ml 
Streptomycin  10 mg/ml  50 µg/ml   100 µg/ml 
 
 
PBS (Phosphate Buffered Saline)  500 ml 
NaCl      4 g 
KCl      0.1008 g 
NaH2PO4     0.557 g 
KH2PO4     0.10 g 
**pH to 7.4, QS to 500 ml with ddH2O. Autoclave. 
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EPS (Electroporation Solution)  500 ml 
Sucrose      46.5 g 
50% glycerol     150 ml 
**QS to 500 ml, with ddH2O Filter sterilize with 0.2 µM filter, store at 4° C.  
 
 
Magne-His Washing/Binding buffer 1 L 
HEPES  100mM    23.883 g 
Imidazole 100mM    6.8 g 
NaCl 100 mM     5.85 g     
 
 
Magne-His Elution buffer   100 ml 
HEPES 100mM    2.383 g 
Imidazole 1M     6.8 g    
 
 
EMSA Buffer     1 L 
50% Glycerol     200 ml 
0.5M EDTA     2 ml 
PMSF (phenylmethylsulfonyl fluoride) 1 ml 
1M Tris pH 7.5    50 ml 
Tween-20     100 µl 
KCl      3.72 g 
DTT (dithiothreitol)    0.154 g 
**QS to 1 Liter with ddH2O, cool to 4° C for dialysis. Freeze 2 ml aliquots at -20° C for 
EMSA protocol. 
 
 
EMSA 3xEO Buffer    10 ml 
Tris-HCl 1M pH 8.0    1.5 ml 
0.5M EDTA     60 µl 
DTT 100mM     200 µl 
Protease inhibitor (ThermoFisher)  240 µl 
Phosphatase inhibitor (ThermoFisher) 60 µl 
50% glycerol     6.0 ml 
ddH2O      1.84 ml 
 
 
TBS-Tween     16 L 
1 M Tris pH 7.5    320 ml 
5 M NaCl     480 ml 
Tween-20     8 ml 
Sodium Azide     3 g 
**QS to 16 L with ddH2O, and store at room temperature. 
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20x Transfer buffer    3 L 
Na2PO4 dibasic    181 g 
NaPO4 monobasic    31 g 
**QS to 3 L with ddH2O, store at room temperature. 
 
 
SDS loading buffer    1 L 
0.5 M Tris pH 7.5    1.0 ml 
ddH2O      1.0 ml 
glycerol     1.5 ml 
2-mercaptoethanol    0.8 ml 
10% SDS     3.2 ml 
0.1% (w/v) Bromophenol Blue  0.4 ml 
**Combine in 15 ml Conical tube, store 4° C. 
 
 
4x Resolving buffer for SDS-PAGE 150 ml 
Tris Base     27.2 g 
ddH2O      100 ml 
**pH to 8.8, QS to 150 ml with ddH2O. Filter sterilize, store at 4° C. 
 
 
4x Stacking buffer for SDS-PAGE  150 ml 
Tris Base     9.1 g 
ddH2O      100 ml 
** pH to 6.8, QS to 150 ml with ddH2O. Filter sterilize, store 4° C. 
 
 
EMSA Blocking buffer   1 L 
NaCl      7.3 g 
Na2HPO4     2.4 g 
NaH2PO4     1 g 
Sodium dodecyl sulfate (SDS)  50 g 
**QS to 1 L with ddH2O. Store in fridge. Warm to 55°C in water bath before use. 
 
 
5x TBE     1 L 
Tris Base     54 g 
Boric acid     27.5 g 
0.5 M EDTA pH 8.0    20 ml 
**QS to 1 L with ddH2O. 
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5x SDS Buffer for Protein gels  1 L 
Tris base     15 g 
Glycine     72 g 
SDS      5 g 
**QS to 1 L with ddH2O. 
 
 
Coomassie Blue stain   500 ml 
MeOH      200 ml 
ddH2O      200 ml 
glacial acetic acid    30 ml 
Coomassie brilliant blue G250  0.8 g 
 
   
Coomassie de-stain solution   1 L 
ddH2O      400 ml 
MeOH      500 ml 
Glacial Acetic acid    100 ml 
 
 
EMSA loading dye      
Ficoll      15% (w/v) 
Orange G     0.4% (w/v) 
 
 
Nucleotide extraction buffer  1 ml 
MeOH      400 µl 
Acetonitrile (MS grade)   400 µl 
ddH2O      200 µl 
Formic Acid     0.1 M  
 
Pro-Q De-stain    1 L 
1M Sodium acetate pH 4.0   50 ml 
ddH2O      750 ml 
Acetonitrile (molecular grade)  200 ml 
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2.2 Bacterial Cultivation 
Borrelia burgdorferi was grown in complete BSK-II medium, unless otherwise 
stated. B. burgdorferi grows much more slowly at 23°C than at 34°C, and as a result alters 
expression of numerous genes when grown at this temperature. For this reason, B. 
burgdorferi is occasionally cultured at 23°C in order to serve as a mechanism to perturb its 
growth.  
In order to alter growth rate without altering temperature, two different deficient 
media were used, while culturing the bacteria at 34°C. One deficient medium consists of 
BSK-II that contains only 1.2% rabbit serum (instead of the usual 6%). The second 
deficient medium consists of 25% BSK-II diluted with PBS, but with the usual 6% rabbit 
serum. 
In order to assess the effect of glycerol on growth rate, two different medias were 
used. In the first, glycerol was added to complete BSK-II medium to a final concentration 
of 4% (v/v). A simplified culture medium, BSK-Lite, contains all components of complete 
BSK-II except for glucose. Bacteria grow in BSK-Lite to a final density that is 
approximately 1 log10 lower than that achieved in complete BSK-II. This media was also 
complemented with either 0.4% glucose (w/v) or 0.4% glycerol (v/v).  
Bacteria were aliquoted in individual stocks supplemented with 10% dimethyl 
sulfoxide (DMSO), and stored at -80°C until needed. To recover from frozen stocks, 500 
µl of thawed bacterial stock was passaged into 5 ml fresh BSK-II at 34°C, and allowed to 
grow for a minimum of three days. Bacteria were visualized by dark field microscopy for 
density and movement, passaged 1:100 into fresh media, allowed to grow to mid-
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exponential phase (approximately 107 bacteria/ml, which takes approximately 3 days), and 
then diluted 1:100 into fresh media for experiments.  
E. coli was grown using either LB broth or on LB agar plates unless otherwise 
noted, with appropriate antibiotic as needed. Following transformation of E. coli with 
plasmids, bacteria were recovered in SOC broth. For plasmid purification, bacteria were 
grown overnight in Super Broth. For protein expression, bacteria were grown in Super 
Broth (SB). E. coli stocks were made by diluting mid-exponential phase culture 1:2 with 
50% glycerol and maintained at -80°C. To recover from frozen stocks, a small scraping 
from the frozen stock was used to inoculate 50 ml LB with the appropriate antibiotic, and 
incubated at 37° C with shaking overnight. 
2.3 Isolation of individual Borrelia burgdorferi colonies 
Individual colonies of B. burgdorferi were isolated using BSK-II agarose plates. 
Agarose for the plates was prepared in the following manner. The percentage of agarose 
used is fairly high, since B. burgdorferi is highly motile. This ensures small, tight colonies 
that are easily distinguishable from one another. A 2.25 g molecular grade agarose (DO 
NOT USE LOW-MELT AGAROSE) was added to 80 ml ddH2O, and autoclaved for 30 
minutes. Next, 8 ml 5% (w/v) sodium bicarbonate was filter sterilized. While the agarose 
was autoclaving, one 100ml bottle of BSK-II 1.5x and 12 ml rabbit serum was thawed in a 
55° C water bath. Thawed BSK, rabbit serum, and sodium bicarbonate were mixed together 
using aseptic technique and returned to the water bath. After autoclaving, the agarose was 
gently mixed by swirling, and allowed to equilibrate in the 55° C water bath for 30 minutes. 
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All of the agarose was added to the BSK under the hood, then returned to the water 
bath for 20 minutes. Under the culture hood, 15 ml of BSK-agarose mixture was added to 
each plate, and the BSK returned to the water bath. Plates were allowed to solidify for 1 
hour. When ready to pour the second layer, 15 ml BSK-agarose was added to a sterile 
conical tube using a sterile pipette. 5 µl B. burgdorferi culture was added to the tube, gently 
mixed, then poured on top of a plate with a solidified layer of BSK-agarose. Plates were 
allowed to set for 1 hour at room temperature. Plates were incubated agar-side-up at 34° C 
with 3% CO2. A pan with ddH2O was placed in the bottom of the incubator to prevent the 
plates from drying out. Plates were incubated for approximately 2 weeks. Individual 
colonies were picked out with a sterile pipette tip, under the hood, and cultured in fresh 
BSK-II media.  
2.4 Growth Curves 
Borrelia burgdorferi cell density was assessed by enumerating cells/ml using a 
Petroff-Hauser counter under darkfield microscopy. A 5 µl culture, either undiluted, or 
diluted with PBS to an appropriate amount was added to the counter, and a cover slip 
carefully placed, resting on both edges of the counting frame. Four counting fields (each 
contain 16 large squares) were counted. To calculate the cell/ml density, the number from 
all four fields was averaged, multiplied by the dilution factor, and then multiplied by 50,000 
as indicated by the manufacturer. Cells were counted once every 24 hours for cultures 
grown at 34° C, or once every 72 hours for cultures grown at 23° C, or cultures grown at 
34° C in BSK + 1.2% rabbit serum and 25% BSK + 6% rabbit serum.  
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For the study using the chA1 and cheA2 mutants, the change in media color 
(acidification) was used as a proxy for growth rate. Cultures were set up in 5 ml screw-cap 
tubes as previously described, and analyzed in triplicate once every 24 hours. 150 µl culture 
was placed in the well of a 96-well culture plate. Three samples from each culture were 
taken for analysis. The plate was covered with an optically clear film, and read in a 
spectrophotometer set to read absorbance at 562 nm and 630 nm. The ratio of nm 562/630 
was calculated for each well, and plotted for all cultures across 4 days. 
2.5 Plasmid Construction 
All plasmids were first cloned and transformed into E. coli DH5a. Plasmids were 
purified and sequenced for accuracy, then electroporated to B. burgdorferi.  Plasmids were 
constructed either by Gibson assembly or restriction digest. 
 For Gibson cloning, oligonucleotide primers were designed to amplify both the 
plasmid backbone and the insert to be cloned. Each primer contained ~ 20 nucleotides that 
overlapped with its complementary primer. Each fragment was amplified using Expand 
High Fidelity polymerase (Sigma Aldrich). PCR products were run on a gel and purified 
using the WIZARD DNA clean-up kit (Promega). DNA fragments were mixed with 
isothermal assembly mix (NEB) and incubated for 60 minutes at 50° C. The mixture was 
then transformed into DH5a cells.  
 For cloning by restriction digest, the plasmid was digested with appropriate 
enzymes overnight at 37° C. DNA was extracted with phenol and chloroform, then briefly 
precipitated with ethanol. DNA pellets were briefly washed with 70% ice-cold ethanol. 
Pellets were allowed to dry before resuspending in ddH2O. Plasmid and insert DNAs were 
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ligated together in 20 µl reactions with 4 µl 5x buffer, and 1 µl ligase. Mixtures were 
incubated for 1 hour at 37° C, then transformed into chemically competent E. coli.  
2.6 Transformation of Bacteria with Foreign DNA 
E. coli transformations were performed as follows: chemically competent cells 
(NEB) were thawed on ice and incubated with cloned products for 30 minutes, on ice. The 
cells were heat shocked at 45° C for 30 seconds, returned to ice, and 1 ml SOC media was 
gently added. The cells were allowed to recover for 1 hour at 37° C, then aseptically plated 
on LB Agar with appropriate antibiotic, and incubated agar-down overnight at 37° C.  
E. coli electroporations were carried out in the following manner. A tube containing 
10 ml LB with appropriate antibiotic was inoculated with a scraping of E. coli glycerol 
stock, and incubated overnight at 37° C with shaking. The following morning, a fresh 10 
ml LB culture was inoculated 1:100 with the overnight culture, and incubated at 37° C with 
shaking until the OD reached between 0.3 and 0.5. Cells were harvested by transferring 2 
ml culture into a 2 ml microfuge tube, and centrifuging at 14,000 RPM (24 x 1.5/2.0 ml 
rotor-ThermoFisher) for 15 minutes. The supernatant was removed, and cells gently 
washed with 500 µl ice cold autoclaved ddH2O. Cells were centrifuged for 10 minutes at 
10,000 RPM (24 x 1.5/2.0 ml rotor-ThermoFisher), washed with 500 µl ice cold ddH2O, 
and centrifuged for 10 minutes at 10,000 RPM (24 x 1.5/2.0 ml rotor-ThermoFisher). Cells 
were gently resuspended in 50 µl ice cold ddH2O, and 5 µl plasmid DNA was added. The 
mixture was transferred to a 1 mm electroporation cuvette, and placed into the cuvette 
bridge attached to a BioRad MicroPulser Electroporater with the following settings: charge 
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1.8kV, resistance 200 ohms, 25 µF. Both buttons of the electroporator were pushed 
simultaneously until the buzz could be heard. The contents of the cuvette were transferred 
to 250 µl SOC broth without antibiotic, and incubated in a heat block at 37° C for 30-45 
minutes. Cells were then plated on an LB agar plate with antibiotic and incubated at 37° C 
overnight.   
B. burgdorferi electrocompetent cells were prepared as follows: A 100 ml B. 
burgdorferi culture was grown to mid-log phase (about 5.0 x 107 cells/ml). Cells were 
harvested in a sterile centrifuge tube 6,000 rpm in a JA-17 fixed angle rotor for 10 minutes. 
The culture medium was decanted, and cells very gently resuspended in 10 ml ice-cold, 
filter-sterilized PBS, then transferred to a sterile 50 ml “oakridge” centrifuge tube. Cells 
were spun at 10,000 rpm for 10 minutes in a JA-10 fixed angle rotor, the supernatant 
removed, and bacteria resuspended in 10 ml ice-cold, filter-sterilized EPS. Cells were 
gently resuspended by swirling the oakridge tube (not shaken or vortexed). Cells were spun 
at 10,000 rpm in a JA-10 fixed angle rotor for 10 minutes, EPS removed, and 10 ml EPS 
added. Cells were gently resuspended as before. Cells were spun 10,000 rpm in a JA-10 
fixed angle rotor for 10 min, EPS removed, and cells resuspended in 500 µl EPS. Aliquots 
were made with 50 µl of cells, then either electroporated right away, or stored at -80° C for 
later use.  
10 µl DNA (as concentrated as possible (at least 200 ng/µl, ideally greater than 1 
µg/µl) was added to a 50 µl aliquot of electrocompetent cells, and allowed to incubate on 
ice for 10 min. Cells were added to an electroporation cuvette with a 2mm gap, and placed 
into the cuvette bridge attached to a BioRad MicroPulser Electroporater set to charge 
2.5kV, resistance 200 ohms, 25 µF.  Both pulse buttons were pushed simultaneously until 
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a continuous beep was heard. Under the hood, about 200 µl BSK-II without antibiotic was 
added to the cuvette with a Pasteur pipette. Media was gently mixed up and down over the 
sides of the cuvette to ensure all the cells were taken up, then inoculated into 5 ml BSK-II. 
Cells were allowed to recover overnight before the appropriate antibiotic was added. Cells 
were allowed to grow for up to 4 weeks, and checked for the presence of living cells. If 
live cells were found, they were passaged 1:100 into fresh BSK-II plus antibiotic, allowed 
to grow to log-phase, then passaged 1:100 again.  
To confirm the cells had taken up the DNA of interest, and had not spontaneously 
developed resistance to the antibiotic used, a 1 ml aliquot of cells from the second passage 
was harvested by centrifugation for 10 minutes at 10,000 RPM (24 x 1.5/2.0 ml rotor-
ThermoFisher). Cells were washed 2x with PBS, then lysed in 100 µl water, and boiled 10 
minutes. Cell debris was removed by centrifuging at 15,000 RPM (24 x 1.5/2.0 ml rotor-
ThermoFisher) for 1 minute. 1µl of the supernatant was used as the DNA template for 
confirmatory PCR.  
2.7 Colony PCR 
Colonies from E. coli transformations were screened for the presence of the correct 
plasmid with the correct insert in the following manner. First, 0.6 ml microfuge tubes were 
labeled with a number 1- X, where X stands for the number of colonies to be screened. 50 
µl ddH2O was added to each one. An LB plate made with the appropriate antibiotic was 
prepared by drawing a grid on the bottom of the plate with a sharpie. Each box on the grid 
was labeled with a number 1- X. Using an autoclaved toothpick, a single bacterial colony 
was picked up, being careful not to gauge the agar, swirled in the 50 µl ddH2O, then spread 
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on the corresponding box on the LB reference plate. Once all of the colonies were prepared, 
the plate was placed in the 37° C incubator, and the tubes with water and bacteria were 
boiled for 10 minutes in a heat block. After boiling, the tubes were centrifuged for 1 minute 
at max speed. 10 µl PCR reactions were set up. A master mix was prepared that included 
Water, Taq buffer, dNTPs, forward and reverse primers, and Taq polymerase. 9 µl of the 
master mix was pipetted into each PCR tube, then 1 µl DNA (from the picked colonies) 
was added to the corresponding tube. After amplification in the thermocycler, 2 µl loading 
dye was added to each PCR mix, then run on an agarose gel, stained with Ethidium 
bromide, and imaged on a UV transilluminator.  
2.8 Recombinant Protein Purification 
Day 1: Prepare overnight culture 
A culture of E. coli Rosetta II transformed with plasmid pCRS2 was inoculated into 
SB media with appropriate concentrations of carbenicillin and chloramphenicol, and grown 
overnight at 37° C with shaking.  
Day 2: Protein induction 
The following morning, two 1 L cultures of SB were each inoculated with 10 ml of 
the overnight culture and appropriate antibiotics. Cultures were grown for 4 hours at 37° C 
with shaking, then induced with 1 mM isopropyl-beta-D-thiogalactoside (IPTG) (final 
concentration) for 2 hours. Cells were harvested by centrifugation for 20 minutes at 6,000 
RPM in a JA-17 fixed angle rotor. Supernatant was removed, cell pellets scraped into a 
single centrifuge tube, and stored at -80° C overnight.  
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Day 3: Protein purification 
The following day, the cell pellet was thawed and resuspended in 50 ml ice-cold 
washing/binding buffer. The mixture was transferred to a 100 ml flask, with 2 ml Bper 
lysis (Thermo Fisher) buffer added. Cells were lysed by sonication at amplitude 20% 15 
seconds on, 30 seconds off until solution turned a milky color (approximately 10-15 
cycles). Solution was stirred in between each sonication. Lysed cells were then centrifuged 
at 15,000 RPM in a JA-10 fixed angle rotor for 30 minutes to separate the soluble proteins 
from the insoluble fraction.  
Following centrifugation, lysate was poured over 1 ml Magne-His beads (Promega) 
in a 50 ml conical tube and incubated at 4° C for 1 hour while rocking. The conical tube 
was placed in a magnetic holder and rocked at 4° C for 15 minutes to allow the beads to 
adhere to the side of the tube. While the conical tube was still in the magnetic holder, the 
lysate was poured off, and 40 ml washing/binding buffer added. The conical tube was taken 
out of the magnetic holder, gently shaken to mix the beads, then incubated for 15 minutes 
at 4° C, while shaking. The conical tube was placed back in the magnetic holder for 5 
minutes at 4° C, while shaking. The washing steps were repeated 3 more times.  
Finally, after the fourth washing/binding buffer had been removed, the conical tube 
was taken out of the magnetic holder, placed in ice, and 1 ml of washing/binding buffer 
was used to wash the beads down the side of the tube. The beads were transferred to a 2 ml 
microfuge tube, placed in a magnetic holder, and rocked to allow the beads to adhere to the 
side of the tube. The Washing/binding buffer was removed. 1 ml Magne-His elution buffer 
was used to wash any remaining beads from the 50 ml conical tube, added to the 2 ml 
microfuge tube with the remaining beads, gently shaken to mix the beads, then incubated 
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at 4° C, while shaking for 5 minutes. The microfuge tube was placed in the magnetic holder, 
and the elution buffer was carefully removed, and placed in a clean 2 ml microfuge tube, 
on ice. The elution steps were repeated 3 more times. 1 small section of dialysis Snakeskin 
membrane (Thermo-Fisher) was cut, and sealed closed on both ends with plastic green 
clips, and allowed to rehydrate in 1 L EMSA buffer at 4° C. One clip was removed, all 4 
mls of elution were added to the snakeskin, the clip returned to seal the dialysis bag, and 
placed in the EMSA buffer at 4° C overnight to dialyze.  
Day 4: Concentrate protein, and measure concentration by BCA assay 
Dialysis membrane was carefully opened by removing one of the clips, and contents 
transferred to 2 ml microfuge tubes pre-chilled on ice. Microfuge tubes were centrifuged 
at 15,000 RPM (24 x 1.5/2.0 ml rotor-ThermoFisher) at 4° C for 1 minute to remove any 
residual beads or aggregated protein. Supernatant was transferred to fresh 2 ml microfuge 
tubes, chilled on ice. Contents were then transferred to a centrifuge concentrator, size 
10,000 Kda for rSpoVG. Protein was concentrated to a total of 200-500 µl, aiming for a 
NaonoDrop reading of greater than 1mg/ml concentration. Protein was aliquoted by 15 µl 
into either PCR tubes or 600 µl Microfuge  tubes and flash frozen in liquid nitrogen. Protein 
aliquots were store at -80° C until needed.  
Protein concentration was measured using a Micro BCA kit (Thermo Scientific). 
Purified rSpoVG was diluted 1:10 and 1:100 in ddH2O, and all of the standards were 
diluted in ddH2O as well. The working range of the kit is 2-40 µg/ml. Use of the two 
different dilutions was to ensure that one of them fell within the range that can be accurately 
measured. 
Standards were prepared as follows: 
28 
 
 
Vial  ddH2O  Volume of bovine serum albumin (BSA)Final concentration 
A  900 µl  100 µl (2 mg/ml stock)  200 µg/ml 
B  1200 µl 300 µl of vial A   40 µg/ml 
C  800 µl  800 µl of vial B   20 µg/ml 
D  800 µl  800 µl of vial C   10 µg/ml   
E  800 µl  800 µl of vial D   5 µg/ml   
F  800 µl  800 µl of vial E   2.5 µg/ml 
G  960 µl  640 µl of vial F   1 µg/ml 
H  800 µl   800 µl of vial G   0.5 µg/ml 
I  500 µl  0     0 ug/ml 
Prepared the working solution by mixing 5 ml Reagent A with 4.8 ml Reagent B and 200 
µl Reagent C in a reservoir for multi-channel pipettes. 150 µl of each standard and purified 
protein was pipetted into a microplate well. Technical triplicates were set up for all 
standards and purified proteins. Using a multichannel pipette, 150 µl of the working 
solution was added to each well and mixed by carefully pipetting up and down without 
introducing bubbles. The plate was covered and incubated at 37° C for 2 hours. The plate 
was read on a spectrophotometer by measuring the absorbance at 562 nm. A standard curve 
was generated in Prism 6 using a best-fit polynomial equation (nonlinear equation). From 
this, the concentration of the purified proteins was derived.  
2.9 RNA Extraction 
RNA was purified from B. burgdorferi cells in the following manner: 
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B. burgdorferi was inoculated 1:100 into fresh media (typically 5 ml) and grown to mid-
log phase unless otherwise noted. Cells were harvested by centrifugation for 10 minutes, 
4° C, 15,000 RPM in a JA-17 fixed angle rotor. The culture media was decanted, and cell 
pellets gently resuspended in 1ml PBS by carefully flicking the centrifuge tube. Cells were 
transferred to 1.6 ml Microfuge tube and centrifuged for 10 minutes at 4° C, 10,000 RPM 
(24 x 1.5/2.0 ml rotor-ThermoFisher). The supernatant was removed, 1ml Trizol added to 
the cell pellet, and incubated at 70° C for 10 minutes. Trizol-lysates were stored at -80° C 
until further use.  
Trizol-lysed cells were thawed on ice, then 200 µl 1-Bromo 3-Chloropropanol was 
added, tube shaken (not vortexed) and incubated 3 minutes at room temperature. Tubes 
were centrifuged for 15 minutes at 4° C, 12,000 RPM (24 x 1.5/2.0 ml rotor-
ThermoFisher). Taking care not to disturb the separated phases, the aqueous phase was 
transferred to a fresh RNAse-free microfuge tube. 500 µl Isopropanol was added, tubes 
shaken, then incubated for 10 minutes at room temperature. Tubes were centrifuged for 10 
minutes at 4° C, 12,000 RPM (24 x 1.5/2.0 ml rotor-ThermoFisher). Liquid was removed, 
taking care not to disturb the small white pellet. The pellet was washed by pipetting 1 ml 
of 75% EtOH, without dislodging the pellet. Tubes were centrifuged for 10 minutes at 4° 
C, 12,000 RPM (24 x 1.5/2.0 ml rotor-ThermoFisher). Liquid was carefully removed, and 
pellets allowed to dry by propping the tubes upside-down (with the lids open) on kimwipes.  
RNAsecure (Roche) was preheated for 10 minutes at 60° C. RNA pellets were 
suspended in 20 µl RNA secure, and incubated for 10 minutes at 60° C. 
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DNAse treatment 
10x DNase buffer and the inactivation reagent were thawed on ice. 2.5 µl DNase 
buffer was added to each tube, then 3 µl DNaseI (Roche) was added. Tubes were incubated 
for 30 minutes at 37° C. Tubes were then placed on ice, and DNase inactivation reagent 
was vortexed. 10 µl DNase inactivation reagent was added to each tube, and briefly 
vortexed. Tubes were incubated for 2 minutes at room temperature. Tubes were then 
centrifuged for 5 minutes at 4° C, 5,000 RPM (24 x 1.5/2.0 ml rotor-ThermoFisher). The 
top phase containing the RNA (clear, not opaque), was transferred to fresh RNAse-free 
microfuge tubes.  
Assessing RNA purity 
RNA integrity was analyzed using an Agilent 2100 Bioanalyzer following the RNA 
6000 Nano Kit protocol (Agilent technologies).  
Preparing cDNA libraries 
20 µl reactions were set up to make cDNA using the iScript cDNA synthesis kit 
from BioRad. Each reaction contained 4 µl of 5x iScript cDNA buffer, ~500 ng RNA, 1 µl 
Reverse transcriptase and RNase-free H2O. No Reverse Transcriptase controls (no-RT) 
were set up to set for DNA contamination. These reactions contained 2 µl RNA and 18 µl 
RNAse-free H2O. Reactions took place in a thermocycler, programed for 5 min at 25° C, 
20 min at 46° C, 1 minute at 95° C. 
cDNAs were then diluted 1:100 in nuclease-free water for analysis by qRT-PCR.  
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2.10 Quantitative Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR) 
qRT-PCR reactions were set up in 96 well plates for thermocycle analysis 
(BioRad). The first reaction used primers for flaB, and analyzed all samples, including the 
no-RT controls. If flaB did not amplify in the no-RT controls, they were not included in 
subsequent analyses. Each reaction contained the following: 
5.0 µl   Sybr Green Master Mix (BioRad) (Sybr Green, polymerase, buffer) 
0.125 µl Primer 1 
0.125 µl  Primer 2 
2.75 µl  Nuclease-free water 
2.0 µl   cDNA 
The Sybr Green master mix was covered in aluminum foil and thawed on ice.  
A master mix was made containing the Sybr Green Master Mix, both primers and water. 
Enough was made for each cDNA to be analyzed in triplicate. Working quickly, but 
carefully, 8 µl was pipetted into each well. Then 2 µl cDNA was added to each well. The 
plate covered in a clear plate cover (BioRad), and centrifuged for 5 minutes at 4° C, 2,000 
RPM (24 x 1.5/2.0 ml rotor-ThermoFisher) to ensure the mixture was situated in the bottom 
of the well. The plate was then placed in the BioRad light cycler, and set for the following 
parameters: 
95° C  2:00 minutes 
95° C  0:05   minutes 
60° C  0:30  minutes 
X 40 cycles 
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Next, the plate was set up in the software, with all variables input into the correct 
well. The sample, the gene targeted, and whether the sample was unknown or a no-RT 
control. The technical replicates were grouped together so that the standard deviation for 
them could be calculated. 
qRT-PCR Analysis 
Data from the Thermocycler run was checked for quality control in the following 
manner. First, the Relative fluorescent units (RFUs) should be in the10,000-99,000 range. 
If the maximum RFUs of a run are in the hundreds or low thousands, that suggests that 
either the Sybr Green or polymerase is no longer active. The entire assay should be re-run 
using a fresh vial of the Sybr Green Master Mix. Next, the standard deviation for each 
technical replicate was checked, to ensure that all were less than 0.3. High standard 
deviations are an indication of poor pipetting, which will introduce a high amount of error 
into the calculations. Finally, the quantification cycle (Cq) of all flaB amplifications were 
analyzed to ensure that all samples were within just a few Cqs of each other, and that they 
fell between a range of 17-22 Cqs. If too much or too little cDNA is loaded, this can also 
introduce a high amount of error.  
Once the data were checked for quality control, and flaB from the no-RT samples 
did not amplify, all other genes of interest were run. After all data were collected, the flaB 
Cq was subtracted from each gene of interest for all samples. This is termed as DCq. In 
order to ascertain whether a particular gene was differentially expressed in one strain of B. 
burgdorferi versus another, t-tests were performed on the difference in DCq between one 
strain (or condition) and another.  The difference in DCq between one strain (or condition) 
and another is also termed the DDCq. The measurement can also be used to ascertain 
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whether the difference in expression of a particular gene is different between different 
strains or conditions. The data were plotted using the GraphPad Prism software. 
2.11 Western Blotting 
Lysates for Western Blots were prepared in the following way. B. burgdorferi were 
grown to mid-log phase, unless otherwise stated, and cells harvested by centrifugation for 
10 minutes at 4° C, 15,000 RPM in a JA-10 fixed angle rotor. Supernatant was poured off, 
and pellet allowed to dry briefly by propping the centrifuge tube upside down for about 5 
minutes. PBS (1 ml) was added, and cells gently resuspended by flicking the bottom of the 
tube until the cell pellet was dislodged and broken up. The cells were then transferred to a 
1.6 ml microfuge tube, and centrifuged for 10 minutes at 4° C, 10,000 RPM (24 x 1.5/2.0 
ml rotor-ThermoFisher). Supernatant was removed and cell pellet dried using a Pasteur 
pipette fitted with a fresh sterile pipette tip attached to a vacuum hose. Cell pellets were 
stored at -80° C at least overnight, until ready to be used. Cell pellets were taken out of the 
-80° C freezer, and an aliquot of SDS loading buffer was added, and mixed by pipetting up 
and down. The amount of buffer used depended on the size and density of the initial culture. 
For 5 ml mid-log B. burgdorferi culture, 200 µl of SDS loading buffer was added. Whole 
cell lysates were boiled for 10 minutes, and stored at 4° C until further use.  
Making SDS-PAGE gels 
12.5% SDS polyacrylamide gels were prepared for protein separation, unless otherwise 
noted. To make 4 gels, the following was used: 
 Resolving Gel 
ddH2O     12.63 ml 
34 
 
 
Bisacrylamide    16.68 ml 
4x Resolving buffer   10 ml 
10% SDS    0.40 ml 
10% Ammonium persulfate  0.30 ml 
TEMED    0.10 ml 
 Stacking Gel 
ddH2O     6.0 ml 
Bisacrylamide    1.34 ml 
4x Resolving buffer   2.5 ml 
10% SDS    0.10 ml 
10% Ammonium persulfate (APS) 0.05 ml 
TEMED    0.05 ml 
All components of the resolving gel except the APS and TEMED were combined 
in a 50 ml conical tube. Four empty 1.5 ml cassettes were set up in a rack, with appropriate 
combs sitting to the side. The pipetman was fitted with a 25 ml glass pipette, and set to the 
side ready to pick up. Working carefully but quickly, the APS and TEMED were added. 
Without pipetting up and down, the solution was gently mixed by swirling the glass pipette 
around in the solution for 1-2 seconds. As much of the solution as will fit in the pipette was 
taken up, then each cassette filled up to the 3rd line. The cassette was sealed by placing the 
comb in the top, and solution allowed to polymerize at least 15 minutes. If any bubbles 
formed at the interface between the gel and air, they were popped by sliding the corner of 
a piece of paper down into the cassette, before the comb was placed. 
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Same steps were repeated for the stacking gel, although a 10 ml glass pipette was 
used, and the solution pipetted until the cassette just overflowed. When placing the combs, 
it was imperative not to introduced bubbles. Therefore, the comb was introduced at an 
angle, starting at one end of the cassette, and letting the comb fall/pushing it into the 
cassette from there.  
Running the gels 
Page Ruler-Plus (5 µl) was loaded into the first lane. Equal amounts of lysate were 
loaded into the subsequent lanes (measured by FlaB quantity). Generally, if the blot was to 
be probed for FlaB, 5 µl of lysate was used, since it is abundantly expressed. For probing 
of most other proteins, 10 µl was used. Gels were run at 200 volts for 50-60 minutes.  
Transferring proteins from gel to nitrocellulose membrane 
Gel cassettes were cracked open using a metal spatula, then the bottom ridge of the 
gel, and the stacking portion of the gel cut off. A plastic cassette was placed in a glass tray 
filled with 1x phospho-transfer buffer. One black sponge was placed on top of the black 
side of the cassette, then a piece of filter paper placed on top. Being careful not to touch 
the gel, it was transferred onto the filter paper, and the metal spatula was used to gently 
smooth out any bubbles. Using tweezers, 1 piece of nitrocellulose paper was placed on the 
gel, and bubbles smoothed out with the spatula. One piece of filter paper was placed on top 
of the nitrocellulose, then the other black sponge placed on top. Once again, the spatula 
was used to ensure there were no bubbles present. The plastic sandwich cassette was 
closed, and placed in the transfer rig (BioRad). The cassette was placed in the red/black 
holder arranged so the black side of the cassette faced the black side of the holder. An ice 
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pack was placed in the empty space, touching the black side of the holder. Proteins were 
transferred at 35 volts for 60 minutes.  
Blocking and Probing 
After the transfer was set up, 50 ml TBS-T was poured into a plastic holder, 2.5 
grams of non-fat milk added, and placed on a rocker so the milk could mix thoroughly 
during the transfer. Once the transfer was completed, the cassette was opened clear side 
up, as it is easier to peel the nitrocellulose membrane off the gel, than to peel the gel off 
the membrane. Using tweezers, the membrane was placed face-up (note the side that has 
the colored ladder) in the milk, and allowed to block at room temperature for 1 hour, while 
rocking.   
The milk was then poured off, about 10 ml of TBS-T was added, shaken vigorously, 
then poured off to remove most of the remaining milk. About 20 ml TBS-T was added, 
then allowed to wash for 5 minutes at room temperature, while shaking. TBS-T was poured 
off, fresh TBS-T was added, allowed to wash for 5 minutes at room temperature, while 
shaking. TBS-T was poured off, and primary antibody added. Primary antibodies were 
incubated for 1 hour, at room temperature, while shaking, unless otherwise noted. Primary 
antibodies were returned to their conical tube and stored at 4° C for future uses.  
  ***Note: antibodies were diluted in TBS-T, which has a small amount of 
sodium azide to help prevent mold from growing. If some mold does grow in the antibody, 
it will be evident by a western blot that has many bands that are recognized that shouldn’t 
have been, and splotches all over the blot. If this occurs, the antibody can be filtered using 
a 0.22 µm filter into a sterile conical tube.*** 
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After the primary antibody was removed, 10 ml TBS-T was added, and vigorously 
shaken for 5 seconds to remove the majority of the antibody. That TBS-T was poured off, 
20 ml TBS-T added, and allowed to wash for 10 minutes at room temperature while 
shaking. The TBS-T was poured off, 20 ml TBS-T added, and allowed to incubate for 10 
minutes at room temperature with shaking.  
Finally, the secondary reagent was added. Protein A-conjugated to HRP (horse 
radish peroxidase) was diluted 1:5,000 in TBS-T. The blot was transferred to a small plastic 
holder, 10 ml of secondary solution was added, and incubated for 1 hour at room 
temperature, while shaking.  
For use with the fluorescently tagged antibodies, the blot was transferred to a red 
box with lid. All antibodies were diluted in TBS-T, and 50 ml was used. IRD800/a-Mouse 
and IRD800/a-Rat were diluted 1:25,000, and IRD700/a-Rabbit was diluted 2:25,000. All 
were incubated for 1 hour at room temperature with shaking.  
All secondaries were washed in the same manner before imaging. The antibody was 
poured off (secondaries were not re-used), and a small amount of TBS-T was added, briefly 
shaken to remove excess antibody. 20 ml TBS-T was added, and allowed to wash for 10 
minutes at room temperature with shaking. This was poured off, fresh 20 ml TBS-T was 
added, and allowed to wash for 10 minutes at room temperature with shaking.  
Protein A was imaged in the following manner: 5 ml of Luminol and 5 ml of 
peroxide solution were added to the blot, and covered with tin foil. The blot was imaged 
by multiple exposures to x-ray film, which then developed.  
The IRD-conjugated antibodies were imaged directly after the last wash using the 
Li-Cor Odyssey. There is no password to login in to the computer. Once the Odyssey 
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software is opened, select new, then find your folder (Mine is named ‘Savage’ and saved 
to the desktop. All my files are named for the date on which they were imaged). Create a 
new file with the date. Select the blue arrow at the top of the screen. The user name is ‘user’ 
and the password is ‘user’. At this point, select the area of the blot on the grid, then check 
the appropriate channel, and ‘Preview’ to find the appropriate intensity. After the 
appropriate intensity is found, select ‘medium’ quality and ‘89’ resolution. Now click 
‘scan’ to generate a useable file. After the scan is complete, click ‘save’ after the file is 
saved, click ‘File’ -> ‘Export’ -> ‘Colorized TIF’ to generate a file that can be saved and 
read by imageJ and Photoshop. 
2.12 Creating Images 
All Files, whether scanned images of x-ray film, or digital files from BioRad or 
Odyssey were converted to black and white in ImageJ, and appropriately cropped. The file 
was saved as a TIF, then opened in Photoshop to add appropriate headings, etc. Final 
images for journals were assembled in photoshop, and always saved as TIF files. 
2.13 Electrophoretic Shift Assays (EMSAs) 
Electrophoretic mobility shift assays (EMSAs) were performed using nucleotides 
in one of the following manner. Unlabeled DNA imaged by staining with Gel Star (Lonza), 
labeled with biotin, and imaged with streptavidin conjugated to HRP, or labeled with a 
fluorophore, and imaged on either an Li-Cor Odyssey or BioRad Chemidoc. All methods 
will be described in detail below, but using nucleotide probes conjugated to a fluorophore 
(either Alexa488 or IRD800 work well) is the preferred method. No downstream transfer, 
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block, incubation with streptavidin, washing, etc steps are needed as with the biotin labeled 
probes: simply run the gel and image on either a Li-Cor Odyssey or BioRad Chemidoc 
right away. And these probes are far more sensitive when imaged than staining with Gel 
Star, meaning far less probe is needed, and binding kinetics can be measured far more 
accurately.  
Preparing the probes 
Both DNA and RNA probes were used in EMSAs. Initially, a large sequence was 
hypothesized to be bound by DNA. In this instance, primers were designed to amplify the 
whole region by PCR. At the stage of designing primers (ordered from Integrated DNA 
Technologies), molecules can be added to the 5’ ends. Only one primer was ordered with 
a modification. Long probes were generated by amplifying the region of interest using Q5 
high fidelity polymerase (NEB). The entire PCR product was run on an agarose gel and 
stained with ethidium bromide to ensure the correct size had been generated. The correct 
band was cut out and purified using a PCR clean-up Wizard kit (Promega).  
Once the binding region had been narrowed to less than 60 base pairs, 
complimentary oligos (one with a modification) were ordered of the exact size needed. 60 
base pairs was used as the cut off, as primers that are longer than 60 base pairs are far more 
expensive. These oligos were annealed together by combining in equal parts (30 µM final 
concentration) in a PCR tube, heated to 95° C for 5 minutes in a thermocycler, then allowed 
to slowly cool to room temperature (on the bench) for a minimum of 1 hour before using. 
Annealed probes were diluted to a concentration of 1-5 ng/µl for use in EMSAs. 
RNAs less than 60 base pairs, that contained the same nucleotide sequence as the 
DNA probes (albeit with uracil instead of thymidine) were also ordered, with a 
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modification on the 5’ end. RNAs were diluted to 100 µM using nuclease-free water. RNAs 
were further diluted (down to 25 nM – 5 µM), aliquoted in nuclease-free microfuge tubes 
and stored at -80° C.  
Setting up the reactions 
Protein aliquots and RNA aliquots (when applicable) were thawed on ice. For the 
probes modified with a biotin, 25 µl reactions were set up in the following manner. 
All reactions were set up in 0.6 ml microfuge tubes. Competitors were unlabeled, and 
diluted to 100x the concentration of the labeled probe. These either contained the same 
sequence as the probe (specific competitor) or a different sequence (non-specific 
competitor).  
The Master Mix contained 65.3 µl 3xEO buffer, 14 µl Poly-dI-dC (ThermoFisher), 
88.7 µl ddH2O. 
Master Mix  EMSA buffer  Protein  Probe  competitor 
11.5 µl   to final 25 µl  0-4 µl  1 µl  0-1 µl 
All reactions contained 11.5 µl Master mix and 1 µl Probe (either DNA or RNA, 
diluted to the appropriate amount). One reaction contained only master mix, EMSA buffer 
and probe. The next few also included protein, in increasing amounts. The next included 
protein as well as non-specific competitor. The next included protein as well as specific 
competitor. All reactions contained enough EMSA buffer to make the final total volume 
25 µl. All reactions were incubated at room temperature for 15 minutes.  
2.5 µl EMSA loading dye was carefully added to each reaction, which were then 
loaded into a 6% TBE precast gel (ThermoFisher) that had been pre-run for 30 minutes. 
Gels were run at 100 volts for 45-100 minutes, depending on the length of the probe. Gels 
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were set up in rigs designated and marked “For EMSA Only” to avoid contamination with 
SDS. 0.5x TBE was used as the running buffer.  
DNA was transferred to positively charged Nylon membrane (GE) in the following 
manner. Plastic cassettes were set up in a glass dish filled with 0.5x TBE. One black sponge 
was placed on the black side of the cassette, then a piece of filter paper placed on top. The 
gel was carefully transferred to the filter paper, and any bubbles gently removed using a 
metal spatula. The nylon membrane was placed on top of the gel, and the corner just above 
the top of the first loaded lane was cut, to help orient the membrane when imaging. Once 
again, bubbles were pushed out with the spatula. A piece of filter paper was placed on top 
of the membrane, with the other black sponge on top of that. Any bubbles were firmly 
pressed out with the spatula, then the cassette closed, and placed inside the cassette holder 
oriented so the black side of the cassette faced the black side of the holder. The holder was 
placed in the transfer apparatus oriented so the ice block is against the black side of the 
holder. Once both the cassette holder and the ice block were placed in the transfer 
apparatus, it was filled with the 0.5x TBE in the glass tray. A small layer of ice was placed 
in a large ice bucket, then the transfer apparatus placed in the ice bucket, and the ice bucket 
was packed full of ice. The transfer took place at 45 volts for 45 minutes.  
While the transfer took place, the blocking buffer and 4x Wash Buffer (stored at 4° 
C) was pre-warmed to 50° C in a water bath. After the transfer was complete, the membrane 
was transferred face up into a plastic box with 20 ml Blocking buffer, and incubated at 
room temperature for 15 minutes with gentle shaking. The blocking buffer was poured off, 
fresh 20 ml blocking buffer plus 70 µl streptavidin-HRP was added, and incubated at room 
temperature for 15 minutes with gentle shaking.  
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1x Wash buffer was prepared by mixing 40 ml 4x Wash buffer with 120 ml ddH2O. 
The streptavidin mixture was poured off, and about 40 ml of 1x Wash buffer was added, 
quickly shaken, then poured off to remove excess streptavidin. Approximately half of the 
remaining wash buffer was added, and incubated at room temperature for 10 minutes with 
gentle shaking. After the wash buffer was removed, the remaining wash buffer was added 
to the membrane, and incubated at room temperature for 15 minutes with gentle shaking.  
After the last wash buffer was removed, 30 ml of Equilibrium buffer was added, 
and quickly shaken. The equilibrium buffer was removed, and 6 ml of Luminol solution, 
and 6 ml Peroxide solution (ThermoFisher) were added to the membrane, and the box 
covered in aluminum foil to protect from light. The membrane, x-ray film and cassette were 
immediately developed.  
2.14 In Silico Proteomic Analyses 
The B. burgdorferi cyclic di-AMP synthase gene (termed cdaA), was identified and 
analyzed in the following manner. Using Blast-P, the B. burgdorferi B31 genome was 
searched against the c-di-AMP synthase from Chlamydia trachomatis (GenBank locus 
number YP_007715533). B. burgdorferi gene Bb_0008 was identified as a 
homologue. The predicted sequence of B. burgdorferi CdaA was aligned with sequences 
of other previously-defined c-di-AMP synthases: Bacillus subtilis CdaA (formerly YbbP, 
GenBank locus BAA19509), Listeria monocytogenes DacA (GenBank locus 
BN389_21520), Staphylococcus aureus (GenBank locus SAV2163), and C. trachomatis 
DacA (GenBank locus YP_007715533) using Clustal X.  
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2.15 Nucleotide Extraction and cyclic-di-AMP analysis in E. coli and B. burgdorferi 
For nucleotides extracted from E. coli, an overnight culture was grown in LB 
media. The next morning, cultures were diluted 1:1000 (2 µl into 2 ml) in fresh LB with 1 
mM IPTG. Cultures were grown for 3 hours, then cells were harvested by centrifuging at 
15,000 RPM (24 x 1.5/2.0 ml rotor-ThermoFisher) for 1 minute.  
For nucleotides extracted from B. burgdorferi, two 5 ml AG1 cultures were set up 
by diluting mid-log cultures 1:100. One culture contained 0.5 µg/ml ATc. Cultures were 
grown for 3 days, and harvested by centrifugation at 15,000 RPM (24 x 1.5/2.0 ml rotor-
ThermoFisher) for 15 minutes.  
Once the cells were harvested, the supernatant was removed, cell pellets 
resuspended in 1 ml ice cold extraction buffer (made the day before using) and transferred 
to a fresh 1.6 ml microfuge tube. Tubes were incubated at -20° C for 30 minutes, then 
centrifuged at 15,000 RPM (24 x 1.5/2.0 ml rotor-ThermoFisher) for 5 minutes to pellet 
cellular debris. The supernatant was transferred to a fresh 1.6 ml microfuge tube, and stored 
at -80° C until ready to ship. Samples were shipped on dry ice to Chris Waters at Michigan 
State University. c-di-AMP was quantified by ultra-performance liquid chromatography—
tandem mass spectrometry (UPLC-MS/MS) of equal volumes of each bacterial extract, and 
analyzed as previously described.  
2.16 RNA Sequencing and Analysis 
Wild-type, spoVG-ON, and DspoVG cultures were grown in triplicate to mid-log 
phase. Cells were harvested by centrifugation, the supernatant was removed, and cells were 
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gently resuspended in PBS. The supernatant was removed, and cells stored at -80° C until 
further use. Frozen cell pellets were shipped on dry ice to igenbio (Chicago IL) for RNA 
extraction, library preparation, and sequencing. 
RNA was extracted with Maxwell RSC simplyRNA Cells kit based on 
manufacturer's instructions. RNAseq libraries were prepared from total RNA utilizing the 
ScripSeq kit from Illumina, according to manufacturers instructions. 100ng of total RNA 
was used as input to the ribo-zero depletion reaction.  Following fragmentation and 
terminal tagging, the cDNA was subjected to 15 cycles of amplification.  Resulting 
amplified libraries were bead cleaned and pooled for sequencing on Illumina NextSeq at 
2x75 bp sequencing. 
2.17 MS/MS on SpoVG in cultured B. burgdorferi and recombinant protein 
Lysates were prepared from wild-type and spoVG-ON cultures grown at 34° C and 
23° C as described for western blots, and separated on a 12.5% SDS-PAGE gel. The gel 
was briefly stained with Coomassie, then thoroughly de-stained. Bands in each lane that 
ran just above the 10 kDa ladder were excised and given to the UK mass spectrometry Core 
Facility for analysis. Similarly, rSpoVG was incubated with either 1 µl EMSA buffer or 1 
µl of 1mM acetyl-phosphate at 37° C for 1 hour, and run on a 12.5% SDS-PAGE gel. 
Purified recombinant SpoVG that had been incubated at 37° C for 1 hour either with or 
without acetyl-phosphate was run on a 12.5% SDS-PAGE gel, and stained with Coomassie. 
The bands were excised and submitted to the mass-spectrometry core for analysis.  
Gel samples were treated with DTT, iodoacetamide (IAA), and digested with 
trypsin. The tryptic samples were filtered through a 0.22um PVDF filter and subjected to 
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LC-MS/MS analysis. Data dependent decision tree with ETD (DDDT) was applied. MS 
data sets were searched in MASCOT against a custom database containing only rSpoVG 
protein sequence. Dynamic Modifications including acetylation on lysine and 
phosphorylation on serine, threonine and tyrosine were used.  
2.18 In Silico Modeling of SpoVG Structure 
spoVG gene sequence was converted to protein sequence by Expasy Translate 
(https://web.expasy.org/translate/). The protein sequence was then fed into PHYRE2 
protein fold recognition server 
(http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index). SpoVGBb was modeled 
with greater than 90% onto the crystal structure 2IA9, which is the Bacillus subtilis 
subspecies subtillis strain 168 SpoVG (DOI: 10.2210/pdb2IA9/pdb). Both the Phyre2 
generated structure and structure 2IA9 were downloaded and opened using the PyMOL 
software (https://pymol.org/2/). Structures were over-layed on one another, and visualized 
using the ribbon structure. 
2.19 Mouse Infection Studies 
All animal procedures were approved by UK IACUUC. B31-A3, CS8, CS9, B31-
S9, and GK1 B. burgdorferi strains were grown to mid-log phase, and cells harvested by 
centrifugation at 10,000 x RPM (24 x 1.5/2.0 ml rotor-ThermoFisher) for 10 minutes. Cells 
were resuspended in PBS to a final concentration of 1 x 106 cells per 100 µl (verified by 
counting). Six female Balbc-J mice (JAX) were infected with each strain. Syringes (1 ml) 
were fitted with size 28 hollow needle, and filled with appropriately concentrated bacteria. 
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Mice were briefly anesthetized by placing them in a glass drop Jar filled with a bed of 
tissues. Heavy mineral oil (5 ml) and 5 ml Isoflurane were added just prior to addition of 
mice. Two mice were anesthetized at a time, just until they lost consciousness. Mice were 
infected by injecting 100 µl containing 1 x 106 bacterial cells into the peritoneum. Mice 
were then transferred to a fresh cage (3 mice per cage) and monitored to ensure they 
recovered completely, then returned to animal facilities. Mice were observed the following 
day to ensure they were all alive, and showing no signs of distress. After three weeks, mice 
were euthanized in the following manner. Mice were placed two at a time in a CO2 
chamber. 100% CO2 from a compressed chamber was introduced at a rate of approximately 
50% of container volume per minute. Mice were left in the chamber past the point that 
respiratory arrest had been noted. Mice were then removed from the chamber and 
decapitated.  
Blood was collected by removing the head, and draining the body over a centrifuge 
tube, and immediately spun max speed for 10 minutes to prevent clotting. The serum was 
then transferred to a fresh centrifuge tube. Bladders were removed using sterile surgical 
scissors, and placed into 5 ml complete BSK-II. Bladders were incubated at 34° C to allow 
for outgrowth of any spirochetes. Cultures were monitored periodically for five weeks for 
the presence of B. burgdorferi. A few of the bladders were contaminated in the process, 
which was obvious within the first week by turbidity of the culture medium. These cultures 
were not included in the infectivity count. 
Hearts were collected from each mouse, flash frozen in liquid nitrogen and stored at 
-80° C. DNA was extracted from the hearts using the NucleoSpin Tissue genomic DNA 
purification kit from TaKaRa in the following manner. Hearts were wrapped in aluminum 
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foil, dunked into liquid nitrogen, then quickly pounded with a mortar and pestle to break 
up into small pieces. Each heart was then placed in a 2 ml tube containing 180 µl Buffer 
T1 and 25 µl Proteinase K. Samples were briefly homogenized with an Omni Tissue 
Homogenizer. Samples were incubated at 56° C for 3 hours, while occasionally vortexed. 
Samples were lysed by adding 200 µl Buffer B3, vigorously vortexed, then incubated at 
70° C for 10 minutes. 210 µl ethanol was added and tubes vigorously vortexed.  
Samples were added to NucleoSpin Tissue columns, then centrifuged for 1 min at 
11,000 x g. Flow-through was discarded, and 500 µl Buffer BW was added. Tubes were 
centrifuged for 1 min at 11,000 x g. Flow-through was discarded and 600 µl Buffer B5 was 
added to each column. Tubes were centrifuged for 1 minute at 11,000 x g. The flow-through 
was discarded, and membrane dried by centrifuging for 1 min at 1,000 x g. DNA was eluted 
with ddH2O.  
Eluted DNA from each heart was diluted 1:10, then subjected to qPCR, using primers 
that amplify the nido gene from mice and flaB gene from B. burgdorferi. Cq values from 
nido were subtracted from Cq values for flaB for each heart, and plotted using GraphPad 
Prism version 6. Tukey’s Multiple comparisons statistical test was used to determine if the 
infectious burden of B. burgdorferi was significantly different between any of the strains.  
2.20 Green Fluorescent Protein (GFP)-transcriptional fusions analyzed by Flow 
Cytometry  
B. burgdorferi strains TB3, TB3 + pCRS5, TB11, TB11 + pCRS5, TB14 and TB14 
+ pCRS5 and B31-A3 (GFP negative control) were grown to mid-log phase at 34° C. Cells 
were harvested by centrifugation at 15,000 RPM in a JA-10 fixed angle rotor for 10 
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minutes, 4° C. Cells were gently resuspended in 1 ml PBS, transferred to a 1.6 ml 
microfuge tube, then centrifuged for 10 minutes at 10,000 RPM (24 x 1.5/2.0 ml rotor-
ThermoFisher), 4° C. Supernatant was removed, and cells gently resuspended in 1 ml PBS, 
then transferred to a 5 ml round-bottom polystyrene tube for analysis by flow cytometry. 
Cells were analyzed on an LSR II Flow cytometer, set with the 488nm Laser, and  read 
with both forward and side scatter. B31-A3 cells were used as the GFP negative control. 
At least 5,000 gated events were measured for each culture. Graphs were generated by 
plotting cell counts against GFP fluorescence intensity, then overlaying each strain with 
and without the plasmid pCRS5.  
This research was supported by the Flow Cytometry and Cell Sorting Shared 
Resource Facility of the University of Kentucky Markey Cancer Center (P30CA177558). 
2.21 Antibody production 
PlzA protein was expressed and purified from E. coli as described above. 5 mg was 
sent to AbClonal (Woburn, MA) for antibody production in 2 New Zealand white rabbits. 
Rabbits were serially inoculated with whole protein three times, and the serum collected.  
Bb0648 was analyzed for a specific, highly antigenic peptide by AbClonal. This peptide 
(VQKIDSPKSNVETLIYFY) was synthesized, and used to serially inoculate 2 New 
Zealand white rabbits. Antibodies against Bb0648 were affinity purified from rabbit serum.  
2.22 2-dimensional gel electrophoresis 
B. burgdorferi wild-type, spoVG-ON and DspoVG strains were cultured at 34° C to 
mid-log phase in 10 ml. Cells were harvested by centrifugation, at 15,000 RPM for 10 
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minutes at 4° C using a JA-17 fixed angle rotor. Cell pellets were gently resuspended in 1 
ml PBS, moved to Microfuge  tubes, and centrifuged for 10 minutes at 10,000 RPM (24 x 
1.5/2.0 ml rotor-ThermoFisher), 4° C. Supernatant was removed, cells washed in 1 ml PBS, 
and centrifuged for 10 minutes at 10,000 RPM (24 x 1.5/2.0 ml rotor-ThermoFisher), 4° 
C. Supernatants were removed, and cell pellets stored at -80° C until further use.  
Cell pellets were gently thawed on ice, then resuspended in 150 µl cell lysis buffer 
(Qiagen) containing protease and phosphatase inhibitors (ThermoFisher). Cells were 
incubated for 30 minutes at 4° C, and vortexed for 30 seconds every 10 minutes. Lysed 
cells were centrifuged for 30 minutes at 10,000 RPM (24 x 1.5/2.0 ml rotor-ThermoFisher), 
4° C to separate cellular debris from proteins. 100 µl of the soluble fraction was transferred 
to a clean Microfuge  tube for protein precipitation.  
Proteins were precipitated using the BioRad ReadyPrep 2-D protein precipitation kit 
as follows. To the 100µl protein, 300 µl Precipitation agent 1 was added, mixed well by 
vortexing, and incubated on ice for 15 minutes. 300 µl Precipitation agent 2 was added, 
and mixed well by vortexing. Tubes were centrifuged max speed for 5 minutes. The 
supernatant was removed, being sure not to disturb the pellet. Tubes were centrifuged for 
30 seconds to collect any remaining liquid, which was promptly removed. 40 µl Wash 
reagent 1 was added, the tubes centrifuged at max speed for 5 minutes, and supernatant 
removed. 25 µl Proteomic grade water was added to the pellet and vortexed for 30 seconds. 
1 ml wash reagent 2 (stored at -20° C) was added along with 5 µl wash reagent 2 
additive. Tubes were vortexed for 1 minute, then incubated at -20° C for 30 minutes. Tubes 
were vortexed every 10 minutes for 30 seconds during this incubation period. Tubes were 
centrifuged for 5 minutes at max speed, and supernatant removed. Tubes were centrifuged 
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again for 30 seconds, and residual supernatant removed. Protein pellets were allowed to 
dry for 5 minutes at room temperature with the cap open. Proteins were resuspended in 185 
µl 2-D sample rehydration buffer (BioRad). 
The 185 µl protein sample was carefully added to a sample rehydration tray, then 1 
11cm IPG strip pH 3-10 (BioRad) was carefully overlaid on the sample, gel side down. 
IPG strips were allowed to re-hydrate in the protein sample overnight at room-temperature.  
The following day, rehydrated IPG strips were carefully placed in the Isoelectric 
focusing tray, and covered with mineral oil. The voltage was incrementally increased from 
250 V to 3500 V over the course of 1.5 hours to avoid setting the strips on fire. Once the 
voltage reached 3500 V, strips were allowed to focus for an additional 11 hours. Strips 
were placed into individual conical tubes and stored at -80° C overnight.  
The following day, IPG strips were thawed at room temperature for no longer than 
20 minutes. Equilibration Buffers I and II were brought to room temperature on a stir plate. 
IPG strips were placed gel side up in individual lanes of the equilibration tray. 2 ml of 
Equilibration Buffer 1 was overlaid on top of each strip, and allowed to incubate at 10 
minutes on an orbital shaker at room temperature. The buffer was carefully poured off, 
being sure not to dump out the IPG strips. 2 ml of Equilibration Buffer II was added to 
each strip, and allowed to incubate for 10 minutes on an orbital shaker at room temperature.  
The IPG strip was then carefully removed using tweezers, and rinsed by dipping into 
a 100 ml graduated cylinder of SDS running buffer. The strip was then carefully loaded 
into the large well of the 20 % polyacrylamide gel, oriented such that the plastic backing 
of the IPG strip was against the plastic cassette, and the end marked “-” was closest to the 
small well for the ladder. 1 ml of melted agarose (from the 2-D ReadyPrep kit) was overlain 
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over both wells. Before the agarose set, 10 µl PageRuler Plus ladder (ThermoFisher) was 
loaded into the ladder well, by inserting the loading tip underneath the agarose.  
Gels were run for 50 minutes at 200 V, then immediately removed from their 
cassettes and incubated in 200 ml fixing solution (same as SDS de-stain solution) overnight 
at room temperature on an orbital rocker. All fixing, staining and de-staining steps were 
carried out in the red boxes with lids to protect from light.  
The following morning, the gels were washed 2x in 100 ml ddH2O, for 10 minutes 
with shaking. Gels were stained with 100 ml Pro-Q Diamond stain for 90 minutes with 
gentle shaking. Gels were de-stained with 100 ml Pro-Q de-stain solution and incubated 
for 30 minutes at room temperature with shaking. This was repeated 2 more times. Gels 
were washed 3x in 200 ml ddH2O for 10 minutes. The wash step was repeated 2 more 
times. Gels were imaged on a Typhoon imager (GE) using the preset settings for imaging 
Pro-Q Diamond stain.  
Gels were then stained with 100 ml Coomassie by microwaving for 2 minutes, then 
incubating at room temperature for 1 hour on an orbital shaker. Gels were rinsed several 
times with ddH2O to remove excess stain, then de-stained overnight in 200 ml Coomassie 
de-stain solution. The following morning, gels were washed with ddH2O to remove de-
stain solution. Gels were imaged with the Odessey imager on the 700 channel.  
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Table 2.1 Plasmids used in this study 
 
Name Background Insertion Resistance Source 
pCRS0 pCR2.1 cdaA Kanamycin This study 
pCRS1 pSZW53-4 Bb_0471 Kanamycin This study 
pCRS2 pET102 spoVG Carbenicilin This study 
pCRS5 pBLS715 spoVG Gentamycin This study 
_0648 pET28a Bb_0648 Carbenicilin This study 
Spy-FRET pBLS715 Spy-FRET Gentamycin This study 
pAG1 pSZW53-4 cdaA Kanamycin This study 
pTB3 pBLS590 PvlsE-full Kanamycin Bykowski, 2006 
pTB11 pBLS590 PvlsE-shorter Kanamycin Bykowski, 2006 
pTB13 pBLS590 PvlsE-shortest Kanamycin Bykowski, 2006 
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Table 2.2 Bacterial Strains used in this study 
 
Name Background Plasmid Source Passage 
CS1 B31-e2 pCRS1 This study high 
CS2 5A4-NP1 pCRS1 This study low 
CS8 B31-A3 pCRS5 This study low 
CS9 B31-A3 pCRS5 This study low 
GK1 B31-S9 pCRS5 This study low 
GK2 ∆plzA pCRS5 This study low 
∆rrp1+spoVG-ON ∆rrp1 pCRS5 This study low 
∆rpos+spoVG-ON ∆rpos pCRS5 This study low 
TB3 B31-e2 pTB3 Bykowski, 2006 high 
TB3+spoVG-ON B31-e2 pTB3+pCRS5 This study high 
TB11 B31-e2 pTB11 Bykowski, 2006 high 
TB11+spoVG-ON B31-e2 pTB11+pCRS5 This study high 
TB13 B31-e2 pTB13 Bykowski, 2006 high 
TB13+spoVG-ON B31-e2 pTB13+pCRS5 This study high 
cdaA-ON B31-A3 pAG1 This study low 
∆spoVG+spoVG ∆spoVG(A3) pCRS5 This study low 
Spy-FRET B31-A3 Spy-FRET This study low 
∆cheA1 B31-A none Li, 2002 high  
∆cheA2 B31-A none Li, 2002 high  
B31-A      high  
B31-e2      high 
B31-S9      low 
B31-A3      low 
5A4-NPI       low 
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Table 2.3 Antibodies used in this study 
 
Target Origin clone/purification 
FlaB Mouse, monoclonal H9724 
SpoVG Rabbit, polyclonal Anti-sera 
GlpD Rat, polyclonal Anti-sera 
AckA Rabbit, polyclonal Anti-sera 
VlsE Rabbit, polyclonal Anti-sera 
OspC Mouse, monoclonal B5 
OspA Mouse, monoclonal C3.78 
PlzA Rabbit, polyclonal Anti-sera 
Bb0648 Rabbit, polyclonal purified Ab 
Ac-Lysine Rabbit, polyclonal purified Ab 
 
Secondaries Isotype Origin Modification Source 
Protein A none  biotin 
Thermo 
Fisher 
𝝰-Mouse IgG Goat IRD800 Li-Cor 
𝝰-Rabbit IgG Goat IRD700 Li-Cor 
𝝰-Rat IgG Goat IRD800 Li-Cor 
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CHAPTER 3. REGULATION OF SPOVG AS A GLOBAL REGULATOR IN B. 
BURGDORFERI 
3.1 Introduction 
Having previously identified SpoVG as a DNA-binding protein in multiple bacteria, 
including B. burgdorferi, we sought to study how this protein acts in B. burgdorferi (164). 
We did this by generating mutant strains that over-express spoVG, or in which spoVG gene 
has been deleted. We performed global RNA-sequencing experiments to identify all of the 
transcripts that were differentially expressed. We also identified culture conditions and 
other regulatory factors that were involved in regulating SpoVG in B. burgdorferi. 
Mouse infection models have been well-established for B. burgdorferi (176, 177). 
Previous work has determined that six infected mice are sufficient to determine infectivity 
(178). Since B. burgdorferi is so motile, bacteria can be cultured and detected in distal 
tissues approximately three weeks after infection. Common tissues assayed include 
bladders and hearts. Culturing tissues in complete BSK, and extracting DNA from tissues 
for quantitative analysis are commonly employed methods for determining whether a 
certain tissue has been infected (176, 179-183).   
Bacteria that harbor extra-chromosomal plasmids must be able to faithfully replicate 
and partition those plasmids into each daughter cell during cell division (184, 185). This 
process is not well understood in B. burgdorferi, which must be able to replicate and 
segregate approximately 20 plasmids (85, 92). As discussed above, B. burgdorferi manages 
to carry out this process with extreme fidelity in the enzootic cycle (76). Although plasmids 
that do not carry genes essential for survival in culture may eventually be lost over the 
course of numerous passages, all plasmids appear to be necessary for completion of the 
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enzootic cycle (186). From an evolutionary perspective, only those bacteria that harbor all 
plasmids will be able to survive.  
PlzA is the only known protein in B. burgdorferi that binds cyclic-di-Guanosine-
Mono-Phosphate (c-di-GMP) (187). PlzA has previously been demonstrated to be essential 
for B. burgdorferi to infect mice and to colonize ticks, while c-di-GMP is only necessary 
for tick colonization (148, 188). This indicates that PlzA performs an important function 
both when c-di-GMP is present, and when it is absent. Until this point, no function had 
been ascribed to PlzA, either with or without c-di-GMP bound to it. Our collaborators 
found that the protein PlzA interacts with SpoVG in the cell, and confirmed this interaction 
in vitro (personal correspondence with Dr. Md. Motaleb, East Carolina University, 
unpublished data). 
3.2 Creation of Mutants 
In order to study the effect of SpoVG on B. burgdorferi, several mutants were 
generated. The spoVG gene was cloned under control of the constitutive flgB promoter, on 
plasmid pBLS715 (Figure 3.1A) (189). This construct was named pCRS5, and was 
introduced into wild-type B. burgdorferi on multiple occasions. pCRS5 was transformed 
into infectious strain B31-A3 to generate strains CS8 and CS9. pCRS5 was also 
transformed into infectious strain B31-S9 by Gabby Keb during her rotation to generate 
strain GK1. These strains demonstrated phenotypic homogeneity, and are collectively 
referred to as spoVG-ON.  
Our collaborator, Dr. Md. Motaleb, generated a chromosomal deletion strain by 
replacing the spoVG gene with a kanr cassette, and is termed DspoVG (Figure 3.1B). An 
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important consideration when generating mutants in infectious backgrounds of B. 
burgdorferi is ensuring that none of the plasmids are lost during the process of 
transformation. Certain plasmids, such as lp28-1, are necessary for vertebrate infectivity, 
and some such as lp25 are necessary for tick colonization (76, 85, 93, 190) (98, 186). 
Plasmid profiles were assayed for all strains by endpoint PCR, using primers specific for 
each plasmid (91). None of the strains generated lost any of plasmids necessary for 
transmission through the entire enzootic cycle, as assayed by endpoint PCR. 
3.3 Infection Studies 
Multiple studies have demonstrated that spoVG mRNA is more highly expressed 
when B. burgdorferi has colonized ticks than when it has infected mice (191, 192). Given 
this information, we hypothesized that spoVG is dispensable for vertebrate infection, and 
that B. burgdorferi that overexpresses spoVG will not be able to infect mice as efficiently 
as wild-type mice. To test this, we infected cohorts of mice with wild-type and spoVG-ON 
strains of B. burgdorferi. Six female mice were infected with each strain. Two wild-type 
strains (B31-A3 and B31-S9) and three spoVG-ON strains (CS8, CS9 {B31-A3 
background}, and GK1 {B31-S9 background}) were used. Each mouse was infected with 
1x106 bacteria suspended in 100 µl, injected into the peritoneum (176).  
After three weeks mice were euthanized, bladders aseptically removed and cultured 
in complete BSK-II media (193). Cultures were periodically examined by darkfield 
microscopy for the presence of B. burgdorferi. A few of the bladders were contaminated 
in the process of harvest, therefore those cultures were not included in the counts of how 
many bladders were infected. B31-A3 infected 6 out 6 mice, CS8 infected 5 out of 6 mouse 
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bladders, and CS9 also infected 5 out 6 mouse bladders. B31-S9 infected 4 out 4 mouse 
bladders, and GK1 infected 4 out 5 mouse bladders. In total, wild-type strains infected 10 
out of 10 mice, while the spoVG-ON strains infected 14 out of 17 mouse bladders (Figure 
3.2 A).  
The heart from each mouse was also harvested, immediately flash frozen in liquid 
nitrogen, and stored at -80° C (177). DNA from each mouse was extracted using TaKaRa 
genomic DNA from tissue kit, then subjected to qPCR. Primers that amplified the nido 
mouse gene and the flaB B. burgdorferi gene were used. The mouse nido gene was also 
amplified as a control for tissue abundance. Whole mouse hearts were processed without 
weighing a specific amount. This allowed us to quantify bacterial load in a certain amount 
of mouse tissue.  flaB was detectable in every sample, indicating that every animal was 
infected (Figure 3.2 B). Cq values for nido were subtracted from flaB Cq values, and plotted 
using GraphPad Prism version 6. Tukey’s multiple comparisons statistical test was used to 
determine if the infectious burden was significantly different between the different strains. 
The infectious burden was not different between the strains. Lower Cq values correlate 
with higher abundance in the sample, since the fluorescence is detectable at an earlier cycle 
number. Therefore, lower plotted values correspond to higher B. burgdorferi genome 
abundance. This infection study, which was conducted once, disproved our hypothesis that 
spoVG-ON B. burgdorferi would be less infectious in mice than wild-type B. burgdorferi. 
We concluded that B. burgdorferi that constitutively express spoVG mRNA are not 
impaired for murine infection. This experiment was performed once, and we decided not 
to further pursue whether there is a fitness advantage for wild-type over spoVG-ON 
bacteria in competition infection experiments. 
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3.4 RNA-Sequencing on wild-type, spoVG-ON, and DspoVG B. burgdorferi 
The Stevenson lab had previously demonstrated that SpoVG binds to DNA near the 
recombination site of the antigenically variable vlsE gene (164). We hypothesized that 
SpoVG likely binds numerous DNAs throughout the genome, and thereby influences 
expression of numerous transcripts. To test this, we performed RNA-sequencing on wild-
type, spoVG-ON and DspoVG strains. All three strains were cultured in triplicate and grown 
to mid-log phase at 34° C. Harvested cells were sent out for RNA purification with strand-
specific sequencing. Sorted Bam files were analyzed by a HISAT2 -> StringTie -> DESeq2 
pipeline (194). Wild-type transcripts were compared to spoVG-ON transcripts, and wild-
type transcripts were compared to DspoVG transcripts. Output files were then sorted by 
transcript ID, and separate files were created for mRNA and non-coding RNA transcripts 
(195). Files were filtered by adjusted p-value internally generated by DESeq2, keeping 
only those smaller than 0.05. Files were further filtered by log2 fold change between wild-
type and mutant transcripts. Only values above 1.0 and below -1.0 were accepted.  
188 mRNA transcripts were differentially expressed between wild-type and 
DspoVG bacteria (Table 3.3). 119 of those transcripts were on various plasmids, 66 were 
on the chromosome, and 3 were tRNAs (Figure 3.10 B). Similarly, 230 mRNA transcripts 
were differentially expressed between wild-type and spoVG-ON bacteria (Table 3.4). 107 
of those transcripts were on various plasmids, 117 were on the main chromosome, and 6 
were tRNAs (Figure 3.10 A). 75 sRNA transcripts were differentially expressed between 
wild-type and DspoVG bacteria (Table 3.2). 29 of those transcripts were on various 
plasmids, and 46 were on the chromosome (Figure 3.10 D). 110 sRNA transcripts were 
differentially expressed between wild-type and spoVG-ON bacteria (Table 3.1). 40 of those 
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transcripts were on plasmids, and 70 were on the main chromosome (Figure 3.10 C). 
mRNA and sRNA differentially expressed transcripts were found on the chromosome as 
well as numerous plasmids. Unsurprisingly, spoVG mRNA was significantly changed in 
both mutants as compared to wild-type. spoVG transcript was 2.6 log2 higher in the spoVG-
ON strain compared to wild-type, with an adjusted p-value of 3.67E-27. spoVG transcript 
was 6.58 log2 fold lower in the DspoVG strain compared to wild-type with an adjusted p-
value of 3.38E-167 (Figure 3.3).  
The differentially expressed mRNA transcripts were analyzed for functional 
clustering by DAVID bioinformatics resource (https://david.ncifcrf.gov/). As the majority 
of genes in the B. burgdorferi genome remain annotated as “unknown function”, many 
transcripts could not be grouped based on their function (23). The largest functional 
category for both spoVG-ON vs. wild-type and DspoVG vs. wild-type was membrane 
proteins (Figure 3.11 A-B). Each group also contained a number of DNA-binding proteins. 
Apart from that, there was not much similarity in how the differentially expressed 
transcripts were classified. For example, a number of coiled-coil domain-containing genes 
were differentially expressed in the DspoVG vs. wild-type, but not the spoVG-ON vs. wild-
type. 
There are numerous examples where a particular transcript is differentially 
expressed in one mutant as compared to wild-type, but not the other (Figure 3.3). One 
example of this is rpoN. rpoN was expressed 2.2 log2 times less in the spoVG-ON mutant 
as compared to wild-type, however expression was unchanged in the DspoVG mutant as 
compared to wild-type. Some transcripts were more or less abundant in both the spoVG-
ON and DspoVG mutants compared to wild-type. For example, transcript BB_0746, which 
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codes for an ABC oligopeptide transporter, was expressed nearly 7 log2 times less in both 
spoVG-ON and DspoVG strains than in wild-type.  
3.5 ParA transcript abundance and Plasmid Quantification 
Although the process of DNA segregation in B. burgdorferi is not well understood, 
each plasmid does carry parA/parB genes, which have been studied extensively in other 
bacteria, and are known to be essential for plasmid replication and segregation (85, 196). 
ParB binds DNA and nucleates along sites near the origin of replication oriC. ParA is an 
ATPase that oscillates across the cell in much the same manner as MinD, and associates 
with the cytoplasmic membrane as well as ParB. In this way, ParA can anchor the plasmids 
to each of the soon-to-be newly formed daughter cells (197-199).  
 We observed that the parA transcripts on many of the different plasmids were 
differentially expressed in the spoVG-ON and DspoVG strains compared to wild-type 
(Figure 3.4 A). To test whether the differences in parA transcript abundance is due to 
differential expression of the gene between strains of B. burgdorferi, or due to differences 
in copy number of plasmid (either within a single cell, or within a population in which 
some cells maintain the plasmid and others do not), DNA was extracted from wild-type, 
spoVG-ON and DspoVG strains. Plasmid abundance was assayed by qPCR using primers 
specific for each plasmid. Plasmid Cq values were normalized flaB Cq values, essentially 
measuring plasmid copy per chromosome copy (Figure 3.4 B). Wild-type values were 
arbitrarily set to 1, and the difference in Cq measured for the mutant strains plotted against 
that. We found that there is a lower abundance of several plasmids compared to wild-type, 
but this was not sufficient to explain the differences in parA transcript abundance. For 
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example, lp28-1 parA transcript is more abundant in spoVG-ON than in wild-type, however 
there was no difference in copy number of lp28-1 between spoVG-ON and wild-type cells.  
3.6 Growth Rates of Wild-type, spoVG-ON, and DspoVG  
Given the fact that SpoVG binds DNA, we hypothesized that dysregulation of this 
protein could have an impact on growth rate in culture. At 34° C, there was no difference 
in growth rate between the wild-type, spoVG-ON or DspoVG strains (Figure 3.5 A). Wild-
type B. burgdorferi grow significantly more slowly at 23°C than at 34°C. Although there 
was no difference in growth rate between wild-type and DspoVG cells at 23°C, spoVG-ON 
cells grew significantly more slowly than wild-type or DspoVG cells (Figure 3.5 B). This 
suggests that another factor(s) is either present or absent in B. burgdorferi at 23°C and not 
34°C that somehow interacts with, or is influenced by, SpoVG, resulting in the further 
reduced growth rate. This demonstrated that our hypothesis was partially correct: at 34° C, 
there was no difference in growth rate, while at 23° C, there was a difference in growth 
rate.  
Previous work from the Stevenson lab demonstrated that B. burgdorferi senses and 
responds to its own replication rate. By separating growth rate from absolute temperature, 
we demonstrated that differential expression of several proteins is actually growth-rate 
dependent, and not temperature dependent as previously thought (200). We hypothesized 
that the reason for reduced growth-rate of the spoVG-ON cells was due to the already 
reduced growth-rate of B. burgdorferi at 23°C, and not due inherently to temperature. To 
test this, we measured growth rate in WT and spoVG-ON cells in two different media that 
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result in reduced growth, even at 34°C. B. burgdorferi is normally grown in BSK 
supplemented with 6% rabbit serum. For the reduced growth rate media, one contains 1.2% 
rabbit serum added to full strength BSK, while the other has the standard 6% rabbit serum 
added to BSK that was diluted to 25% strength. Although we predicted that spoVG-ON 
cells would grow more slowly than WT, both cells grew at the same rate in both media at 
34°C (Figure 3.5 C and D). This indicates that the disparity in growth rate between the WT 
and spoVG-ON strains at 23° is not specifically due to reduced growth rate, but to some as 
yet-unidentified factor, which may be temperature itself. These studies disproved our 
hypothesis that differences in growth rate between wild-type and spoVG-ON B. 
burgdorferi were due to growth rate and not temperature. 
3.7 spoVG Expression in wild-type and spoVG-ON grown at 34° C and 23° C 
We hypothesized that expression of SpoVG could be regulated in culture, since we 
had demonstrated that its expression was differentially regulated when B. burgdorferi 
colonized ticks or infected mice (191). In order to test this, WT B. burgdorferi cells were 
harvested for both RNA extraction and protein analysis from different time points, 
representing mid-log, stationary, and late stationary. spoVG transcript abundance 
normalized to flaB transcript abundance did not change during different stages of growth 
(Figure 3.6A). We had previously demonstrated by RNA-seq that flaB transcript abundance 
does not appreciably change across different growth stages (201). In contrast to transcript 
abundance, the amount of SpoVG protein made during different growth stages did 
significantly change. SpoVG protein is abundantly produced by mid-log growing cells, and 
is nearly undetectable in late stationary cells (Figure 3.6 C).  
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Expression of SpoVG transcript and protein was also measured in WT and SpoVG-
ON cells grown both at 34°C and 23°C and harvested during mid-log growth. spoVG 
transcripts were significantly more abundant in the SpoVG-ON cells than WT cells grown 
at 34°C (Figure 3.6 B). The graph is plotted on a log2 scale on the y-axis to demonstrate 
the differences in Cq values that were measured. The difference in Cq value between WT 
cells grown at 34°C and 23°C is 3.63, which equates to 13.2 times more spoVG transcript 
made by WT cells growing at 34°C than at 23°C. SpoVG-ON cells grown at 23°C did not 
produce more spoVG transcript than SpoVG-ON cells grown at 34°C. At 23°C, there was 
an even greater difference in the amount of spoVG mRNA produced between WT and 
spoVG-ON cells. The difference in Cq values was measured to be 5.54, which equates to 
nearly 31 times more spoVG transcript in the spoVG-ON cells than the WT cells, both 
grown at 23°C.  
SpoVG protein abundance was not significantly different between strains, or 
between cells grown at different temperatures (figure 3.6 D). This experiment was repeated 
on three different cultures with similar results. Taken together, these data indicate that B. 
burgdorferi regulates levels of SpoVG at both the level of transcription and translation, 
and that SpoVG plays a role in regulation of itself.  This finding is not altogether surprising, 
given the evidence that B. subtilis also strongly regulates expression of SpoVG at multiple 
levels (165). 
3.8 SpoVG Binds Its Own DNA and RNA in Vitro 
Because SpoVG-ON cells did not produce more SpoVG protein than WT cells, we 
hypothesized that SpoVG could regulate its own expression by binding to nucleic acid 
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associated with its own gene. To test this, we performed electrophoretic mobility shift 
assays (EMSAs) between SpoVG and DNA or RNA. Corresponding to the spoVG 
upstream region, DNAs and RNAs were labeled with a biotin molecule to allow for 
visualization by streptavidin. Recombinant SpoVG was incubated with a labeled 38bp 
segment of double stranded DNA that consisted of the sequence just upstream of the 
translational start codon of spoVG (Figure 3.7 A). The presence of a shifted band of DNA 
when incubated with SpoVG indicated that SpoVG bound to that piece of DNA. Addition 
of 100x unlabeled non-specific DNA was insufficient to eliminate the shifted band, 
indicating that SpoVG preferentially binds to the DNA sequence upstream of its own gene. 
100x unlabeled DNA that contained the exact DNA sequence as the labeled probe did result 
in reduction of the shifted band.  
The lane containing 100x unlabeled DNA contains a band not present in any other 
lane, which is consistent with SpoVG “spreading”. Once one SpoVG protein has bound to 
a single piece of DNA, it is possible that it acts as a nucleating factor, and more SpoVG 
proteins bind to the same DNA. A sufficient amount of SpoVG protein was added in the 
second lane such that all of the DNAs have multiple proteins bound to them, likely with 
free SpoVG as well. This is why there is only a single shift visible. The unlabeled 
competitor is able to shift away only some of the protein from the labeled piece of DNA 
because there is an excess of protein (i.e. enough to bind to all DNAs present in the 
mixture). In this case, the labeled DNAs contain fewer SpoVG protein complexes, which 
explains why there is still a shifted band, but that has migrated faster through the gel than 
the labeled DNAs in lane two. Figure 3.8 also demonstrates this. Adding more SpoVG 
protein to DNA resulted in additional higher protein-DNA complexes. It was not 
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investigated whether the DNA-bound SpoVG proteins can then attract an additional piece 
of DNA, which would provide evidence for DNA-bending and packing.  
Measuring SpoVG transcript and protein abundance demonstrated that RNA levels 
are not necessarily predictive of the amount of protein abundance, therefore we tested 
whether SpoVG also binds to RNA associated with its gene. A labeled RNA that covered 
the same sequence as the DNA tested, on just the strand that gets transcribed was also used 
to test for SpoVG binding (Figure 3.7 B). Addition of SpoVG with this RNA resulted in a 
shifted band, consistent with SpoVG binding to this piece of RNA. Incubation of SpoVG 
with an unrelated labeled RNA did not result in a shift, indicating that SpoVG binds to 
specific RNA sequences, just as it does with DNA (Figure 3.7 C).  
3.9 SpoVG expression in B. burgdorferi deficient for PlzA, or c-di-GMP 
 PlzA and SpoVG interact, and both PlzA and c-di-GMP have global impacts on 
gene expression (101, 144, 146-148). Therefore, we hypothesized that it is possible the 
PlzA and or c-di-GMP could regulate expression of SpoVG. In order to test this, we first 
measured spoVG expression levels in various mutants (Figure 3.9 A). Wild-type, DplzA 
mutant, and complemented DplzA+plzA were grown to mid-log phase at 34° C. Cells were 
harvested, RNA extracted and subjected to cDNA synthesis. cDNAs were subjected to 
analysis by qRT-PCR, using primers that amplified within the coding region of spoVG. 
spoVG transcript was measured to be nearly 3 log2 times lower in the DplzA strain as 
compared to the wild-type or DplzA+plzA strains. 
Additionally, we measured SpoVG protein levels by Western Blot on several 
strains of B. burgdorferi (Figure 3.9 B). The DplzA strain was complemented with 
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exogenous plzA on a plasmid termed DplzA+plzA (101). The protein that synthesizes c-di-
GMP is the response regulator of a two-component system, termed rrp1 (188). Lysates 
were prepared from Wild-type, DplzA, DplzA+plzA, and Drrp1 strains grown to mid-log 
phase at 34° C. FlaB was used as the loading control. SpoVG was readily detectable in 
both the wild-type and DplzA+plzA lysates, but undetectable in the DplzA and Drrp1 lysates. 
PlzA is the only known target of c-di-GMP in B. burgdorferi, therefore we 
hypothesize that PlzA needs to have c-di-GMP bound to it in order to regulate expression 
of SpoVG. It was previously known that both DplzA and Drrp1 strains regulate expression 
of other genes. In order to determine if they do so only by regulating spoVG, we 
transformed both mutant strains with plasmid pCRS5 to introduce exogenous expression 
of SpoVG in these strains (Figure 3.9 C). Use of these strains in future studies will enable 
us to determine whether the effects on gene regulation observed in the DplzA and Drrp1 
strains are directly impacted by PlzA and or c-di-GMP, or if they are due to absence of 
SpoVG expression.  
3.10 Discussion 
Although fewer mouse bladders (14/17 for spoVG-ON compared to 10/10 for wild-
type) were infected with the mutant strains of B. burgdorferi, all of the hearts were as 
assessed by qPCR. The fact that mice were successfully infected by strains constitutively 
expressing spoVG disproved our hypothesis that constitutive expression would render these 
strains entirely incapable of establishing infection in mice. Additionally, our collaborator 
Dr. Motaleb found that DspoVG strains are deficient in their ability to transmit between 
ticks and mice and establish persistent infections in mice, which disproves our hypothesis 
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that spoVG is dispensable for mouse infection (data unpublished). It is possible that 
constitutive expression of spoVG would be prohibitive in a direct competition infection 
study. Further studies will focus on quantifying bacterial loads in various organs (heart, 
bladder and ears are often used to demonstrate dissemination throughout the body), as well 
as quantifying whether wild-type B. burgdorferi are able to more efficiently infect and 
disseminate when co-infected with spoVG-ON and DspoVG mutants.  
Transcriptomic analysis between spoVG-ON, DspoVG and wild-type demonstrated 
that numerous genes are differentially expressed in the mutant strains of B. burgdorferi 
compared to wild-type. The DspoVG strain had more transcripts differentially expressed 
on the chromosome, in contrast to the spoVG-ON strain, which had more transcripts 
differentially expressed on the chromosome than on the plasmids. Of the tRNAs that were 
differentially expressed, two of them were the same in both the spoVG-ON and DspoVG 
mutants compared to wild-type. Functional clustering analysis revealed that genes involved 
in numerous cell processes were differentially expressed. The group with the largest 
number of differentially expressed genes in both groups was membrane lipoproteins. This 
is unsurprising, given what we know about how important regulation of membrane proteins 
is for B. burgdorferi (116, 202). Apart from the membrane proteins, there are differences 
in how the differentially expressed genes cluster in the two mutant strains. This gives 
further indication that SpoVG acts broadly across the entire genome, and not on just a few 
specific transcripts.  
Given that so many transcripts are differentially expressed between the wild-type 
and mutant strains, and the wide range of cell processes those genes are involved in, we 
hypothesize that SpoVG has a global effect on genome expression. It is possible that 
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SpoVG affects expression of a (or multiple) global regulator, however a couple of pieces 
of evidence counter this assumption, and point to the possibility that rather than working 
in a manner to specifically target certain genes, SpoVG exerts its influence by globally 
influencing the three-dimensional structure of the nucleoid. First, there is not significant 
overlap between those transcripts that are differentially expressed in the spoVG-ON mutant 
compared to wild-type than in the DspoVG mutant compared to wild-type. Other regulatory 
factors could be involved in the spoVG-ON mutant that are unchanged between wildtype 
and DspoVG mutant.
Recent debate in the scientific community has centered around the almost 
deification of the p-value (203). This test measures the statistical probability that a 
percentage of tests will be false-positives. False discovery rate adjusted p-values (by 
DESeq2) are used in instances where a large number of tests are being evaluated: for 
example, in RNA-sequencing data sets. Adjusted p-values provide the probability that a 
certain percentage of the statistically significant tests are false-positives. Many are 
currently arguing that in relying so heavily on using p-values as cutoffs to measure 
significance, it is possible that in so doing we miss biological relevance. For this reason, in 
addition to the curated tables presented that use both log2 fold-change and adjusted p-value 
of less than 0.05 to determine which transcripts are significantly differentially expressed 
between the mutant strains and wild-type, Tables A5.1 and  A5.2 include all of the data 
from the Deseq analysis, which can be used for exploratory purposes.  
That SpoVG showed impacts on expression of the parA/parB systems has broad 
implications for how plasmids are maintained. Although beyond the scope of this work, an 
intriguing hypothesis is that SpoVG has a critical role in the faithful replication and 
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maintenance of each plasmid during each point of the enzootic cycle. This could also 
partially explain why DspoVG cells are deficient in their ability to infect mice. One 
explanation for why so many parA transcripts were differentially expressed could be due 
to loss of copy number of individual plasmids, or individual cells within a population losing 
certain plasmids. It is not known how many copies of each plasmid are maintained within 
a single cell.  
Just as there was circumstantial evidence that SpoVG could regulate its own 
expression in B. subtilis, it appears as though B. burgdorferi SpoVG also regulates its own 
protein production. We have seen evidence of another regulator in B. burgdorferi, BpuR, 
that also regulates its own expression (155, 156). Autoregulation of regulators in bacteria 
are beginning to be appreciated as a wide-spread evolutionary tactic (204-206). 
Additionally, it is recently appreciated that many classical DNA-binding proteins in 
bacteria may also bind RNA. The evidence that SpoVG binds both DNA and RNA makes 
sense for a bacterium with a reduced genome (156, 175, 207, 208). B. burgdorferi has 
limited coding capacity for unique proteins in contrast to other organisms. Using post-
translational mechanisms of regulating activity of proteins allows the cell to perform all of 
the functions it needs to survive the enzootic cycle while limiting the resources it has to 
expend on maintaining the genome, and transcribing and translating individual genes.  
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Figure 3.1 pCRS5 (spoVG-ON) plasmid and DspoVG constructions  
 
 
 
 
A. pCRS5 (spoVG-ON) plasmid construction. spoVG was cloned into the BamHI 
and KpnI sites of our previously described pBLS715 plasmid. The parental construct was 
created to contain a consensus ribosome-binding site (RBS) appropriately placed 5′ of the 
insert. The constitutively expressed borrelial flgB promoter drives expression of both the 
gentamicin resistance gene (aacC1) and spoVG. The identically produced pBLS715revA 
produces elevated levels of both revA mRNA and RevA protein. 
 B. The spoVG gene was replaced in the chromosome with a Kanamycin resistance 
gene (Neomycin phosphotransferase II) to create the DspoVG strain. 
 
spoVG
kanr
A
B
Adapted from Christina R. Savage et al. J. Bacteriol. 2018; doi:10.1128/JB.00033-18 
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Figure 3.2 Infection Study 
 
 
 
B31-A3 (WT1), CS8, CS9 (spoVG-ON), B31-S9 (WT2) and GK1 (spoVG-ON) 
were used to infect mice. 1 x 106 bacterial cells were used for each mouse. Infections were 
allowed to proceed for 3 weeks, after which time bladders were cultured in complete BSK-
II media (A). 6 mice were infected with each strain, however a few of the cultured bladders 
became contaminated, so they were not included in the final counts. Cultures were 
examined by darkfield microscopy for the presence of B. burgdorferi. DNA was extracted 
from each mouse heart. DNA was analyzed by qPCR using primers that amplified the nido 
gene (present only in mice), and the flaB gene present only in B. burgdorferi). The 
difference in Cq value between flaB and nido was calculated for each mouse. flaB DNA 
was detectable in every mouse heart, indicating that every mouse was infected. The cohorts 
of hearts infected with each strain was analyzed by Tukeys Multiple comparisons statistical 
test. The infectious burden between strains was not different between any of the strains of 
B. burgdorferi.   
Strain Cultured bladders 
WT1 6/6
CS8 5/6
CS9 5/6
WT2 4/4
GK1 4/5 
WT                  10/10
spoVG-ON      14/17
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Figure 3.3 RNA-seq transcripts 
 
        
 
 Examples from RNA sequencing that demonstrate that individual genes show 
different patterns of regulation between wild-type, spoVG-ON and DspoVG strains.  
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Figure 3.4 parA transcript abundance and plasmid quantification 
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Log2 differences in parA transcript abundance for individual plasmids, measured by RNA-
seq (A). DNA was extracted from each strain, and plasmid quantity probed by qPCR using 
previously established primers unique to each plasmid (209). Log2 differences in plasmid 
abundance, as measured by qPCR (B).  
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Figure 3.5 Effect of spoVG on growth rate of B. burgdorferi 
 
  
 
 
 
 (A and B) Cultured wild-type (WT) spoVG-ON and DspoVG B. burgdorferi strains were 
grown in complete medium at 34°C and counted every 24 h (A) or were grown in complete 
medium at 23°C and counted every 3 days (B).  
(C and D) Cultured wild-type and spoVG-ON B. burgdorferi strains were also grown at 
34°C in one of two deficient media, i.e., grown in 1.2% rabbit serum medium and counted 
every 3 days (C) or grown in 25% BSK medium and counted on days 2, 4, 8, and 16 (D).  
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Adapted from Christina R. Savage et al. J. Bacteriol. 2018; doi:10.1128/JB.00033-18 
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Figure 3.6 SpoVG transcript and protein expression in culture 
 
 
 
 
SpoVG transcript and protein expression in culture. (A) RNA extracted from cultured B. 
burgdorferi harvested on days 2, 5, 7, and 9 was analyzed by qRT-PCR. spoVG transcript 
levels were determined, relative to flaB transcripts, by the ΔΔCT method. (B) RNAs 
extracted from cultured wild-type (WT) and spoVG-ON B. burgdorferi grown at 34°C and 
23°C were analyzed by qRT-PCR. Relative spoVG transcript abundance was normalized 
to flaB transcript levels by the ΔΔCT method. (C) Lysates from cultured B. burgdorferi 
harvested on days 3, 5, 7, and 9 were analyzed for SpoVG protein production. FlaB protein 
levels were used as a loading control. (D) Lysates from wild-type and spoVG-ON B. 
burgdorferi were harvested on day 3 from cultures grown at 34°C and on day 10 from 
cultures grown at 23°C and were analyzed by Western blotting. SpoVG abundance is 
shown with FlaB as the loading control. 
Christina R. Savage et al. J. Bacteriol. 2018; doi:10.1128/JB.00033-18 
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Figure 3.7 SpoVG binds its own DNA and RNA 
 
 
 
 
SpoVG binding of its own DNA and RNA. EMSAs were performed using either labeled 
DNA or RNA derived from the sequence 5′ of the spoVG translational start site or RNA 
derived from the sequence 5′ of the unrelated erpAB operon (23). The spoVG RNA probe 
formed a secondary structure in the absence of added protein (indicated by an asterisk). (A) 
Lane 1, 1 ng DNA probe; lane 2, 1 ng DNA probe with 2.4 μM rSpoVG; lane 3, 1 ng DNA 
probe with 4.8 μM rSpoVG; lane 4, 1 ng DNA probe with 4.8 μM rSpoVG and 100 ng 
unlabeled spoVG DNA; lane 5, 1 ng DNA probe with 4.8 μM rSpoVG and 100 ng 
unlabeled EMSA-pCR2.1 DNA. (B) Lane 1, 1 ng RNA probe (asterisk indicates a 
secondary structure of the RNA); lane 2, 1 ng RNA probe with 2.4 μM rSpoVG; lane 3, 1 
ng RNA probe with 2.4 μM rSpoVG and 100 ng unlabeled spoVG DNA; lane 4, 1 ng RNA 
probe with 2.4 μM rSpoVG and 1,000 ng unlabeled spoVG DNA. (C) Lanes 1 to 5, 1 ng 
erp RNA; lanes 6 to 10, 1 ng spoVG RNA; lanes 1 and 6, no protein; lanes 2 and 7, 1.6 μM 
D
Christina R. Savage et al. J. Bacteriol. 2018; doi:10.1128/JB.00033-18 
79 
 
 
r SpoVG; lanes 3 and 8, 160 nM rSpoVG; lanes 4 and 9, 16 nM rSpoVG; lanes 5 and 10, 
1.6 nM rSpoVG. (D)  
The sequence is shown as DNA, although SpoVG also bound to this site in single-stranded 
RNA. The DNA/RNA target region used for EMSAs are underlined. Intergenic region 
between the start of the spoVG open reading frame (ORF) and the gene located 
immediately upstream, rsf. The transcriptional start site of the spoVG ORF is highlighted 
in bold black type, and the stop codon of the rsf gene is highlighted in bold blue type. 
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Figure 3.8 Multiple SpoVG complexes bind to a single DNA 
 
 
 
SpoVG protein was added in increasing amounts to a 100 bp DNA probe. Presence of 
multiple shifted bands indicate that multiple SpoVG proteins bind to a single DNA. Protein 
concentration ranged from 1-500x. All lanes contain 1 ng DNA. Lane 1: no protein. Lane 
2: 1 µl of (1:1,00x) protein. Lane 3: 2 µl of (1:1,00x) protein. Lane 4: 5 µl of (1:1,00x) 
protein. Lane 6: 1 µl of (1:10x) protein. Lane 7: 2 µl of (1:10 x) protein. Lane 8: 5 µl of 
1:10x protein). Lane 9: 1 µl of protein. Lane 10: 1 µl of protein. Lane 11: 2 µl of protein. 
Lane 12: 5 µl protein.  
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81 
 
 
Figure 3.9 PlzA and c-di-GMP are necessary for expression of SpoVG 
 
 
 
qRT-PCR on levels of spoVG transcript expressed by wild-type, DplzA and DplzA+plzA 
strains grown at 34° C. spoVG transcripts were normalized to flaB transcripts. Three 
biological replicates are graphed (A). Western Blot on wild-type, DplzA, DplzA+plzA, and 
Drrp1 strains, probed for SpoVG and FlaB. Cultures were grown at 34° C, and lysates 
prepared at mid-log phase growth. Representative blot of at least three biological replicates 
(B).  List of newly generated strains to study the impact that SpoVG has on expression of 
down-stream genes (C). 
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Figure 3.10 Distribution of differentially expressed RNAs 
 
 
 
 
Distribution of differentially expressed RNAs across the main chromosome and plasmids. 
Each graph represents how many differentially expressed transcripts are found on the 
chromosome and how many are found on the various plasmids. 
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Figure 3.11 Functional clustering of differentially expressed transcripts 
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Table 3.1 Small RNAs differentially expressed between wild-type and spoVG-ON 
 
SR ID    Start Stop Strand log2FoldChange padj 
SR0001 chr 3151 3343 - 1.358484046 0.002241441 
SR0014 chr 25903 25952 - 1.032088033 0.019764571 
SR0028 chr 45908 45970 - 1.674028232 0.000643201 
SR0042 chr 62874 62965 + 1.112696054 0.036858673 
SR0067 chr 109635 109750 + -1.267874699 0.021292417 
SR0072 chr 115524 115593 + -1.015940954 0.042829818 
SR0089 chr 138320 138376 + -1.302812659 0.000224418 
SR0111 chr 164373 164418 + 1.34051063 0.000415857 
SR0112 chr 164713 164837 - 1.304637546 0.03426588 
SR0126 chr 176642 176691 + -1.308248535 0.038847748 
SR0165 chr 211234 211296 + 2.054932353 0.00017475 
SR0168 chr 218334 218546 + 1.309936809 7.14E-05 
SR0173 chr 223054 223124 - -1.355726705 0.000196887 
SR0186 chr 245945 246070 - 2.636228597 5.11E-24 
SR0187 chr 246367 246464 - 2.349616463 5.02E-21 
SR0196 chr 260581 260796 - -1.218449775 0.00716771 
SR0215 chr 295449 295594 - 12.3762417 1.22E-09 
SR0233 chr 327895 328102 + 1.103912915 0.003147874 
SR0246 chr 340302 340576 + 5.233280979 1.10E-92 
SR0263 chr 369675 369724 - -1.00333115 0.026546899 
SR0264 chr 373474 373545 + -1.690678454 0.03231015 
SR0276 chr 394805 394853 + 1.284819642 3.57E-08 
SR0277 chr 395312 395387 - 1.757089302 0.002885601 
SR0278 chr 396334 396428 + 1.555158272 0.0085385 
SR0279 chr 399917 400036 + -1.11627616 0.036858673 
SR0284 chr 408412 408480 - 1.609669841 0.00047551 
SR0303 chr 421685 421769 - -1.366458316 0.039063197 
SR0305 chr 423518 423638 - -1.698033543 0.002381768 
SR0309 chr 428415 428516 - -1.278242083 0.003342058 
SR0324 chr 443571 443751 + 1.526204778 0.001062938 
SR0341 chr 465040 465110 - 1.07500888 0.002993145 
SR0345 chr 467849 467895 + -1.892810192 0.000506069 
SR0347 chr 472002 472086 + -1.816307144 0.013983777 
SR0359 chr 482082 482232 + 1.286200447 0.025638451 
SR0392 chr 515629 515807 + -2.183927843 2.70E-07 
SR0395 chr 523418 523524 + -1.006586325 0.009388403 
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SR0396 chr 526293 526449 + -1.817469144 5.61E-06 
SR0399 chr 531636 531704 - 1.680167476 0.021492887 
SR0412 chr 551933 552192 + 2.411574701 0.000267652 
SR0416 chr 559261 559321 + -1.295063237 0.006823882 
SR0457 chr 605915 605979 + -1.019257396 0.010928101 
SR0481 chr 631929 631984 - 1.074316651 0.000356408 
SR0520 chr 662542 662591 + -1.590596006 0.026316987 
SR0524 chr 666067 666185 + -2.300506847 1.22E-05 
SR0540 chr 679320 679394 + -1.68300255 0.000594103 
SR0565 chr 708075 708215 - -1.179179049 0.00077605 
SR0568 chr 711583 711679 - -1.152227018 0.011684339 
SR0573 chr 714672 714720 + 1.127634628 0.034153959 
SR0579 chr 722022 722071 - -1.014394943 0.003784733 
SR0582 chr 723012 723154 - -1.018788592 0.001107488 
SR0591 chr 731768 731852 + 2.233046335 0.001062938 
SR0603 chr 742476 742541 + 1.586866727 0.000233071 
SR0607 chr 745826 745919 - -1.053451084 0.016961865 
SR0620 chr 760922 760971 - -1.294347604 0.014953278 
SR0630 chr 769844 769938 + -1.140244903 0.005389163 
SR0635 chr 774458 774512 + 1.886801477 0.012248752 
SR0643 chr 790233 790281 + -2.61818306 1.44E-07 
SR0648 chr 796463 796547 + -1.015529348 0.000724873 
SR0649 chr 797921 797971 + -1.156381075 0.000191952 
SR0655 chr 810040 810190 + -1.77556561 3.41E-05 
SR0657 chr 812265 812439 - -1.748940548 0.002761958 
SR0665 chr 822408 822454 - -1.312375594 0.014941865 
SR0666 chr 822940 822989 - 4.586636326 4.62E-50 
SR0667 chr 823166 823231 + 1.018733002 0.000145481 
SR0672 chr 831633 831683 + 1.26306113 0.035671486 
SR0701 chr 871538 871606 + -1.242085797 0.00260175 
SR0708 chr 881440 881553 + -1.69877351 5.82E-05 
SR0709 chr 881987 882036 + -1.617477403 0.006444542 
SR0710 chr 883224 883285 + -1.09376124 0.01455037 
SR0715 chr 889701 889829 + -1.109120463 0.004391075 
SR0727 lp17 6593 6703 + 1.11827335 0.001338578 
SR0728 lp17 8155 8220 + 1.237899082 0.011123802 
SR0730 lp17 8407 8487 - 1.539037024 1.04E-05 
SR0731 lp17 9414 9567 + 1.01345801 0.012086859 
SR0734 lp17 10785 10832 + 1.881576623 0.00626945 
SR0745 lp25 5310 5359 - -4.784601894 0.000739504 
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SR0746 lp25 7036 7267 - -2.981708151 1.86E-11 
SR0747 lp25 9409 9553 - -2.730403714 6.04E-11 
SR0749 lp25 10817 10862 + -3.096381485 0.003784733 
SR0751 lp25 12423 12473 + -3.732903036 6.04E-12 
SR0752 lp25 13269 13417 - -4.702350755 3.23E-07 
SR0754 lp25 15673 15944 - -4.537944456 2.92E-24 
SR0755 lp25 15951 16076 + -3.057487337 1.86E-09 
SR0791 lp28-3 16481 16565 + 1.602897444 0.047405899 
SR0793 lp28-3 19459 19508 + 1.021166642 0.029522634 
SR0804 lp28-4 10785 10862 + 1.293920146 0.004680575 
SR0805 lp28-4 12723 12840 - -1.189420478 0.037148785 
SR0811 lp28-4 18054 18137 + 2.100094268 0.001254413 
SR0824 lp36 12209 12260 - -1.358430595 0.045530176 
SR0832 lp36 16149 16291 + 1.309117095 0.014449111 
SR0836 lp36 22363 22451 + -6.330188517 4.91E-06 
SR0839 lp36 25584 25675 - 1.424315373 0.006382234 
SR0840 lp36 25705 25783 + 1.837727784 0.030049609 
SR0848 lp36 35057 35217 + 1.619337802 3.34E-06 
SR0853 lp38 10402 10463 - 3.30339277 5.87E-15 
SR0856 lp38 13386 13469 - 2.070162064 7.63E-08 
SR0888 lp54 11715 11849 + 1.974205146 4.28E-07 
SR0889 lp54 11974 12040 - 1.191854086 0.043761506 
SR0900 lp54 29365 29422 - -1.264039477 0.043761506 
SR0907 lp54 41530 41649 + -1.056680102 0.015541862 
SR0922 lp56 19795 19847 - -2.133046718 8.22E-09 
SR0925 lp56 31737 31810 - -3.215641219 0.010126645 
SR0931 cp9 2128 2308 + 13.28855496 4.36E-25 
SR0945 cp26 870 955 + 1.780785847 3.07E-09 
SR0948 cp26 2376 2476 + 1.925642304 1.48E-05 
SR0951 cp26 3191 3257 + 2.290735083 8.64E-11 
SR0957 cp26 7794 7856 + 2.092446604 0.000348321 
SR0958 cp26 8033 8111 - 1.032843739 0.035837546 
SR0980 cp32-1 22671 22740 - -1.422555192 0.002381768 
SR0994 cp32-6 27219 27266 + 1.180157235 0.013416925 
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Table 3.2 Small RNAs differentially expressed between wild-type and DspoVG 
 
    Start Stop Strand log2FoldChange padj 
SR0006 chr 7249 7383 + -1.159123135 0.004614012 
SR0007 chr 7600 7661 + -1.270580901 0.039173648 
SR0021 chr 39498 39674 - -1.643695488 0.049572294 
SR0053 chr 80423 80539 - -1.80540166 0.015018283 
SR0078 chr 124199 124250 + 1.093696337 0.034904635 
SR0122 chr 174087 174144 - -5.896443438 0.030086279 
SR0132 chr 181625 181673 + -1.498631428 0.004865585 
SR0186 chr 245945 246070 - -2.497585903 2.16E-21 
SR0187 chr 246367 246464 - -3.153125812 3.01E-33 
SR0189 chr 250385 250467 + -1.159727406 0.004614012 
SR0203 chr 269511 269626 + -1.498171463 0.009379819 
SR0244 chr 336511 336565 + -1.024994359 0.047423471 
SR0245 chr 338243 338293 + -1.588537322 0.001486185 
SR0246 chr 340302 340576 + -1.02136926 0.002085611 
SR0247 chr 340555 340650 - -1.006465242 0.010664288 
SR0254 chr 358532 358589 - 1.364565297 0.011245213 
SR0273 chr 391800 391853 - -1.190443551 0.015018283 
SR0324 chr 443571 443751 + -1.5775048 0.000988458 
SR0326 chr 444712 444783 + 10.480605 3.57E-12 
SR0332 chr 451393 451459 + 1.467490808 0.016587548 
SR0389 chr 513193 513273 + -1.225657468 0.000894501 
SR0390 chr 514927 514976 - -1.084538764 0.033792599 
SR0417 chr 561897 561958 - 1.307866788 0.000440003 
SR0429 chr 577156 577205 + -1.832714092 0.011272339 
SR0451 chr 600874 600966 + -1.236582183 0.035067448 
SR0459 chr 607624 607706 - 1.049962515 0.029441872 
SR0472 chr 621854 621957 - 2.59978124 0.025861453 
SR0513 chr 657818 657937 - 1.360417685 0.021798156 
SR0514 chr 658746 658855 - 1.44876326 0.004573995 
SR0520 chr 662542 662591 + -2.930390418 6.62E-06 
SR0521 chr 663063 663145 - -3.645138546 1.16E-08 
SR0537 chr 674835 674884 + -1.954569165 1.86E-06 
SR0538 chr 675672 675744 - -1.340456717 0.000152096 
SR0549 chr 688778 688888 - 1.059840465 0.046441965 
SR0557 chr 696669 696840 + -1.455782412 5.26E-07 
SR0559 chr 699758 699987 - 7.802998976 2.03E-06 
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SR0616 chr 754389 754503 - -1.579633071 0.013711721 
SR0643 chr 790233 790281 + -1.71542151 0.001400635 
SR0644 chr 791442 791497 + -1.640720176 0.032465907 
SR0652 chr 803502 803604 - -1.597307653 0.002085611 
SR0657 chr 812265 812439 - -2.320974658 6.31E-05 
SR0666 chr 822940 822989 - -7.064279447 9.11E-76 
SR0667 chr 823166 823231 + -1.181558845 1.18E-05 
SR0692 chr 860131 860278 + -1.730488146 0.007179662 
SR0693 chr 860333 860544 - -1.72865893 0.000957821 
SR0697 chr 863477 863549 - -1.489284025 0.005046202 
SR0728 lp17 8155 8220 + 3.005385284 1.05E-13 
SR0729 lp17 8211 8257 - 2.659286196 4.83E-05 
SR0730 lp17 8407 8487 - 2.028182494 1.03E-09 
SR0738 lp17 12902 12951 + 1.736504713 0.02204039 
SR0751 lp25 12423 12473 + -1.631260433 0.004865585 
SR0752 lp25 13269 13417 - -2.29987205 0.005232047 
SR0755 lp25 15951 16076 + -1.497872176 0.004940813 
SR0766 lp28-1 10442 10547 - -1.770008208 0.00095639 
SR0768 lp28-1 13306 13355 + -2.624185545 0.000125427 
SR0779 lp28-2 26424 26497 + 2.223505386 0.004614012 
SR0788 lp28-3 9510 9570 - -2.018714944 5.60E-05 
SR0805 lp28-4 12723 12840 - -1.380152775 0.016637921 
SR0812 lp28-4 19115 19207 - 1.335542101 0.034401719 
SR0815 lp28-4 26351 26421 + 2.703553681 4.87E-07 
SR0830 lp36 15735 15794 - 1.305942792 0.017463607 
SR0837 lp36 22421 22583 - -1.526193511 0.000443694 
SR0841 lp36 26891 26940 - 1.270671751 0.013500781 
SR0848 lp36 35057 35217 + 1.176672551 0.002180512 
SR0852 lp38 6872 6947 + -1.35492921 0.045065494 
SR0865 lp38 26484 26597 + 1.65914682 0.029441872 
SR0866 lp38 26536 26600 - 1.638570844 0.04052967 
SR0879 lp38 38374 38508 - 3.405986738 2.67E-09 
SR0896 lp54 23118 23236 + 1.349938919 0.000740556 
SR0909 lp54 44646 44713 - 1.60009289 0.029441872 
SR0911 lp54 45194 45286 + 1.727973613 0.007710031 
SR0953 cp26 7013 7135 - 1.801787455 1.76E-05 
SR0958 cp26 8033 8111 - 1.176239568 0.01770918 
SR0980 cp32-1 22671 22740 - -1.209487177 0.016598983 
SR0996 cp32-7 18868 18934 - -1.808827538 0.041740727 
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Table 3.3 mRNAs differentially expressed between wild-type and spoVG-ON  
Gene 
Log2 
Change padj 
BB_0008| conserved hypothetical protein0008|  -1.190 5.55E-05 
BB_0009| conserved hypothetical protein0009|  -1.493 1.88E-10 
BB_0013| conserved hypothetical protein0013|  -1.056 9.43E-03 
BB_0014| priA| primosomal protein N'0014|  -1.527 4.28E-07 
BB_0015| udk| uridine kinase0015|  -1.449 1.35E-06 
BB_0023| ruvA| holliday junction DNA helicase RuvA0023|  1.149 3.52E-03 
BB_0034| outer membrane protein P130034|  1.219 2.06E-03 
BB_0043| conserved hypothetical protein0043|  1.824 2.74E-04 
BB_0044| conserved hypothetical protein0044|  1.752 5.82E-04 
BB_0047| conserved hypothetical protein0047|  2.071 4.46E-04 
BB_0076| ftsY| signal recognition particle-docking protein  -1.098 6.20E-05 
BB_0080| ABC transporter%2C ATP-binding protein0080|  -1.249 2.12E-03 
BB_0081| efflux ABC transporter  -1.224 8.95E-03 
BB_0098| MutS2 protein0098|  -1.113 1.46E-02 
BB_0134| tetratricopeptide repeat domain protein0134|  -1.056 3.72E-03 
BB_0184| csrA| carbon storage regulator0184|  -1.521 1.85E-03 
BB_0189| rpmI| ribosomal protein L350189|  1.100 1.78E-03 
BB_0211| DNA mismatch repair protein MutL0211|  -1.016 8.26E-04 
BB_0212| borrelia ORF-A superfamily0212|  1.092 1.89E-02 
BB_0217| pstA| phosphate ABC transporter -1.166 3.16E-04 
BB_0225| tRNA-dihydrouridine synthase A0225|  -1.348 1.43E-02 
BB_0238| conserved hypothetical protein0238|  1.156 3.12E-03 
BB_0240| glycerol uptake facilitator0240|  2.581 6.31E-25 
BB_0241| glpK| glycerol kinase0241|  2.320 1.07E-12 
BB_0242| conserved hypothetical protein0242|  2.370 5.89E-10 
BB_0243| glycerol-3-phosphate dehydrogenase 2.409 1.30E-10 
BB_0251| leuS| leucyl-tRNA synthetase0251|  -1.677 5.65E-05 
BB_0273| fliR| flagellar biosynthetic protein FliR0273|  -1.070 2.51E-02 
BB_0282| hypothetical protein0282|  1.015 1.41E-02 
BB_0295| hslU| heat shock protein HslVU  ATPase subunit  -1.057 5.06E-04 
BB_0296| ATP-dependent protease HslV0296|  -1.202 5.94E-05 
BB_0304| murF -1.085 2.24E-03 
BB_0305| conserved hypothetical protein0305|  -1.515 3.19E-09 
BB_0306| mraW| S-adenosyl-methyltransferase MraW0306|  -1.190 1.11E-06 
BB_0323| LysM domain protein0323|  1.103 1.46E-03 
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BB_0332| ABC transporter%2C permease protein0332|  -1.271 3.39E-04 
BB_0334| oligopeptide transport ATP-binding protein OppD -1.129 2.67E-02 
BB_0355| transcription factor%2C putative0355|  1.019 2.09E-04 
BB_0360| conserved hypothetical protein0360|  -1.054 1.33E-04 
BB_0362| lgt| prolipoprotein diacylglyceryl transferase0362|  -1.038 2.30E-05 
BB_0363| periplasmic protein0363|  -1.562 7.24E-11 
BB_0366| vacuolar aminopeptidase I0366|  1.394 2.01E-03 
BB_0367|  phosphotransferase enzyme IIb component 1.687 4.63E-05 
BB_0374| HD domain protein0374|  -1.621 7.32E-04 
BB_0375| pfs| putative nucleosidase%2C Pfs protein0375|  -1.855 9.62E-10 
BB_0376| metK| methionine adenosyltransferase0376|  -1.954 3.76E-08 
BB_0377| luxS| S-ribosylhomocysteinase LuxS0377|  -1.520 4.72E-05 
BB_0384| bmpC| basic membrane protein C (bmpC)0384|  1.088 8.45E-06 
BB_0385| bmpD| basic membrane protein D (bmpD)0385|  1.255 1.53E-02 
BB_0409| conserved hypothetical protein0409|  -1.884 2.90E-05 
BB_0412| membrane protein%2C putative0412|  -1.065 1.61E-02 
BB_0417| adenylate kinase (ATP-AMP transphosphorylase) -1.357 1.24E-06 
BB_0426| nucleoside 2-deoxyribosyltransferase superfamily 1.365 6.31E-04 
BB_0445| fbaA| fructose-bisphosphate aldolase 1.115 6.27E-03 
BB_0447| Na+/H+ antiporter0447|  -1.362 6.27E-03 
BB_0450| rpoN| RNA polymerase sigma-54 factor0450|  -2.221 4.21E-05 
BB_0451| chromate transport protein%2C putative0451|  -1.467 2.14E-02 
BB_0452| chromate transporter superfamily0452|  -1.628 2.59E-02 
BB_0472| murA|  -1.019 7.42E-05 
BB_0475| lipoprotein%2C putative0475|  1.165 5.62E-03 
BB_0507| conserved hypothetical protein0507|  -1.078 3.01E-02 
BB_0512| conserved hypothetical protein0512|  -1.270 1.98E-03 
BB_0535| conserved hypothetical protein0535|  1.257 7.76E-04 
BB_0537| tetratricopeptide repeat domain protein0537|  -1.734 1.99E-06 
BB_0538| hypothetical protein0538|  -1.506 6.68E-06 
BB_0548| polA| DNA polymerase I superfamily0548|  -1.101 7.95E-05 
BB_0555| conserved hypothetical protein0555|  -1.038 2.54E-03 
BB_0577| conserved hypothetical protein0577|  1.290 2.25E-04 
BB_0586| FemA protein0586|  -1.140 1.68E-03 
BB_0592| caax amino protease family0592|  1.231 3.67E-03 
BB_0603| p66| integral outer membrane protein P660603|  1.099 1.46E-03 
BB_0617| conserved hypothetical protein0617|  1.401 7.25E-04 
BB_0626| rnmV| ribonuclease M50626|  1.477 2.00E-04 
BB_0633| recB| exodeoxyribonuclease  -1.440 3.57E-03 
BB_0639| spermidine/putrescine ABC transporter0639|  -1.286 1.20E-02 
91 
 
 
BB_0640| binding-protein-dependent transport systems  -1.714 1.30E-04 
BB_0641| putrescine transport system permease protein  -1.848 2.09E-05 
BB_0642| potA| spermidine/putrescine ABC  -1.499 1.31E-03 
BB_0649| groL| chaperonin GroL0649|  1.140 1.84E-02 
BB_0661| conserved hypothetical protein0661|  1.540 4.24E-09 
BB_0662| conserved hypothetical protein0662|  1.404 3.36E-04 
BB_0671| CheC-like family protein0671|  -1.082 8.63E-05 
BB_0672| CheY0672|  -1.268 6.77E-03 
BB_0673| conserved hypothetical protein0673|  -1.006 3.69E-02 
BB_0677| rbsA| sugar ABC transporter -1.028 1.84E-02 
BB_0679| ribose/galactose ABC transporter  -1.082 3.91E-02 
BB_0690| napA| neutrophil activating protein A (napA)0690|  1.736 2.46E-03 
BB_0712| RNA polymerase sigma factor RpoD  -1.341 3.71E-05 
BB_0713| conserved hypothetical protein0713|  -1.759 6.02E-12 
BB_0721| pgsA| 0721|  -1.055 3.06E-02 
BB_0722| conserved hypothetical protein0722|  -1.270 1.07E-02 
BB_0734| Sua5/YciO/YrdC/YwlC family protein -1.060 3.41E-03 
BB_0740| conserved hypothetical protein0740|  -1.724 1.12E-07 
BB_0746| oligopeptide ABC transporter permease protein -6.706 3.23E-06 
BB_0754| ABC transporter%2C ATP-binding protein0754|  -1.229 1.22E-04 
BB_0755| rnz| ribonuclease Z0755|  -1.208 1.76E-04 
BB_0764| sensory transduction histidine kinase -1.993 2.86E-07 
BB_0765| conserved hypothetical protein0765|  -1.932 1.64E-04 
BB_0766| cvpA| CvpA family protein0766|  -2.768 1.08E-07 
BB_0767| murG| 0767|  -2.196 2.90E-05 
BB_0768| pyridoxal kinase0768|  -2.056 5.69E-07 
BB_0769| glycoprotease family0769|  -2.530 1.99E-08 
BB_0770| divergent polysaccharide deacetylase superfamily -2.116 1.33E-07 
BB_0771a| hypothetical protein0771a|  -1.236 1.52E-02 
BB_0782| nadD|  -1.198 1.68E-04 
BB_0783| conserved hypothetical protein0783|  -1.051 2.38E-03 
BB_0784| iojap-like ribosome-associated protein0784|  -1.062 8.47E-03 
BB_0785|  spoVG (Stage V sporulation protein G)0785|  2.617 3.67E-27 
BB_0807| conserved hypothetical integral membrane protein -1.510 4.23E-04 
BB_0808| putative permease%2C YjgP/YjgQ family0808|  -1.196 7.37E-03 
BB_0809| tgt| queuine tRNA-ribosyltransferase0809|  -1.095 1.01E-04 
BB_0833| ileS| isoleucyl-tRNA synthetase0833|  -1.234 4.68E-03 
BB_0837| uvrA| excinuclease ABC%2C A subunit0837|  -1.448 1.37E-04 
BB_0838| conserved hypothetical protein0838|  -1.238 3.12E-03 
BB_0841| arcA| arginine deiminase0841|  1.956 6.87E-12 
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BB_0842| argF| ornithine carbamoyltransferase0842|  1.752 6.16E-05 
BB_0843| arginine-ornithine antiporter0843|  1.224 7.99E-07 
BB_A08| conserved hypothetical proteinA08|  1.078 9.39E-03 
BB_A38| putative phage portal protein%2C HI1409 
familyA38|  -1.075 1.76E-02 
BB_A40| lyme disease proteins of unknown functionA40|  -1.218 9.17E-04 
BB_A41| conserved hypothetical proteinA41|  -1.320 1.34E-03 
BB_A42| conserved hypothetical proteinA42|  -1.351 1.63E-03 
BB_A53| Bbs27 proteinA53|  -1.352 4.38E-02 
BB_A74| osm28| outer membrane porin OMS28A74|  -2.318 8.04E-04 
BB_B01| acylphosphataseB01|  1.065 3.20E-03 
BB_B03| resT| telomere resolvase ResTB03|  1.029 6.93E-03 
BB_B04| chbC| chitibiose transporter protein chbCB04|  2.610 7.82E-14 
BB_B10| borrelia ORF-A superfamilyB10|  1.243 8.57E-05 
BB_B24| conserved hypothetical proteinB24|  -1.357 6.65E-05 
BB_B29| pts system%2C iibc componentsB29|  1.287 8.21E-04 
BB_C01| BBC01C01|  11.520 5.85E-19 
BB_C03| BBC03C03|  10.782 2.25E-16 
BB_C05| BBC05C05|  9.565 1.85E-12 
BB_D14| borrelia ORF-A superfamilyD14|  1.670 5.61E-06 
BB_E09| protein p23E09|  -3.640 8.11E-14 
BB_E16| bptA| BptA proteinE16|  -3.894 2.50E-36 
BB_E17| conserved hypothetical proteinE17|  -3.173 4.16E-23 
BB_E18| PF-49 proteinE18|  -3.896 1.33E-20 
BB_E19| PF-32 proteinE19|  -4.272 1.40E-26 
BB_E20| borrelia family of unknown functionE20|  -4.332 5.15E-29 
BB_E21| conserved hypothetical proteinE21|  -3.794 9.10E-39 
BB_E22| pncA|  -4.970 2.44E-03 
BB_E31| putative surface proteinE31|  -2.651 1.49E-19 
BB_F23| PF49F23|  -1.556 1.33E-02 
BB_G08| stage 0 sporulation protein JG08|  -1.073 4.02E-02 
BB_H37| lipoprotein%2C putativeH37|  -1.481 1.62E-02 
BB_I16| vraA|I16|  1.187 6.44E-03 
BB_I22| PF-49 proteinI22|  -1.414 1.72E-02 
BB_J08| putative surface proteinJ08|  1.263 4.38E-02 
BB_J09| ospD| outer surface protein D (OspD)J09|  -1.693 3.48E-02 
BB_J19| borrelia ORF-A superfamilyJ19|  1.225 7.40E-04 
BB_K01| lipoprotein%2C putativeK01|  -2.160 6.10E-06 
BB_K40| conserved hypothetical proteinK40|  1.712 3.34E-03 
BB_K47| conserved hypothetical proteinK47|  -1.198 3.39E-02 
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BB_K49| conserved hypothetical proteinK49|  -1.095 4.59E-02 
BB_K52| putative lipoproteinK52|  1.466 5.68E-05 
BB_L20| conserved hypothetical proteinL20|  -1.174 1.31E-03 
BB_L21| conserved hypothetical proteinL21|  -1.504 1.96E-04 
BB_L22| conserved hypothetical proteinL22|  -1.170 8.35E-04 
BB_L25| 2.9-6 ORF-CL25|  -1.730 9.88E-07 
BB_L26| borrelia orf-D familyL26|  -1.785 7.92E-08 
BB_L31| borrelia family of unknown functionL31|  -1.016 2.38E-03 
BB_L32| PF-32 proteinL32|  -1.109 1.16E-03 
BB_M20| conserved hypothetical proteinM20|  -1.393 1.46E-04 
BB_M21| conserved hypothetical proteinM21|  -1.494 2.33E-04 
BB_M25| 2.9-6 ORF-CM25|  -1.389 2.26E-04 
BB_M30| BBC01M30|  1.161 3.62E-03 
BB_M33| PF-49 proteinM33|  -1.812 2.58E-03 
BB_M34| BdrKM34|  -1.456 1.98E-03 
BB_N19| conserved hypothetical proteinN19|  1.036 1.75E-02 
BB_N25| 2.9-6 ORF-CN25|  -1.112 2.22E-03 
BB_N27| BdrRN27|  1.158 2.08E-02 
BB_N28| lipoproteinN28|  1.683 1.23E-03 
BB_N33| PF-49 proteinN33|  -1.532 4.75E-03 
BB_N34| BdrQN34|  -1.177 1.35E-02 
BB_O21| conserved hypothetical proteinO21|  -1.423 7.34E-04 
BB_O22| conserved hypothetical proteinO22|  -1.151 1.03E-03 
BB_O26| borrelia orf-D familyO26|  -1.127 3.56E-04 
BB_O33| putative plasmid partition protein%3B Orf3O33|  -1.750 8.45E-03 
BB_O34| BdrMO34|  -1.400 1.72E-02 
BB_O39| erpL| ErpL proteinO39|  3.779 1.24E-02 
BB_P20| conserved hypothetical proteinP20|  -1.393 1.46E-04 
BB_P21| conserved hypothetical proteinP21|  -1.552 1.33E-04 
BB_P22| conserved hypothetical proteinP22|  -1.152 1.07E-03 
BB_P25| 2.9-7 ORF-CP25|  -1.490 1.63E-03 
BB_P26| borrelia orf-D familyP26|  -1.384 4.75E-03 
BB_P31| borrelia family of unknown functionP31|  -1.576 1.27E-04 
BB_P32| PF-32 proteinP32|  -2.934 8.85E-07 
BB_P33| PF-49 proteinP33|  -2.877 8.57E-08 
BB_P34| BdrAP34|  -2.231 3.07E-06 
BB_Q03| outer membrane proteinQ03|  -1.283 6.03E-03 
BB_Q06| borrelia membrane protein P13Q06|  -1.188 1.62E-02 
BB_Q09| borrelia family of unknown functionQ09|  -1.884 1.34E-03 
BB_Q14| conserved hypothetical proteinQ14|  -5.022 4.38E-02 
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BB_Q23| conserved hypothetical proteinQ23|  -1.230 3.68E-02 
BB_Q26| conserved hypothetical proteinQ26|  -1.083 3.34E-03 
BB_Q27| conserved hypothetical proteinQ27|  -1.417 1.01E-04 
BB_Q28| conserved hypothetical proteinQ28|  -1.768 2.90E-05 
BB_Q29| conserved hypothetical proteinQ29|  -2.395 2.53E-13 
BB_Q30| holin%2C BlyA familyQ30|  -1.092 1.63E-02 
BB_Q31| hemolysin accessory proteinQ31|  -1.242 1.98E-03 
BB_Q32| 2.9-6 ORF-CQ32|  -1.554 3.41E-05 
BB_Q33| borrelia orf-D familyQ33|  -1.986 2.45E-10 
BB_Q39| borrelia family of unknown functionQ39|  -1.132 3.07E-04 
BB_Q40| PF-32 proteinQ40|  -2.722 3.41E-08 
BB_Q48| conserved hypothetical proteinQ48|  -1.706 4.88E-05 
BB_Q49| hypothetical proteinQ49|  -1.531 6.43E-04 
BB_Q62| conserved hypothetical proteinQ62|  -2.884 2.09E-05 
BB_Q67| adenine specific DNA methyltransferaseQ67|  -1.731 1.78E-03 
BB_R05| lyme disease proteins of unknown functionR05|  -1.032 4.08E-02 
BB_R20| conserved hypothetical proteinR20|  -1.240 5.60E-04 
BB_R21| conserved hypothetical proteinR21|  -1.407 4.76E-04 
BB_R22| conserved hypothetical proteinR22|  -1.521 3.25E-06 
BB_R23| holin%2C BlyA familyR23|  -1.118 1.52E-02 
BB_R25| 2.9-6 ORF-CR25|  -1.501 6.35E-05 
BB_R26| borrelia orf-D familyR26|  -1.412 4.85E-05 
BB_R27| BdrHR27|  1.187 4.93E-03 
BB_R28| lipoproteinR28|  1.426 2.82E-03 
BB_R32| borrelia family of unknown functionR32|  -1.037 6.44E-03 
BB_R33| PF-32 proteinR33|  -1.579 6.65E-05 
BB_R34| PF-49 proteinR34|  -1.569 9.06E-04 
BB_S20| conserved hypothetical proteinS20|  -1.419 1.13E-04 
BB_S21| conserved hypothetical proteinS21|  -1.278 1.34E-03 
BB_S25| 2.9-6 ORF-CS25|  -1.497 5.82E-05 
BB_S26| borrelia orf-D familyS26|  -1.293 5.02E-04 
EBG00001182584| tRNA| biotype=tRNA00001182584 -1.124 1.70E-02 
EBG00001182585| tRNA| biotype=tRNA00001182585 1.412 4.01E-02 
EBG00001182601| tRNA| biotype=tRNA00001182601 1.144 4.23E-03 
EBG00001182604| tRNA| biotype=tRNA00001182604 1.170 3.71E-02 
EBG00001182606| tRNA| biotype=tRNA00001182606 1.772 5.46E-03 
EBG00001182619| tRNA| biotype=tRNA00001182619 1.833 6.43E-04 
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Table 3.4 mRNAs differentially expressed between wild-type and DspoVG 
gene 
Log2 
Change padj 
BB_0006| membrane protein0006|  -1.161 4.61E-03 
BB_0025| DNA-binding regulatory protein YebC/PmpR  1.507 1.07E-02 
BB_0026| methylenetetrahydrofolate dehydrogenase0026|  1.338 8.69E-03 
BB_0036| DNA topoisomerase II (N-region) domain protein -1.474 6.59E-03 
BB_0037| 1-acyl-sn-glycerol-3-phosphate acyltransferase  -1.464 2.18E-03 
BB_0039| conserved hypothetical protein0039|  -1.320 2.31E-02 
BB_0040| cheR| CheR methyltransferase 1.011 3.29E-02 
BB_0084| aminotransferase%2C class V superfamily0084|  -1.849 1.09E-02 
BB_0114| single-stranded DNA-binding protein  1.117 4.22E-03 
BB_0115| 30S ribosomal protein S60115|  1.224 8.38E-04 
BB_0138| conserved hypothetical protein0138|  -1.738 4.75E-03 
BB_0168| DnaK suppressor%2C putative0168|  -1.092 6.83E-05 
BB_0174| conserved hypothetical protein0174|  -1.081 2.97E-02 
BB_0179| trmE| tRNA modification GTPase TrmE0179|  -1.170 9.97E-04 
BB_0193| lipoprotein%2C putative0193|  -1.233 1.77E-02 
BB_0240| glycerol uptake facilitator0240|  -3.036 3.31E-34 
BB_0241| glpK| glycerol kinase0241|  -3.124 4.93E-23 
BB_0242| conserved hypothetical protein0242|  -3.620 1.25E-22 
BB_0243| glycerol-3-phosphate dehydrogenase -2.348 5.13E-10 
BB_0244| conserved hypothetical protein0244|  -1.303 3.32E-04 
BB_0245| hypothetical protein0245|  -1.012 3.33E-03 
BB_0246| M23 peptidase domain protein0246|  -1.582 1.12E-06 
BB_0258| undecaprenol kinase0258|  -1.170 1.45E-02 
BB_0275| fliP| flagellar biosynthetic protein FliP0275|  -1.152 4.58E-02 
BB_0295| hslU|  1.073 5.71E-04 
BB_0317| conserved hypothetical integral membrane prot -1.001 4.20E-02 
BB_0330| bacterial extracellular solute-binding protein -1.755 8.65E-03 
BB_0364| mgsA| methylglyoxal synthase0364|  -1.203 6.20E-03 
BB_0426| nucleoside 2-deoxyribosyltransferase superfamily 1.001 2.45E-02 
BB_0429| conserved hypothetical protein0429|  1.574 3.24E-03 
BB_0434| spo0J| stage 0 sporulation protein J0434|  1.012 4.56E-02 
BB_0438| dnaN| DNA polymerase III%2C beta subunit0438|  1.756 3.45E-04 
BB_0439| conserved hypothetical protein0439|  1.395 3.19E-04 
BB_0454| lipopolysaccharide biosynthesis-related protein 1.422 1.24E-02 
BB_0470| conserved hypothetical protein0470|  -1.046 4.75E-03 
BB_0508| engA| ribosome-associated GTPase EngA0508|  -1.569 2.03E-05 
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BB_0584| conserved hypothetical integral membrane prot -1.730 8.49E-06 
BB_0588| bgp| MTA/SAH nucleosidase Glycosaminoglycan 
binding  1.094 2.77E-02 
BB_0592| caax amino protease family0592|  -1.185 8.01E-03 
BB_0626| rnmV| ribonuclease M50626|  1.144 8.37E-03 
BB_0631| conserved hypothetical protein0631|  -3.524 1.25E-26 
BB_0636| zwf| glucose-6-phosphate 1-dehydrogenase  -1.229 9.97E-04 
BB_0637| Na+/H+ antiporter family0637|  -1.047 6.31E-05 
BB_0638| Na+/H+ antiporter0638|  -1.484 4.84E-07 
BB_0639| spermidine/putrescine ABC transporter -1.230 2.30E-02 
BB_0656| oxygen-independent coproporphyrinogen III oxidase -1.054 1.70E-04 
BB_0657| rpiA| ribose 5-phosphate isomerase A0657|  -1.355 8.60E-06 
BB_0658| phosphoglycerate mutase family protein 1.194 4.18E-03 
BB_0678| ribose/galactose ABC transporter -1.315 1.77E-03 
BB_0679| ribose/galactose ABC transporter -1.380 7.69E-03 
BB_0689| lipoprotein%2C putative0689|  1.408 5.38E-05 
BB_0691| fusA| translation elongation factor G0691|  1.321 3.50E-02 
BB_0693| xylose operon regulatory protein0693|  1.020 1.36E-02 
BB_0716| mreC| rod shape-determining protein MreC0716|  -1.134 4.62E-02 
BB_0717| conserved hypothetical integral membrane protein -1.709 5.99E-03 
BB_0719| mrdB| rod shape-determining protein RodA0719|  -1.414 5.39E-03 
BB_0737| histidine phosphokinase/phophatase -1.230 4.38E-03 
BB_0746| oligopeptide ABC transporter%2C permease  -6.982 1.34E-06 
BB_0747| oligopeptide ABC transporter%2C permease  -1.448 2.79E-02 
BB_0770| divergent polysaccharide deacetylase superfamily -1.645 1.16E-04 
BB_0776| conserved hypothetical protein0776|  1.453 8.95E-03 
BB_0777| apt| adenine phosphoribosyltransferase0777|  1.497 1.35E-02 
BB_0785|  spoVG (Stage V sporulation protein G)0785|  -6.583 3.38E-167 
BB_0814| panF| sodium/pantothenate symporter0814|  -1.675 1.06E-08 
BB_0816| conserved hypothetical protein0816|  -1.154 7.42E-05 
BB_0817| murC| UDP-N-acetylmuramate--alanine ligase0817|  -1.029 4.69E-02 
BB_0844| lipoprotein%2C putative0844|  3.121 1.16E-08 
BB_A24| dbpA| decorin-binding protein AA24|  2.807 2.17E-31 
BB_A25| dbpB| decorin-binding protein BA25|  2.825 9.13E-27 
BB_A32| conserved hypothetical proteinA32|  1.498 5.39E-03 
BB_A34| bacterial extracellular solute-binding protein 1.980 2.19E-08 
BB_A36| lipoproteinA36|  2.844 1.85E-16 
BB_A37| conserved hypothetical proteinA37|  1.483 4.06E-02 
BB_A52| outer membrane proteinA52|  -1.163 3.47E-02 
BB_A53| Bbs27 proteinA53|  -1.508 2.82E-02 
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BB_A54| conserved hypothetical proteinA54|  -1.232 4.17E-02 
BB_A58| conserved hypothetical proteinA58|  -1.991 1.40E-04 
BB_A59| hypothetical proteinA59|  -2.335 7.42E-20 
BB_A66| outer surface proteinA66|  1.603 2.27E-02 
BB_A74| osm28| outer membrane porin OMS28A74|  -1.605 4.15E-02 
BB_B09| lipoprotein%2C putativeB09|  1.569 7.71E-07 
BB_D09| conserved hypothetical proteinD09|  1.485 2.49E-04 
BB_D10| BBD10D10|  1.584 2.54E-03 
BB_D13| conserved hypothetical proteinD13|  1.835 3.32E-04 
BB_D14| borrelia ORF-A superfamilyD14|  2.154 1.15E-09 
BB_D15| BBD15D15|  1.415 1.12E-02 
BB_D21| CdsMD21|  1.453 5.15E-03 
BB_E18| PF-49 proteinE18|  -1.410 4.61E-03 
BB_E19| PF-32 proteinE19|  -1.657 2.93E-04 
BB_E20| borrelia family of unknown functionE20|  -1.859 1.29E-05 
BB_F14| borrelia family of unknown functionF14|  -2.407 1.00E-02 
BB_F17| putative transmembrane proteinF17|  -2.082 1.77E-05 
BB_F23| PF49F23|  -2.691 3.03E-06 
BB_F24| PF32F24|  -2.636 5.38E-07 
BB_F25| borrelia family of unknown functionF25|  -2.088 1.46E-04 
BB_F26| borrelia ORF-A superfamilyF26|  -1.773 7.91E-04 
BB_G16| conserved hypothetical proteinG16|  1.273 3.92E-02 
BB_G17| conserved hypothetical proteinG17|  1.263 1.07E-02 
BB_G18| conserved hypothetical proteinG18|  1.515 4.61E-03 
BB_G19| putative phage terminaseG19|  1.665 2.63E-03 
BB_G20| putative phage portal protein%2C HI1409 familyG20|  1.221 4.93E-02 
BB_G26| conserved hypothetical proteinG26|  2.393 4.53E-02 
BB_G29| borrelia ORF-A superfamilyG29|  2.103 1.16E-05 
BB_G31| borrelia family of unknown functionG31|  1.510 1.03E-02 
BB_G32| putative replicative helicaseG32|  1.040 4.87E-02 
BB_G33| RepUG33|  1.614 1.76E-03 
BB_H09| type I restriction enzyme r protein n terminus  1.624 1.27E-03 
BB_H09a| conserved hypothetical proteinH09a|  1.401 2.92E-02 
BB_H32| antigen%2C P35%2C putativeH32|  1.610 3.33E-03 
BB_H41| borrelia membrane protein P13H41|  2.710 1.18E-07 
BB_I20| borrelia family of unknown functionI20|  -1.085 8.52E-03 
BB_I21| PF-32 proteinI21|  -1.075 2.59E-02 
BB_I36| antigen%2C P35%2C putativeI36|  1.381 4.15E-02 
BB_I41| conserved hypothetical proteinI41|  1.074 4.90E-02 
BB_I42| outer membrane proteinI42|  2.276 2.36E-07 
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BB_J08| putative surface proteinJ08|  1.356 3.67E-02 
BB_J09| ospD| outer surface protein D (OspD)J09|  -2.206 5.05E-03 
BB_J19| borrelia ORF-A superfamilyJ19|  1.253 7.91E-04 
BB_J23| tetratricopeptide repeat domain proteinJ23|  3.236 6.48E-16 
BB_J24| conserved hypothetical proteinJ24|  2.349 4.02E-15 
BB_J25| conserved hypothetical proteinJ25|  2.260 1.08E-08 
BB_J26| ABC transporter%2C ATP-binding proteinJ26|  3.279 1.05E-09 
BB_J27| efflux ABC transporter%2C permease proteinJ27|  2.743 2.41E-12 
BB_J28| conserved hypothetical proteinJ28|  2.612 7.08E-21 
BB_J29| conserved hypothetical proteinJ29|  1.997 5.58E-12 
BB_J31| conserved hypothetical proteinJ31|  2.469 5.40E-12 
BB_J43| conserved hypothetical proteinJ43|  1.884 5.66E-08 
BB_J45| putative lipoproteinJ45|  2.462 7.46E-12 
BB_J46| conserved hypothetical proteinJ46|  1.923 2.81E-10 
BB_J47| conserved hypothetical proteinJ47|  1.191 6.59E-03 
BB_J48| conserved hypothetical proteinJ48|  1.562 1.46E-04 
BB_K0058| hypothetical proteinK0058|  2.267 7.55E-05 
BB_K07| lipoprotein%2C putativeK07|  2.981 5.11E-06 
BB_K17| adeC| adenine deaminaseK17|  1.239 5.39E-03 
BB_K32| bbk32| fibronectin-binding protein BBK32K32|  2.191 1.58E-18 
BB_K34| conserved hypothetical proteinK34|  -1.085 2.27E-02 
BB_K35| conserved hypothetical proteinK35|  -2.055 4.57E-03 
BB_K48| immunogenic protein P37%2C putativeK48|  2.060 3.57E-12 
BB_K52| putative lipoproteinK52|  1.045 9.68E-03 
BB_K53| outer membrane proteinK53|  2.055 3.95E-06 
BB_K54| conserved hypothetical proteinK54|  2.413 2.72E-05 
BB_L27| BdrPL27|  1.426 2.89E-03 
BB_L28| lipoproteinL28|  1.929 1.13E-04 
BB_L29| 2.9-5 36K%3B minus strand ORFL29|  1.064 7.45E-03 
BB_L36| BppAL36|  1.300 4.03E-02 
BB_L37| BppBL37|  1.277 1.43E-02 
BB_L39| erpA8| ErpA8 proteinL39|  1.256 2.20E-02 
BB_L40| erpB8| ErpB8 proteinL40|  1.448 1.25E-04 
BB_M27| rev proteinM27|  2.717 2.79E-25 
BB_M29| 2.9-5 36K%3B minus strand ORFM29|  1.145 7.94E-03 
BB_M35| BppAM35|  1.283 3.50E-02 
BB_M36| BppBM36|  1.078 4.57E-02 
BB_M37| BppCM37|  1.059 4.24E-02 
BB_M38| erpK| ErpK proteinM38|  3.120 6.96E-06 
BB_N19| conserved hypothetical proteinN19|  1.450 5.44E-04 
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BB_N20| conserved hypothetical proteinN20|  1.040 1.47E-02 
BB_N27| BdrRN27|  1.708 3.36E-04 
BB_N28| lipoproteinN28|  1.376 1.50E-02 
BB_N30| BBC01N30|  -1.011 4.83E-03 
BB_N39| erpQ| ErpQ proteinN39|  1.344 3.17E-03 
BB_O19| conserved hypothetical proteinO19|  1.759 8.69E-06 
BB_O20| conserved hypothetical proteinO20|  1.531 3.83E-04 
BB_O24| hemolysin accessory proteinO24|  1.271 5.65E-04 
BB_O27| BdrNO27|  1.091 7.18E-03 
BB_O28| lipoproteinO28|  1.443 4.70E-03 
BB_O29| 2.9-5 36K%3B minus strand ORFO29|  1.251 1.40E-03 
BB_O36| BppAO36|  1.293 4.41E-02 
BB_O37| BppBO37|  1.283 1.47E-02 
BB_O38| BppCO38|  1.080 4.24E-02 
BB_O39| erpL| ErpL proteinO39|  5.358 2.11E-04 
BB_O40| erpM| ErpM proteinO40|  2.795 1.14E-07 
BB_P27| revA1| surface protein (RevA1)P27|  2.627 1.04E-23 
BB_P29| 2.9-5 36K%3B minus strand ORFP29|  1.097 4.18E-03 
BB_P38| erpA| ErpA proteinP38|  1.250 2.28E-02 
BB_P39| erpB1| ErpB1 proteinP39|  1.446 1.25E-04 
BB_Q03| outer membrane proteinQ03|  1.929 7.35E-06 
BB_Q47| erpX| ErpX proteinQ47|  4.061 1.99E-13 
BB_Q62| conserved hypothetical proteinQ62|  -2.089 4.37E-03 
BB_R27| BdrHR27|  1.095 1.49E-02 
BB_R29| 2.9-5 36K%3B minus strand ORFR29|  1.093 4.51E-02 
BB_R44| hypothetical proteinR44|  1.052 1.47E-02 
BB_S29| bdrF| KID repeat proteinS29|  1.287 9.81E-04 
BB_S30| lipoproteinS30|  1.375 3.03E-02 
BB_S31| 2.9-5 36K%3B minus strand ORFS31|  1.048 6.05E-03 
BB_S41| erpG| ErpG proteinS41|  2.061 1.95E-08 
BB_S42| bapA| BapA proteinS42|  2.338 2.54E-09 
BB_U06| putative plasmid partition proteinU06|  1.195 3.20E-02 
EBG00001182586| tRNA| biotype=tRNA -1.710 4.75E-03 
EBG00001182601| tRNA| biotype=tRNA -1.181 4.87E-03 
EBG00001182606| tRNA| biotype=tRNA -1.608 4.15E-02 
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CHAPTER 4. SPOVG REGULATES EXPRESSION OF NUMEROUS GENES 
4.1 Introduction 
Our transcriptomic data identified numerous genes involved in many different 
cellular processes that were regulated at the RNA level in a spoVG-dependent manner. We 
sought to further identify whether several of these genes are regulated at the level of protein 
abundance, and whether SpoVG directly interacts with nucleic acids associated with these 
genes. We chose to investigate genes of known significance, involved in carbon 
metabolism, essential outer surface proteins, cell wall synthesis and post-translational 
modifications.  
Borrelia burgdorferi must be able to metabolize glycerol to survive within a tick and 
efficiently transmit to a vertebrate (210). While other bacteria have more complex systems 
for bringing in glycerol, and regulation of how it is metabolized, B. burgdorferi encodes 
one three-gene operon termed glpFKD (211-218) (Figure 4.1). GlpF is a transport 
facilitator that brings glycerol across the cell membranes (216). GlpK phosphorylates 
glycerol (219). At this point, glycerol-3-P can be used to assemble phospholipids and 
lipoproteins, which are cell membrane components. Glycerol-3 phosphate can also be 
converted into di-hydroxy-acetone-phosphate (DHAP) by GlpD (220). GlpD shuttles B. 
burgdorferi into glycolysis, allowing glycerol to be used as a source to generate ATP. 
Previously, several groups have demonstrated that PlzA and c-di-GMP have an 
impact on regulating expression of the glpFKD operon (144, 145, 147, 221). It has been 
known for some time that PlzA binds c-di-GMP, but apart from that interaction, and an 
indirect impact on regulation of several genes, no other function has been ascribed to PlzA. 
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It has been speculated that PlzA could interact with other proteins, or perhaps it could bind 
nucleic acids, but no studies have demonstrated either of these actions (147, 187, 222).  
SpoVG was initially identified as a DNA-binding protein from previous studies on 
vlsE from the Stevenson lab (164). vlsE codes for an outer surface protein is unique in that 
the coding region of the gene undergoes antigenic variation when B. burgdorferi is in a 
vertebrate (Figure 4.6 A). vlsE is not expressed and does not undergo variation when B. 
burgdorferi is in a tick. The gene is proceeded by about 15 silent cassettes that can 
rearrange and slot into the coding portion guided by two identical direct repeat DNA 
sequences that are present on all of the cassettes and within the coding portion (139, 223-
227). Although the mechanism of precisely how rearrangement takes place is unknown, 
the direct repeats act to guide rearrangement (223, 228-234).  
A recent study on the acetylome in Borrelia burgdorferi reported that SpoVG is 
acetylated in the cell, and that global acetylation was dependent on growth rate (235). We 
hypothesized that acetylation could impact the activity of SpoVG, and that levels of 
acetylated SpoVG could be different in the different mutants, and grown under different 
conditions. B. burgdorferi does not have any dedicated acetyl-transferases, therefore 
proteins become acetylated due to an accumulation of free acetyl-phosphate, and this is 
directly dependent on AckA (235). It is hypothesized that global acetylation could be 
important in the tick, as a mechanism of inhibiting enzyme activity without expending 
energy to degrade proteins. B. burgdorferi brings in acetate from the environment, AckA 
phosphorylates it, then phosphotransacetylase (PTA) converts acetyl-P to Acetyl-CoA, 
which is used as a substrate for lipid II biosynthesis, a component of the cell wall material 
peptidoglycan (236, 237). In the absence of AckA, essentially no proteins in the cell were 
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acetylated. In the absence of PTA, however, in which an accumulation of Acetyl-P is 
present, even more proteins were acetylated, and on more sites, than in Wild-type B. 
burgdorferi (235).  
4.2 SpoVG Regulates Expression of the glpFKD Operon 
RNA-seq on wild-type, spoVG-ON, and DspoVG strains revealed that the entire 
glpFKD operon is expressed at different levels in the mutants as compared to the wild-type 
(Figure 4.2 A). The operon is arranged such that the first gene is glpF, followed by glpK 
then an un-characterized putative ORF of about 300 base pairs, and finally glpD (Figure 
4.2 D). RNA-sequencing on triplicate cultures demonstrated that the amount of glpFKD 
RNA was approximately 3 log2 more abundant in the spoVG-ON strain than in wild-type, 
which was arbitrarily set to 1, while the amount of glpFKD RNA was approximately 3 log2 
less abundant than in wild-type.  
 Two small, antisense non-coding RNAs are associated with glpF, one at the 5’ end 
and the other near the 3’ end (110, 195, 201). Both sRNAs overlap entirely with the coding 
region of the gene. These are designated SR00186 and SR00187. Anti-sense RNAs 
(asRNAs) can exhibit a variety of regulatory functions on their target RNAs, both at the 
levels of transcription and translation. For example, asRNAs that anneal to the 3’ end of an 
mRNA transcript can increase stability of the transcript by inhibiting RNAse processing 
(238). asRNA can also inhibit translation by annealing the 5’UTR, and overlapping the 
ribosome-binding site (239). As these two anti-sense RNAs were only recently discovered, 
it is not known what impact they have on expression of glpF or the remainder of the operon. 
What makes their functions particularly unclear is that SR00186 does not overlap the 
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ribosome binding site. Both SR00186 and SR00187 are also differentially expressed in the 
spoVG-ON and DspoVG strains as compared to wild type (Figure 4.2 B). Just as the mRNA 
of the glpFKD operon is more abundant in the spoVG-ON strain than in wild-type, the two 
asRNA transcripts are also more abundant. The two asRNAs are also less abundant in the 
DspoVG strain compared to wild-type, as are the mRNA transcripts.  
Because we had previously observed that SpoVG can affect gene regulation at both 
the levels of transcription and translation, we wanted to test whether the GlpD protein was 
also expressed at different levels in the mutant strains. GlpD protein was not appreciably 
altered in the spoVG-ON mutant as compared to wild-type, however the protein abundance 
is markedly decreased in the DspoVG strain as compared to both wild-type and spoVG-ON 
strains (Figure 4.2 C).  
4.3 SpoVG binds to glpFKD DNA and RNA 
Given that SpoVG impacts expression of the glpFKD operon, we tested whether 
SpoVG interacts directly with the DNA and RNA of the operon. glpF is transcribed with 
an approximately 200bp 5’ UTR (untranslated region) (110, 145, 154). Previous work 
demonstrated that a 42bp region directly 3’ of the transcriptional promoter has a positive 
impact on transcription (240). Using a 52bp DNA probe that spans this regulatory region, 
we demonstrated by EMSA that SpoVG binds directly (Figure 4.3 A). SpoVG also bound 
to RNA that contained the same sequence as the DNA probe (4.3 B). 1,000x unlabeled 
DNA of the same sequence was not sufficient to entirely compete away the shifted protein-
RNA complex, indicating that SpoVG has a higher binding affinity for RNA than DNA. 
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This apparent higher affinity that SpoVG has for RNA over DNA is consistent with every 
probe tested.  
Approximately 400bp separate the end of glpK and the start of glpD. Within this 
region lies a hypothetical ORF, which, if translated, would code for about a 100 amino acid 
protein. Within this region lies a promoter that drives expression of glpD independently of 
glpFK (110, 241). Being able to independently control expression of glpD could potentially 
drive whether glycerol is shuttled into glycolysis or used for membrane construction. We 
tested whether SpoVG can also bind to DNA associated with this region, as this could have 
consequences for how B. burgdorferi uses glycerol within different environments. We 
found that SpoVG specifically binds to a 38bp DNA just 3’ of the transcriptional promoter, 
which we named glpKD (Figure 4.3 C). As with the spoVG and glpF sites, SpoVG also 
binds to RNA which contains the same sequence as glpKD, and 1,000x unlabeled glpKD 
DNA was unable to completely compete away the shifted SpoVG-RNA complex (Figure 
4.3 D). 
4.4 PlzA binds to glpF DNA 
 Given our knowledge that PlzA and SpoVG interact with one another, we 
hypothesized that PlzA would also bind to the sequence of glpF DNA that SpoVG does 
(MD Motaleb, personal communication). To test this, we performed an EMSA using 
labeled glpF DNA and recombinant PlzA protein (Figure 4.4). The presence of a shifted 
band when PlzA is present in the reaction demonstrates that PlzA does interact with the 
DNA. Increasing PlzA concentration resulted in a super-shift, indicating that multiple PlzA 
proteins were bound to each DNA. 100x unlabeled non-specific DNA was added to a 
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reaction with 40 nM PlzA. The addition of competitor DNA was insufficient to compete 
away the shifted band, indicating that the interaction between PlzA and DNA is specific.  
4.5 Impact of Glycerol on Growth Rate 
Previous work demonstrated that B. burgdorferi needs to use glycerol as a carbon 
source for maximum survival within the tick (210). B. burgdorferi essentially stops 
growing once the blood meal has been digested within the tick, and it has been speculated 
that perhaps B. burgdorferi senses glycerol, and it acts as a signal to slow growth (43, 242). 
Given that SpoVG regulates expression of the glpFKD operon, we hypothesized that 
cultured B. burgdorferi would grow more slowly when glycerol was added to the culture 
medium, and that this would be dependent in part, on expression of SpoVG.  
Wild-type and spoVG-ON B. burgdorferi were cultured in triplicate in either 
complete BSK-II or complete BSK-II + 4% glycerol at 34° C (Figure 4.5 A). Cultures were 
counted once every 24 hours for density. Wild-type B. burgdorferi cultured in the presence 
of glycerol grew significantly more slowly, and reached a lower final density than those 
cultured in BSK-II without glycerol. In contrast, there was not a significant difference in 
growth rate or final density between spoVG-ON bacteria cultured in BSK-II with and 
without glycerol (Figure 4.5 B).  
Given that there was a difference in growth rate in wild-type B. burgdorferi when 
exogenous glycerol was present or not, we tested by qRT-PCR whether transcript 
abundance of several genes was altered (Figure 4.5 C). We found that several genes were 
differentially expressed when glycerol is present, including spoVG, which was more highly 
expressed. A bit surprisingly, both glpF and glpD were less abundant when glycerol was 
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added to the media. This suggests that transcript abundance of other regulators may also 
be altered, and could compete with spoVG for impact on the glpFKD operon. Consistent 
with this, we found that plzA, and hk1 (which encodes the histidine kinase that stimulates 
Rrp1 to produce c-di-GMP) were also more abundantly produced in the presence of 
glycerol. In addition, dnaA, which encodes the master regulator of DNA replication, and 
recA, which encodes a vital in DNA repair enzyme, were also more abundant when cultured 
in media containing glycerol (243, 244).  
Previous studies from the Stevenson lab used BSK-Lite media to study the impact of 
different carbon sources on growth rate (245). BSK-Lite contains all of the components of 
complete BSK-II media, except that it lacks the 0.4% glucose (w/v). B. burgdorferi grows 
at the same rate in this media, however they reach a lower final density than they do in 
complete BSK-II. We hypothesized that wild-type spoVG-ON, and DspoVG strains would 
grow differently in BSK-Lite supplemented with glycerol, specifically that the spoVG-ON 
strain would reach a higher final density in BSK-II supplemented with glycerol than the 
DspoVG strain. To test this, we cultured all three strains at 34° C in BSK-Lite, BSK-Lite 
supplemented with 0.4% glucose (w/v) or 0.4% glycerol (v/v), then enumerated cell density 
once every 24 hours (Figure 4.6 A-C). All cultures were performed in triplicate. As 
expected, all three strains reached a lower final density in BSK-Lite than in BSK-Lite 
supplemented with glucose. Unexpectedly, all three strains reached the same final density 
grown in BSK-Lite supplemented with glycerol as BSK-Lite. This indicates that none of 
the strains were able to utilize glycerol to reach a higher density. This implies that B. 
burgdorferi cannot rely entirely on glycerol as an energy source, even when SpoVG is 
present and the glpFKD operon is abundantly expressed.  
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4.6 SpoVG and PlzA impact VlsE protein expression 
 We hypothesized that SpoVG could be involved in regulating expression of VlsE, 
given that SpoVG was initially identified as binding to DNA associated with the vlsE gene 
(Figure 4.7 A). To test this, wild-type and spoVG-ON cultures were grown at 34° C and 
23° C to mid-log phase (Figure 4.7 B). Lysates were probed with polyclonal a-VlsE in 
rabbit serum. At 34° C, VlsE was less abundant in the spoVG-ON lysate than in wild-type 
(A3) lysate. As previously reported, VlsE is far more abundant in wild-type lysate grown 
at 23° C than at 34° C (246). Surprisingly, VlsE was more abundant in spoVG-ON lysate 
than wild-type when cultured at 23° C. Given the fact that SpoVG protein abundance did 
not appreciably change when either wild-type or spoVG-ON cells were cultured at 23° C 
versus 34° C, this indicates that some other cellular component(s) also regulate VlsE 
expression.  
Given that we had demonstrated that SpoVG expression is undetectable in both 
DplzA (cannot respond to c-di-GMP) and Drrp1 (cannot synthesize c-di-GMP), we 
hypothesized that VlsE would be significantly less abundant in these strains as well. To 
test this, B31-S9 (wild-type), DplzA, DplzA+plzA and Drrp1 strains were grown to mid-log 
phase at 34°C (Figure 4.7 C). Lysates were probed with a-VlsE antibody. Although VlsE 
was readily detectable in both the wild-type and DplzA+plzA strains, it was greatly reduced 
in the DplzA and Drrp1 strains. What is not immediately obvious is exactly what effect the 
reduction in SpoVG expression by these strains has on the expression of VlsE. Using the 
newly generated DplzA+spoVG and Drrp1+spoVG will allow us to probe the SpoVG-vlsE 
relationship more in-depth, by measuring VlsE protein abundance. If SpoVG is the 
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responsible for altered VlsE expression in the DplzA and Drrp1 strains, then introducing 
SpoVG on the plasmid should restore wild-type VlsE expression.  
4.7 SpoVG Does Not Impact vlsE Transcription 
 A significant hurdle to studying transcription of vlsE resides in the genomic 
location of the gene. vlsE is encoded on linear plasmid lp28-1 (247). vlsE is the last encoded 
before the right telomere, which is a closed hairpin loop. Sequencing through this region 
has historically been very difficult-when the genome of strain B31 was first sequenced in 
1997, this region was not able to be resolved. Transcripts from our RNA-seq studies were 
not able to reliably map to this region, and multiple attempts to amplify cDNA by qRT-
PCR using multiple primer pairs has proven fruitless.  
 In order to circumvent these obstacles, we took advantage of some GFP fusions 
previously generated by the Stevenson lab (246). Previously, Dr. Bykowski cloned the 
entire DNA region from the start of translation of vlsE up until the first silent cassette into 
a plasmid that contains a promoterless GFP gene (Figure 4.8 A). This includes the 
transcriptional promoter, as well as a unique large inverted repeat region that is 
hypothesized to be involved in region of expression and or recombination, although the 
mechanism of that has not been elucidated. He then created several additional plasmids by 
deleting sections of DNA all the way up until the -35 nucleotide of the transcriptional 
promoter. Dr. Bykowski then cloned each individual plasmid into B31-e2, an easily 
transformable, high-passage non-infectious strain of B. burgdorferi. B31-e2 is non-
infectious because it has lost many plasmids. It is possible that loss of plasmids could have 
109 
 
 
an impact on vlsE expression, however since the background strain is the same in all cases, 
the effect of SpoVG on vlsE transcript abundance can still be measured. 
We took advantage of these previously made strains by transforming them with 
plasmid pCRS5, the spoVG-ON construct. The strains used were TB3, which contained the 
longest transcriptional fusion, TB3+spoVG-ON, TB11, TB11+spoVG-ON, TB13 (which 
contains only the -35 nucleotide through start codon of GFP), and TB13+spoVG-ON. TB12 
was not utilized in the subsequent studies because multiple attempts to transform the strain 
with pCRS5 failed (246). All six strains, including wild-type without GFP as a negative 
control were grown to mid-log phase at 34° C.  
All six strains were subjected to analysis by Flow-cytometry (Figure 4.8 B-D). Each 
strain was directly compared to its sister strain that additionally carried spoVG-ON. The 
strains that contained spoVG-ON all exhibited less Green Fluorescence intensity than the 
parental strain without exogenous spoVG expression. This indicates the SpoVG-dependent 
expression of VlsE protein does not rely on DNA upstream of the transcriptional promoter. 
Given that the start of transcription of vlsE is only a few nucleotides upstream of the 
ribosomal binding site, this suggests that the effect of SpoVG on VlsE protein levels occurs 
on a post-transcriptional level. 
4.8 SpoVG and PlzA bind DNA just up-stream of the vlsE gene 
We hypothesized that since SpoVG regulates VlsE expression, that it likely binds to 
nucleic acids between the transcriptional start site and the start of translation (Figure 4.9 
C). Even though SpoVG regulates expression post-transcriptionally, we started with a 
DNA probe given how prohibitively expensive RNA probes are (Figure 4.9 A). SpoVG 
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does indeed bind to this region of DNA. Future studies will test whether SpoVG also binds 
to RNA containing this same sequence.  
Given that we had previously demonstrated that PlzA also binds to DNA, and that 
VlsE protein abundance is lower in a DplzA strain, we hypothesized that PlzA also binds 
to DNA upstream of the vlsE coding gene. We tested this hypothesis using recombinant 
PlzA and the same vlsE DNA probe used in the SpoVG-binding assay (Figure 4.9 B). PlzA 
did bind to this region of DNA, although its role in regulating VlsE expression and activity 
within the cell are still unclear.  
4.9 Potential role for SpoVG in vlsE recombination 
Given that SpoVG was initially identified using a piece of DNA near the 
recombination site of vlsE as a probe, we hypothesized that SpoVG could be involved in 
the process of recombination (164). Western blots probing for abundance of VlsE in wild-
type and DspoVG protein lysates revealed an unusual pattern. A single, readily visible band 
of the correct size was observed in the lane loaded with wild-type lysate (Figure 4.10 A). 
The lane loaded with DspoVG lysate contains multiple bands, many of them smaller than 
that corresponding to the correct size. The source of antibody used is from rabbit serum, 
so it possible that other antibodies within the serum bind to other proteins in the lysate. If 
this were the case however, the multiple bands should be detected in both lanes, those 
loaded with wild-type lysates as well as DspoVG lysates.  
 We hypothesized that the multiple bands could be due to rearrangements at the vlsE 
locus. Perhaps SpoVG acts to stabilize the sites of recombination. These sites contain runs 
of guanosine nucleotides, which can potentially form G-quadruplex DNA structures, which 
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are unstable and prone to damage and breakages. We assayed by PCR across the coding 
region of vlsE using DNA extracted from wild-type and DspoVG cells (Figure 4.9 B). The 
product amplified from wild-type was the expected size-a little over 1 Kb. The amplified 
product from DspoVG was much smaller, just shy of 500 Kb. This suggests that DNA may 
have broken and been improperly repaired. For example, it is possible that the DNA 
between the recombination sites was lost without being replaced with another cassette.  
4.10 SpoVG and acetylation 
We hypothesized that the percentage of SpoVG that is acetylated in the cell could 
vary under different culture conditions, since the acetylome was altered at different growth 
rates (235). To test this, we separated lysates by SDS-PAGE from wild-type and spoVG-
ON cultures grown at 34° C and 23° C. Cultures were grown in double for all strains and 
conditions. The gels were stained with Coomassie blue, the bands corresponding to the size 
of SpoVG were cut out, subjected to digestion by trypsin and analyzed by LC MS/MS 
(Figure 4.11 A). As expected, a very small percentage of SpoVG was acetylated in any 
condition. 0.3% of SpoVG was acetylated in wild-type and spoVG-ON cultures grown at 
34° C. Approximately twice as much SpoVG was acetylated in both wild-type and spoVG-
ON cultures grown at 34° C than those grown at 23° C. There was no difference in the 
amount of SpoVG that was acetylated in the wild-type and spoVG-ON cultures grown at 
either temperature. 
RNA-sequencing revealed that the ackA transcript is less abundant in DspoVG than 
in wild-type or spoVG-ON strains (Figure 4.11 B). Transcript abundance of 
phosphotransacetylase (PTA) was unchanged in any strain. Given that deletion of ackA 
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resulted in almost no acetylated proteins in the cell, but deletion of PTA had no effect, we 
hypothesized that there would be reduced acetylated proteins in the DspoVG than in wild-
type or spoVG-ON strains (235). Protein analysis of AckA revealed that that the abundance 
of protein was not appreciably altered in the DspoVG strain (Figure 4.11 C).  
Given that SpoVG was identified as an acetylated protein in B. burgdorferi, and 
that we confirmed that a small percentage of SpoVG is acetylated in the cell, we wanted to 
test how acetylation affects the activity of SpoVG (235). The Stevenson lab previously 
demonstrated that SpoVG multimerizes, and binds DNA as a multimer (164). We 
hypothesized that acetylation would disrupt SpoVG multimerization. To test this, SpoVG 
was incubated either with or without 1 mM acetyl-phosphate for 60 minutes at 37° C. This 
method was used because B. burgdorferi does not encode any dedicated acetyl-transferases 
that acetylate individual proteins specifically (23). We confirmed by mass spec that after 
incubation with acetyl-phosphate that 100 % of SpoVG was acetylated. SpoVG that had 
been incubated with and without acetyl-phosphate was run on a Native-PAGE gel (Figure 
4.12 A). Although SpoVG ran as a single band on SDS-PAGE gels, multiple bands were 
visible on the Native gel. This is likely due to different numbers of SpoVG proteins 
multimerizing together. The banding pattern did not differ when SpoVG was acetylated, 
indicating that acetylation does not disrupt multimerization.  
Additionally, we tested the ability of acetylated SpoVG to bind nucleic acids. 
EMSA using RNA just upstream of the ackA gene and SpoVG pre-incubated with or 
without acetyl-phosphate (Figure 4.12 B). The only consistent motif across all known 
SpoVG-DNA binding sites is a run of at least four thymidine nucleotides. The ackA DNA 
probe was selected because it also contains a run of thymidine nucleotides. Two 
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concentrations of SpoVG protein were added: in one set only part of the RNA was shifted, 
and in the other, all of the RNA was shifted. Both acetylated and un-acetylated SpoVG 
bound the RNA, as evidenced by the shifted bands in both lanes. This indicates that, 
acetylation has no impact on SpoVG-RNA interactions. The same sequence was used as a 
DNA probe (Figure 4.12 C). As with the RNA, two concentrations of SpoVG protein was 
used, and at neither concentration was there a difference in Shifted DNA between 
acetylated and un-acetylated SpoVG protein. These assays were repeated twice with the 
same results. These studies demonstrate that acetylation has no impact on SpoVG binding 
to RNA or DNA.  
4.11 Discussion 
Glycolysis is the only mechanism by which B. burgdorferi generates ATP, therefore 
regulating this process is very important for survival (23, 210). Glycerol has only 3 carbons, 
and only 1 net molecule of ATP is generated per molecule of glycerol. Additionally, no net 
NADH molecules are generated, which are needed to keep the process of glycolysis going. 
This is all in contrast to the cell using glucose as the substrate for glycolysis. Glucose 
contains 6 carbons, and produces a net of 2 ATP and 1 NADH molecules. The means that 
glycerol is a pretty energy-poor way to generate ATP in an organism that is already 
severely limited in mechanisms for ATP production.  
One can imagine that in an environment where nutrients are abundant that B. 
burgdorferi would not waste energy on using glycerol as a substrate for ATP. If glycerol 
is available, however, it would be expedient to use it for the purpose of membrane 
construction. This would eliminate the need to divert glucose away from glycolysis for this 
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purpose. When nutrients are very limited, say, when B. burgdorferi is in a tick that has 
completely digested the blood meal, and glucose is not readily available, using glycerol to 
generate ATP might provide just enough energy to survive until the next blood meal is 
taken.  
The importance of B. burgdorferi metabolizing glycerol to survive within the tick 
has been established (210). A recent study using a Tn-Seq library of B. burgdorferi mutants 
did not identify Bb240-242 as unrecoverable from the tick (248). There are several reasons 
why this could by the case, including the fact that the library is not completely saturated, 
and it was not confirmed that those mutants were present in the library used. Understanding 
how the operon is regulated by B. burgdorferi is of considerable interest. The studies within 
this work present the first evidence of protein regulators interacting directly with DNA and 
RNA of the glpFKD operon. Additionally, although it has been postulated that PlzA is 
somehow involved in regulation of the operon, this is the first data demonstrating the PlzA 
binds to DNA upstream of glpF. It remains to be determined the exact effect that SpoVG 
and PlzA have on the protein abundance of each gene in the operon. This is particularly 
pertinent because of the two anti-sense RNAs that are associated with glpF.  
In order to test these questions, antibodies should be raised against glpF, glpK, and 
potentially the ORF. (Our proteomics studies, which are currently in progress, will 
determine whether the ORF does get translated into a functional protein). The entire 
operon, from the transcriptional promoter could be cloned and transformed into E. coli. 
Since E. coli does not make either SpoVG or PlzA, the effect of each could be determined 
by transforming E. coli with additional plasmids that express SpoVG and PlzA. Using the 
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newly raised antibodies, the effects of SpoVG and PlzA on protein abundance of each 
individual gene on the glpFKD operon could be measured. 
Finally, it is unknown the effect that expressing these proteins will have on glycerol 
metabolism. We hypothesize that SpoVG biases metabolism towards ATP production from 
glycerol, and that when SpoVG is very low or absent, that glycerol would still be used, but 
used for building cell membranes rather than ATP production.  
Known interactions are enumerated as follows.  PlzA binds to c-di-GMP, which is 
produced by cultured B. burgdorferi. PlzA interacts with SpoVG within the cell, although 
it is unknown if it binds to SpoVG when c-di-GMP is present or absent. It is not known 
what effect that the PlzA-SpoVG interaction has on the ability of SpoVG to bind DNA or 
the ability of SpoVG to bind RNA. It is not known what effect that c-di-GMP has on the 
ability of PlzA to bind DNA. It is also unknown what effect that interacting with SpoVG 
has on the ability of PlzA to bind to DNA. The interaction with SpoVG could be stabilizing, 
or it could be competitive. A significant hurdle we faced was the inability to purify 
recombinant PlzA from E. coli without c-di-GMP bound to it. E. coli encodes about 5 
known/hypothesized c-di-GMP synthases, so deleting all of them from Rosetta-II strain 
that can express recombinant proteins would be rather difficult. We attempted to express 
recombinant PlzA in SF9 insect cell line designed to produce recombinant proteins, 
however the cells did not produce appreciable levels of PlzA.  
Recombination at the vlsE locus has never been observed to occur in cultured B. 
burgdorferi, which has significantly hindered the Borrelial research community’s ability 
to study the mechanism. Having a model to study the mechanism of recombination in 
culture would significantly move the field forward. Wild-type, spoVG-ON and DspoVG 
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cultures were first plated on BSK-II -agarose plates, in order to isolate individual colonies 
that gave rise from a single bacterium. Three individual colonies from each strain were 
grown at 34° C and passaged three times over the course of three weeks to allow ample 
time for recombination or DNA deterioration to occur. DNA was extracted from each 
culture for long-read PacBio sequencing. A particular hurdle that we currently face is the 
fact that vlsE can no longer be amplified from DNA extracted from DspoVG cultures. 
Multiple primer pairs were used, however we were limited in their design as the end of the 
vlsE gene is very near the hairpin telomere.  
The importance and prevalence of post-translational modification by bacteria are 
only just beginning to be understood, not least in B. burgdorferi. We have identified that 
SpoVG can be phosphorylated, and confirmed that it can be acetylated, although the 
consequences of these modifications remain to be elucidated (Figure 4.13). It is possible 
that there is no biological impact of acetylation on how SpoVG acts in the cell. Because 
there are no specific acetyl-transferases in the cell, protein acetylation in B. burgdorferi is 
merely the consequence of accumulated acetyl-phosphate sticking to lysine residues that 
happen to be easily accessible.  
It has been hypothesized that B. burgdorferi uses this strategy to survive within the 
tick: when ATP levels are low, flux through the lipid I biosynthesis pathway will be stalled, 
leading to accumulation of acetyl-phosphate. This acetyl-phosphate then acetylates all 
readily available lysine residues indiscriminately (235). This strategy may provide an 
evolutionary advantage of quickly stalling activity of enzymes within the cell, without 
spending energy to break down proteins. Additionally, these proteins are already made, 
and ready to be useful once the blood meal comes in. The influx of nutrients from the blood 
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meal would then allow flux through the lipid I pathway, reducing the amount of free acetyl-
phosphate, which would then reduce acetylation on enzymes, instantly activating those 
enzymes. Multiple enzymes in the glycolysis pathway were demonstrated to be far less 
active when acetylated. Acetylation of SpoVG may simply be an accident of this strategy, 
with no real biological consequences.  
It is also possible that acetylation of SpoVG influences how it interacts with PlzA, 
or the relative affinity that SpoVG has for DNA vs RNA, shifting its activity in that manner. 
In order to fully understand whether or not acetylation has an impact on activity within the 
cell, in vitro experiments could be done on SpoVG in both the DackA and DPTA strains. 
Pull-downs to identify what proteins SpoVG is or is not interacting with, ChiP-seq and 
RIP-seq would identify whether there are any changes in these strains vs in wild-type B. 
burgdorferi.  
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Figure 4.1 Glycerol metabolism 
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Figure 4.2 SpoVG regulates expression of glpFKD operon 
 
 
 
 
A. RNA-seq results depicting log2 differences in expression of each gene of the 
glpFKD operon between wild-type, spoVG-ON and DspoVG. Wild-type levels were 
arbitrarily set to 1, and the fold difference between mutants and wild-type added to, or 
subtracted from, 1. B. RNA-sequencing results depicting the log2 differences in expression 
of the two RNAs anti-sense to glpF between wild-type, spoVG-ON and DspoVG. C. 
Western Blots on wild-type, spoVG-ON, and DspoVG protein lysates from cultures grown 
at 34° C. Shown are three biological replicates. Blots were probed for GlpD, SpoVG, and 
FlaB. D. Schematic of the layout of glpFKD including location of the two anti-sense RNAs.   
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Figure 4.3 SpoVG binds to glpFKD DNA and RNA 
 
 
 
 
E
F
Christina R. Savage et al. J. Bacteriol. 2018; doi:10.1128/JB.00033-18 
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SpoVG binding to DNA and RNA at two sites in the glpFKD operon. (A and B) 
Sequence 5′ of glpF. (C and D) Region between glpK and glpD. EMSAs were performed 
using either labeled DNA or RNA. (A) Lane 1, 1 ng glpF DNA; lane 2, 1 ng glpF DNA 
with 2.4 μM rSpoVG; lane 3, 1 ng glpF DNA with 4.8 μM rSpoVG; lane 4, 1 ng glpF DNA 
with 4.8 μM rSpoVG and 100 ng unlabeled glpF DNA; lane 5, 1 ng glpF DNA with 4.8 
μM rSpoVG and 100 ng unlabeled EMSA-pCR2.1 DNA. (B) Lane 1, 1 ng glpF RNA; lane 
2, 1 ng glpF RNA with 2.4 μM rSpoVG; lane 3, 1 ng glpF RNA with 2.4 μM rSpoVG and 
100 ng unlabeled glpF DNA; lane 4, 1 ng glpF RNA with 2.4 μM rSpoVG and 1,000 ng 
unlabeled glpF DNA. (C) Lane 1, 1 ng glpKD DNA; lane 2, 1 ng glpKD DNA with 0.73 
μM rSpoVG; lane 3, 1 ng glpKD DNA with 1.47 μM rSpoVG; lane 4, 1 ng glpKD DNA 
with 3 μM rSpoVG; lane 5, 1 ng glpKD DNA with 3 μM rSpoVG and 100 ng unlabeled 
glpKD DNA; lane 6, 1 ng glpKD DNA with 3 μM rSpoVG and 100 ng unlabeled EMSA-
pCR2.1 DNA. (D) Lane 1, 1 ng glpKD RNA; lane 2, 1 ng glpKD RNA with 2.4 μM 
rSpoVG; lane 3, 1 ng glpKD RNA with 2.4 μM rSpoVG and 100 ng unlabeled glpKD 
DNA; lane 4, 1 ng glpKD RNA with 2.4 μM rSpoVG and 1,000 ng unlabeled glpKD DNA. 
A graphic representation of SpoVG-binding sites and promoters, relative to the glpFKD 
operon, is shown at the bottom.  
Nucleic acid sequences that contain SpoVG binding sites. The sequences are shown 
as DNA, although SpoVG also bound to these sites in single-stranded RNA. The 
DNA/RNA target regions used for EMSAs are underlined. (E) Sequence 5′ of the glpFKD 
operon. The −35 and −10 sequences of the probable transcriptional promoter are boxed, 
and the translational initiation codon of glpF is in bold black type. The maximal sequence 
bound by SpoVG is underlined. The region previously identified as having a stimulatory 
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effect on transcript levels is shown in blue type. (F) Sequence of the intergenic region 
between glpK and glpD. The maximal sequence bound by SpoVG is underlined. The −35 
and −10 sequences of the predicted transcriptional promoter are boxed. The transcription 
start site is marked with an asterisk. The translational initiation codon of glpD is in bold 
type. A small ORF of unknown function, bb0242, is indicated in blue. 
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Figure 4.4 PlzA binds to glpF DNA 
 
 
 
EMSA demonstrating that PlzA protein binds to DNA upstream of glpF gene (A). Lane 1 
contains just glpF DNA. Lane 2 and 3 contain DNA and 40 nM PlzA. Lane 4 contains 
DNA and 400 nM PlzA. Lane 5 contains DNA, 40 nM PlzA, and 100x unlabeled non-
specific DNA. PlzA binds to the same DNA sequence as SpoVG (B).   
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Figure 4.5 Complete BSK + glycerol 
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Figure 4.6 BSK-Lite + glycerol 
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Figure 4.7 VlsE expression 
 
 
 
 Schematic (A) of the vlsE gene locus. The coding region is white. The colored 
boxes represent some of the silent cassettes upstream of the gene. The black bars represent 
the direct repeat sequences that are present in the coding region and each of the silent 
cassettes. SpoVG was found to bind a portion of DNA near one of the Direct repeats within 
the coding region. (B) Western Blots of FlaB and VlsE. A3, which is the wild-type, and 
spoVG-ON cultures were grown to mid-log phase at 34° C and 23° C. This experiment was 
repeated three times with similar results. (C) Western Blots of FlaB and VlsE. Wild-type, 
DplzA, DplzA+plzA and Drrp1 were grown to mid-log phase at 34° C. This experiment was 
repeated three times with similar results.  
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Figure 4.8 Transcriptional GFP fusions 
 
 
 
Schematic (A) of vlsE promoter fusions to GFP. A version of this figure originally 
appeared in Bykowski et al 2006. pTB3, pTB11 and pTB13 were transformed with the 
spoVG-ON plasmid (246). (B-D) Flow cytometry analysis of GFP intensity of original 
fusions (black), and strains harboring spoVG-ON as well (green). This experiment was 
repeated twice with similar results.  
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Figure 4.9 SpoVG and PlzA bind to vlsE DNA 
 
  
 
EMSA (A) demonstrating the SpoVG binds to vlsE DNA. Multiple shifted bands appear 
with increasing amounts of SpoVG protein added. (B) EMSA demonstrating that PlzA also 
binds to vlsE DNA. (C) Location of the DNA probe used in relation to the coding portion 
of vlsE.   
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Figure 4.10 Potential role for SpoVG in vlsE recombination 
 
 
 
 
Western Blot (A) of VlsE from wild-type and DspoVG protein lysates. Multiple bands were 
recognized in the DspoVG lysates. (B) PCR amplification of the vlsE coding gene from 
DNA extracted from wild-type and DspoVG. 
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Figure 4.11 Acetylation and ackA expression 
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Figure 4.12 Effect of Acetylation on SpoVG activity 
 
 
 
SpoVG purified from E. coli was incubated with and without acetyl-phosphate at 37° C for 
1 hour, then separated on a Native gel (A). EMSA using ackA RNA and purified SpoVG 
incubated with or without acetyl-phosphate (B). EMSA using ackA DNA and SpoVG 
incubated with and without acetyl-phosphate. 
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Figure 4.13 SpoVG alignments 
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CHAPTER 5. SPOVG AND CYCLIC-DI-AMP REGULATE OSPC TRANSLATION 
INDEPENDENTLY OF TRANSCRIPTION 
5.1 Introduction 
There are few defined or hypothetical regulators in the B. burgdorferi genome (23, 
247). Use of nucleotide second messengers as regulators is useful, because they can work 
at multiple levels of regulation. RNA riboswitches can bind them, in order to regulate 
expression of specific genes at specific times (249, 250). Nucleotides can bind protein 
partners, which may have distinct functions whether the nucleotide is present or not, 
conserving energy that would have gone into transcription and translation. Most recently, 
ppGpp has been found to bind DNA near the E. coli oriC, thus directly impacting DNA 
replication (251) 
Although new discoveries and mechanisms of action of signaling through the 
second-messenger c-di-GMP continues to occur, its importance has been well established 
in most laboratory-studied bacteria (252-256). More recently, newly described nucleotides 
as signaling messengers in bacteria have emerged (257-260). The synthesis of cyclic-di-
adenosine monophosphate (cyclic di-AMP) by several members of gram-positive bacteria 
has also been described (261). This molecule has a demonstrated role in gene regulation, 
potassium transport, biofilm formation and eliciting an immune response from eukaryotic 
organisms (262-269).   
 Before I began my studies, the presence of c-di-GMP and ppGpp had already been 
demonstrated in B. burgdorferi (144, 148, 187, 188, 221, 241). We sought to examine 
whether B. burgdorferi can also synthesize another modified nucleotide messenger, c-di-
AMP, and establish a functional role for the molecule within the cell. Establishing another 
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nucleotide second messenger in B. burgdorferi would expand our repertoire of known 
regulatory factors, allowing us to gain further insight into how B. burgdorferi controls its 
cellular processes at each point along the enzootic cycle. 
 OspC is an outer-surface protein, expressed by B. burgdorferi during transmission 
from tick to vertebrate, and during the early stages of establishing infection in the vertebrate 
(270-272). Regulation of this gene is very tightly controlled, and absolutely essential for 
B. burgdorferi to survive (273-275). Some upstream DNA elements have been 
demonstrated to have an effect on expression. ospC is transcribed from an RpoD-dependent 
promoter, but there is evidence that RpoS-mediated proteins are involved in regulation of 
ospC (276-280).  
The prevailing hypothesis states that OspC is under transcriptional control of the 
alternative sigma factor RpoS. This model states that RpoS is expressed once the blood 
meal comes in, then is responsible for ospC expression (200, 274, 276, 281-283). This 
model leaves much to be desired, and several remaining questions. For one, ospC is still 
expressed (albeit at lower levels) in a DrpoS strain of B. burgdorferi (284, 285). Two, RpoS 
is expressed throughout vertebrate infection, yet OspC expression gets repressed early after 
infection has been established. The ospC gene is likely regulated at the levels of 
transcription, translation and post-translation. Any insight into the intricate regulatory 
mechanism of this essential protein will be valuable for understanding how B. burgdorferi 
is able to transition between transmitting from a tick to infecting a vertebrate. 
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5.2 Bb0008 Encodes a Cyclic-di-AMP synthase 
Although Borrelia burgdorferi is technically classified as a gram-negative 
bacterium due to the presence of an outer membrane, many of the proteins it possesses are 
more closely related to those found in gram-positive organisms (recall that SpoVG is only 
present in gram-positive bacteria and spirochetes).  Protein-BLAST (BLAST-P) analysis 
revealed that the gene Bb0008 is predicted to encode a c-di-AMP synthase based on the 
fact that it contains a putative di-adenylate-cyclase domain (DAC) domain (Figure 5.1).  E. 
coli does not naturally make c-di-AMP, therefore the gene Bb0008 was cloned and 
expressed in E. coli in order to determine if it does make a functional c-di-AMP synthase 
(266, 286).  
Bb0008 was amplified from the genome, cloned into plasmid pCR2.1, and 
transformed into DH5a E. coli cells. This plasmid was named pCRS0. pCR 2.1 allows 
transcription of the cloned product from the lac promoter Using an E. coli cell line that 
contains the lacI repressor was essential, otherwise the cells used available ATP, and were 
unable to grow. Overnight cultures of pCRS0 were passaged 1:1000 with 1 mM IPTG, and 
allowed to grow for 3 hours. The nucleotide fraction was extracted, and analyzed by LC-
MS/MS by our collaborator Dr. Chris Waters, for the presence of c-di-AMP. C-di-AMP 
was readily detected, indicating that the gene does in fact encode a functional c-di-AMP 
synthase (Figure 5.2). Gene Bb0008 was thus named cdaA after the similar genes in 
Bacillus and Listeria (287, 288). 
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5.3 Overexpression of CdaA does not alter intracellular levels of c-di-AMP 
C-di-AMP has been demonstrated in other bacteria to be essential for growth (288, 
289). For this reason, we elected to study the effects of overexpressing cdaA rather than 
deleting the gene from the chromosome. The cdaA gene was amplified from B. burgdorferi 
genomic DNA and cloned into plasmid pSZW53-4 in which the cdaA gene is transcribed 
from a TetR-regulated hybrid Post promoter, which is inducible with anhydrous 
tetracycline (ATc) (162, 290). This construct was named pAG1. pAG1 was transformed 
into non-infectious, high passage B31-e2 and low-passage, infectious B31-A3 strains of B. 
burgdorferi. The strain created in the B31-e2 background was named AG1. pSZW53-4 
without cdaA cloned into it was transformed into B31-e2, and named KS50. The strain 
created in the low-passage, B31-A3 background was named cdaA-ON. 
 AG1 was grown without ATc at 34° C to early-log phase, then split into two 
cultures. Final concentration of 0.5 µg/ml ATc was added to one culture, and both were 
incubated for an additional 24 hours at 34° C. Nucleotide fractions were purified from AG1 
with and without ATc, flash frozen in liquid nitrogen and shipped on dry ice to Dr. Chris 
Waters at Michigan State University for analysis. This group is expert at identifying and 
quantifying small nucleotide second messengers. The concentration of c-di-AMP was very 
low in the wild-type strains, and not detectably different in the cultures that were induced 
with ATc to overexpress cdaA (Figure 5.3 A). This was repeated with similar results. 
Protein lysates were prepared from AG1 and KS50 strains, grown with and without 0.5 
µg/ml final concentration of ATc at 34° C. Although FlaB is readily detectable in all 
strains, CdaA was undetectable in both KS50 cultures as well as the uninduced AG1 
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cultures. CdaA was abundantly produced in AG1 induced with 0.5 µg/ml ATc (Figure 5.3 
B).  
 RNA was also extracted from KS50 and AG1 grown with and without ATc, and 
subjected to qRT-PCR. The difference in Cq value between ATc uninduced and induced 
cultures was calculated for each gene transcript. flaB is the gene usually used to normalize 
qRT-PCR and Western Blot data, as it is consistently expressed in culture. To ensure that 
our data were not skewed in the event that flaB is regulated by c-di-AMP, we normalized 
all Cq values to flaB and recA. Cq values for each gene were normalized to flaB (Figure 
5.3 C) or recA (Figure 5.3 D) transcripts. Plotted on the graph are the normalized Cq values 
for both AG1 and KS50 strains. cdaA from AG1 culture was the only transcript 
differentially expressed. This indicates that the action of c-di-AMP within B. burgdorferi 
is not at the level of transcription.  
5.4 CdaA affects expression levels of OspC protein 
Given the fact that overexpression of CdaA did not alter any of the transcripts we 
examined apart from cdaA, we hypothesized that it could influence gene regulation at the 
level of translation. cdaA-ON was cultured with 0, 0.5, 1.0 or 2.0 µg/ml final concentration 
of ATc at 34° C to mid-log phase. Protein lysates were separated by SDS-PAGE and 
probed with a-OspC, a-SpoVG and a-FlaB antibodies (Figure 5.4). FlaB is readily 
detectable in all lanes, and SpoVG abundance is not altered from the different lysates, 
indicating that SpoVG is not regulated by CdaA. OspC expression decreases as increasing 
amounts of ATc inducer was added to the culture medium. In protein lysates from cultures 
induced with 2.0 µg/ml ATc, OspC is not detectable at all. This indicates the CdaA does 
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regulate expression of OspC protein in a SpoVG-independent manner that is independent 
of ospC transcriptional regulation.  
5.5 SpoVG regulates OspC protein but not transcript 
RNA-sequencing revealed that the cdaA transcript was about 2 times less abundant 
in the spoVG-ON strain compared to wild-type (Figure 5.5 A). The cdaA transcript was not 
altered in the DspoVG strain compared to wild-type. Since the spoVG-ON strain alters 
transcript abundance of cdaA, and we demonstrated that increasing CdaA protein results in 
less OspC protein, we hypothesized that levels of OspC protein would also be altered. In 
order to understand the level of regulation at which SpoVG may be acting, we looked at 
ospC transcript abundance from our RNA-sequencing. The ospC transcript was not altered 
in either spoVG-ON compared to wild-type, nor DspoVG compared to wild-type (Figure 
5.5A).  
 We next tested whether levels of OspC protein was altered by over expression of 
spoVG or temperature (Figure 5.5 B). Predictably, OspC was detectable, but not highly 
abundant in protein lysates from wild-type bacteria grown at 34° C (291). OspC has been 
shown to be expressed at very low levels at both 23° C and 34° C, but expression increases 
dramatically when cultures grown at 23° C are shifted to 34° C (200, 271, 291, 292). As 
we hypothesized, OspC is significantly more abundant in spoVG-ON cultures than wild-
type when grown at 34° C. OspC is less abundant in spoVG-ON cultures grown at 23° C 
than spoVG-ON cultures grown at 34° C.  
 As we had previously observed that spoVG transcript increases when glycerol is 
added to the culture medium, we hypothesized that OspC protein expression would also 
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increase when glycerol was added to culture medium (Figure 5.5 C). As hypothesized, 
OspC was more abundant in wild-type cultures grown with glycerol. Counterintuitively, 
OspC protein was less abundant when spoVG-ON cells were cultured with glycerol than 
without. We previously saw that the spoVG-ON strain responded differently to the addition 
of glycerol than did wild-type.  
 Finally, we tested whether OspC would be differentially expressed in the DspoVG 
strain compared to wild-type (Figure 5.5 D). Wild-type, spoVG-ON and DspoVG were 
cultured at 34° C to mid-log phase. OspC was not detectable in the lysates from either the 
wild-type or DspoVG strains. OspC was highly abundant in the lysate from spoVG-ON 
cells, which skews the ability to detect protein in cultures expressing significantly less 
OspC protein. In order to determine if OspC is differentially expressed in the DspoVG strain 
as compared to wild-type, lysates from these two strains will need to be analyzed in the 
future on a blot without spoVG-ON lysate.  
5.6 SpoVG binds to RNA associated with ospC gene 
OspC protein expression, but not mRNA expression, is regulated by B. burgdorferi 
that overexpress spoVG. We hypothesized that SpoVG protein binds directly to RNA 
associated with the ospC gene. There are numerous ways that an RNA transcript can 
regulate translation of the gene associated with it (250, 293). The start of transcription for 
ospC was identified just a few nucleotides upstream of the ribosomal binding site (276, 
294). This eliminates the possibility of a long 5’ untranslated region (UTR) that could be 
involved. Riboswitches are ubiquitous across the bacterial kingdom as a mechanism of 
posttranscriptional control by binding small molecules (249, 250, 295, 296). To date, no 
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riboswitches have been identified or even predicted for B. burgdorferi, although they have 
been identified in other Spirochetes (249, 295, 297), {and personal communication with 
Dr. McCown}. Additionally, we looked for anti-sense RNAs that may be associated with 
the mRNA transcript: none were identified (110, 195, 201).  
A unique feature of the DNA sequence that codes for OspC, is that the first few 
amino acids (less than 20) are absolutely conserved across all known B. burgdorferi species 
and subspecies, but a large portion of the gene codes for highly variable amino acids (298-
300). We hypothesized that the sequence that codes for the first few amino acids could be 
essential for translational regulation of the ospC gene. We  predicted the structure of a 50 
bp RNA that spans from the transcriptional start site through the first 10 coded amino acids 
using http://rnaanalyzer.bioapps.biozentrum.uni-wuerzburg.de/ (Figure 5.6 A). This RNA 
is predicted with high certainty to be highly structured (Figure 5.6 B). It is conceivable that 
the RNA folds into this structure, and needs some other interacting molecule to enable 
RNA polymerase to break the long stem loop that is predicted to form. Or perhaps 
regulation works by a molecule stabilizing the stem loop, and only when that molecule is 
not present or able to bind does translation occur.  
 To answer these questions, we ordered a 49 bp RNA labeled with Alexa/488 from 
IDT DNA Inc. We hypothesized that since SpoVG and c-di-AMP regulate OspC protein 
but not transcription that one or both bind to the RNA. SpoVG binds to this RNA by 
evidence of a shifted band in the reaction that included SpoVG (Figure 5.6 C). Addition of 
c-di-AMP to a reaction that contains SpoVG and RNA did not disrupt the higher-order 
complex, indicating that c-di-AMP does not interrupt SpoVG-RNA binding. A reaction 
containing RNA and c-di-AMP did not yield a shifted band. In order to test for c-di-AMP-
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RNA interaction, an RNase experiment will need to be done. In this experiment, RNA is 
treated with RNase and in different reactions, RNase plus increasing amounts of c-di-AMP. 
Different cleavage patterns would be expected if c-di-AMP binds to the RNA.  
It is unknown if SpoVG recognizes a specific sequence, or if SpoVG binds to a 
particular structure. To test this, we designed four additional labeled RNAs that are the 
same length as the original RNA, but a few nucleotides are mutated at various locations 
(Figure 5.7 B). We used the same RNA prediction software to predict the structure of each 
RNA (Figure 5.7 A). Some of these structurally look more similar to the original sequence, 
and others look structurally very different. SpoVG bound to all of the RNAs using the 
highest concentration of protein (Figure 5.8). This is seen in the third lane for each panel. 
The second lane in each panel contains 1/10 as much SpoVG protein as the third lanes in 
each panel. Some of RNA A was shifted in the second lane, which suggests that SpoVG 
binds to this RNA with a slightly higher affinity than RNA B or RNA C. RNA A contains 
an additional UUUU site, which we hypothesize SpoVG recognizes.  
5.7 Discussion 
Very little is known about mechanisms of post-transcriptional regulation in B. 
burgdorferi. Growing evidence suggests that regulating protein production independently 
from transcriptional restraints plays an important role in the ability of B. burgdorferi to 
survive throughout the enzootic cycle (191, 195, 201, 301, 302). From an evolutionary 
perspective, this makes sense, as both transcription and translation require an enormous 
amount of energy. B. burgdorferi must both survive the nutrient-poor environment of the 
tick mid-gut, and quickly respond to the incoming blood meal in order to survive. The 
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evidence presented here, of an additional cyclic-di-nucleotide, and the example of a gene 
that is regulated post-transcriptionally by c-di-AMP provides a significant advance to our 
understanding of how B. burgdorferi regulates gene expression.  
The exact role that c-di-AMP has on B. burgdorferi physiology remains to be 
determined. No knockout of the cdaA gene has been generated, and overproduction of the 
enzyme does not result in altered intracellular levels of c-di-AMP. Additionally, no protein 
or RNA partners have been identified for c-di-AMP in B. burgdorferi.  
It is tempting to postulate how c-di-AMP could serve as a sensor for intracellular 
ATP levels within the cell. Bacteria that are unable to slow growth in the presence of 
antibiotics are far less likely to survive in the presence of, and develop resistance to, 
antibiotics. In the same way, one can imagine that if B. burgdorferi within a tick is unable 
to slow those cellular processes that require large amounts of ATP before the blood meal 
has been digested, they would be far more likely to die. Perhaps depletion of c-di-AMP 
acts as a sensor that intracellular levels of ATP are running low. Or perhaps it serves as a 
reserve, to store ATP, until absolutely necessary. 
The identification of the predicted highly structured RNA associated with ospC, and 
the subsequent demonstration of two systems that affect only OspC protein but not 
transcription provides substantial insight into additional mechanisms involved in gene 
regulation. The prevailing dogma of the Borrelia field states that Hk1/Rrp1 govern survival 
in the tick, then Hk2/Rrp2 govern transition to, and infection within, vertebrates. There has 
been strong evidence over the years that this simplistic model, with all regulation lying 
under one of the two two-component systems is not sufficient to describe the complexity 
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of regulation and survival. Here we present evidence for additional mechanisms of 
regulation distinct from classical two-component systems. 
The fact that SpoVG binds to the structured RNA associated with ospC could have 
one of a number of effects. Binding of SpoVG could stabilize or disrupt the structure of 
the RNA. The fact that SpoVG was still able to bind to a (mostly similar) sequence of RNA 
that was predicted to have a very different structure indicates that SpoVG does not interact 
with unique structures per se, but rather with sequences within that RNA. SpoVG binding 
with higher affinity to an RNA with an added UUUU site gives further support for this 
hypothesis. This binding could have the effect of either blocking the ribosome binding site, 
thus inhibiting translation or opening the ribosome binding site to be available, thus 
allowing translation to proceed. It is also possible that if SpoVG bound to double-stranded 
RNA, that it could stall the RNA polymerase, thus prevent the complete RNA from being 
transcribed in the first place. 
Finally, although there have been no identified or predicted riboswitches in B. 
burgdorferi, here we present evidence of a structured RNA involved in regulation of 
translation of ospC, but not transcription. It remains to be elucidated exactly how this RNA 
structure functions. Can c-di-AMP interact with the RNA, thus providing an entirely new 
class of riboswitches that could have implications for other organisms in addition to B. 
burgdorferi? Is this RNA stable during, and after transcription, or is there some form of 
processing that occurs that regulates whether the protein will be expressed or not? And 
finally, what is the direct effect of SpoVG binding to the RNA? Does SpoVG effectively 
hide the ribosomal binding site, thus preventing translation, or does it work to open and 
stabilize the RNA in a way that allows ribosomes access?  
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Figure 5.1 cdaA alignments 
 
 
 
 
The two regions of conserved residues that constitute the DAC domain are boxed 
in blue. Residues found in all 5 proteins are indicated by an asterisk (*), residues in 4 
proteins by a colon (:), and those in 3 proteins by a period (.). Enzyme sequences are 
identified as: Bb, B. burgdorferi CdaA; Bs, Bacillus subtilis CdaA (formerly YbbP); Lm, 
Listeria monocytogenes CdaA/DacA 
 
  
Savage CR, et al. doi.org/10.1371/journal.pone.0125440 
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Figure 5.2 B. burgdorferi synthesizes c-di-AMP 
 
 
 
 
 
Representative mass spectrometric analysis of cytoplasmic extract from IPTG-
induced E. coli strain CRS-0, which expresses B. burgdorferi CdaA from a chimeric 
plasmid. The identity of the peak at 3.35 min was not determined. 
 
 
 
 
Savage CR, et al. doi.org/10.1371/journal.pone.0125440 
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Figure 5.3 Effects of overexpression cdaA in B. burgdorferi 
 
 
 
 
A. Measurements of B. burgdorferi cytoplasmic c-di-AMP levels in samples of 
uninduced and induced AG1. Bacteria were cultured to mid-exponential phase 
(approximately 107 bacteria/ml), divided equally divided into two tubes, then cdaA 
transcription was induced by addition of 0.5 μg/ml (final concentration) 
anhydrotetracycline (ATc) to one tube, and both were incubated for 24h at 34°C. Equal 
volumes of borrelial cell extracts were analyzed. B. Immunoblot analyses of KS50 and 
Savage CR, et al. doi.org/10.1371/journal.pone.0125440 
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AG1, without and with inclusion of 0.5 μg/ml anhydrotetracycline (ATc) inducer (- and +, 
respectively). Membranes were probed with antibodies directed against CdaA or the 
constitutively-expressed FlaB subunit of the flagella. Wild-type and uninduced AG1 
bacteria produced substantially less CdaA than did induced AG1, and the immunoblot 
signal was not detectable for those strains/conditions at the illustrated exposure. Analyses 
of mRNA levels also indicated that cdaA is expressed at low levels by uninduced AG1 
(data not shown). C and D. Q-RT-PCR analyses of the effects of CdaA hyperexpression on 
transcription of select B. burgdorferi mRNAs. Transcript fold changes are shown as the 
difference between uninduced and induced cultures for both strains KS50 and AG1, 
relative to control flaB or recA, respectively. Multiple t tests were performed for each strain 
and examined transcript. Only the differences in levels of cdaA transcripts in induced 
cultures of AG1 were significant (indicated by **, p = 0.0012 when compared with flaB, 
and p = 0.0023 when compared with recA) 
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Figure 5.4 Impact of cdaA on OspC and SpoVG expression 
 
 
 
Western Blots of OspC, SpoVG and FlaB. cdaA-ON was cultured at 34° C with 0, 0.5, 1.0 
or 2.0 µg/ml ATc to induce CdaA at varying levels. Cultures were grown to mid-log, and 
protein lysates separated by SDS-PAGE. a-rabbit (SpoVG) conjugated to IRD700 and a-
mouse (FlaB and OspC) conjugated to IRD800 were used for secondary antibodies.  
 
 
  
OspC
SpoVG
FlaB
Atc (ug/ml) 0 0.5 1.0 2.0
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Figure 5.5 Impact of SpoVG on cdaA and OspC expression 
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Figure 5.6 SpoVG binds to ospC RNA 
 
 
 
The sequence of RNA used for SpoVG-RNA EMSA spans from just upstream of the 
ribosomal binding site through the coding region for the first several amino acids for OspC 
(A). The predicted structure of the ospC RNA (B). The sequence listed in A was run 
through http://rnaanalyzer.bioapps.biozentrum.uni-wuerzburg.de/ prediction software. 
EMSA using the ospC RNA and SpoVG protein (C). Lane 1 contains RNA, Lane 2 
contains RNA and SpoVG protein, Lane 3 contains RNA, SpoVG protein and c-di-AMP, 
Lane 4 contains RNA and c-di-AMP.  
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SpoVG-ospCRNA 
complex
1 2 3 4A
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UAAAAAGGAGGCACAAAUUAAUGAAAAAGAAUACAUUAAGUGCAAUAUUA
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Figure 5.7 Mutated ospC RNAs to test SpoVG-RNA binding 
 
The predicted structures for all RNAs ordered to test SpoVG binding to (A). All structures 
were predicted using http://rnaanalyzer.bioapps.biozentrum.uni-wuerzburg.de/ software. 
The sequences for all mutated RNAs (B). 
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Figure 5.8 SpoVG binding to mutated RNAs 
 
 
EMSA using purified SpoVG protein and mutated ospC RNAs. Panel A contains RNA 
A, panel B contains RNA B, and Panel C contains RNA C. For each Panel, the first lane 
contains no protein, the second lane contains RNA and SpoVG, and the third lane 
contains RNA and 10x more SpoVG protein. 
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CHAPTER 6. DISCUSSION 
6.1  SpoVG in B. burgdorferi 
The studies presented in this work shed light on the importance of SpoVG within the 
cell, and the ways in which it impacts regulation of numerous genes, both at the level of 
transcription and translation.  We had hypothesized the SpoVG would be dispensable for 
B. burgdorferi to survive within a mouse, given the fact that spoVG transcript abundance 
is very low. We further hypothesized that over-expressing SpoVG would render B. 
burgdorferi incapable of infecting mice. Our infection studies, using multiple strains of B. 
burgdorferi that overexpress spoVG demonstrated that this was not the case. In infection 
studies conducted by our collaborator Dr. Motaleb demonstrated that deletion of the spoVG 
gene made the bacteria non-infectious in mice. 
This could be due to one of a number of reasons, including that even a small amount 
of SpoVG is necessary for survival. Our studies on cultured B. burgdorferi revealed that 
RNA levels do not necessarily predict protein abundance, and furthermore, SpoVG appears 
to regulate itself at the level of translation. Simply because RNA levels of spoVG are low 
when B. burgdorferi is inside a mouse, does not indicate that protein levels are necessarily 
low as well. 
6.2 Transcriptomics on spoVG-ON, DspoVG and wild-type 
Transcriptomics on mutant strains of B. burgdorferi in which spoVG had either been 
deleted or over-expressed revealed that numerous transcripts are differentially expressed 
within these mutants compared to wild-type. Differentially expressed genes were 
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distributed across both the chromosome and the various plasmids. Additionally, functional 
clustering analysis revealed that genes involved in a wide variety of processes are involved, 
including DNA repair, carbon metabolism, and ABC transporters. The most abundant 
group for both spoVG-ON vs. wild-type and DspoVG vs wild-type was membrane 
lipoproteins. Even looking at differentially expressed genes by how they cluster into 
functional groups, there was great overlap between the genes that were differentially 
expressed in the spoVG-ON mutant compared to the genes that were differentially 
expressed in the DspoVG mutant. These data suggest that SpoVG has wide-ranging effects 
on gene-regulation in B. burgdorferi, rather than regulating a very specific set of genes.  
Some might argue that in order to be defined as a regulator, that a particular gene 
must regulate a defined set of genes, and demonstrate that there is high specificity for those 
genes. It might also be argued that nucleoid-associated proteins cannot be defined as 
regulators. To these points, I would make a counter-argument, specifically with regard to 
SpoVG. We provide evidence that SpoVG is regulated at the levels of transcription and 
translation, and evidence that the spoVG gene is regulated in culture as well as in the 
enzootic cycle. The evidence that we present that SpoVG acts broadly does not disprove 
our hypothesis that SpoVG serves a necessary function for fitness throughout the enzootic 
cycle, and that it is a regulator in that it enables B. burgdorferi to express the right genes at 
the appropriate levels when needed.  
Nearly all of the plasmid parA genes were differentially expressed, which could not 
be explained away by differential plasmid abundance. In addition to gene regulation, this 
has broad implications for plasmid replication and segregation. It is still unknown how B. 
burgdorferi manages to faithfully maintain 20 extra-chromosomal plasmids. We 
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demonstrated that the differences in parA transcript abundance could not be explained 
simply by a difference in plasmid copy number. Regulating expression of parA/B genes 
could have effects in multiple ways. Regulating expression of the genes could have impacts 
on plasmid replication and segregation over time. It may be possible that B. burgdorferi 
employs different plasmid maintenance programs when it is inside the tick versus inside 
the vertebrate. For example, previous work has demonstrated that B. burgdorferi can 
exchange plasmids with other Borrelia when inside a tick (303). Perhaps SpoVG plays a 
role in this by regulating how plasmids replicate, particularly when inside the tick.  
6.3 Regulation of ospC gene by SpoVG and c-di-AMP 
SpoVG interacts directly with DNAs and RNAs associated with genes that it 
regulates. We found examples where SpoVG impacted the transcript of a gene but not the 
protein, and examples where SpoVG regulated protein abundance of a gene but not the 
transcript. Understanding the why SpoVG interacts with certain DNAs and RNAs, and the 
factors that impact the relative affinity SpoVG has for one or the other may provide insight 
into these observed differences in regulation. 
We demonstrated for the first time that B. burgdorferi synthesizes cyclic-di-AMP. 
Both c-di-AMP and SpoVG have impacts on expression of the outer surface protein OspC 
that is necessary only during transmission from tick to mouse. Both of these regulators 
influence only OspC protein abundance, but not transcript abundance. SpoVG interacts 
directly with the RNA transcript, although the detailed mechanism of how it influences 
protein abundance remains to be determined. Likewise, the mechanism of how c-di-AMP 
regulates OspC remains to be determined. Although c-di-AMP riboswitches are ubiquitous 
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in other bacteria that also synthesize c-di-AMP, no riboswitch has been found in the 
Borrelial genome. It is possible that this represents a new class of riboswitch that has never 
been experimentally confirmed before now. It is also possible that c-di-AMP binds to a 
protein that only interacts with the ospC RNA when c-di-AMP is present, or not. Our 
EMSAs with SpoVG and ospC RNA with and without c-di-AMP indicate that SpoVG does 
not interact with c-di-AMP, or at least that it does not impact whether or not SpoVG 
interacts with the RNA.  Studies that determine cellular components that c-di-AMP 
interacts with would be very useful.  
6.4 Structural insights into SpoVG  
The structure of SpoVG from B. burgdorferi has not been solved, however it models 
with high confidence on the solved structure of Bacillus subtilis subsp. subtilis str. 168 
(2IA9) SpoVG (Figure 4.13). Shown in grey is the B. subtilis SpoVG, as a hexamer. In 
orange is one subunit of SpoVG modeled from B. burgdorferi. Putting together everything 
we know about the different residues, in lilac are the residues required for interacting with 
the DNA back-bone. These residues are delineated by two red arrows on the sequence 
alignment, and are highly conserved across all SpoVG homologues. In dark blue are the 
residues involved in recognizing specific sequences, and are delineated by the magenta box 
on the sequence alignments, which are highly divergent between different species (164).  
The residue in red is the one that can be acetylated, and in turquoise are the residues that 
can be phosphorylated.  
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6.5 SpoVG as a potential nucleoid-associated protein 
It remains to be determined if B. burgdorferi SpoVG forms hexamers, and if this is 
the active unit that binds nucleic acid. Observing how one unit of SpoVG models onto the 
hexameric structure of B. subtilis, reveals some intriguing insight. All of the residues 
involved in non-specific interactions with the DNA backbone are on one face of the SpoVG 
hexamer, and all of the residue involved in sequence-specific interactions are on the 
opposite face. By definition, bacteria, as prokaryotes do not have a membrane-bound 
nucleus, however they package their DNA into nucleoid like structures within the cell, 
packaged by nucleoid-associated proteins (159, 304-308). We hypothesize that SpoVG is 
one such nucleoid-associated protein. It is tempting to think of a SpoVG hexamer almost 
as analogous to a histone, with the DNA wrapping around the faces-one one side anchoring 
DNA via interactions with its backbone, and on the other, pulling in recognized sequences.  
Studies on nucleoid structure in bacteria are possible, and widely observed in many 
species of bacteria (306, 307, 309, 310). Studies involving intracellular imaging on 
Borrelia burgdorferi are particularly challenging for a number of reasons. For one, B. 
burgdorferi is very thin, even for a bacterium. Their diameter is about 200 nm, which is 
smaller than the wavelength of visible light. Even using high-resolution microscopy, it is 
very difficult to accurately resolve cell membranes-cytoplasm-cell membranes. Secondly, 
it has been widely observed using stains such as DAPI that nucleic acid material runs 
throughout the majority of the length of the bacteria (159, 307).  
There are two distinct states that have been seen: one in which essentially the entire 
bacterium stains consistently, and one in which “beads on a string” (to borrow terminology 
from Eukaryotes) is visible (307). No one has been able to effectively determine what 
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causes one state over the other. Associations with growth rate, or the presence or absence 
of regulatory factors does not provide consistent insight. Attempts to stain fixed bacteria 
with a-SpoVG antibodies did not yield any consistent results. In a newly-published paper, 
the Jacobs-Wagner lab profiled nucleoid size across a vast array of different bacteria, they 
did not include any Spirochetes in their analyses because they were unable to consistently 
define nucleoid size or shape. (38, 306, 311) (Personal correspondence with Dr. Jutras). 
Moving forward, there are a number of studies that could be employed to discern 
whether or not SpoVG actually influences the three-dimensional structure of the DNA. 
More recently, we have hypothesized that perhaps SpoVG only gets expressed at a certain 
time in the cell cycle. In order to test this, a fusion of the SpoVG promoter to GFP could 
determine if cells only some cells in a population express GFP at a given time. This could 
help determine whether there is any correlation between SpoVG expression and nucleoid 
shape with in B. burgdorferi.  
Approaches that do not require light microscopy could also be employed to probe 
whether SpoVG helps shape the nucleoid. Atomic force microscopy has been employed to 
determine if bacterial chromosomes develop a different conformation with or without the 
presence of a protein of interest. This method directly probes purified chromosome in an 
in vitro environment, free of the cell. Hi-C sequencing could also be employed. This 
approach essentially sequencing regions of DNA that are in close physical proximity to 
one another, and has been employed to demonstrate that when a specific protein of interest 
is absent within a cell, that the regions of DNA close to one another drastically change, 
thus indicating a conformational role of the protein of interest.  
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6.6 Presence of Poly-T sites 
The only motif consistent with every identified DNA sequence that SpoVG interacts 
with is a run of poly-Thymidine. This is not an uncommon motif in the B. burgdorferi 
genome, which is composed of approximately 70% A-T. In this genome, a run of 5 
Thymidines in a row occurs 23,869 times on the main chromosome alone. Keeping in mind 
that the main chromosome is only about 910 KB, this represents a substantial percentage 
of the chromosome. The ubiquitous poly-Ts are not surprising given then A-T content of 
the genome, however, it could offer a reason why B. burgdorferi SpoVG evolved to bind 
the nucleotide residues that it does. Our data indicate that SpoVG influences regulation of 
numerous genes throughout the genome. It could be that rather than specifically targeting 
a set of genes to hold under its control, that SpoVG acts in a more general manner to 
influence the overall structure of the chromosome within the cell.  
Poly-U sites are present in each of the RNAs that SpoVG binds to as well. 
Throughout the studies described in this work, focus was placed on studying the 5’ ends of 
genes, to understand how SpoVG has an impact on transcription and translation. Bacteria 
have two mechanisms for transcription termination: intrinsic and rho-dependent 
terminators (312). Intrinsic transcriptional terminators contain a sequence that forms a stem 
loop when transcribed into RNA, followed by a poly-U sequence. It is possible that SpoVG 
exerts its global effects, not just by regulating the start of transcription and translation, but 
also by regulating transcription termination. Another possibility is that perhaps SpoVG 
binds to these pol-U sites on the 3’ends of transcripts, and protects them from degradation. 
The half-life of RNA transcripts in B. burgdorferi is unusually long for a bacterium, at 45 
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minutes (313). The mechanism of how the half-life of transcripts is so long is not known. 
Perhaps SpoVG has a role in the regulation of the half-life of transcripts in B. burgdorferi. 
6.7 Post-translational modification of SpoVG 
It is still unclear what role, if any the post-translational modifications of acetylation 
and phosphorylation has on SpoVG activity. Each individually, or both, may impact the 
relative affinity of SpoVG for DNA vs RNA. Our studies demonstrated that SpoVG 
appears to possess a higher affinity for RNA than DNA, and this would be consistent with 
what was observed in L. monocytogenes (175). It has been reported that phosphorylation 
of S. aureus SpoVG impacts its ability to bind DNA (174). There was no indication that 
acetylation had an impact on SpoVG multimerization, however it remains to be tested 
whether it has an impact on the interaction between SpoVG and PlzA. Additionally, 
phosphorylation of SpoVG remains to be tested. There are two putative serine/threonine 
kinases encoded in the genome that have not been studied at all (23).  
6.8 Model of SpoVG network in B. burgdorferi 
Putting together everything we know of how SpoVG is regulated, and how it acts 
within the cell, it becomes clear that SpoVG is central to numerous processes (Figure 6.2). 
SpoVG is regulated by numerous regulatory factors including CsrA, PlzA, BadR, RpoS 
and the stringent response regulator ppGpp (154, 221, 284, 314, 315). These factors include 
DNA-RNA binding proteins, an alternative sigma factor, and nucleotide second 
messengers. Each of these factors has been reported to be necessary at different stages of 
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the enzootic cycle. Perhaps SpoVG acts as a sensor for the current environment, and what 
is present within the cell.  
SpoVG acts in multiple ways, including binding DNA, binding RNA and interacting 
with at least one other protein. Although the effect of post-translational modifications on 
SpoVG activity has yet to be elucidated, it is possible that they modulate how SpoVG acts 
in the cell. In this way, B. burgdorferi, with its reduced genome, could conserve energy on 
translating multiple different proteins, and instead re-purpose the same protein to behave 
differently when the environment changes.   
6.9 SpoVG as potentially analogous to a eukaryotic cell-cycle checkpoint protein 
The studies on Bacillus subtilis SpoVG from the 1980s and 1990s appear to present 
conflicting results. In one scenario, when SpoVG was absent, sporulation was halted in 
almost every cell, and in another scenario, a non-sense mutation in SpoVG restored the 
ability of cells to continue sporulation (165, 166, 169, 316). It is important to remember 
that SpoVG is expressed during stage 1 of sporulation, even when SpoVG was deleted on 
its own, it halted sporulation at stage 5. These data suggest that perhaps SpoVG serves a 
purpose in monitoring the progress of sporulation. Rather than regulating a certain set of 
genes necessary for advancement through the different stages of sporulation, it acts to 
ensure fidelity of the process, and to halt proceeding if something is not right. 
Bacteria do not have a programed cell cycle in the same way that eukaryotes do, but 
they still have to coordinate different processes such as DNA replication, cell growth and 
cell division. If a cell were to divide without properly replicating and segregating their 
chromosome(s), those cells would not survive. The process of sporulation offers insight 
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into a more organized cell program, but the notion of true checkpoint proteins in 
sporulating and non-sporulating bacteria is still rather a foreign concept.  
Even though Borrelia burgdorferi does not form spores, the rigidity of the enzootic 
cycle they traverse confers external cell program constraints. There are very specific times 
when B. burgdorferi must be highly motile, times when they must replicate rapidly, and 
times when they must essentially lie quiescent-within the unfed tick. Not only this, but they 
must be prepared to rapidly alter their cellular functions when new cues come in. Perhaps 
SpoVG acts to ensure that cell processes are progressing as they should, thereby serving as 
a type of prokaryotic cell cycle checkpoint protein.  
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Figure 6.1 Modeled SpoVG structure 
 
 
 
 Borrelia burgdorferi SpoVG protein sequence (orange) modeled on the solved 
crystal structure of Bacillus subtilis SpoVG protein (grey). The grey represents a hexamer 
of SpoVG, the orange depicts a monomer of SpoVG. In light purple are the residues 
necessary for interacting with DNA backbone. Nucleotides in dark blue depict those 
necessary for interacting with specific sequences. In red is the Lysine residue that can be 
acetylated. In turquoise are the residues that can be phosphorylated. 
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Figure 6.2 Model of SpoVG activities 
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APPENDICES 
 
APPENDIX 1. CHEA MUTANTS RESPOND TO GLYCEROL DIFFERENTLY THAN WILD-TYPE B. 
BURGDORFERI 
A.1.1 Introduction 
Wild-type B. burgdorferi responds to the presence of glycerol added to BSK media 
by reducing growth rate and altering transcription of genes involved in various cellular 
processes such as growth rate, DNA replication, and DNA repair. Cells over-expressing 
spoVG did not respond in the same manner. We wondered how the cells recognized 
glycerol, and how that recognition was transduced to transcriptional outputs. As previously 
stated, B. burgdorferi has very few known regulatory proteins.  
 The process of chemotaxis by bacteria has been extensively studied. At the core of 
how the system works, MCP (methyl-accepting chemotactic proteins) are receptors that 
span the outer and inner membrane of the cell wall and can bind different molecules. The 
cytoplasmic portion of the protein interacts with the histidine-kinase (CheA) of a two-
component system. The response regulator, CheY can be phosphorylated by CheA and can 
interact with the flagellar motor. This system was first studied in laboratory strains of E. 
coli, which encodes one gene for cheA and one gene for cheY. This was used as the model 
system to study chemotaxis for a number of decades (317).  
 Most bacteria that are not E. coli have multiple proteins that are homologous to 
CheA, and multiple proteins that are homologous to CheY (318). Under the classical 
chemotaxis assay, many of these additional systems served no apparent role, thus were 
dismissed for several decades as unnecessary, and unworthy of pursuit. Recently, studies 
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within a few bacteria have revealed that these additional systems are necessary for 
chemotaxis in different conditions, for example transition in and out of biofilms, and have 
additional signaling roles distinct from chemotaxis, such as gene regulation, and cell 
division(255, 319-322). B. burgdorferi has two CheA proteins, and three CheY proteins. 
Only one of each is necessary for chemotaxis. The function of the other proteins is 
unknown (80, 99, 102, 323-325). 
 
A.1.2 DcheA1 and DcheA2 growth response to glycerol 
 We hypothesized that perhaps glycerol was sensed through the Che system, thus 
potentially linking nutrient availability to growth rate and gene regulation. For this, we 
obtained both CheA mutants: DcheA1 and DcheA2 from Dr. Chris Li. These mutants form 
massive clumps in liquid culture, making it impossible to conduct growth curves by 
counting cell density (Figure A1.1 A) (80).  
For this reason, we relied on a previously-published method to circumvent this 
obstacle (326). BSK-II media contains the pH indicator phenol Red. As B. burgdorferi 
produces ATP, lactic acid is secreted from the cells, and the once red media turns yellow. 
This color change can be measured by a spectrophotometer by calculating the absorbance 
at 562 nm divided by the absorbance at 630 nm. In cultures grown in BSK without glycerol, 
the media from both DcheA1 and DcheA2 strains acidified significantly more slowly that 
wild-type (Figure A1.1 B and C). This indicates that there is a difference in how both of 
the mutant strains are able to metabolize available sugars and produce ATP.  
There is a slight difference in media acidification between wild-type grown in BSK 
with and without glycerol. This difference is significantly greater in both DcheA1 and 
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DcheA2 cultures (Figure A1.1 B and C). This indicates that both CheA proteins may be 
involved in carbon metabolism as well as chemotaxis, and potentially other processes as 
well.  
 
A.1.3 DcheA1 and DcheA2 transcriptional response to glycerol 
We next sought to test whether there were transcriptional differences in how wild-
type, DcheA and DcheA2 respond to glycerol. We first compared relative transcript 
abundance from wild-type, DcheA1 and DcheA2 grown in BSK without glycerol (Figure 
A1.2 A). The only transcript that was differentially expressed was dnaA in the Dche1 strain. 
The implication for regulation of DNA replication is intriguing, but was not pursued 
further.  
We next compared the differences in transcript abundance in response to 4% 
glycerol added to BSK media for each strain (Figure A1.2 B). For example, we had 
previously reported that spoVG transcript is more abundant when glycerol is added to the 
medium. spoVG transcript was unaltered in either DcheA1 or DcheA2. Additionally, dnaA 
transcript was more abundant in both wild-type and DcheA2 when glycerol was added to 
the media, but remained unchanged in DcheA1. These data indicate that both CheA1 and 
CheA2 are involved in cellular processes beyond chemotaxis.  
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Figure A1.1 Differences in growth rate in response to glycerol 
 
 
 
Representative clump of bacteria that both cheA mutants form in culture (A). (B) Wild-
type (B31-A), and cheA1 cultured with and without 4% glycerol. (C) Wild-type (B31-A), 
and cheA2 cultured with and without 4% glycerol. Media acidification was measured using 
a spectrophotometer. Wild-type (black and grey) is plotted on each graph to demonstrate 
the differences between the cheA mutants and wild-type.  
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Figure A1.2 Differences in Transcriptional response to glycerol 
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APPENDIX 2 . Intracellular c-di-GMP analysis by FRET 
 
 The ability to synthesize cyclic-di-GMP is essential for B. burgdorferi to survive 
within a tick, and successfully transmit to a mouse. As with many other bacteria, it also has 
a role in motility and chemotaxis. C-di-GMP is synthesized by the response regulator rrp1 
of a two-component signaling system in B. burgdorferi (Figure A2.1 A). Both the Histidine 
Kinase (Hk1) and Rrp1 are produced in culture, but it is unclear what Hk1 responds to in 
culture or in the enzootic cycle in order to stimulate c-di-GMP synthesis. Given the newly 
discovered link between c-di-GMP signaling pathway with gene regulation by SpoVG (via 
interacting with PlzA), we were particularly motivated to develop a method that would 
allow us to gain insight into this system.  
 We took advantage of a newly developed FRET sensor for c-di-GMP inside living 
bacterial cells. A few other systems have been developed for studying c-di-GMP, each with 
their own limitations for application in B. burgdorferi (327-329).  This system is ideal, 
because the FRET sensor is always expressed by B. burgdorferi, and FRET is dependent 
on c-di-GMP binding. Using this method, we will be able to visualize c-di-GMP 
synthesis/degradation in real time, and in mouse infection/tick colonization studies.  
 Christen et al linked the gene for a Pilz-domain protein (binds c-di-GMP) to the 
gene for CFP on one end, and the gene for YFP on the other (figure A2.1 C). They tested 
numerous c-di-GMP proteins, and settled on the one the underwent the largest structural 
change, and thus the clearest distinction with FRET signal (330).  
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We had the DNA for the entire CFP-PilZ-YFP construct synthesized using optimized 
codons for B. burgdorferi end a BamH1 restriction site on the CFP end and a Kpn1 
restriction site on the YFP end. This was then cloned into pBLS715 and transformed into 
B31-A3 cells (Figure A2.1 D).  
 A Zeiss LSM 880 upright multiphoton microscope was used to image B. 
burgdorferi expressing the FRET plasmid (Figure A2.2A). The initial images confirmed 
that the construct is expressed well, and that FRET can be detected. Current work in 
progress is to transform additional strains for analysis (Figure A2.2 B). The Drrp1 strain 
will serve as c-di-GMP negative control, and the DpdeADpdeB will serve as a c-di-GMP 
positive control, since PdeA and PdeB both degrade c-di-GMP (Figure A2.1 A).  
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Figure A2.1 Construction of FRET sensor for c-di-GMP 
 
 
Figure adapted from Radolf et al. Nature Reviews. 2012. And  
 
C-di-GMP is synthesized by one protein in B. burgdorferi: the response regulator Rrp1 of 
a two-component system (A). (B) Structure of c-di-GMP. (C) Structure of the FRET 
construct. C-di-GMP binds to PilZ domains.  
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Figure A2.2 B. burgdorferi expressing the FRET sensor 
 
 
 
B. burgdorferi B31-A3 expressing FRET sensor (A). Demonstrates that YFP and CFP are 
expressed and visualized well. Also, able to detect FRET, indicating the sensor does fold 
correctly. (B). Will transform additional strains with the same sensor for positive and 
negative controls. 
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APPENDIX 3: Additional binding interactions 
A3.1 C-di-GMP inhibits SpoVG binding to DNA.  
 In our initial studies to determine how the interaction between SpoVG and PlzA 
impacted the binding affinity of SpoVG for DNA, c-di-GMP was included in these studies. 
It was observed that when c-di-GMP was added, the interaction between SpoVG and DNA 
was competed away (Figure A3.1). The SpoVG-DNA complex is evidenced by the 
presence of a shifted band in lane 3 of the EMSA. Lane 4 contains the same concentration 
of DNA and SpoVG, as well as 1 mM c-di-GMP. The band seen in lane 3 is almost entirely 
shifted back down. This result was seen numerous times, every time c-di-GMP was added 
to a reaction with SpoVG and DNA. We know that SpoVG has a higher affinity for RNA 
than DNA, although it is not yet clear what RNA motif SpoVG interacts with. Knowing 
this, it is not entirely surprising that c-di-GMP would interrupt SpoVG-DNA interactions: 
c-di-GMP essentially looks like an RNA. Additionally, neither c-di-GMP nor c-di-AMP 
are able to compete away SpoVG-RNA interactions.  
 The biological significance of this remains to be elucidated. It is not known if either 
c-di-GMP nor c-di-AMP are ever produced in within B. burgdorferi when their canonical 
binding partners are not also produced. If they were, is it possible that they would act as 
sponges to essentially “soak up” any SpoVG that may be binding to DNA, thus ensuring 
that SpoVG exerts its effects at only post-transcriptionally? 
 
A3.2 SpoVG binds to DNA upstream of the ospA promoter  
Every identified DNA sequence that SpoVG binds to contains a run of poly-Ts. 
Previous work had identified a region of DNA with runs of poly-Ts upstream of the ospA 
transcriptional promoter involved in regulation of the gene (Figure A3.2 B) (274, 331). 
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OspA is an outer surface protein that is expressed during, and absolutely essential, for B. 
burgdorferi to colonize ticks. This protein interacts with the receptor TROSPA, which is 
expressed on the outer surface of tick mid-gut cells. The interaction between OspA and 
TROSPA allows B. burgdorferi to attach to the midgut through the molt. Expression of 
this protein gets turned off during the blood meal, allowing B. burgdorferi to detach and 
transmit into the vertebrate (117-119, 332).  
 Knowing that regulation of this gene is tightly controlled, and that the upstream 
region contains two runs of poly-Ts, we hypothesized that SpoVG could bind to this 
sequence of DNA. An EMSA using ospA DNA and SpoVG demonstrates that SpoVG does 
interact with this region (Figure A3.2 A). Lanes 2 and 3 contain increasing amounts of 
SpoVG. Lane 4 contains the same concentration of SpoVG as Lane 3, as well as 100x 
unlabeled ospA DNA.  
 
A3.3 PlzA binds to DNA associated with its own gene 
 There is evidence to suggest that PlzA regulates its own expression (144, 148, 333). 
We therefore hypothesized that PlzA binds to DNA associated with its own gene. To test 
this, we used a DNA probe that spans the approximately 300 base pairs between it and the 
down-stream gene (Figure A3.3 C). Addition of PlzA protein to the DNA probe resulted 
in a shifted band, indicating that PlzA does in fact, bind its own DNA (Figure A3.3 A). 
Although PlzA regulates expression of SpoVG, RNA-sequencing from our spoVG-mutant 
strains revealed that SpoVG does not impact plzA transcription. It remains to be tested 
whether SpoVG influences PlzA translation. 
 
 
176 
 
 
Figure A3.1 c-di-GMP inhibits SpoVG binding to DNA 
 
 
 
As previously demonstrated, SpoVG binds to the glpKD DNA. Lane 1: glpKD DNA. Lane 
2 glpKD DNA and diluted SpoVG protein. Lane 3: glpKD DNA and more SpoVG. Lane 
4: glpKD DNA, the same concentration of SpoVG as in lane 3, and c-di-GMP. 
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Figure A3.2: SpoVG binds to ospA DNA 
 
 
 
SpoVG binds to DNA upstream of the transcriptional promoter of ospA (A). Lane 1: ospA 
DNA. Lanes 2 and 3: ospA DNA and SpoVG. Lane 4: ospA DNA, SpoVG (amount used 
in Lane 3), unlabeled specific competitor. The sequence of DNA that ospA binds to (B).  
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A3.3: PlzA binds to its own promoter DNA 
  
 
PlzA protein binds to DNA in the intergenic region between the upstream PBP gene and 
plzA (A). RNA-seq results demonstrating that SpoVG does not regulate plzA at the level of 
transcription (B). Schematic of DNA probe used for EMSA (C). 
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APPENDIX 4: Proteomics 
 RNA-sequencing revealed that numerous transcripts are altered when spoVG is 
dysregulated. We hypothesized that our spoVG mutant strains would reveal differences in 
numerous protein abundances as well. Furthermore, given the fact that SpoVG binds RNA 
in addition to DNA, we hypothesized that some proteins would be differentially regulated 
without differences in their transcript abundance. We already have two examples of this: 
VlsE and OspC, however we set out to identify more examples.  
 Additionally, post-translational modifications on proteins can impact their activity. 
We have already discussed acetylation above (235, 334, 335). Another common 
modification employed by all forms of life, including bacteria, is phosphorylation (336). 
Apart from work on the two-component systems, no one has studied the potential 
phosphorylome of B. burgdorferi. A group studying SpoVG in Staphylococcus aureus 
discovered that SpoVG can be phosphorylated by S. aureus, and furthermore, that SpoVG 
nucleic acid-binding activity is dependent on phosphorylation (174). 
 We hypothesized that SpoVG could be phosphorylated in B. burgdorferi as well, 
and that its activity could be dependent on phosphorylation states as well. Furthermore, we 
hypothesized that it is possible that SpoVG not only regulates the abundance of numerous 
transcripts and proteins, but that perhaps the overall phosphorylome of B. burgdorferi is 
also differentially regulated. SpoVG from B. burgdorferi was phosphorylated, as 
demonstrated by MS/MS.  
 To address these questions, we conducted 2-dimensional gel electrophoresis to 
compare overall proteomes and phosphorylomes between wild-type, spoVG-ON and 
DspoVG strains of B. burgdorferi. Each strain was grown to mid-log phase in 10 ml 
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cultures. Proteins were extracted, and separated by isoelctric focusing on strips containing 
a pH gradient from 3 to 10. Proteins were then separated by size on 20% polyacrylamide 
gels. Gels were first stained with Pro-Q diamond to detect phosphorylated proteins, then 
stained with Coomassie in order to visualize all proteins.  
 Although none of the spots were subjected to mass-spec for analysis (the gels were 
handled with bare hands by someone who should have known better), these gels did serve 
as preliminary data that the full proteomes of these strains should be analyzed. Rather than 
wasting more time running 2-D gels, we are moving forward with full proteomics with our 
collaborator Dr. Wolfram Zückert.  
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Figure A4 2-D gel analysis of total and phosphorylated proteins 
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2-Dimensional gels, each separated by pH horizontally, and size vertically. Each gel was 
first stained with Pro-Q Diamond, to visualize phosphorylated proteins, and imaged on a 
typhoon. The same gels were then stained with Coomassie to visualize total protein and 
imaged on an Odyssey imager.  
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APPENDIX 5: Full transcriptomic tables 
Figure A5.1 WT vs spoVG-ON and WT vs DspoVG mRNA Full table 
gene 
WT vs 
ON log2 WT vs ON padj 
WT vs ∆ 
log2 
WT vs ∆ 
padj 
BB_0001|      hypothetical protein 0.02 9.78E-01 -0.65 1.27E-01 
BB_0002| glycosyl hydrolase family 3 N domain protein   0.82 2.94E-02 -0.10 9.37E-01 
BB_0004| phosphoglucomutase  -0.05 9.59E-01 -0.10 8.78E-01 
BB_0005| trpS| tryptophanyl-tRNA synthetase -0.40 2.85E-01 -0.45 2.42E-01 
BB_0006| membrane protein  -0.01 9.95E-01 -1.16 4.61E-03 
BB_0007|      hypothetical protein  0.46 4.46E-01 -0.88 7.78E-02 
BB_0008|      hypothetical protein  -1.19 5.55E-05 0.16 7.85E-01 
BB_0009|      hypothetical protein -1.49 1.88E-10 0.22 5.55E-01 
BB_0010| holo-(acyl-carrier-protein) synthase 0.32 5.45E-01 0.32 5.41E-01 
BB_0011|      hypothetical protein  -0.78 6.27E-03 -0.16 7.57E-01 
BB_0012| truA| tRNA pseudouridine synthase A   -0.90 1.43E-02 -0.40 4.07E-01 
BB_0013|      hypothetical protein -1.06 9.43E-03 -0.29 6.52E-01 
BB_0014| priA| primosomal protein N'  -1.53 4.28E-07 -0.44 2.91E-01 
BB_0015| udk| uridine kinase -1.45 1.35E-06 -0.50 2.10E-01 
BB_0016| GlpE protein -0.97 3.41E-03 -0.22 6.77E-01 
BB_0017|      hypothetical integral membrane protein -0.62 2.27E-01 -0.73 1.55E-01 
BB_0019|      hypothetical protein 0.01 9.84E-01 -0.33 3.95E-01 
BB_0022| ruvB| holliday junction DNA helicase RuvB 0.95 4.05E-03 0.25 6.28E-01 
BB_0023| ruvA| holliday junction DNA helicase RuvA  1.15 3.52E-03 0.98 2.25E-02 
BB_0024|      hypothetical protein  0.88 9.75E-03 -0.58 1.41E-01 
BB_0025| DNA-binding regulatory protein YebC/PmpR family -0.08 9.59E-01 1.51 1.07E-02 
BB_0026| methylenetetrahydrofolate dehydrogenase  0026|  0.40 5.93E-01 1.34 8.69E-03 
BB_0027|      hypothetical protein  0027|  0.98 2.61E-02 0.04 9.89E-01 
BB_0028| lipoprotein          0028|  0.09 9.59E-01 0.21 8.40E-01 
BB_0029| YaiI/YqxD family protein  0029|  -0.64 2.35E-01 -0.56 3.35E-01 
BB_0030| lepB| signal peptidase I  0030|  -0.78 4.36E-02 -0.11 9.29E-01 
BB_0031| lepB| signal peptidase I  0031|  0.26 6.19E-01 0.38 3.95E-01 
BB_0032|      hypothetical protein  0032|  -0.36 3.18E-01 0.20 6.52E-01 
BB_0033| smpB| SsrA-binding protein  0033|  -0.21 7.21E-01 0.73 6.22E-02 
BB_0034| outer membrane protein P13  0034|  1.22 2.06E-03 -0.13 9.12E-01 
BB_0035| DNA gyrase/topoisomerase IV 5.56 NA 5.77 NA 
BB_0036| DNA topoisomerase II (N-region) -0.43 5.87E-01 -1.47 6.59E-03 
BB_0037| 1-acyl-sn-glycerol-3-phosphate acyltransferase   -0.36 6.26E-01 -1.46 2.18E-03 
BB_0039|      hypothetical protein  0039|  -0.66 3.27E-01 -1.32 2.31E-02 
BB_0040| cheR| CheR methyltransferase 0.07 9.59E-01 1.01 3.29E-02 
BB_0042| phoU| phosphate transport system 0.73 1.09E-01 -0.09 9.64E-01 
BB_0043|      hypothetical protein  0043|  1.82 2.74E-04 0.72 2.76E-01 
BB_0044|      hypothetical protein  0044|  1.75 5.82E-04 0.34 6.89E-01 
BB_0045| P115 protein  0045|  -0.13 9.06E-01 0.11 9.32E-01 
BB_0046| rnhB| ribonuclease HII  0046|  0.63 4.68E-02 -0.31 4.51E-01 
BB_0047|      hypothetical protein  0047|  2.07 4.46E-04 0.60 4.73E-01 
BB_0048|      hypothetical protein  0048|  0.70 3.11E-01 0.60 4.20E-01 
BB_0050| transporter  0050|  -0.26 7.61E-01 -0.66 2.70E-01 
BB_0051|      integral membrane protein -0.24 5.87E-01 -0.03 9.89E-01 
BB_0052| tRNA/rRNA methyltransferase  0052|  -0.05 9.59E-01 -0.59 1.81E-01 
BB_0053| ung| uracil-DNA glycosylase  0053|  -0.07 9.59E-01 -0.88 7.69E-03 
BB_0054| protein-export membrane protein SecG 0.41 5.39E-01 0.19 8.47E-01 
BB_0055| tpiA| triose-phosphate isomerase  0055|  -0.04 9.61E-01 0.27 6.68E-01 
BB_0056| pgk| phosphoglycerate kinase  0056|  -0.16 8.30E-01 0.15 8.51E-01 
BB_0057| gap| glyceraldehyde-3-phosphate dehydrogenase 0.10 8.98E-01 -0.05 9.89E-01 
BB_0058| tetratricopeptide repeat domain protein  0058|  -0.11 9.59E-01 -0.79 1.40E-01 
BB_0059| CBS domain pair protein  0059|  -0.18 8.07E-01 -0.30 5.86E-01 
BB_0060|      hypothetical protein  0060|  0.17 8.32E-01 -0.25 6.75E-01 
BB_0061| trx| thioredoxin  0061|  0.68 2.41E-01 0.85 1.40E-01 
BB_0062| RNA methyltransferase    RsmE family  0062|  0.22 7.07E-01 -0.26 6.27E-01 
BB_0063| pasta domain protein  0063|  -0.12 8.91E-01 -0.13 8.78E-01 
BB_0064| fmt| methionyl-tRNA formyltransferase  0064|  0.24 7.42E-01 0.28 6.76E-01 
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BB_0065| def| peptide deformylase  0065|  -0.03 9.59E-01 0.21 6.69E-01 
BB_0066|      hypothetical protein  0066|  0.52 9.63E-02 0.36 3.35E-01 
BB_0068| haloacid dehalogenase-like hydrolase  0068|  -0.20 7.51E-01 0.63 1.31E-01 
BB_0069| aminopeptidase II  0069|  -0.43 4.60E-01 0.86 6.68E-02 
BB_0070|      hypothetical protein  0070|  -0.27 7.25E-01 0.64 2.64E-01 
BB_0072| membrane protein          0072|  -0.90 2.26E-04 0.36 2.63E-01 
BB_0073|      hypothetical protein  0073|  -0.86 7.43E-03 0.60 9.94E-02 
BB_0074| prfB| peptide chain release factor 2  0074|  -0.12 8.27E-01 0.47 1.15E-01 
BB_0075|      hypothetical protein  0075|  -0.68 3.37E-02 0.54 1.36E-01 
BB_0076| ftsY| signal recognition particle-docking protein  -1.10 6.20E-05 0.71 2.15E-02 
BB_0080| ABC transporter    ATP-binding protein  0080|  -1.25 2.12E-03 -0.01 9.89E-01 
BB_0081| efflux ABC transporter    permease protein  -1.22 8.95E-03 0.03 9.89E-01 
BB_0082|      hypothetical protein  0082|  -0.58 2.57E-01 -0.22 7.77E-01 
BB_0083|      hypothetical protein  0083|  0.06 9.59E-01 -0.13 8.66E-01 
BB_0084| aminotransferase    class V superfamily  0084|  -0.88 3.03E-01 -1.85 1.09E-02 
BB_0085|      hypothetical protein  0085|  0.37 4.48E-01 0.05 9.89E-01 
BB_0086|      Mg chelatase homolog  0086|  0.01 9.90E-01 -0.24 6.59E-01 
BB_0087| L-lactate dehydrogenase  0087|  0.83 1.76E-02 0.03 9.89E-01 
BB_0088| lepA| GTP-binding protein LepA  0088|  0.00 9.95E-01 -0.27 5.76E-01 
BB_0089|      hypothetical protein  0089|  -0.09 9.35E-01 -0.44 2.34E-01 
BB_0090| V-type ATPase    subunit K  0090|  0.52 2.33E-01 0.07 9.80E-01 
BB_0092| V-type ATPase    D subunit  0092|  -0.53 2.37E-01 -0.27 6.46E-01 
BB_0093|  ATP synthase beta chain (V-type ATPase subunitB) -0.35 3.38E-01 -0.16 7.47E-01 
BB_0095|      hypothetical protein  0095|  -0.33 5.45E-01 -0.21 7.49E-01 
BB_0096|  ATP synthase subunit E (V-type ATPase subunit E)  0.02 9.84E-01 -0.50 3.85E-01 
BB_0097|      hypothetical protein  0097|  0.37 6.01E-01 -0.44 5.05E-01 
BB_0098| MutS2 protein  0098|  -1.11 1.46E-02 -0.36 5.87E-01 
BB_0099| rsgA| ribosome small subunit-dependent GTPase A  0.02 9.76E-01 -0.14 8.60E-01 
BB_0100| murI| glutamate racemase  0100|  0.57 7.88E-02 0.07 9.55E-01 
BB_0101| asnS| asparaginyl-tRNA synthetase  0101|  -0.17 7.00E-01 0.24 5.49E-01 
BB_0102|      hypothetical protein  0102|  -0.16 7.82E-01 0.26 5.63E-01 
BB_0103| phosphoribosyl transferase domain protein  0103|  -0.17 7.81E-01 0.23 6.69E-01 
BB_0104| periplasmic serine protease DO  0104|  0.49 3.64E-01 0.25 7.31E-01 
BB_0105| map| methionine aminopeptidase    type I  -0.25 7.15E-01 0.09 9.73E-01 
BB_0106| tetratricopeptide repeat domain protein  0106|  -0.80 1.43E-02 -0.43 2.83E-01 
BB_0107| nusB| transcription antitermination factor NusB -0.67 6.89E-02 -0.12 8.97E-01 
BB_0108| basic membrane protein  0108|  0.04 9.59E-01 -0.46 1.80E-01 
BB_0109| acetyl-CoA acetyltransferases subfamily  0109|  -0.25 5.74E-01 -0.54 1.24E-01 
BB_0110|      hypothetical protein  0110|  0.07 9.59E-01 -0.17 7.99E-01 
BB_0111| dnaB| replicative DNA helicase  0111|  -0.43 3.09E-01 -0.15 8.40E-01 
BB_0112| rplI| ribosomal protein L9  0112|  0.14 8.99E-01 0.52 2.91E-01 
BB_0113| rpsR| ribosomal protein S18  0113|  0.25 7.00E-01 0.61 2.12E-01 
BB_0114| single-stranded DNA-binding protein (SSB)  0.27 6.55E-01 1.12 4.22E-03 
BB_0115| 30S ribosomal protein S6  0115|  0.53 2.28E-01 1.22 8.38E-04 
BB_0116| pts system glucose-specific iiabc component 0.04 9.59E-01 0.71 1.36E-01 
BB_0117| membrane protein  0117|  0.03 9.63E-01 -0.14 8.07E-01 
BB_0118| rseP| RIP metalloprotease RseP  0118|  0.00 9.98E-01 -0.25 6.69E-01 
BB_0120| uppS| di-transpoly-cis-decaprenylcistransferase   0.27 5.73E-01 -0.35 4.07E-01 
BB_0121| frr| ribosome recycling factor  0121|  0.28 5.21E-01 0.02 9.89E-01 
BB_0122| tsf| translation elongation factor Ts  0122|  0.42 3.37E-01 0.24 6.62E-01 
BB_0123| rpsB| ribosomal protein S2  0123|  0.51 2.73E-01 0.56 2.39E-01 
BB_0124|      hypothetical protein  0124|  -0.24 7.00E-01 0.24 6.99E-01 
BB_0125|      hypothetical protein  0125|  0.06 9.59E-01 0.26 6.62E-01 
BB_0126|      hypothetical protein  0126|  0.24 7.60E-01 0.12 9.38E-01 
BB_0127| ribosomal protein S1  0127|  0.33 5.69E-01 0.62 1.87E-01 
BB_0128| cmk| cytidylate kinase  0128|  0.45 4.15E-01 0.65 1.99E-01 
BB_0129|  RNA pseudouridine synthase  -0.79 4.53E-02 -0.38 4.43E-01 
BB_0130|      hypothetical protein  0130|  -0.60 3.66E-01 -0.64 3.39E-01 
BB_0131| recA| protein RecA  0131|  -0.29 6.19E-01 -0.55 2.42E-01 
BB_0132| transcription elongation factor GreA  -0.30 6.06E-01 -0.46 3.53E-01 
BB_0133| tetratricopeptide repeat domain protein  0133|  0.53 1.30E-01 -0.25 5.78E-01 
BB_0134| tetratricopeptide repeat domain protein  0134|  -1.06 3.72E-03 -0.31 5.59E-01 
BB_0135| hisS| histidyl-tRNA synthetase  0135|  0.00 9.99E-01 -0.10 9.36E-01 
BB_0136| penicillin-binding protein  0136|  -0.14 7.42E-01 -0.20 5.87E-01 
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BB_0137| long-chain-fatty-acid CoA ligase  0137|  0.85 2.74E-02 -0.18 7.93E-01 
BB_0138|      hypothetical protein  0138|  0.13 9.59E-01 -1.74 4.75E-03 
BB_0139|      hypothetical protein  0139|  -0.83 1.48E-02 0.15 8.24E-01 
BB_0141| membrane fusion protein  0141|  0.17 7.27E-01 -0.47 1.73E-01 
BB_0142| outer membrane efflux protein  0142|  0.61 6.26E-02 -0.75 1.99E-02 
BB_0143|      hypothetical protein YidD  0143|  0.05 9.61E-01 0.46 5.45E-01 
BB_0144| glycine betaine L-proline ABC transporter 0.16 9.11E-01 0.24 7.85E-01 
BB_0145| glycine betaine L-proline ABC transporter permease protein 0.41 4.74E-01 0.33 5.89E-01 
BB_0146| glycine betaine L-proline ABC transporter ATP-binding protein 0.67 2.49E-01 0.44 5.35E-01 
BB_0147| p41  0147|  0.50 3.58E-01 0.21 8.01E-01 
BB_0151| nagA| N-acetylglucosamine-6-phosphate deacetylase  0151|  -0.51 3.48E-01 0.35 5.78E-01 
BB_0152| nagB| glucosamine-6-phosphate isomerase  0152|  -0.76 5.56E-02 0.08 9.73E-01 
BB_0153| superoxide dismutase (Mn) (General stress protein 24) -0.80 9.16E-02 -0.55 3.14E-01 
BB_0154| secA| preprotein translocase    SecA subunit  0154|  -0.11 8.62E-01 -0.63 3.91E-02 
BB_0155| lipoprotein          0155|  0.25 6.29E-01 0.51 2.12E-01 
BB_0156|      hypothetical protein  0156|  -0.01 9.94E-01 0.41 4.11E-01 
BB_0157|      hypothetical protein  0157|  0.31 7.19E-01 0.95 1.02E-01 
BB_0158| S2 lipoprotein  0158|  0.20 7.66E-01 0.31 5.80E-01 
BB_0159|      hypothetical protein  0159|  -0.30 6.60E-01 0.44 4.51E-01 
BB_0160| alr| alanine racemase  0160|  0.17 7.00E-01 0.53 8.37E-02 
BB_0161|      hypothetical protein  0161|  -0.11 9.04E-01 -0.69 5.58E-02 
BB_0162|      hypothetical protein  0162|  -0.11 9.57E-01 -0.65 2.05E-01 
BB_0163|      hypothetical protein  0163|  0.65 9.30E-02 -0.24 6.62E-01 
BB_0164|      K+-dependent Na+/Ca+ exchanger homolog  0164|  -0.52 2.08E-01 -0.53 2.21E-01 
BB_0165|      hypothetical protein  0165|  -0.66 1.36E-01 -0.87 4.41E-02 
BB_0166| malQ| 4-alpha-glucanotransferase  0166|  0.60 2.43E-01 0.02 9.89E-01 
BB_0167| outer membrane protein  0167|  -0.16 8.27E-01 -0.93 1.66E-02 
BB_0168| DnaK suppressor          0168|  0.23 5.99E-01 -1.09 6.83E-05 
BB_0169| infA| translation initiation factor IF-1  0169|  -0.74 1.13E-01 -0.72 1.45E-01 
BB_0170|      hypothetical protein  0170|  -0.18 8.59E-01 -0.76 1.46E-01 
BB_0171| tetratricopeptide repeat domain protein  0171|  0.08 9.59E-01 -0.05 9.89E-01 
BB_0172| von Willebrand factor type A domain protein  0172|  -0.33 4.53E-01 -0.33 4.43E-01 
BB_0174|      hypothetical protein  0174|  -0.67 2.17E-01 -1.08 2.97E-02 
BB_0175|      hypothetical protein  0175|  -0.75 8.89E-02 -0.81 6.92E-02 
BB_0176| ATPase family associated with various cellular activities (AAA)  -0.21 7.26E-01 -0.86 1.86E-02 
BB_0177| gidB| 16S rRNA methyltransferase GidB  0177|  -0.82 2.23E-02 -0.67 9.48E-02 
BB_0178| gidA| tRNA uridine 5-carboxymethylaminomethyl modification -0.45 1.69E-01 -0.76 1.10E-02 
BB_0179| trmE| tRNA modification GTPase TrmE  0179|  -0.05 9.59E-01 -1.17 9.97E-04 
BB_0180| FlbF protein  0180|  0.01 9.84E-01 0.20 6.99E-01 
BB_0183|      hypothetical protein  0183|  -0.79 9.11E-02 0.22 7.77E-01 
BB_0184| csrA| carbon storage regulator  0184|  -1.52 1.85E-03 -0.38 6.06E-01 
BB_0185| glycoprotease family  0185|  -0.75 2.07E-01 -0.24 8.07E-01 
BB_0186| ATPase    YjeE family  0186|  0.40 4.52E-01 0.32 5.81E-01 
BB_0187|      hypothetical protein  0187|  0.40 4.04E-01 0.14 8.71E-01 
BB_0189| rpmI| ribosomal protein L35  0189|  1.10 1.78E-03 0.40 3.96E-01 
BB_0190| infC| translation initiation factor IF-3  0190|  0.82 2.83E-02 0.38 4.31E-01 
BB_0192|      hypothetical protein  0192|  0.17 8.30E-01 -0.72 9.28E-02 
BB_0193| lipoprotein          0193|  0.51 4.36E-01 -1.23 1.77E-02 
BB_0194| hydrolase    TatD family  0194|  -0.04 9.59E-01 -0.60 1.55E-01 
BB_0195| TPR domain protein  0195|  -0.12 9.13E-01 -0.59 1.94E-01 
BB_0197| protoporphyrinogen oxidase          0197|  0.71 1.04E-01 -0.52 2.92E-01 
BB_0198| ((ppGpp)ase)  0.60 1.74E-01 -0.43 3.95E-01 
BB_0200| D-alanine--D-alanine ligase  -0.01 9.91E-01 0.97 8.89E-02 
BB_0201| UDP-MurNAc-tripeptide synthetase 0.63 1.13E-01 0.65 1.14E-01 
BB_0202| hemolysin          0202|  0.52 1.92E-01 -0.04 9.89E-01 
BB_0203| hflK| HflK protein  0203|  -0.54 2.37E-01 -0.85 4.17E-02 
BB_0204| hflC| HflC protein  0204|  -0.52 3.23E-01 0.11 9.46E-01 
BB_0205|      hypothetical protein  0205|  -0.09 9.59E-01 0.34 6.01E-01 
BB_0206|      methyltransferase  0206|  -0.39 6.40E-01 -0.21 8.71E-01 
BB_0209| tetratricopeptide repeat domain protein  0209|  0.73 5.11E-02 0.22 7.08E-01 
BB_0211| DNA mismatch repair protein MutL  0211|  -1.02 8.26E-04 0.84 1.07E-02 
BB_0212| borrelia ORF-A superfamily  0212|  1.09 1.89E-02 0.15 9.07E-01 
BB_0213| lipoprotein          0213|  0.94 7.11E-04 -0.20 6.69E-01 
BB_0214| efp| translation elongation factor P  0214|  -0.42 4.79E-01 -0.13 9.19E-01 
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BB_0215| phosphate ABC transporter  0.68 1.67E-02 0.02 9.89E-01 
BB_0216| pstC| phosphate ABC transporter permease protein PstC  -0.87 2.18E-03 -0.41 2.61E-01 
BB_0217| pstA| phosphate ABC transporter permease protein PstA   -1.17 3.16E-04 -0.28 5.78E-01 
BB_0218| pstB| phosphate ABC transporter ATP-binding protein 0.12 9.14E-01 -0.49 2.62E-01 
BB_0219| zinc (Zn2+)-iron (Fe2+) permease (ZIP) family   0.31 5.73E-01 -0.58 1.86E-01 
BB_0220| alanyl-tRNA synthetase  0220|  -0.49 2.47E-01 -0.06 9.89E-01 
BB_0221| flagellar motor switch protein  0221|  0.01 9.82E-01 0.46 2.03E-01 
BB_0222| 6-phosphogluconolactonase (6PGL)  0222|  -0.31 5.40E-01 -0.42 3.50E-01 
BB_0225| tRNA-dihydrouridine synthase A  0225|  -1.35 1.43E-02 -0.68 3.27E-01 
BB_0226| serS| seryl-tRNA synthetase  0226|  -0.45 5.02E-01 -0.80 1.60E-01 
BB_0227|      hypothetical protein  0227|  0.09 9.59E-01 -0.24 7.69E-01 
BB_0228| peptidase M16 inactive domain family  0228|  -0.41 5.48E-01 -0.37 5.81E-01 
BB_0229| rpmE| ribosomal protein L31  0229|  0.19 7.97E-01 -0.12 9.27E-01 
BB_0230| rho| transcription termination factor Rho  0230|  -0.67 1.20E-01 -0.40 4.43E-01 
BB_0231| hypothetical protein  0231|  -0.31 6.40E-01 -0.33 6.03E-01 
BB_0232| hbb| small DNA-binding protein Hbb  0232|  -0.25 6.54E-01 -0.66 1.00E-01 
BB_0233| rpsT| ribosomal protein S20  0233|  0.18 8.31E-01 -0.68 1.69E-01 
BB_0234|      hypothetical integral membrane protein  0234|  0.07 9.59E-01 -0.29 7.12E-01 
BB_0235| ychF| GTP-binding protein YchF  0235|  -0.02 9.79E-01 -0.10 9.27E-01 
BB_0236| tetratricopeptide repeat domain protein  0236|  0.52 1.74E-01 -0.66 8.18E-02 
BB_0237| lnt| apolipoprotein N-acyltransferase  0237|  -0.10 9.59E-01 -0.32 6.59E-01 
BB_0238|      hypothetical protein  0238|  1.16 3.12E-03 0.32 5.81E-01 
BB_0239| deoxyguanosine/deoxyadenosine kinase  0239|  -0.14 8.28E-01 -0.14 8.38E-01 
BB_0240| glycerol uptake facilitator  0240|  2.58 6.31E-25 -3.04 3.31E-34 
BB_0241| glpK| glycerol kinase  0241|  2.32 1.07E-12 -3.12 4.93E-23 
BB_0242|      hypothetical protein  0242|  2.37 5.89E-10 -3.62 1.25E-22 
BB_0243| glycerol-3-phosphate dehydrogenase    anaerobic  0243|  2.41 1.30E-10 -2.35 5.13E-10 
BB_0244|      hypothetical protein  0244|  0.15 8.53E-01 -1.30 3.32E-04 
BB_0245| hypothetical protein  0245|  -0.11 9.13E-01 -1.01 3.33E-03 
BB_0246| M23 peptidase domain protein  0246|  -0.09 9.50E-01 -1.58 1.12E-06 
BB_0247| rdgB| non-canonical purine NTP pyrophosphatase  0.02 9.78E-01 0.07 9.57E-01 
BB_0248| pepF| oligoendopeptidase F  0248|  -0.57 8.92E-02 -0.42 2.73E-01 
BB_0249| phosphatidyltransferase  0249|  -0.64 9.75E-02 -0.60 1.53E-01 
BB_0250| DedA protein  0250|  0.02 9.76E-01 -0.57 1.28E-01 
BB_0251| leuS| leucyl-tRNA synthetase  0251|  -1.68 5.65E-05 0.32 6.44E-01 
BB_0253| lon| ATP-dependent protease La  0253|  0.92 2.94E-02 0.41 4.51E-01 
BB_0254| recJ| single-stranded-DNA-specific exonuclease RecJ  0254|  -0.57 5.05E-01 -1.04 1.36E-01 
BB_0255| M23 peptidase domain protein  0255|  -0.45 5.71E-01 -0.97 1.19E-01 
BB_0256| rpsU| ribosomal protein S21  0256|  -0.03 9.76E-01 0.05 9.89E-01 
BB_0258| undecaprenol kinase  0258|  -0.63 2.39E-01 -1.17 1.45E-02 
BB_0259| transglycosylase SLT domain protein  0259|  -0.90 8.06E-02 -0.94 7.87E-02 
BB_0260|      hypothetical protein  0260|  0.70 2.40E-01 -0.86 1.49E-01 
BB_0261| tetratricopeptide repeat domain protein  0261|  0.09 9.59E-01 0.20 8.14E-01 
BB_0262| M23 peptidase domain protein  0262|  -0.26 6.10E-01 -0.30 5.27E-01 
BB_0263| lepB| signal peptidase I  0263|  -0.53 4.62E-01 -0.57 4.09E-01 
BB_0264| heat shock protein 70  0264|  -0.56 1.74E-01 -0.17 8.10E-01 
BB_0265|      hypothetical protein  0265|  -0.22 7.97E-01 0.13 9.26E-01 
BB_0266|      hypothetical protein  0266|  0.38 4.79E-01 0.01 9.91E-01 
BB_0267|      hypothetical protein  0267|  0.75 1.79E-01 0.05 9.89E-01 
BB_0268|      hypothetical protein  0268|  0.79 1.28E-01 -0.16 9.07E-01 
BB_0269| ATP-binding protein  0269|  0.43 2.87E-01 -0.17 7.81E-01 
BB_0270| flagellar biosynthesis protein FlhF  -0.83 3.22E-02 -0.54 2.39E-01 
BB_0271| flhA| flagellar biosynthesis protein FlhA  0271|  0.05 9.59E-01 -0.61 7.23E-02 
BB_0272| flhB| flagellar biosynthetic protein FlhB  0272|  0.98 1.27E-02 0.14 8.81E-01 
BB_0273| fliR| flagellar biosynthetic protein FliR  0273|  -1.07 2.51E-02 -0.86 1.03E-01 
BB_0274| fliQ| flagellar biosynthetic protein FliQ  0274|  -0.89 1.69E-01 -1.19 5.63E-02 
BB_0275| fliP| flagellar biosynthetic protein FliP  0275|  -0.72 2.51E-01 -1.15 4.58E-02 
BB_0276| flagellar protein FliZ  0276|  0.04 9.67E-01 -0.83 2.01E-01 
BB_0277| flagellar switch protein FliY  0277|  0.24 6.64E-01 -0.09 9.44E-01 
BB_0278| fliM| flagellar motor switch protein FliM  0278|  -0.18 7.59E-01 -0.25 6.26E-01 
BB_0279| fliL| flagellar basal body-associated protein FliL  0279|  -0.27 6.16E-01 -0.30 5.57E-01 
BB_0280| flagellar motor apparatus  0280|  -0.20 7.11E-01 -0.21 6.85E-01 
BB_0281| chemotaxis protein MotA (Motility protein A)  0281|  -0.26 5.96E-01 -0.28 5.55E-01 
BB_0282| hypothetical protein  0282|  1.01 1.41E-02 0.22 7.63E-01 
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BB_0283| flagellar hook protein FlgE  0283|  0.03 9.59E-01 0.00 1.00E+00 
BB_0284| flgD| flagellar hook capping protein  0284|  0.19 8.40E-01 -0.03 9.89E-01 
BB_0285| flagellar protein  0285|  -0.26 7.27E-01 -0.14 9.20E-01 
BB_0286| flagellar protein  0286|  -0.05 9.59E-01 0.05 9.89E-01 
BB_0287| flagellar protein  0287|  -0.17 8.71E-01 0.14 9.19E-01 
BB_0288| fliI| flagellar protein export ATPase FliI  0288|  0.23 7.00E-01 0.03 9.89E-01 
BB_0289| flagellar assembly protein FliH  0289|  -0.20 7.59E-01 -0.02 9.89E-01 
BB_0290| fliG| flagellar motor switch protein FliG  0290|  -0.45 1.69E-01 -0.23 5.76E-01 
BB_0291| fliF| flagellar M-ring protein FliF  0291|  0.01 9.92E-01 -0.35 3.06E-01 
BB_0292| fliE| flagellar hook-basal body complex protein (FliE)  0.52 2.02E-01 -0.53 2.12E-01 
BB_0293| flgC| flagellar basal-body rod protein FlgC  0293|  0.32 4.44E-01 -0.37 3.43E-01 
BB_0294| flgB| flagellar basal-body rod protein FlgB  0294|  0.31 4.87E-01 -0.19 7.34E-01 
BB_0295| hslU| heat shock protein HslVU ATPase subunit HslU  -1.06 5.06E-04 1.07 5.71E-04 
BB_0296| ATP-dependent protease HslV  -1.20 5.94E-05 0.32 4.57E-01 
BB_0297| protein smf  0297|  -0.82 8.47E-03 -0.03 9.89E-01 
BB_0298| tetratricopeptide repeat domain protein  0298|  -0.10 9.58E-01 -0.22 7.39E-01 
BB_0299| ftsZ| cell division protein FtsZ  0299|  0.56 1.24E-01 0.17 7.69E-01 
BB_0300| ftsA| cell division protein FtsA  0300|  0.17 7.96E-01 0.17 7.74E-01 
BB_0301| DivIB  0301|  0.23 7.14E-01 0.24 6.94E-01 
BB_0302| ftsW| cell division protein FtsW  0302|  -0.84 1.06E-03 -0.48 1.15E-01 
BB_0303| mraY| phospho-N-acetylmuramoyl-pentapeptide-transferase -0.85 5.59E-03 -0.72 3.14E-02 
BB_0304| UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase  -1.08 2.24E-03 -0.68 1.04E-01 
BB_0305|      hypothetical protein  0305|  -1.52 3.19E-09 -0.03 9.89E-01 
BB_0306| mraW| S-adenosyl-methyltransferase MraW  0306|  -1.19 1.11E-06 -0.14 7.69E-01 
BB_0307|      hypothetical protein  0307|  -0.90 1.73E-03 -0.46 1.98E-01 
BB_0308|      hypothetical protein  0308|  -0.07 9.59E-01 -0.73 1.14E-01 
BB_0309|      hypothetical protein  0309|  0.23 6.15E-01 -0.23 6.16E-01 
BB_0311|      inorganic polyphosphate/ATP-NAD kinase -0.01 9.94E-01 -0.07 9.79E-01 
BB_0312| purine-binding chemotaxis protein  0312|  0.18 6.85E-01 0.29 4.26E-01 
BB_0313| rrmJ| ribosomal RNA large subunit methyltransferase J  0.26 5.29E-01 0.40 2.57E-01 
BB_0314| octaprenyl-diphosphate synthase  0314|  -0.27 7.33E-01 -0.07 9.89E-01 
BB_0315|      hypothetical protein  0315|  -0.64 1.85E-01 -0.55 2.88E-01 
BB_0316|      hypothetical integral membrane protein  0316|  0.05 9.59E-01 -0.90 5.46E-02 
BB_0317|      hypothetical integral membrane protein  0317|  -0.56 3.11E-01 -1.00 4.20E-02 
BB_0318|      ABC transporter ATP-binding protein  0318|  -4.22 NA -4.38 NA 
BB_0319| exported protein  0319|  0.11 8.99E-01 -0.66 4.62E-02 
BB_0321|      hypothetical protein  0321|  -0.17 7.82E-01 -0.80 2.10E-02 
BB_0322|      hypothetical protein  0322|  0.04 9.59E-01 -0.55 2.76E-01 
BB_0323| LysM domain protein  0323|  1.10 1.46E-03 -0.52 2.40E-01 
BB_0324|      hypothetical protein  0324|  0.05 9.59E-01 -0.78 2.63E-02 
BB_0325|      hypothetical protein  0325|  -0.39 2.40E-01 -0.10 8.80E-01 
BB_0326| tetratricopeptide repeat domain protein  -0.45 3.52E-01 -0.83 4.87E-02 
BB_0327| glycerol-3-phosphate O-acyltransferase  0.25 7.14E-01 -0.88 5.35E-02 
BB_0328| bacterial extracellular solute-binding protein family 5  0.69 1.13E-01 -0.74 9.52E-02 
BB_0330| bacterial extracellular solute-binding protein family 5  -0.16 9.58E-01 -1.75 8.65E-03 
BB_0331| Hypothetical protein  0331|  -0.98 3.73E-01 -1.79 6.66E-02 
BB_0332| ABC transporter    permease protein  0332|  -1.27 3.39E-04 -0.85 3.47E-02 
BB_0333| oligopeptide transport system permease protein OppC  0333|  -0.55 3.73E-01 -0.58 3.48E-01 
BB_0334| oligopeptide transport ATP-binding protein OppD  0334|  -1.13 2.67E-02 -0.97 7.97E-02 
BB_0335| OppF  0335|  -1.00 7.93E-02 -0.68 3.10E-01 
BB_0337| eno| phosphopyruvate hydratase  0337|  0.28 7.34E-01 -0.28 7.30E-01 
BB_0338| rpsI| ribosomal protein S9  0338|  0.17 8.31E-01 -0.52 2.92E-01 
BB_0339| rplM| ribosomal protein L13  0339|  -0.07 9.59E-01 -0.17 7.79E-01 
BB_0340|      hypothetical protein  0340|  -0.99 4.63E-02 -0.90 9.46E-02 
BB_0341| glu-trnagln amidotransferase suBunit b  0341|  -0.63 1.69E-01 -0.77 8.89E-02 
BB_0342| glutamyl-tRNA(Gln) amidotransferase subunit A  -0.32 5.87E-01 -0.52 2.79E-01 
BB_0343| gatC| glutamyl-tRNA(Gln) amidotransferase C subunit 0.77 3.50E-01 -0.46 6.57E-01 
BB_0344| DNA helicase  0344|  -0.20 8.14E-01 -0.96 3.78E-02 
BB_0345|      hypothetical protein  0345|  0.72 1.69E-01 -0.66 2.43E-01 
BB_0346| export chaperone  0346|  0.78 4.22E-02 -0.23 6.95E-01 
BB_0347| fibronectin/fibrinogen-binding protein          0347|  0.18 7.82E-01 -0.74 6.14E-02 
BB_0348| pyk| pyruvate kinase  0348|  0.04 9.69E-01 0.95 8.12E-02 
BB_0349|      hypothetical protein  0349|  -0.13 8.27E-01 0.34 3.87E-01 
BB_0350| rpmB| ribosomal protein L28  0350|  -0.39 4.50E-01 -0.13 8.98E-01 
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BB_0351|      hypothetical protein  0351|  -0.52 9.35E-02 0.03 9.89E-01 
BB_0352|      hypothetical protein  0352|  -0.58 9.59E-01 -2.58 6.44E-01 
BB_0353| membrane protein          0353|  -0.50 3.46E-01 -0.76 1.22E-01 
BB_0354|      hypothetical protein  0354|  0.69 1.29E-01 -0.26 6.85E-01 
BB_0355| transcription factor          0355|  1.02 2.09E-04 -0.38 3.04E-01 
BB_0358| RNA methyltransferase    RsmE family  0358|  -0.18 8.40E-01 -0.65 2.12E-01 
BB_0360|      hypothetical protein  0360|  -1.05 1.33E-04 -0.46 1.92E-01 
BB_0361| ATP-binding protein  0361|  -0.40 7.47E-01 0.10 9.89E-01 
BB_0362| lgt| prolipoprotein diacylglyceryl transferase  0362|  -1.04 2.30E-05 -0.35 2.92E-01 
BB_0363| periplasmic protein  0363|  -1.56 7.24E-11 -0.47 1.42E-01 
BB_0364| mgsA| methylglyoxal synthase  0364|  -0.56 2.80E-01 -1.20 6.20E-03 
BB_0365| la7| outer surface 22 kda lipoprotein (antigen IpLA7)  0365|  -1.44 NA -1.51 NA 
BB_0366| vacuolar aminopeptidase I  0366|  1.39 2.01E-03 0.55 3.58E-01 
BB_0367|      phosphotransferase enzyme IIb component  0367|  1.69 4.63E-05 0.46 4.32E-01 
BB_0368| glycerol-3-phosphate dehydrogenase 0.40 2.10E-01 -0.63 3.15E-02 
BB_0369| ATP-dependent Clp protease    subunit A  0369|  -0.82 1.52E-01 -0.73 2.36E-01 
BB_0370| tyrS| tyrosyl-tRNA synthetase  0370|  -0.66 2.23E-01 -0.82 1.28E-01 
BB_0371| glyS| glycyl-tRNA synthetase  0371|  0.05 9.59E-01 -0.61 2.45E-01 
BB_0372| gltX| glutamyl-tRNA synthetase  0372|  -0.17 8.67E-01 -0.56 3.14E-01 
BB_0373| P31-23 protein  0373|  0.86 1.39E-01 -0.87 1.55E-01 
BB_0374| HD domain protein  0374|  -1.62 7.32E-04 -0.86 1.40E-01 
BB_0375| pfs|      nucleosidase    Pfs protein  0375|  -1.86 9.62E-10 -0.82 2.45E-02 
BB_0376| metK| methionine adenosyltransferase  0376|  -1.95 3.76E-08 -0.62 1.99E-01 
BB_0377| luxS| S-ribosylhomocysteinase LuxS  0377|  -1.52 4.72E-05 -0.55 2.70E-01 
BB_0378|      hypothetical protein  0378|  -0.20 7.55E-01 0.04 9.89E-01 
BB_0379| protein kinase C1 inhibitor  0379|  0.48 2.20E-01 -0.25 6.19E-01 
BB_0380| mgtE| magnesium transporter  0380|  0.45 1.63E-01 -0.55 8.68E-02 
BB_0381| trehalase  0381|  -0.07 9.59E-01 -0.65 1.45E-01 
BB_0382| bmpB| basic membrane protein B (bmpB)  0382|  0.24 6.62E-01 -0.82 2.44E-02 
BB_0383| bmpA| basic membrane protein A (bmpA)  0.53 2.21E-01 -0.54 2.31E-01 
BB_0384| bmpC| basic membrane protein C (bmpC)  0384|  1.09 8.45E-06 0.77 4.61E-03 
BB_0385| bmpD| basic membrane protein D (bmpD)  0385|  1.25 1.53E-02 0.39 6.16E-01 
BB_0386| rpsG| ribosomal protein S7  0386|  0.42 2.63E-01 -0.06 9.83E-01 
BB_0387| rpsL| ribosomal protein S12  0387|  0.35 4.20E-01 -0.19 7.23E-01 
BB_0388| rpoC| DNA-directed RNA polymerase    beta' subunit  0388|  -0.82 6.72E-02 -0.37 5.27E-01 
BB_0390| rplL| ribosomal protein L7/L12  0390|  -0.34 6.23E-01 0.13 9.29E-01 
BB_0391| ribosomal protein L10  0391|  0.10 9.48E-01 0.15 8.63E-01 
BB_0392| rplA| ribosomal protein L1  0392|  0.18 8.07E-01 -0.29 6.08E-01 
BB_0393| rplK| ribosomal protein L11  0393|  0.14 8.53E-01 -0.04 9.89E-01 
BB_0394| nusG| transcription termination/antitermination factor  0.89 1.76E-02 0.54 2.32E-01 
BB_0395| secE| preprotein translocase    SecE subunit  0395|  0.92 7.70E-02 0.22 8.28E-01 
BB_0396| rpmG| ribosomal protein L33  0396|  0.89 7.02E-02 0.52 3.90E-01 
BB_0397|      hypothetical protein  0397|  0.39 3.39E-01 0.12 8.90E-01 
BB_0398| lipoprotein          0398|  0.21 6.76E-01 0.15 7.94E-01 
BB_0399|      ankyrin repeat protein  0399|  0.44 9.17E-01 1.14 5.69E-01 
BB_0400|      hypothetical protein  0400|  -0.98 4.14E-03 0.99 5.46E-03 
BB_0401| glutamate transporter          0401|  -0.10 8.67E-01 -0.21 5.91E-01 
BB_0402| proS| prolyl-tRNA synthetase  0402|  -0.35 3.70E-01 0.35 3.86E-01 
BB_0403|      hypothetical protein  0403|  0.44 4.36E-01 -0.30 6.42E-01 
BB_0404|      hypothetical protein  0404|  -0.75 2.46E-01 0.47 5.45E-01 
BB_0405|      hypothetical protein  0405|  -0.97 8.82E-01 2.24 5.47E-01 
BB_0406|      hypothetical protein  0406|  -0.12 8.88E-01 0.42 3.11E-01 
BB_0407| manA| mannose-6-phosphate isomerase    class I  0407|  0.07 9.59E-01 -0.49 5.33E-01 
BB_0408| pts system    fructose-specific iiabc component  0408|  -0.58 4.67E-01 -0.65 3.94E-01 
BB_0409|      hypothetical protein  0409|  -1.88 2.90E-05 -0.99 6.41E-02 
BB_0412| membrane protein          0412|  -1.07 1.61E-02 -0.88 6.90E-02 
BB_0413|      hypothetical integral membrane protein  0413|  0.19 7.07E-01 -0.70 3.48E-02 
BB_0414| chemotaxis protein methyltransferase  0414|  -0.57 2.11E-01 0.17 8.27E-01 
BB_0415|      protein-glutamate methylesterase  0415|  -0.46 2.70E-01 0.78 3.92E-02 
BB_0416| pheromone shutdown protein  0416|  -0.82 5.43E-02 -0.56 2.59E-01 
BB_0417| adenylate kinase (ATP-AMP transphosphorylase)  -1.36 1.24E-06 -0.08 9.46E-01 
BB_0418|      hypothetical protein  0418|  -0.76 7.04E-02 0.45 3.69E-01 
BB_0419| response regulatory protein  0419|  -0.26 6.64E-01 -0.27 6.41E-01 
BB_0420| sensory transduction histidine kinase          0420|  -0.22 6.96E-01 -0.27 5.92E-01 
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BB_0421| haloacid dehalogenase-like hydrolase  0421|  -0.23 7.66E-01 -0.95 4.17E-02 
BB_0422| DNA-3-methyladenine glycosylase  0422|  0.10 9.35E-01 -0.66 7.13E-02 
BB_0426| nucleoside 2-deoxyribosyltransferase superfamily  0426|  1.37 6.31E-04 1.00 2.45E-02 
BB_0427|      hypothetical protein  0427|  0.34 3.96E-01 0.03 9.89E-01 
BB_0428|      hypothetical protein  0428|  0.46 3.38E-01 0.39 4.57E-01 
BB_0429|      hypothetical protein  0429|  -0.13 9.59E-01 1.57 3.24E-03 
BB_0430|      hypothetical protein  0430|  0.79 7.81E-02 0.80 8.66E-02 
BB_0431| CobQ/CobB/MinD/ParA nucleotide binding domain -0.31 6.39E-01 -0.43 4.43E-01 
BB_0434| spo0J| stage 0 sporulation protein J  0434|  -0.14 9.35E-01 1.01 4.56E-02 
BB_0435| gyrA| DNA gyrase    A subunit  0435|  0.60 1.09E-01 0.20 7.34E-01 
BB_0436| gyrB| DNA gyrase    B subunit  0436|  0.42 4.27E-01 -0.05 9.89E-01 
BB_0437| dnaA| chromosomal replication initiator protein DnaA  0437|  -0.68 6.89E-02 -0.24 6.55E-01 
BB_0438| dnaN| DNA polymerase III    beta subunit  0438|  0.36 6.46E-01 1.76 3.45E-04 
BB_0439|      hypothetical protein  0439|  -0.02 9.79E-01 1.40 3.19E-04 
BB_0440| rpmH| ribosomal protein L34  0440|  0.78 1.29E-01 0.78 1.53E-01 
BB_0441| rnpA| ribonuclease P protein component  0441|  0.44 6.30E-01 0.06 9.89E-01 
BB_0443| spoiiij-associtated protein  0443|  -0.73 5.59E-02 0.12 9.15E-01 
BB_0444| WbnF  0444|  -0.62 5.68E-02 -0.36 3.69E-01 
BB_0445| fbaA| fructose-bisphosphate aldolase    class II  0445|  1.11 6.27E-03 0.44 4.18E-01 
BB_0446| aspS| aspartyl-tRNA synthetase  0446|  -0.90 7.93E-03 0.15 8.36E-01 
BB_0447| Na+/H+ antiporter  0447|  -1.36 6.27E-03 -0.75 2.21E-01 
BB_0448| phosphocarrier protein HPr  0448|  -1.00 8.28E-02 -0.71 2.83E-01 
BB_0449|      hypothetical protein  0449|  -0.77 5.05E-02 -0.86 3.14E-02 
BB_0450| rpoN| RNA polymerase sigma-54 factor  0450|  -2.22 4.21E-05 -0.17 9.33E-01 
BB_0451| chromate transport protein          0451|  -1.47 2.14E-02 -0.35 7.47E-01 
BB_0452| chromate transporter superfamily  0452|  -1.63 2.59E-02 -0.54 6.06E-01 
BB_0453| transporter small conductance mechanosensitive ion channel 0.04 9.59E-01 -0.41 3.83E-01 
BB_0454| lipopolysaccharide biosynthesis-related protein  0454|  0.19 8.98E-01 1.42 1.24E-02 
BB_0455| DNA polymerase III    delta subunit superfamily  0455|  -0.21 8.80E-01 -0.19 8.97E-01 
BB_0456|      hypothetical protein  0456|  -0.61 3.51E-01 -0.31 7.24E-01 
BB_0457| uvrC| excinuclease ABC    C subunit  0457|  -0.67 2.06E-02 -0.22 5.89E-01 
BB_0459| tetratricopeptide repeat domain protein  0459|  0.03 9.74E-01 -0.73 2.12E-01 
BB_0460| lipoprotein          0460|  0.65 7.91E-02 -0.44 3.11E-01 
BB_0461| DNA polymerase III    subunits gamma and tau  0461|  -0.75 1.44E-01 -0.76 1.65E-01 
BB_0462| efbC|      DNA-binding protein    ebfC protein  0462|  -0.64 4.20E-02 -0.44 2.34E-01 
BB_0463| nucleoside diphosphate kinase (NDK) (NDP kinase) 0.18 7.12E-01 0.01 9.89E-01 
BB_0464|      hypothetical protein  0464|  0.12 8.40E-01 -0.30 4.18E-01 
BB_0465|      hypothetical protein  0465|  0.66 1.93E-01 0.52 3.56E-01 
BB_0466| ABC transporter    ATP-binding protein  0466|  0.05 9.59E-01 0.40 4.37E-01 
BB_0467|      hypothetical protein  0467|  0.23 8.35E-01 0.31 7.26E-01 
BB_0468|      hypothetical protein  0468|  -0.06 9.59E-01 -0.49 4.14E-01 
BB_0469| lspA| signal peptidase II  0469|  -0.34 6.02E-01 -0.47 4.04E-01 
BB_0470|      hypothetical protein  0470|  -0.27 6.30E-01 -1.05 4.75E-03 
BB_0471|      hypothetical protein  0471|  -0.46 3.56E-01 -0.54 2.66E-01 
BB_0472| murA| UDP-N-acetylglucosamine 1-carboxyvinyltransferase -1.02 7.42E-05 0.29 4.32E-01 
BB_0473|      hypothetical integral membrane protein  0473|  0.26 6.91E-01 -0.59 2.24E-01 
BB_0475| lipoprotein          0475|  1.16 5.62E-03 0.12 9.32E-01 
BB_0476| tuf| translation elongation factor Tu  0476|  -0.30 6.54E-01 -0.48 3.95E-01 
BB_0477| rpsJ| ribosomal protein S10  0477|  -0.24 7.38E-01 -0.61 2.17E-01 
BB_0478| rplC| ribosomal protein L3  0478|  -0.25 7.00E-01 -0.61 1.92E-01 
BB_0479| rplD| ribosomal protein L4/L1 family  0479|  -0.42 3.89E-01 -0.51 2.79E-01 
BB_0480| rplW| ribosomal protein L23  0480|  -0.58 2.52E-01 -0.71 1.55E-01 
BB_0481| rplB| ribosomal protein L2  0481|  -0.79 1.20E-01 -0.67 2.35E-01 
BB_0482| rpsS| ribosomal protein S19  0482|  -0.62 1.89E-01 -0.67 1.69E-01 
BB_0483| rplV| ribosomal protein L22  0483|  -0.73 1.43E-01 -0.61 2.74E-01 
BB_0484| rpsC| ribosomal protein S3  0484|  -0.55 2.02E-01 -0.54 2.37E-01 
BB_0485| rplP| ribosomal protein L16  0485|  -0.39 4.10E-01 -0.24 6.65E-01 
BB_0486| rpmC| ribosomal protein L29  0486|  -0.21 7.33E-01 -0.06 9.89E-01 
BB_0487| rpsQ| ribosomal protein S17  0487|  -0.19 7.93E-01 -0.20 7.71E-01 
BB_0488| rplN| ribosomal protein L14  0488|  -0.26 7.00E-01 -0.09 9.68E-01 
BB_0489| rplX| ribosomal protein L24  0489|  -0.25 7.05E-01 -0.28 6.42E-01 
BB_0490| ribosomal L5P family C-terminus protein  0490|  -0.28 6.38E-01 -0.19 7.85E-01 
BB_0491| rpsN| ribosomal protein S14p/S29e  0491|  -0.07 9.59E-01 0.18 7.75E-01 
BB_0492| rpsH| ribosomal protein S8  0492|  0.03 9.74E-01 0.04 9.89E-01 
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BB_0493| ribosomal protein L6          0493|  -0.11 9.16E-01 0.04 9.89E-01 
BB_0494| rplR| ribosomal protein L18  0494|  -0.13 8.67E-01 -0.23 6.51E-01 
BB_0495| rpsE| ribosomal protein S5  0495|  0.23 6.75E-01 -0.13 8.71E-01 
BB_0496| ribosomal protein L30  0496|  -0.28 7.33E-01 -0.21 8.22E-01 
BB_0497| rplO| ribosomal protein L15  0497|  -0.25 6.70E-01 -0.49 2.87E-01 
BB_0498| preprotein translocase    SecY subunit  0498|  -0.21 7.00E-01 -0.44 2.79E-01 
BB_0499| rpmJ| ribosomal protein L36  0499|  0.60 3.05E-01 0.44 5.26E-01 
BB_0500| rpsM| ribosomal protein S13p/S18e  0500|  0.23 7.02E-01 0.25 6.75E-01 
BB_0501| rpsK| ribosomal protein S11  0501|  0.02 9.77E-01 -0.21 6.82E-01 
BB_0502| rpoA| DNA-directed RNA polymerase    alpha subunit  0502|  -0.31 5.45E-01 -0.27 6.07E-01 
BB_0503| rplQ| ribosomal protein L17  0503|  -0.01 9.88E-01 -0.11 9.04E-01 
BB_0504|      hypothetical protein  0504|  -0.14 8.65E-01 -0.61 1.49E-01 
BB_0505|      hypothetical protein  0505|  -0.43 3.18E-01 -0.73 6.13E-02 
BB_0507|      hypothetical protein  0507|  -1.08 3.01E-02 -0.50 4.37E-01 
BB_0508| engA| ribosome-associated GTPase EngA  0508|  -0.86 3.61E-02 -1.57 2.03E-05 
BB_0509|      hypothetical protein  0509|  -0.69 6.07E-02 -0.87 1.66E-02 
BB_0512|      hypothetical protein  0512|  -1.27 1.98E-03 -0.37 5.41E-01 
BB_0514| pheT| phenylalanyl-tRNA synthetase    beta subunit  0514|  -0.65 2.36E-01 -0.46 4.57E-01 
BB_0517| dnaJ| chaperone protein DnaJ  0517|  -0.85 3.89E-01 0.25 8.91E-01 
BB_0518| dnaK| chaperone protein DnaK  0518|  -1.24 6.61E-02 -0.18 9.35E-01 
BB_0519| grpE| co-chaperone GrpE  0519|  -0.76 1.85E-01 -0.11 9.64E-01 
BB_0524| Inositol monophosphatase family protein  0524|  0.58 2.59E-01 -0.45 4.32E-01 
BB_0525|      hypothetical protein  0525|  0.98 1.98E-03 0.08 9.57E-01 
BB_0526|      hypothetical protein  0526|  0.31 4.48E-01 -0.40 2.79E-01 
BB_0527| transcriptional activator            Baf family  0527|  -0.96 2.28E-02 0.01 9.89E-01 
BB_0528| aldose reductase          0528|  0.52 1.12E-01 -0.05 9.89E-01 
BB_0533| PhnP protein  0533|  0.60 1.07E-01 -0.35 4.45E-01 
BB_0534| xth| exodeoxyribonuclease III  0534|  0.92 2.07E-02 -0.10 9.50E-01 
BB_0535|      hypothetical protein  0535|  1.26 7.76E-04 -0.22 7.42E-01 
BB_0536| zinc protease          0536|  0.65 2.83E-02 -0.34 3.59E-01 
BB_0537| tetratricopeptide repeat domain protein  0537|  -1.73 1.99E-06 -0.72 1.15E-01 
BB_0538| hypothetical protein  0538|  -1.51 6.68E-06 -0.65 1.23E-01 
BB_0539| membrane protein          0539|  -0.32 4.88E-01 -0.11 9.07E-01 
BB_0540| fusA| translation elongation factor G  0540|  -0.58 1.26E-01 -0.36 4.14E-01 
BB_0543|      hypothetical protein  0543|  -0.09 9.59E-01 -0.64 1.92E-01 
BB_0544| phosphoribosyl pyrophosphate synthetase  0544|  -0.42 3.58E-01 -0.14 8.75E-01 
BB_0545| xylulokinase  0545|  -0.39 2.70E-01 -0.64 4.74E-02 
BB_0546|      hypothetical protein  0546|  0.49 1.99E-01 0.06 9.89E-01 
BB_0547| coaE| dephospho-CoA kinase  0547|  -0.45 4.50E-01 0.32 6.20E-01 
BB_0548| polA| DNA polymerase I superfamily  0548|  -1.10 7.95E-05 0.53 1.26E-01 
BB_0549|      hypothetical protein  0549|  -0.79 1.18E-01 0.17 8.78E-01 
BB_0550| fliS| flagellar protein FliS  0550|  -0.20 6.40E-01 0.57 5.38E-02 
BB_0551| CheY  0551|  0.82 8.23E-03 0.81 1.36E-02 
BB_0552| ligA| DNA ligase    NAD-dependent  0552|  -0.49 2.80E-01 -0.01 9.91E-01 
BB_0554|      hypothetical protein  0554|  -0.58 9.22E-02 -0.13 8.44E-01 
BB_0555|      hypothetical protein  0555|  -1.04 2.54E-03 -0.05 9.89E-01 
BB_0556|      hypothetical protein  0556|  -0.36 6.02E-01 -0.60 2.92E-01 
BB_0557| phosphocarrier protein HPr  0557|  0.21 6.81E-01 -0.13 8.63E-01 
BB_0558| ptsP| phosphoenolpyruvate-protein phosphotransferase 0.29 5.23E-01 -0.23 6.26E-01 
BB_0559| PTS system    glucose-specific IIA component  0559|  0.64 8.06E-02 0.04 9.89E-01 
BB_0560| chaperone protein HtpG  0560|  -0.09 9.59E-01 0.06 9.89E-01 
BB_0561| gnd| 6-phosphogluconate dehydrogenase decarboxylating -0.55 4.36E-01 -0.99 9.30E-02 
BB_0562|      hypothetical protein  0562|  -0.01 9.91E-01 -0.28 5.59E-01 
BB_0563|      hypothetical protein  0563|  -0.62 3.78E-02 0.69 2.35E-02 
BB_0564|      hypothetical protein  0564|  -0.01 9.94E-01 0.28 7.18E-01 
BB_0565| purine-binding chemotaxis protein  0565|  -0.67 4.46E-02 0.52 1.72E-01 
BB_0566|      hypothetical protein  0566|  -0.67 4.54E-02 0.33 4.36E-01 
BB_0567| chemotaxis histidine kinase  0567|  -0.85 1.51E-03 0.53 9.28E-02 
BB_0568| CheB -0.06 9.59E-01 0.43 2.75E-01 
BB_0569|      hypothetical protein  0569|  0.10 9.33E-01 0.39 3.53E-01 
BB_0570| chemotaxis response regulator  0570|  0.52 4.13E-01 0.92 8.94E-02 
BB_0571| uridylate kinase  0571|  -0.95 1.35E-02 0.08 9.72E-01 
BB_0572| glycosyl transferase  0572|  0.05 9.59E-01 -0.57 3.06E-02 
BB_0574|      hypothetical integral membrane protein  0574|  0.79 4.84E-02 -0.34 5.33E-01 
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BB_0575| pyrG| CTP synthase  0575|  0.33 4.62E-01 0.00 1.00E+00 
BB_0576|      hypothetical protein  0576|  -0.09 9.59E-01 0.18 7.81E-01 
BB_0577|      hypothetical protein  0577|  1.29 2.25E-04 0.38 4.49E-01 
BB_0578| methyl-accepting chemotaxis protein  0578|  0.02 9.84E-01 0.44 3.13E-01 
BB_0579| DNA polymerase III subunit alpha  0579|  -0.47 1.36E-01 0.35 3.31E-01 
BB_0580|      hypothetical integral membrane protein  0580|  -0.23 5.66E-01 0.23 5.66E-01 
BB_0581| recG| ATP-dependent DNA helicase RecG  0581|  -0.80 1.68E-03 0.79 2.64E-03 
BB_0582| carboxypeptidase          0582|  0.46 4.85E-01 -0.87 1.09E-01 
BB_0583|      hypothetical integral membrane protein  0583|  0.26 4.97E-01 -0.78 5.46E-03 
BB_0584|      hypothetical integral membrane protein  0584|  -0.41 4.74E-01 -1.73 8.49E-06 
BB_0585| murD| UDP-N-acetylmuramoylalanine--D-glutamate ligase 0.05 9.59E-01 0.49 3.29E-01 
BB_0586| FemA protein  0586|  -1.14 1.68E-03 -0.04 9.89E-01 
BB_0587| metG| methionyl-tRNA synthetase  0587|  -0.94 1.39E-02 -0.33 5.46E-01 
BB_0588| bgp| MTA/SAH nucleosidase Glycosaminoglycan binding  0.97 4.53E-02 1.09 2.77E-02 
BB_0590| ksgA| dimethyladenosine transferase  0590|  -0.87 1.41E-01 -0.65 3.35E-01 
BB_0591| competence locus E          0591|  0.27 6.54E-01 0.08 9.72E-01 
BB_0592| caax amino protease family  0592|  1.23 3.67E-03 -1.19 8.01E-03 
BB_0593| long-chain-fatty-acid CoA ligase  0593|  0.55 2.11E-01 -0.81 5.07E-02 
BB_0594| argS| arginyl-tRNA synthetase  0594|  -0.38 4.36E-01 0.09 9.51E-01 
BB_0595|      hypothetical protein  0595|  -0.48 3.90E-01 -0.53 3.30E-01 
BB_0596| methyl-accepting chemotaxis protein  0596|  -0.15 8.45E-01 -0.40 3.79E-01 
BB_0597| methyl-accepting chemotaxis protein  0597|  0.55 1.19E-01 0.29 5.32E-01 
BB_0598| murB| UDP-N-acetylenolpyruvoylglucosamine reductase -0.32 4.91E-01 0.57 1.42E-01 
BB_0599| cysS| cysteinyl-tRNA synthetase  0599|  0.12 9.32E-01 -0.87 5.23E-02 
BB_0600| IPT/TIG domain protein  0600|  -0.13 9.59E-01 -0.36 7.78E-01 
BB_0601| glyA| serine hydroxymethyltransferase  0601|  -0.26 5.48E-01 -0.79 9.76E-03 
BB_0602| chaperonin          0602|  0.13 8.95E-01 -0.91 1.86E-02 
BB_0603| p66| integral outer membrane protein P66  0603|  1.10 1.46E-03 -0.50 2.63E-01 
BB_0604| L-lactate permease  0604|  -0.91 1.43E-01 -0.17 9.25E-01 
BB_0605| serine-type D-Ala-D-Ala carboxypeptidase  0605|  0.52 7.95E-02 -0.28 4.45E-01 
BB_0606| CheD family  0606|  0.45 2.46E-01 0.04 9.89E-01 
BB_0607| pcrA| ATP-dependent DNA helicase PcrA  0607|  -0.55 2.81E-01 -0.67 1.94E-01 
BB_0608| aminoacyl-histidine dipeptidase  0608|  -0.63 1.76E-01 -0.37 5.25E-01 
BB_0610| tig| trigger factor  0610|  -0.01 9.92E-01 0.38 2.61E-01 
BB_0611| clpP| ATP-dependent Clp protease proteolytic subunit  -0.22 6.86E-01 0.15 8.23E-01 
BB_0612| clpX| ATP-dependent Clp protease ATP-binding subunit  -0.47 3.01E-01 0.04 9.89E-01 
BB_0613| lon| ATP-dependent protease La  0613|  -0.33 4.92E-01 -0.27 6.01E-01 
BB_0614|      hypothetical protein  0614|  0.77 2.35E-01 -0.02 9.89E-01 
BB_0615| rpsD| ribosomal protein S4  0615|  0.85 5.46E-03 0.57 1.05E-01 
BB_0616|      hypothetical integral membrane protein  0616|  0.16 9.04E-01 -0.19 8.42E-01 
BB_0617|      hypothetical protein  0617|  1.40 7.25E-04 0.75 1.41E-01 
BB_0618| cdd| cytidine deaminase  0618|  0.10 9.51E-01 -0.07 9.88E-01 
BB_0619| DHH family  0619|  0.26 7.14E-01 0.50 3.63E-01 
BB_0620| beta-glucosidase          0620|  0.11 9.06E-01 0.28 5.68E-01 
BB_0621| 4-methyl-5  0621|  -0.07 9.59E-01 -0.14 9.49E-01 
BB_0622| ackA| acetate kinase  0622|  -0.39 5.67E-01 -0.87 9.64E-02 
BB_0623| mfd| transcription-repair coupling factor  0623|  -0.83 1.39E-01 -0.70 2.54E-01 
BB_0624|      hypothetical protein  0624|  0.88 2.16E-03 -0.39 2.92E-01 
BB_0625| N-acetylmuramoyl-L-alanine amidase          0625|  -0.14 8.80E-01 -0.80 4.97E-02 
BB_0626| rnmV| ribonuclease M5  0626|  1.48 2.00E-04 1.14 8.37E-03 
BB_0628| lipoprotein          0628|  0.09 9.59E-01 -0.10 9.55E-01 
BB_0629| pts system    fructose-specific iiabc component  0629|  0.72 8.44E-02 0.21 7.49E-01 
BB_0630| pfkB| 1-phosphofructokinase  0630|  0.05 9.59E-01 -0.17 8.71E-01 
BB_0631|      hypothetical protein  0631|  0.86 3.46E-02 -3.52 1.25E-26 
BB_0632| recD| exodeoxyribonuclease V    alpha subunit  0632|  -0.83 1.20E-01 -0.04 9.89E-01 
BB_0633| recB| exodeoxyribonuclease V    beta subunit  0633|  -1.44 3.57E-03 0.14 9.38E-01 
BB_0635| pncB| nicotinate phosphoribosyltransferase  0635|  -0.95 7.02E-02 -0.49 4.55E-01 
BB_0636| zwf| glucose-6-phosphate 1-dehydrogenase  0636|  -0.24 7.00E-01 -1.23 9.97E-04 
BB_0637| Na+/H+ antiporter family  0637|  0.28 4.48E-01 -1.05 6.31E-05 
BB_0638| Na+/H+ antiporter  0638|  0.48 2.05E-01 -1.48 4.84E-07 
BB_0639| spermidine/putrescine ABC transporter     -1.29 1.20E-02 -1.23 2.30E-02 
BB_0640| binding-protein-dependent transport systems  -1.71 1.30E-04 -0.69 2.34E-01 
BB_0641| putrescine transport system permease protein PotH  0641|  -1.85 2.09E-05 -0.79 1.49E-01 
BB_0642| potA| spermidine/putrescine ABC transporter -1.50 1.31E-03 -0.29 7.26E-01 
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BB_0643| ylqF| ribosome biogenesis GTP-binding protein YlqF  0643|  0.24 5.99E-01 0.81 7.58E-03 
BB_0644|      N-acetylmannosamine-6-P epimerase  0644|  -0.69 5.23E-01 -1.18 1.94E-01 
BB_0645| pts system    iibc components  0645|  -0.30 8.10E-01 -1.18 9.57E-02 
BB_0646|      hypothetical protein  0646|  0.43 4.04E-01 -0.49 3.39E-01 
BB_0647| bosR| Borrelia oxidative stress regulator protein BosR  0647|  0.34 4.15E-01 0.18 7.49E-01 
BB_0649| groL| chaperonin GroL  0649|  1.14 1.84E-02 0.90 9.77E-02 
BB_0650|      hypothetical protein  0650|  0.49 4.33E-01 0.63 2.79E-01 
BB_0651| yajC| preprotein translocase    YajC subunit  0651|  0.80 9.42E-02 0.43 4.63E-01 
BB_0652| secD| protein-export membrane protein SecD  0652|  0.42 3.70E-01 -0.20 7.60E-01 
BB_0653| secF| protein-export membrane protein SecF  0653|  0.35 3.90E-01 -0.21 6.72E-01 
BB_0654|      hypothetical protein  0654|  -0.99 3.17E-03 -0.84 2.20E-02 
BB_0655| heat shock protein  0655|  0.00 9.95E-01 -0.26 5.66E-01 
BB_0656| oxygen-independent coproporphyrinogen III oxidase  0.81 4.05E-03 -1.05 1.70E-04 
BB_0657| rpiA| ribose 5-phosphate isomerase A  0657|  0.61 8.78E-02 -1.36 8.60E-06 
BB_0658| phosphoglycerate mutase family protein          0658|  0.08 9.59E-01 1.19 4.18E-03 
BB_0659| lysS| lysyl-tRNA synthetase  0659|  -1.03 1.61E-01 -0.83 3.12E-01 
BB_0660| era| GTP-binding protein Era  0660|  -0.12 9.39E-01 -0.06 9.89E-01 
BB_0661|      hypothetical protein  0661|  1.54 4.24E-09 0.65 4.24E-02 
BB_0662|      hypothetical protein  0662|  1.40 3.36E-04 0.42 4.46E-01 
BB_0663|      hypothetical protein  0663|  0.82 1.48E-02 -0.01 9.89E-01 
BB_0664| lipoprotein          0664|  0.78 4.56E-02 0.79 5.58E-02 
BB_0665|      hypothetical protein  0665|  1.10 NA 0.64 NA 
BB_0666| N-acetylmuramoyl-L-alanine amidase domain protein  0.06 9.84E-01 -1.00 6.33E-01 
BB_0667|      hypothetical protein  0667|  -0.44 5.59E-01 -0.98 8.89E-02 
BB_0668| flagellar filament outer layer protein  0668|  -0.40 3.93E-01 -0.42 3.61E-01 
BB_0669| CheA  0669|  -0.80 5.70E-02 -0.38 4.85E-01 
BB_0670| purine-binding chemotaxis protein  0670|  -0.75 1.43E-02 0.13 8.38E-01 
BB_0671| CheC-like family protein  0671|  -1.08 8.63E-05 0.46 1.94E-01 
BB_0672| CheY  0672|  -1.27 6.77E-03 0.08 9.89E-01 
BB_0673|      hypothetical protein  0673|  -1.01 3.69E-02 -0.24 7.64E-01 
BB_0674| membrane protein          0674|  -0.58 6.81E-02 0.14 8.18E-01 
BB_0675|      hypothetical protein  0675|  -0.87 1.07E-01 -0.60 3.39E-01 
BB_0676| phosphoglycolate phosphatase  0676|  -0.26 8.30E-01 -0.65 3.96E-01 
BB_0677| rbsA| sugar ABC transporter    ATP-binding protein  0677|  -1.03 1.84E-02 -0.83 8.64E-02 
BB_0678| ribose/galactose ABC transporter    permease protein  0678|  -0.87 4.88E-02 -1.32 1.77E-03 
BB_0679| ribose/galactose ABC transporter    permease protein  0679|  -1.08 3.91E-02 -1.38 7.69E-03 
BB_0680| methyl-accepting chemotaxis protein  0680|  -0.81 4.68E-02 -0.03 9.89E-01 
BB_0681| methyl-accepting chemotaxis protein  0681|  -0.89 4.31E-03 -0.26 5.69E-01 
BB_0682| trmU| tRNA methyltransferase -0.71 9.63E-02 -0.52 2.86E-01 
BB_0683| hydroxymethylglutaryl-CoA synthase  0683|  -0.35 5.89E-01 0.56 2.92E-01 
BB_0684| fni| isopentenyl-diphosphate delta-isomerase    type 2  0684|  -0.45 2.93E-01 -0.03 9.89E-01 
BB_0685| hydroxymethylglutaryl-CoA reductase    degradative  0685|  -0.59 1.61E-01 -0.33 5.25E-01 
BB_0686| mvaD| diphosphomevalonate decarboxylase  0686|  0.10 9.19E-01 -0.23 5.98E-01 
BB_0687| phosphomevalonate kinase          0687|  0.45 2.70E-01 -0.01 9.89E-01 
BB_0688| mvk| mevalonate kinase  0688|  0.70 9.59E-02 0.07 9.85E-01 
BB_0689| lipoprotein          0689|  -0.03 9.62E-01 1.41 5.38E-05 
BB_0690| napA| neutrophil activating protein A (napA)  0690|  1.74 2.46E-03 1.19 6.87E-02 
BB_0691| fusA| translation elongation factor G  0691|  0.91 1.69E-01 1.32 3.50E-02 
BB_0693| xylose operon regulatory protein  0693|  0.31 6.02E-01 1.02 1.36E-02 
BB_0694| ffh| signal recognition particle protein  0694|  0.00 9.98E-01 0.46 2.74E-01 
BB_0695| rpsP| ribosomal protein S16  0695|  0.69 3.07E-01 1.03 1.03E-01 
BB_0696|      hypothetical protein  0696|  0.94 1.77E-01 1.10 1.15E-01 
BB_0697| rimM| 16S rRNA processing protein RimM  0697|  -0.05 9.59E-01 0.47 3.35E-01 
BB_0698| trmD| tRNA (guanine-N1)-methyltransferase  0698|  0.14 7.82E-01 0.58 5.54E-02 
BB_0699| rplS| ribosomal protein L19  0699|  0.49 2.18E-01 0.59 1.36E-01 
BB_0701|      hypothetical protein  0701|  0.31 5.37E-01 0.17 7.85E-01 
BB_0702| coaD| pantetheine-phosphate adenylyltransferase  0702|  0.09 9.47E-01 0.40 3.05E-01 
BB_0703| rpmF| ribosomal protein L32  0703|  -0.06 9.59E-01 0.11 9.12E-01 
BB_0704| acpP| acyl carrier protein  0704|  6.37 NA 0.20 NA 
BB_0705| rnc| ribonuclease III  0705|  -0.43 2.86E-01 -0.01 9.91E-01 
BB_0706| polynucleotide adenylyltransferase  0706|  -0.53 2.20E-01 -0.23 7.04E-01 
BB_0707|      hypothetical protein  0707|  0.98 3.73E-02 0.32 6.55E-01 
BB_0708|      hypothetical protein  0708|  0.88 1.50E-01 -1.16 5.43E-02 
BB_0709|      hypothetical protein  0709|  -0.81 4.67E-02 -0.49 3.25E-01 
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BB_0712| RNA polymerase sigma factor RpoD (Sigma-70)  0712|  -1.34 3.71E-05 -0.28 5.81E-01 
BB_0713|      hypothetical protein  0713|  -1.76 6.02E-12 0.17 7.43E-01 
BB_0714| tetratricopeptide repeat domain protein  0714|  0.60 1.83E-01 -0.95 2.28E-02 
BB_0715| cell division protein FtsA          0715|  0.71 2.74E-02 -0.66 5.46E-02 
BB_0716| mreC| rod shape-determining protein MreC  0716|  0.06 9.59E-01 -1.13 4.62E-02 
BB_0717|      hypothetical integral membrane protein  0717|  -0.03 9.84E-01 -1.71 5.99E-03 
BB_0718| penicillin-binding protein  0718|  -0.39 6.54E-01 -1.19 5.02E-02 
BB_0719| mrdB| rod shape-determining protein RodA  0719|  -0.49 4.67E-01 -1.41 5.39E-03 
BB_0721| pgsA| -1.06 3.06E-02 -0.84 1.25E-01 
BB_0722|      hypothetical protein  0722|  -1.27 1.07E-02 -0.81 1.69E-01 
BB_0725| lectin  0725|  -0.01 9.86E-01 0.37 3.04E-01 
BB_0726| ATP-binding protein  0726|  -0.34 5.65E-01 0.51 3.10E-01 
BB_0727| phosphofructokinase  0727|  -0.31 5.30E-01 0.32 5.12E-01 
BB_0728| cdr| CoA-disulfide reductase  0728|  -0.86 2.62E-03 0.10 9.12E-01 
BB_0729|  (na+ or H+) symporter (daacs) family -0.50 1.46E-01 0.28 5.08E-01 
BB_0730| pgi| glucose-6-phosphate isomerase  0730|  -0.93 7.34E-03 0.00 9.99E-01 
BB_0731|      hypothetical protein  0731|  -1.00 4.26E-02 -0.69 2.32E-01 
BB_0732| penicillin-binding protein  0732|  -0.58 1.18E-01 -0.56 1.53E-01 
BB_0733|      hypothetical protein  0733|  0.32 5.21E-01 -0.11 9.20E-01 
BB_0734| Sua5/YciO/YrdC/YwlC family protein          0734|  -1.06 3.41E-03 -0.31 5.57E-01 
BB_0735| rare lipoprotein A  0735|  0.23 6.67E-01 -0.09 9.51E-01 
BB_0737| histidine phosphokinase/phophatase          0737|  -0.23 7.63E-01 -1.23 4.38E-03 
BB_0738| valS| valyl-tRNA synthetase  0738|  -0.34 5.59E-01 -0.84 5.20E-02 
BB_0740|      hypothetical protein  0740|  -1.72 1.12E-07 -0.70 8.00E-02 
BB_0741| groS| chaperonin GroS  0741|  0.22 7.38E-01 0.23 7.19E-01 
BB_0742| ABC transporter    ATP-binding protein  0742|  -0.06 9.59E-01 -0.25 5.65E-01 
BB_0743|      hypothetical protein  0743|  -0.46 3.25E-01 -0.38 4.55E-01 
BB_0744| p83/100| Borrelia P83/P100 antigen  0744|  0.34 4.45E-01 0.50 2.12E-01 
BB_0745| endonuclease III  0745|  0.33 3.17E-01 0.37 2.56E-01 
BB_0746| oligopeptide ABC transporter    permease protein  0746|  -6.71 3.23E-06 -6.98 1.34E-06 
BB_0747| oligopeptide ABC transporter    permease protein  0747|  -1.21 6.58E-02 -1.45 2.79E-02 
BB_0748| septum formation initiator subfamily          0748|  -0.09 9.59E-01 -0.61 3.54E-01 
BB_0749|      hypothetical protein  0749|  0.91 5.74E-04 -0.11 8.71E-01 
BB_0751|      hypothetical protein  0751|  -0.85 4.93E-02 -0.16 8.75E-01 
BB_0754| ABC transporter    ATP-binding protein  0754|  -1.23 1.22E-04 -0.14 8.62E-01 
BB_0755| rnz| ribonuclease Z  0755|  -1.21 1.76E-04 -0.38 3.96E-01 
BB_0756| FAD dependent oxidoreductase          0756|  0.39 4.08E-01 0.66 1.02E-01 
BB_0757| clpP| Clp protease  0757|  -0.49 3.58E-01 -0.16 8.79E-01 
BB_0758|      hypothetical protein  0758|  -0.84 2.04E-01 -0.33 7.26E-01 
BB_0759| membrane protein          0759|  0.12 9.57E-01 -0.53 3.83E-01 
BB_0760| gene 37 protein (Gp37)  0760|  0.10 9.59E-01 -0.42 5.87E-01 
BB_0764| sensory transduction histidine kinase          0764|  -1.99 2.86E-07 -0.53 3.39E-01 
BB_0765|      hypothetical protein  0765|  -1.93 1.64E-04 -0.82 2.10E-01 
BB_0766| cvpA| CvpA family protein  0766|  -2.77 1.08E-07 -0.80 2.52E-01 
BB_0767| murG|  -2.20 2.90E-05 -0.63 3.95E-01 
BB_0768| pyridoxal kinase  0768|  -2.06 5.69E-07 -0.72 1.90E-01 
BB_0769| glycoprotease family  0769|  -2.53 1.99E-08 -0.88 1.36E-01 
BB_0770| divergent polysaccharide deacetylase superfamily  0770|  -2.12 1.33E-07 -1.65 1.16E-04 
BB_0771| rpoS| RNA polymerase sigma factor (rpoS)  0771|  -0.41 5.67E-01 0.58 3.43E-01 
BB_0771a| hypothetical protein  0771a|  -1.24 1.52E-02 -0.97 8.68E-02 
BB_0772| flagellar P-ring protein (Basal body P-ring protein)  0772|  0.12 8.99E-01 -0.27 6.06E-01 
BB_0773|      hypothetical protein  0773|  -0.97 1.00E-01 -0.60 3.93E-01 
BB_0774| flgG| flagellar basal-body rod protein FlgG  0774|  -0.26 7.00E-01 0.47 3.95E-01 
BB_0775| flagellar hook-basal body complex protein  0775|  -0.02 9.78E-01 0.36 3.76E-01 
BB_0776|      hypothetical protein  0776|  -0.47 5.44E-01 1.45 8.95E-03 
BB_0777| apt| adenine phosphoribosyltransferase  0777|  -0.59 4.48E-01 1.50 1.35E-02 
BB_0778| rplU| ribosomal protein L21  0778|  0.08 9.46E-01 0.49 1.41E-01 
BB_0779|      hypothetical protein  0779|  -1.56 6.14E-01 0.79 8.71E-01 
BB_0780| rpmA| ribosomal protein L27  0780|  0.39 5.99E-01 1.05 5.20E-02 
BB_0781| GTP-binding protein Obg/CgtA  0781|  0.30 6.29E-01 0.86 5.07E-02 
BB_0782| nadD| nicotinamide nucleotide adenylyltransferase  -1.20 1.68E-04 0.02 9.89E-01 
BB_0783|      hypothetical protein  0783|  -1.05 2.38E-03 -0.26 6.40E-01 
BB_0784| iojap-like ribosome-associated protein  0784|  -1.06 8.47E-03 -0.47 3.77E-01 
BB_0785| spoVG ( 2.62 3.67E-27 -6.58 3.38E-167 
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BB_0786| ribosomal protein L25    Ctc-form  0786|  -0.26 6.29E-01 -0.50 2.48E-01 
BB_0787| pth| peptidyl-tRNA hydrolase  0787|  0.00 9.96E-01 -0.28 4.57E-01 
BB_0788| tilS| tRNA(Ile)-lysidine synthetase  0788|  0.60 2.09E-01 0.14 8.97E-01 
BB_0789| cell division protein FtsH  0789|  0.57 2.30E-01 0.14 8.89E-01 
BB_0790|      hypothetical protein  0790|  -0.17 8.57E-01 -0.48 3.95E-01 
BB_0791| thymidine kinase  0791|  -0.48 1.85E-01 -0.05 9.89E-01 
BB_0792|      hypothetical protein  0792|  -0.24 6.31E-01 -0.07 9.63E-01 
BB_0793| tmk| thymidylate kinase  0793|  0.06 9.59E-01 -0.40 4.67E-01 
BB_0795| outer membrane protein  0795|  0.37 2.47E-01 -0.93 4.72E-04 
BB_0796|      hypothetical protein  0796|  0.14 8.95E-01 -0.87 3.98E-02 
BB_0797| mutS| DNA mismatch repair protein MutS  0797|  -0.57 2.78E-01 -0.60 2.73E-01 
BB_0798| competence protein F          0798|  -0.85 1.24E-01 -0.87 1.36E-01 
BB_0799|      hypothetical protein  0799|  0.36 6.18E-01 -0.01 9.89E-01 
BB_0800| transcription elongation protein NusA  0800|  0.34 6.32E-01 -0.17 8.76E-01 
BB_0801| translation initiation factor IF-2          0801|  -0.19 8.56E-01 -0.41 5.26E-01 
BB_0802| rbfA| ribosome-binding factor A  0802|  0.40 5.28E-01 0.29 6.85E-01 
BB_0803| truB| tRNA pseudouridine synthase B  0803|  0.15 9.35E-01 0.02 9.89E-01 
BB_0804| rpsO| ribosomal protein S15  0804|  0.32 6.33E-01 0.57 2.88E-01 
BB_0805| polyribonucleotide nucleotidyltransferase  0.16 8.20E-01 0.19 7.54E-01 
BB_0806| lipoprotein          0806|  -0.59 1.92E-01 0.05 9.89E-01 
BB_0807|      hypothetical integral membrane protein  0807|  -1.51 4.23E-04 0.11 9.52E-01 
BB_0808|      permease    YjgP/YjgQ family  0808|  -1.20 7.37E-03 -0.37 5.66E-01 
BB_0809| tgt| queuine tRNA-ribosyltransferase  0809|  -1.09 1.01E-04 0.02 9.89E-01 
BB_0810| mviN| integral membrane protein MviN  0810|  -0.71 1.25E-01 -0.16 8.71E-01 
BB_0811|      hypothetical protein  0811|  -0.55 9.05E-02 0.04 9.89E-01 
BB_0812| coaBC|  0.10 9.25E-01 0.60 1.15E-01 
BB_0814| panF| sodium/pantothenate symporter  0814|  0.16 8.07E-01 -1.68 1.06E-08 
BB_0816|      hypothetical protein  0816|  -0.11 8.95E-01 -1.15 7.42E-05 
BB_0817| murC| UDP-N-acetylmuramate--alanine ligase  0817|  -0.17 8.95E-01 -1.03 4.69E-02 
BB_0818|      hypothetical protein  0818|  -0.63 2.47E-01 -0.63 2.76E-01 
BB_0819| cytidylate kinase  0819|  -0.47 3.46E-01 -0.64 1.85E-01 
BB_0820| rpoZ| DNA-directed RNA polymerase omega subunit  0.14 9.47E-01 0.03 9.89E-01 
BB_0821| miaA| tRNA delta(2)-isopentenylpyrophosphate transferase  0.29 6.54E-01 -0.41 4.57E-01 
BB_0823| lipoprotein          0823|  0.43 4.37E-01 -0.62 2.19E-01 
BB_0824|      hypothetical protein  0824|  0.53 1.09E-01 -0.82 8.59E-03 
BB_0825|      hypothetical protein  0825|  -0.26 5.98E-01 -0.43 2.88E-01 
BB_0826|      hypothetical protein  0826|  0.11 9.61E-01 0.91 5.76E-01 
BB_0827| ATP-dependent helicase HrpA  0827|  -1.00 2.59E-02 -0.26 7.30E-01 
BB_0828| topA| DNA topoisomerase I  0828|  -0.29 6.02E-01 -0.14 8.75E-01 
BB_0829|      Exonuclease SbcD homolog  0829|  -0.64 4.08E-01 -0.78 2.88E-01 
BB_0830| exonuclease SbcC  0830|  -1.14 8.93E-02 -0.90 2.34E-01 
BB_0831| xylose operon regulatory protein  0831|  0.16 8.31E-01 0.34 5.12E-01 
BB_0832| lipoprotein          0832|  -0.58 1.01E-01 -0.45 2.50E-01 
BB_0833| ileS| isoleucyl-tRNA synthetase  0833|  -1.23 4.68E-03 -0.35 5.97E-01 
BB_0834| ATP-dependent Clp protease    subunit C  0834|  -0.46 4.45E-01 -0.23 7.80E-01 
BB_0835| phosphomannomutase  0835|  -0.47 6.19E-01 -0.19 9.26E-01 
BB_0837| uvrA| excinuclease ABC    A subunit  0837|  -1.45 1.37E-04 0.03 9.89E-01 
BB_0838|      hypothetical protein  0838|  -1.24 3.12E-03 -0.14 9.15E-01 
BB_0838a| hypothetical protein  0838a|  -0.26 7.53E-01 -0.11 9.61E-01 
BB_0839|      hypothetical protein  0839|  0.44 3.18E-01 0.48 2.79E-01 
BB_0840| lipoprotein          0840|  0.16 7.96E-01 -0.23 6.41E-01 
BB_0841| arcA| arginine deiminase  0841|  1.96 6.87E-12 -0.70 5.02E-02 
BB_0842| argF| ornithine carbamoyltransferase  0842|  1.75 6.16E-05 -0.03 9.89E-01 
BB_0843| arginine-ornithine antiporter  0843|  1.22 7.99E-07 -0.32 3.57E-01 
BB_0844| lipoprotein          0844|  -0.64 4.37E-01 3.12 1.16E-08 
BB_0852| type I restriction enzyme r protein n terminus (hsdr_n) 0.07 9.59E-01 0.80 2.09E-02 
BB_A0078| lipoprotein          A0078|  -0.57 4.31E-01 -0.79 2.29E-01 
BB_A03| outer membrane protein  A03|  -1.06 2.33E-01 -1.09 2.39E-01 
BB_A04| S2 antigen  A04|  -0.11 9.56E-01 0.30 6.69E-01 
BB_A05| S1 antigen  A05|  0.08 9.59E-01 -0.04 9.89E-01 
BB_A07| chpAI protein          A07|  0.11 9.59E-01 -0.65 5.10E-01 
BB_A08|      hypothetical protein  A08|  1.08 9.39E-03 0.74 1.22E-01 
BB_A09|      hypothetical protein  A09|  0.47 3.50E-01 0.94 3.07E-02 
BB_A10|      hypothetical protein  A10|  -0.02 9.79E-01 0.58 2.42E-01 
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BB_A11|      hypothetical protein  A11|  0.51 2.05E-01 0.71 6.26E-02 
BB_A12| holin    BlyA family  A12|  -0.19 9.01E-01 0.65 3.29E-01 
BB_A13|      hypothetical protein  A13|  -0.14 9.35E-01 0.48 4.34E-01 
BB_A15| ospA| outer surface protein A (OspA)  A15|  0.30 6.91E-01 -0.23 7.93E-01 
BB_A16| ospB| outer surface protein B (OspB)  A16|  0.51 3.77E-01 -0.11 9.58E-01 
BB_A19| borrelia family of unknown function  A19|  -0.02 9.76E-01 0.08 9.68E-01 
BB_A20| PF-32 protein  A20|  -0.39 2.15E-01 -0.25 5.02E-01 
BB_A21| PF-49 protein  A21|  -0.56 1.59E-01 -0.61 1.37E-01 
BB_A23| BppB  A23|  0.86 8.97E-03 0.99 2.79E-03 
BB_A24| dbpA| decorin-binding protein A  A24|  -0.56 7.02E-02 2.81 2.17E-31 
BB_A25| dbpB| decorin-binding protein B  A25|  -0.83 8.52E-03 2.83 9.13E-27 
BB_A30|      hypothetical protein  A30|  -0.35 7.09E-01 -0.31 7.55E-01 
BB_A31|      phage terminase    pbsx family  A31|  -0.92 1.03E-01 -0.62 3.53E-01 
BB_A32|      hypothetical protein  A32|  -0.24 8.31E-01 1.50 5.39E-03 
BB_A33| lipoprotein          A33|  0.15 9.59E-01 1.29 6.20E-02 
BB_A34| bacterial extracellular solute-binding protein family 5  -0.56 2.31E-01 1.98 2.19E-08 
BB_A36| lipoprotein  A36|  0.06 9.59E-01 2.84 1.85E-16 
BB_A37|      hypothetical protein  A37|  -0.30 8.26E-01 1.48 4.06E-02 
BB_A38|      phage portal protein    HI1409 family  A38|  -1.08 1.76E-02 0.02 9.89E-01 
BB_A40| lyme disease proteins of unknown function  A40|  -1.22 9.17E-04 0.38 4.59E-01 
BB_A41|      hypothetical protein  A41|  -1.32 1.34E-03 0.45 4.20E-01 
BB_A42|      hypothetical protein  A42|  -1.35 1.63E-03 0.37 5.60E-01 
BB_A43|      hypothetical protein  A43|  -0.04 9.63E-01 0.32 6.51E-01 
BB_A45|      hypothetical protein  A45|  -0.51 2.78E-01 0.64 1.70E-01 
BB_A46|      hypothetical protein  A46|  -0.71 7.86E-02 0.67 1.22E-01 
BB_A47|      hypothetical protein  A47|  -0.70 1.94E-01 0.72 1.99E-01 
BB_A48|      hypothetical protein  A48|  -0.49 3.86E-01 0.91 5.84E-02 
BB_A49|      hypothetical protein  A49|  -0.42 6.17E-01 1.10 6.56E-02 
BB_A51|      hypothetical protein  A51|  -0.09 9.59E-01 0.93 1.45E-02 
BB_A52| outer membrane protein  A52|  -0.66 2.83E-01 -1.16 3.47E-02 
BB_A53| Bbs27 protein  A53|  -1.35 4.38E-02 -1.51 2.82E-02 
BB_A54|      hypothetical protein  A54|  -0.97 1.15E-01 -1.23 4.17E-02 
BB_A57| P45-13  A57|  -0.14 9.59E-01 0.52 5.33E-01 
BB_A58|      hypothetical protein  A58|  -0.73 2.63E-01 -1.99 1.40E-04 
BB_A59| hypothetical protein  A59|  0.07 9.59E-01 -2.33 7.42E-20 
BB_A60| surface lipoprotein P27  A60|  0.42 5.16E-01 -0.91 7.03E-02 
BB_A61|      hypothetical protein  A61|  -0.87 5.27E-02 -0.86 6.69E-02 
BB_A62| lp6.6| 6.6 kDa lipoprotein (Lp6.6 protein)  A62|  0.61 5.23E-01 0.58 5.41E-01 
BB_A64| P35 antigen  A64|  1.04 7.54E-02 0.96 1.27E-01 
BB_A65| lipoprotein          A65|  1.54 5.89E-02 1.07 2.60E-01 
BB_A66| outer surface protein  A66|  0.24 8.90E-01 1.60 2.27E-02 
BB_A68| cspA|  (CRASP-1) 0.36 3.72E-01 0.53 1.56E-01 
BB_A69|      surface protein  A69|  0.19 7.80E-01 -0.15 8.71E-01 
BB_A73|      antigen P35  A73|  0.26 8.31E-01 -1.04 1.37E-01 
BB_A74| osm28| outer membrane porin OMS28  A74|  -2.32 8.04E-04 -1.61 4.15E-02 
BB_A76| thyX| thymidylate synthase    flavin-dependent  A76|  -0.73 1.58E-01 -0.90 7.92E-02 
BB_B01| acylphosphatase  B01|  1.07 3.20E-03 -0.22 7.30E-01 
BB_B02|      hypothetical protein  B02|  0.13 7.97E-01 0.24 5.39E-01 
BB_B03| resT| telomere resolvase ResT  B03|  1.03 6.93E-03 -0.46 3.50E-01 
BB_B04| chbC| chitibiose transporter protein chbC  B04|  2.61 7.82E-14 -0.47 3.64E-01 
BB_B05| chbA| chitibiose transporter protein chbA  B05|  0.86 3.62E-03 0.27 5.35E-01 
BB_B06| chbB| chitibiose transporter protein chbB  B06|  0.06 9.59E-01 -0.19 8.96E-01 
BB_B07|      alpha3-beta1 integrin-binding protein  B07|  0.05 9.59E-01 -0.40 5.97E-01 
BB_B09| lipoprotein          B09|  0.68 6.98E-02 1.57 7.71E-07 
BB_B10| borrelia ORF-A superfamily  B10|  1.24 8.57E-05 0.89 1.07E-02 
BB_B12| PF-32 protein  B12|  -0.33 3.33E-01 0.02 9.89E-01 
BB_B13|      plasmid partition protein  B13|  -0.11 9.54E-01 0.29 6.77E-01 
BB_B14|      hypothetical protein  B14|  -0.19 8.02E-01 0.14 8.91E-01 
BB_B16| oppAIV| oligopeptide ABC transporter OppAIV  B16|  0.93 5.27E-02 0.72 1.88E-01 
BB_B17| guaB| inosine-5'-monophosphate dehydrogenase  B17|  -0.26 6.74E-01 -0.35 5.27E-01 
BB_B18| guaA| GMP synthase  B18|  -0.33 6.13E-01 -0.65 2.03E-01 
BB_B19| ospC| outer surface protein C (OspC)  B19|  -0.48 3.61E-01 0.75 1.11E-01 
BB_B22|      guanine/xanthine permease  B22|  0.06 9.59E-01 0.63 2.17E-01 
BB_B23|      guanine/xanthine permease  B23|  -0.78 4.83E-02 -0.50 2.90E-01 
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BB_B24|      hypothetical protein  B24|  -1.36 6.65E-05 -0.79 4.56E-02 
BB_B25|      hypothetical protein  B25|  -0.24 7.31E-01 -0.48 3.79E-01 
BB_B26|      hypothetical protein  B26|  0.38 3.20E-01 -0.35 3.95E-01 
BB_B27| lipoprotein          B27|  -0.08 9.59E-01 -0.69 2.11E-01 
BB_B28|      ankyrin repeat protein  B28|  -0.56 4.75E-01 -0.46 5.81E-01 
BB_B29| pts system    iibc components  B29|  1.29 8.21E-04 0.17 8.41E-01 
BB_C01| BBC01  C01|  11.52 5.85E-19 0.95 8.07E-01 
BB_C02| borrelia family of unknown function  C02|  NA NA NA NA 
BB_C03| BBC03  C03|  10.78 2.25E-16 0.00 1.00E+00 
BB_C05| BBC05  C05|  9.56 1.85E-12 1.01 8.11E-01 
BB_C06| eppA| exported protein A (eppA)  C06|  NA NA NA NA 
BB_C07| BBC07  C07|  NA NA NA NA 
BB_C10| revB| rev protein  C10|  NA NA NA NA 
BB_C11| BBC11  C11|  NA NA NA NA 
BB_D001| lipoprotein          D001|  0.44 9.14E-01 1.85 2.24E-01 
BB_D0027| hypothetical protein  D0027|  0.81 2.84E-01 -0.06 9.89E-01 
BB_D0031| hypothetical protein  D0031|  0.75 6.62E-01 1.81 1.28E-01 
BB_D01|      hypothetical protein  D01|  0.24 9.33E-01 0.47 7.23E-01 
BB_D04|      hypothetical protein  D04|  0.76 6.46E-01 1.30 3.12E-01 
BB_D09|      hypothetical protein  D09|  -0.31 6.39E-01 1.49 2.49E-04 
BB_D10| BBD10  D10|  0.38 6.37E-01 1.58 2.54E-03 
BB_D13|      hypothetical protein  D13|  0.41 6.17E-01 1.84 3.32E-04 
BB_D14| borrelia ORF-A superfamily  D14|  1.67 5.61E-06 2.15 1.15E-09 
BB_D15| BBD15  D15|  -0.61 3.74E-01 1.42 1.12E-02 
BB_D18|      hypothetical protein  D18|  -0.36 7.00E-01 0.07 9.89E-01 
BB_D21| CdsM  D21|  -0.31 7.15E-01 1.45 5.15E-03 
BB_D22|      hypothetical protein  D22|  -0.86 1.50E-01 1.05 7.13E-02 
BB_D24|      hypothetical protein  D24|  -2.20 4.42E-01 1.74 4.03E-01 
BB_E09| protein p23  E09|  -3.64 8.11E-14 -0.59 4.03E-01 
BB_E16| bptA| BptA protein  E16|  -3.89 2.50E-36 0.25 6.51E-01 
BB_E17|      hypothetical protein  E17|  -3.17 4.16E-23 0.24 6.89E-01 
BB_E18| PF-49 protein  E18|  -3.90 1.33E-20 -1.41 4.61E-03 
BB_E19| PF-32 protein  E19|  -4.27 1.40E-26 -1.66 2.93E-04 
BB_E20| borrelia family of unknown function  E20|  -4.33 5.15E-29 -1.86 1.29E-05 
BB_E21|      hypothetical protein  E21|  -3.79 9.10E-39 -0.95 7.94E-03 
BB_E22| pncA| pyrazinamidase/nicotinamidase    PncA protein  E22|  -4.97 2.44E-03 -0.80 8.07E-01 
BB_E31|      surface protein  E31|  -2.65 1.49E-19 0.59 1.43E-01 
BB_F0034| hypothetical protein  F0034|  0.87 1.98E-01 0.20 8.97E-01 
BB_F0039| hypothetical protein  F0039|  -0.35 9.59E-01 -0.47 9.60E-01 
BB_F0040| hypothetical protein  F0040|  -0.32 9.59E-01 -2.10 4.34E-01 
BB_F0041| outer surface protein VlsE1  F0041|  0.52 5.99E-01 0.03 9.89E-01 
BB_F01| hypothetical protein  F01|  0.00 9.99E-01 0.64 5.49E-01 
BB_F02|      hypothetical protein  F02|  1.30 3.61E-01 -1.19 5.35E-01 
BB_F03| RepU  F03|  0.78 4.35E-01 -1.08 3.06E-01 
BB_F06|      hypothetical protein  F06|  1.25 4.64E-01 0.54 8.46E-01 
BB_F08|      hypothetical protein  F08|  1.19 3.41E-01 -0.17 9.89E-01 
BB_F14| borrelia family of unknown function  F14|  0.92 3.39E-01 -2.41 1.00E-02 
BB_F17|      transmembrane protein  F17|  0.91 6.89E-02 -2.08 1.77E-05 
BB_F20| BBF20  F20|  -0.50 6.13E-01 -0.72 3.97E-01 
BB_F23| PF49  F23|  -1.56 1.33E-02 -2.69 3.03E-06 
BB_F24| PF32  F24|  -0.88 1.82E-01 -2.64 5.38E-07 
BB_F25| borrelia family of unknown function  F25|  0.13 9.59E-01 -2.09 1.46E-04 
BB_F26| borrelia ORF-A superfamily  F26|  0.90 1.21E-01 -1.77 7.91E-04 
BB_G0036| hypothetical protein  G0036|  0.79 3.20E-01 0.90 2.52E-01 
BB_G01|      lipoprotein  G01|  -0.88 2.98E-01 1.09 1.91E-01 
BB_G02| adenine specific DNA methyltransferase  G02|  0.06 9.63E-01 0.13 9.73E-01 
BB_G07| borrelia family of unknown function  G07|  -0.86 1.09E-01 0.25 7.76E-01 
BB_G08| stage 0 sporulation protein J  G08|  -1.07 4.02E-02 0.27 7.54E-01 
BB_G09|      plasmid partition protein  G09|  -0.87 1.35E-01 0.56 4.08E-01 
BB_G12|      hypothetical protein  G12|  -0.37 6.56E-01 0.87 1.59E-01 
BB_G13|      hypothetical protein  G13|  -0.46 5.90E-01 1.04 1.09E-01 
BB_G14|      hypothetical protein  G14|  -0.02 9.91E-01 1.25 8.17E-02 
BB_G15|      hypothetical protein  G15|  -0.45 6.80E-01 0.91 2.73E-01 
BB_G16|      hypothetical protein  G16|  0.37 7.00E-01 1.27 3.92E-02 
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BB_G17|      hypothetical protein  G17|  0.05 9.59E-01 1.26 1.07E-02 
BB_G18|      hypothetical protein  G18|  0.29 7.56E-01 1.52 4.61E-03 
BB_G19|      phage terminase  G19|  0.12 9.59E-01 1.66 2.63E-03 
BB_G20|      phage portal protein    HI1409 family  G20|  0.67 3.50E-01 1.22 4.93E-02 
BB_G21| phage terminase    large subunit    pbsx family  G21|  0.46 5.96E-01 0.90 1.94E-01 
BB_G22|      hypothetical protein  G22|  0.41 7.50E-01 1.16 1.92E-01 
BB_G23|      hypothetical protein  G23|  0.60 5.37E-01 1.33 7.47E-02 
BB_G24|      hypothetical protein  G24|  0.52 6.33E-01 1.35 9.21E-02 
BB_G25| borrelia orf-D family  G25|  0.10 9.59E-01 1.26 1.44E-01 
BB_G26|      hypothetical protein  G26|  1.47 2.80E-01 2.39 4.53E-02 
BB_G27|      hypothetical protein  G27|  0.52 8.29E-01 2.37 5.63E-02 
BB_G28|      hypothetical protein  G28|  0.73 5.29E-01 1.23 1.98E-01 
BB_G29| borrelia ORF-A superfamily  G29|  0.45 5.47E-01 2.10 1.16E-05 
BB_G30|      hypothetical protein  G30|  0.05 9.66E-01 1.20 1.11E-01 
BB_G31| borrelia family of unknown function  G31|  -0.14 9.59E-01 1.51 1.03E-02 
BB_G32|      replicative helicase  G32|  -0.86 1.09E-01 1.04 4.87E-02 
BB_G33| RepU  G33|  0.50 4.83E-01 1.61 1.76E-03 
BB_G34|      hypothetical protein  G34|  0.06 9.59E-01 0.40 4.03E-01 
BB_H0042| hypothetical protein  H0042|  -0.65 9.59E-01 -0.91 9.33E-01 
BB_H02| CdsC  H02|  0.37 8.24E-01 0.53 6.85E-01 
BB_H04|      hypothetical protein  H04|  0.65 4.53E-01 1.02 1.81E-01 
BB_H05|      hypothetical protein  H05|  1.22 4.45E-01 1.32 3.88E-01 
BB_H06| cspZ|  (CRASP-2) -0.81 1.12E-01 0.75 1.73E-01 
BB_H09| type I restriction enzyme r protein n terminus (hsdr_n)  -0.04 9.68E-01 1.62 1.27E-03 
BB_H09a|      hypothetical protein  H09a|  -0.34 7.69E-01 1.40 2.92E-02 
BB_H13| RepU  H13|  0.30 6.14E-01 0.08 9.73E-01 
BB_H17|      hypothetical protein  H17|  0.87 4.74E-01 0.38 8.46E-01 
BB_H26| borrelia ORF-A superfamily  H26|  1.24 7.13E-01 0.88 8.38E-01 
BB_H27| borrelia family of unknown function  H27|  -0.38 6.38E-01 0.44 5.59E-01 
BB_H28| PF-32 protein  H28|  -0.52 5.66E-01 0.53 5.47E-01 
BB_H29|      plasmid partition protein  H29|  -0.53 4.44E-01 0.56 4.02E-01 
BB_H32| antigen    P35          H32|  -1.07 6.43E-02 1.61 3.33E-03 
BB_H33| adenine deaminase (Adenase) (Adenine aminase)  H33|  -0.33 5.33E-01 0.60 1.54E-01 
BB_H37| lipoprotein          H37|  -1.48 1.62E-02 0.21 8.97E-01 
BB_H39|      hypothetical protein  H39|  1.20 2.20E-01 0.88 4.30E-01 
BB_H40| transposase    family  H40|  0.50 7.66E-01 0.85 5.05E-01 
BB_H41| borrelia membrane protein P13  H41|  -0.88 1.98E-01 2.71 1.18E-07 
BB_I0044|      hypothetical protein  I0044|  0.84 1.55E-01 0.78 2.17E-01 
BB_I01|      hypothetical protein  I01|  1.21 9.22E-02 0.14 9.72E-01 
BB_I06| mtnN| MTA/SAH nucleosidase  I06|  0.10 9.59E-01 0.68 1.76E-01 
BB_I12|      hypothetical protein  I12|  0.19 8.63E-01 0.46 5.06E-01 
BB_I15| Borrelia burgdorferi virulent strain associated lipoprotein  0.05 9.70E-01 0.52 6.08E-01 
BB_I16| vraA| virulent strain-associated repetitive antigen A 1.19 6.44E-03 0.09 9.73E-01 
BB_I18|      hypothetical protein  I18|  0.08 9.59E-01 -0.91 4.96E-02 
BB_I19| BBC01  I19|  0.76 8.40E-01 -0.67 8.78E-01 
BB_I20| borrelia family of unknown function  I20|  -0.57 2.25E-01 -1.09 8.52E-03 
BB_I21| PF-32 protein  I21|  -0.92 5.25E-02 -1.08 2.59E-02 
BB_I22| PF-49 protein  I22|  -1.41 1.72E-02 -1.25 5.23E-02 
BB_I26| transporter    major facilitator family  I26|  1.87 6.99E-01 2.64 5.26E-01 
BB_I29|  virulent strain associated lipoprotein  I29|  0.18 9.04E-01 0.63 3.57E-01 
BB_I34|  virulent strain associated lipoprotein  I34|  1.01 2.21E-01 0.19 9.39E-01 
BB_I36| antigen    P35          I36|  -0.04 9.78E-01 1.38 4.15E-02 
BB_I38|      surface antigen  I38|  -0.04 9.78E-01 1.32 5.11E-02 
BB_I39|      surface antigen  I39|  -0.57 4.62E-01 0.62 4.09E-01 
BB_I41|      hypothetical protein  I41|  0.41 5.87E-01 1.07 4.90E-02 
BB_I42| outer membrane protein  I42|  -0.67 2.47E-01 2.28 2.36E-07 
BB_J0056| hypothetical protein  J0056|  0.45 9.50E-01 0.47 9.37E-01 
BB_J0058| hypothetical protein  J0058|  0.11 9.59E-01 0.60 5.35E-01 
BB_J08|      surface protein  J08|  1.26 4.38E-02 1.36 3.67E-02 
BB_J09| ospD| outer surface protein D (OspD)  J09|  -1.69 3.48E-02 -2.21 5.05E-03 
BB_J11|      hypothetical protein  J11|  0.49 4.47E-01 0.69 2.29E-01 
BB_J13|      hypothetical protein  J13|  0.71 3.64E-01 1.11 1.15E-01 
BB_J16|      plasmid partition protein  J16|  -0.52 2.17E-01 0.76 5.40E-02 
BB_J17| PF-32 protein  J17|  -0.03 9.59E-01 0.76 5.46E-03 
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BB_J18| borrelia family of unknown function  J18|  0.76 1.20E-01 0.72 1.67E-01 
BB_J19| borrelia ORF-A superfamily  J19|  1.22 7.40E-04 1.25 7.91E-04 
BB_J23| tetratricopeptide repeat domain protein  J23|  -0.20 8.42E-01 3.24 6.48E-16 
BB_J24|      hypothetical protein  J24|  -0.23 6.89E-01 2.35 4.02E-15 
BB_J25|      hypothetical protein  J25|  0.27 7.16E-01 2.26 1.08E-08 
BB_J26| ABC transporter    ATP-binding protein  J26|  0.69 3.76E-01 3.28 1.05E-09 
BB_J27| efflux ABC transporter    permease protein  J27|  0.11 9.57E-01 2.74 2.41E-12 
BB_J28|      hypothetical protein  J28|  -0.46 2.47E-01 2.61 7.08E-21 
BB_J29|      hypothetical protein  J29|  -0.47 2.56E-01 2.00 5.58E-12 
BB_J31|      hypothetical protein  J31|  0.28 6.64E-01 2.47 5.40E-12 
BB_J34|      lipoprotein  J34|  -0.15 8.99E-01 -0.44 4.57E-01 
BB_J36| lipoprotein          J36|  -0.39 6.82E-01 1.22 5.63E-02 
BB_J37|      hypothetical protein  J37|  0.42 6.91E-01 0.64 4.52E-01 
BB_J41|      antigen P35  J41|  -0.29 7.90E-01 0.33 7.30E-01 
BB_J42|      hypothetical protein  J42|  1.56 5.37E-01 0.40 9.68E-01 
BB_J43|      hypothetical protein  J43|  -0.23 7.42E-01 1.88 5.66E-08 
BB_J45|      lipoprotein  J45|  0.30 6.39E-01 2.46 7.46E-12 
BB_J46|      hypothetical protein  J46|  0.06 9.59E-01 1.92 2.81E-10 
BB_J47|      hypothetical protein  J47|  -0.84 6.90E-02 1.19 6.59E-03 
BB_J48|      hypothetical protein  J48|  -0.42 4.88E-01 1.56 1.46E-04 
BB_K0058| hypothetical protein  K0058|  0.28 8.17E-01 2.27 7.55E-05 
BB_K0059| hypothetical protein  K0059|  1.65 1.43E-01 1.08 4.25E-01 
BB_K01| lipoprotein          K01|  -2.16 6.10E-06 -0.26 7.87E-01 
BB_K07| lipoprotein          K07|  -0.92 2.80E-01 2.98 5.11E-06 
BB_K09|      hypothetical protein  K09|  0.76 6.03E-01 1.07 3.95E-01 
BB_K13|      hypothetical protein  K13|  -0.25 6.91E-01 -0.15 8.75E-01 
BB_K15| antigen    P35          K15|  -0.58 3.30E-01 -0.31 6.89E-01 
BB_K17| adeC| adenine deaminase  K17|  -0.98 2.97E-02 1.24 5.39E-03 
BB_K19|      lipoprotein  K19|  0.45 5.13E-01 0.40 5.65E-01 
BB_K21| PF-32 protein  K21|  0.11 9.59E-01 0.42 5.91E-01 
BB_K22| borrelia family of unknown function  K22|  -0.08 9.59E-01 0.51 5.33E-01 
BB_K23| borrelia ORF-A superfamily  K23|  0.42 5.77E-01 0.58 3.69E-01 
BB_K24| PF-49 protein  K24|  0.87 NA -0.75 NA 
BB_K32| bbk32| fibronectin-binding protein BBK32  K32|  -0.26 5.53E-01 2.19 1.58E-18 
BB_K33|      hypothetical protein  K33|  0.85 4.25E-01 0.36 8.38E-01 
BB_K34|      hypothetical protein  K34|  0.75 1.20E-01 -1.08 2.27E-02 
BB_K35|      hypothetical protein  K35|  1.17 1.29E-01 -2.06 4.57E-03 
BB_K40|      hypothetical protein  K40|  1.71 3.34E-03 0.90 2.12E-01 
BB_K41|      hypothetical protein  K41|  0.55 2.20E-01 -0.17 8.38E-01 
BB_K42|      hypothetical protein  K42|  0.79 6.40E-02 0.77 8.49E-02 
BB_K45| immunogenic protein P37  K45|  -0.16 8.14E-01 -0.54 1.86E-01 
BB_K47|      hypothetical protein  K47|  -1.20 3.39E-02 -1.15 5.43E-02 
BB_K48| immunogenic protein P37          K48|  -0.45 2.71E-01 2.06 3.57E-12 
BB_K49|      hypothetical protein  K49|  -1.09 4.59E-02 -1.00 9.17E-02 
BB_K50| immunogenic protein P37  K50|  -0.37 7.07E-01 0.86 2.39E-01 
BB_K52|      lipoprotein  K52|  1.47 5.68E-05 1.04 9.68E-03 
BB_K53| outer membrane protein  K53|  -0.90 8.92E-02 2.06 3.95E-06 
BB_K54|      hypothetical protein  K54|  1.04 1.36E-01 2.41 2.72E-05 
BB_L01|      hypothetical protein  L01|  -0.29 6.39E-01 0.53 2.74E-01 
BB_L02|      hypothetical protein  L02|  -0.30 7.15E-01 0.55 3.96E-01 
BB_L03| lyme disease proteins of unknown function  L03|  -0.32 6.51E-01 0.53 3.62E-01 
BB_L04| lyme disease proteins of unknown function  L04|  -0.56 4.01E-01 0.35 6.59E-01 
BB_L06|      hypothetical protein  L06|  -0.92 1.02E-01 0.55 4.04E-01 
BB_L07|      hypothetical protein  L07|  -0.31 6.62E-01 0.35 5.81E-01 
BB_L08|      hypothetical protein  L08|  -0.32 6.91E-01 0.33 6.59E-01 
BB_L09|      hypothetical protein  L09|  -0.36 6.44E-01 0.37 6.09E-01 
BB_L10|      hypothetical protein  L10|  -0.70 2.46E-01 0.30 7.23E-01 
BB_L11|      hypothetical protein  L11|  -0.64 2.92E-01 0.29 7.37E-01 
BB_L12|      hypothetical protein  L12|  -0.63 3.18E-01 0.50 4.54E-01 
BB_L13|      hypothetical protein  L13|  -0.78 2.10E-01 0.29 7.48E-01 
BB_L14|      hypothetical protein  L14|  -0.05 9.76E-01 0.42 7.30E-01 
BB_L15|      hypothetical protein  L15|  -0.28 7.12E-01 0.32 6.50E-01 
BB_L16|      hypothetical protein  L16|  -0.74 1.20E-01 0.13 9.19E-01 
BB_L17|      hypothetical protein  L17|  0.13 8.85E-01 0.23 6.80E-01 
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BB_L18|      hypothetical protein  L18|  -0.44 5.62E-01 0.51 4.44E-01 
BB_L19|      hypothetical protein  L19|  -0.85 1.84E-02 0.40 3.96E-01 
BB_L20|      hypothetical protein  L20|  -1.17 1.31E-03 0.31 5.67E-01 
BB_L21|      hypothetical protein  L21|  -1.50 1.96E-04 0.36 5.55E-01 
BB_L22|      hypothetical protein  L22|  -1.17 8.35E-04 0.37 4.36E-01 
BB_L23| holin    BlyA family  L23|  -0.46 2.92E-01 0.41 3.65E-01 
BB_L24| BlyB  L24|  -0.60 1.91E-01 0.25 6.92E-01 
BB_L25| 2.9-6 ORF-C  L25|  -1.73 9.88E-07 -0.29 6.21E-01 
BB_L26| borrelia orf-D family  L26|  -1.78 7.92E-08 0.00 9.99E-01 
BB_L27| BdrP  L27|  0.78 1.40E-01 1.43 2.89E-03 
BB_L28| lipoprotein  L28|  0.84 1.57E-01 1.93 1.13E-04 
BB_L29| 2.9-5 36K%3B minus strand ORF  L29|  0.30 6.19E-01 1.06 7.45E-03 
BB_L30| BBC01  L30|  0.64 1.46E-01 -0.44 3.92E-01 
BB_L31| borrelia family of unknown function  L31|  -1.02 2.38E-03 -0.24 6.59E-01 
BB_L32| PF-32 protein  L32|  -1.11 1.16E-03 -0.97 7.69E-03 
BB_L35| BdrO  L35|  -0.90 2.46E-02 -0.61 1.96E-01 
BB_L36| BppA  L36|  0.01 9.92E-01 1.30 4.03E-02 
BB_L37| BppB  L37|  -0.10 9.59E-01 1.28 1.43E-02 
BB_L38| BppC  L38|  -0.33 5.94E-01 0.54 2.87E-01 
BB_L39| erpA8| ErpA8 protein  L39|  0.95 8.95E-02 1.26 2.20E-02 
BB_L40| erpB8| ErpB8 protein  L40|  0.31 5.99E-01 1.45 1.25E-04 
BB_L41|      hypothetical protein  L41|  -0.82 4.50E-02 0.00 9.97E-01 
BB_L42| hypothetical protein  L42|  -0.26 7.51E-01 0.55 3.39E-01 
BB_L43| phage terminase    large subunit    pbsx family  L43|  -0.21 8.40E-01 0.19 8.71E-01 
BB_M01|      hypothetical protein  M01|  -0.33 5.92E-01 0.49 3.39E-01 
BB_M02|      hypothetical protein  M02|  -0.27 7.54E-01 0.65 2.76E-01 
BB_M03| lyme disease proteins of unknown function  M03|  -0.43 5.03E-01 0.65 2.34E-01 
BB_M04| lyme disease proteins of unknown function  M04|  -0.37 4.78E-01 0.54 2.40E-01 
BB_M05| lyme disease proteins of unknown function  M05|  -0.92 1.14E-01 0.27 7.66E-01 
BB_M06|      hypothetical protein  M06|  -0.40 5.23E-01 0.48 3.94E-01 
BB_M07|      hypothetical protein  M07|  -0.20 8.25E-01 0.24 7.38E-01 
BB_M08|      hypothetical protein  M08|  -0.29 7.14E-01 0.62 2.88E-01 
BB_M09|      hypothetical protein  M09|  -0.01 9.92E-01 0.57 3.66E-01 
BB_M10|      hypothetical protein  M10|  -0.72 3.39E-01 0.47 5.79E-01 
BB_M11|      hypothetical protein  M11|  -0.68 2.64E-01 0.43 5.60E-01 
BB_M12|      hypothetical protein  M12|  -0.64 3.18E-01 0.52 4.37E-01 
BB_M13|      hypothetical protein  M13|  -0.79 2.07E-01 0.31 7.18E-01 
BB_M14|      hypothetical protein  M14|  -1.00 2.11E-01 0.42 6.81E-01 
BB_M15|      hypothetical protein  M15|  -0.15 9.22E-01 0.43 5.18E-01 
BB_M16|      hypothetical protein  M16|  -0.49 3.98E-01 0.27 7.13E-01 
BB_M17|      hypothetical protein  M17|  0.48 2.03E-01 0.09 9.44E-01 
BB_M18|      hypothetical protein  M18|  0.16 9.42E-01 0.60 3.96E-01 
BB_M19|      hypothetical protein  M19|  -0.94 1.17E-02 0.58 1.94E-01 
BB_M20|      hypothetical protein  M20|  -1.39 1.46E-04 0.67 1.37E-01 
BB_M21|      hypothetical protein  M21|  -1.49 2.33E-04 0.42 4.59E-01 
BB_M23| holin    BlyA family  M23|  -0.48 2.55E-01 0.41 3.69E-01 
BB_M24| hemolysin accessory protein  M24|  -0.38 4.71E-01 0.35 5.24E-01 
BB_M25| 2.9-6 ORF-C  M25|  -1.39 2.26E-04 0.07 9.85E-01 
BB_M26| borrelia orf-D family  M26|  -0.78 5.07E-02 0.36 4.76E-01 
BB_M27| rev protein  M27|  -0.33 4.47E-01 2.72 2.79E-25 
BB_M28| lipoprotein  M28|  -0.57 1.85E-01 -0.27 6.33E-01 
BB_M29| 2.9-5 36K%3B minus strand ORF  M29|  0.06 9.59E-01 1.15 7.94E-03 
BB_M30| BBC01  M30|  1.16 3.62E-03 0.46 3.95E-01 
BB_M31| borrelia family of unknown function  M31|  -0.84 3.69E-02 0.19 7.85E-01 
BB_M32| PF-32 protein  M32|  -0.95 2.23E-02 -0.29 6.39E-01 
BB_M33| PF-49 protein  M33|  -1.81 2.58E-03 0.27 8.38E-01 
BB_M34| BdrK  M34|  -1.46 1.98E-03 0.33 6.62E-01 
BB_M35| BppA  M35|  0.07 9.59E-01 1.28 3.50E-02 
BB_M36| BppB  M36|  0.03 9.82E-01 1.08 4.57E-02 
BB_M37| BppC  M37|  0.47 4.79E-01 1.06 4.24E-02 
BB_M38| erpK| ErpK protein  M38|  1.02 2.49E-01 3.12 6.96E-06 
BB_M39|      hypothetical protein  M39|  0.90 1.56E-02 0.69 9.94E-02 
BB_M41| hypothetical protein  M41|  0.00 9.98E-01 0.72 2.76E-01 
BB_M42| phage terminase    large subunit    pbsx family  M42|  -0.05 9.59E-01 0.58 3.41E-01 
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BB_N01|      hypothetical protein  N01|  0.52 2.17E-01 0.50 2.61E-01 
BB_N02|      hypothetical protein  N02|  0.55 2.90E-01 0.46 4.11E-01 
BB_N03| lyme disease proteins of unknown function  N03|  0.02 9.78E-01 0.48 3.23E-01 
BB_N04| lyme disease proteins of unknown function  N04|  -0.14 8.53E-01 0.30 5.36E-01 
BB_N07|      hypothetical protein  N07|  -0.14 9.10E-01 0.02 9.89E-01 
BB_N08|      hypothetical protein  N08|  -0.33 7.00E-01 0.33 6.81E-01 
BB_N09|      hypothetical protein  N09|  0.04 9.63E-01 0.09 9.73E-01 
BB_N10|      hypothetical protein  N10|  -0.48 4.45E-01 0.04 9.89E-01 
BB_N12|      hypothetical protein  N12|  -0.79 1.39E-01 0.39 5.55E-01 
BB_N14|      hypothetical protein  N14|  0.23 9.42E-01 0.51 6.92E-01 
BB_N15|      hypothetical protein  N15|  -0.15 9.14E-01 0.25 7.59E-01 
BB_N17|      hypothetical protein  N17|  0.26 6.54E-01 0.21 7.33E-01 
BB_N19|      hypothetical protein  N19|  1.04 1.75E-02 1.45 5.44E-04 
BB_N20|      hypothetical protein  N20|  -0.30 6.46E-01 1.04 1.47E-02 
BB_N23| holin    BlyA family  N23|  0.65 5.72E-01 0.12 9.89E-01 
BB_N24| BlyB  N24|  -0.60 1.98E-01 0.22 7.54E-01 
BB_N25| 2.9-6 ORF-C  N25|  -1.11 2.22E-03 0.03 9.89E-01 
BB_N26| borrelia orf-D family  N26|  0.39 7.12E-01 0.50 5.87E-01 
BB_N27| BdrR  N27|  1.16 2.08E-02 1.71 3.36E-04 
BB_N28| lipoprotein  N28|  1.68 1.23E-03 1.38 1.50E-02 
BB_N30| BBC01  N30|  0.07 9.59E-01 -1.01 4.83E-03 
BB_N31| borrelia family of unknown function  N31|  -0.75 3.68E-02 -0.22 6.96E-01 
BB_N32| PF-32 protein  N32|  -0.82 4.26E-02 -0.59 2.10E-01 
BB_N33| PF-49 protein  N33|  -1.53 4.75E-03 -0.64 3.74E-01 
BB_N34| BdrQ  N34|  -1.18 1.35E-02 -0.36 6.10E-01 
BB_N35| BppA  N35|  0.12 9.59E-01 1.08 7.94E-02 
BB_N36| BppB  N36|  0.27 7.71E-01 0.45 5.27E-01 
BB_N38| erpP| ErpP protein  N38|  0.49 5.09E-01 1.01 9.16E-02 
BB_N39| erpQ| ErpQ protein  N39|  0.45 4.62E-01 1.34 3.17E-03 
BB_N41|      hypothetical protein  N41|  0.02 9.82E-01 -0.32 5.47E-01 
BB_N42| hypothetical protein  N42|  0.19 8.26E-01 0.46 4.04E-01 
BB_N43| phage terminase    large subunit    pbsx family  N43|  -0.22 7.71E-01 0.05 9.89E-01 
BB_O01|      hypothetical protein  O01|  -0.34 5.48E-01 0.61 1.87E-01 
BB_O02|      hypothetical protein  O02|  -0.25 7.82E-01 0.73 2.31E-01 
BB_O03| lyme disease proteins of unknown function  O03|  -0.31 6.77E-01 0.55 3.50E-01 
BB_O04| lyme disease proteins of unknown function  O04|  -0.14 9.38E-01 0.82 1.46E-01 
BB_O06|      hypothetical protein  O06|  -0.91 1.11E-01 0.64 3.23E-01 
BB_O07|      hypothetical protein  O07|  -0.34 5.65E-01 0.63 1.86E-01 
BB_O08|      hypothetical protein  O08|  -0.30 7.04E-01 0.61 2.94E-01 
BB_O09|      hypothetical protein  O09|  -0.16 9.13E-01 0.61 3.07E-01 
BB_O10|      hypothetical protein  O10|  -0.79 3.28E-01 0.51 5.76E-01 
BB_O11|      hypothetical protein  O11|  -0.77 2.01E-01 0.55 4.11E-01 
BB_O12|      hypothetical protein  O12|  -0.99 1.19E-01 0.76 2.61E-01 
BB_O13|      hypothetical protein  O13|  -0.67 4.48E-01 0.93 2.13E-01 
BB_O14|      hypothetical protein  O14|  0.40 8.14E-01 0.65 6.00E-01 
BB_O15|      hypothetical protein  O15|  -0.52 3.40E-01 0.41 5.06E-01 
BB_O16|      hypothetical protein  O16|  -0.72 3.09E-01 0.43 5.98E-01 
BB_O17|      hypothetical protein  O17|  -0.64 2.86E-01 0.49 4.57E-01 
BB_O18|      hypothetical protein  O18|  -0.33 7.12E-01 0.16 9.30E-01 
BB_O19|      hypothetical protein  O19|  0.12 9.44E-01 1.76 8.69E-06 
BB_O20|      hypothetical protein  O20|  -0.51 3.76E-01 1.53 3.83E-04 
BB_O21|      hypothetical protein  O21|  -1.42 7.34E-04 0.67 2.04E-01 
BB_O22|      hypothetical protein  O22|  -1.15 1.03E-03 0.38 4.18E-01 
BB_O23| holin    BlyA family  O23|  -0.46 2.82E-01 0.40 3.69E-01 
BB_O24| hemolysin accessory protein  O24|  0.40 4.33E-01 1.27 5.65E-04 
BB_O25| 2.9-7 ORF-C  O25|  -0.55 2.43E-01 0.59 2.05E-01 
BB_O26| borrelia orf-D family  O26|  -1.13 3.56E-04 0.14 8.46E-01 
BB_O27| BdrN  O27|  0.98 1.35E-02 1.09 7.18E-03 
BB_O28| lipoprotein  O28|  0.79 1.68E-01 1.44 4.70E-03 
BB_O29| 2.9-5 36K%3B minus strand ORF  O29|  0.54 2.55E-01 1.25 1.40E-03 
BB_O30| BBC01  O30|  0.28 5.38E-01 -0.28 5.27E-01 
BB_O31| borrelia family of unknown function  O31|  -0.45 2.35E-01 0.23 6.42E-01 
BB_O32| PF-32 protein  O32|  -0.77 7.04E-02 -0.22 7.51E-01 
BB_O33|      plasmid partition protein%3B Orf3  O33|  -1.75 8.45E-03 -0.20 9.22E-01 
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BB_O34| BdrM  O34|  -1.40 1.72E-02 -0.04 9.89E-01 
BB_O36| BppA  O36|  -0.03 9.79E-01 1.29 4.41E-02 
BB_O37| BppB  O37|  -0.09 9.59E-01 1.28 1.47E-02 
BB_O38| BppC  O38|  0.47 4.96E-01 1.08 4.24E-02 
BB_O39| erpL| ErpL protein  O39|  3.78 1.24E-02 5.36 2.11E-04 
BB_O40| erpM| ErpM protein  O40|  0.89 1.88E-01 2.80 1.14E-07 
BB_O43| hypothetical protein  O43|  -2.61 1.83E-01 2.11 3.14E-01 
BB_O44| phage terminase    large subunit    pbsx family  O44|  -0.39 5.45E-01 0.52 3.69E-01 
BB_P01|      phage portal protein  P01|  -0.29 6.39E-01 0.53 2.79E-01 
BB_P02|      hypothetical protein  P02|  -0.30 7.15E-01 0.55 3.98E-01 
BB_P03| lyme disease proteins of unknown function  P03|  -0.32 6.54E-01 0.53 3.63E-01 
BB_P04| lyme disease proteins of unknown function  P04|  -0.56 3.98E-01 0.35 6.58E-01 
BB_P06|      hypothetical protein  P06|  -0.92 1.02E-01 0.56 4.01E-01 
BB_P07|      hypothetical protein  P07|  -0.31 6.54E-01 0.37 5.58E-01 
BB_P08|      hypothetical protein  P08|  -0.35 6.39E-01 0.32 6.66E-01 
BB_P09|      hypothetical protein  P09|  -0.35 6.54E-01 0.41 5.59E-01 
BB_P10|      hypothetical protein  P10|  -0.69 2.52E-01 0.30 7.28E-01 
BB_P11|      hypothetical protein  P11|  -0.65 2.81E-01 0.29 7.30E-01 
BB_P12|      hypothetical protein  P12|  -0.65 2.94E-01 0.48 4.67E-01 
BB_P13|      hypothetical protein  P13|  -0.88 1.45E-01 0.33 6.85E-01 
BB_P14|      hypothetical protein  P14|  -0.19 9.54E-01 0.36 7.80E-01 
BB_P15|      hypothetical protein  P15|  -0.28 7.15E-01 0.32 6.55E-01 
BB_P16|      hypothetical protein  P16|  -0.73 1.20E-01 0.13 9.12E-01 
BB_P17|      hypothetical protein  P17|  0.12 9.13E-01 0.23 6.91E-01 
BB_P18|      hypothetical protein  P18|  -0.39 6.19E-01 0.52 4.29E-01 
BB_P19|      hypothetical protein  P19|  -0.64 1.60E-01 0.55 2.63E-01 
BB_P20|      hypothetical protein  P20|  -1.39 1.46E-04 0.48 3.14E-01 
BB_P21|      hypothetical protein  P21|  -1.55 1.33E-04 0.35 5.65E-01 
BB_P22|      hypothetical protein  P22|  -1.15 1.07E-03 0.38 4.32E-01 
BB_P23| blyA1| holin protein (BlyA1)  P23|  -0.46 2.73E-01 0.40 3.69E-01 
BB_P24| blyB1|      hemolysin accessory protein  P24|  -0.84 7.46E-02 0.16 8.83E-01 
BB_P25| 2.9-7 ORF-C  P25|  -1.49 1.63E-03 -0.21 8.31E-01 
BB_P26| borrelia orf-D family  P26|  -1.38 4.75E-03 -0.62 3.31E-01 
BB_P27| revA1| surface protein (RevA1)  P27|  -0.35 3.95E-01 2.63 1.04E-23 
BB_P28| mlpA| surface protein    mlp lipoprotein family  P28|  -0.58 1.74E-01 -0.20 7.69E-01 
BB_P29| 2.9-5 36K%3B minus strand ORF  P29|  0.32 5.67E-01 1.10 4.18E-03 
BB_P30| BBC01  P30|  0.32 4.79E-01 -0.79 2.25E-02 
BB_P31| borrelia family of unknown function  P31|  -1.58 1.27E-04 -0.81 1.03E-01 
BB_P32| PF-32 protein  P32|  -2.93 8.85E-07 -1.12 1.42E-01 
BB_P33| PF-49 protein  P33|  -2.88 8.57E-08 -0.91 2.05E-01 
BB_P34| BdrA  P34|  -2.23 3.07E-06 -0.90 1.37E-01 
BB_P35| bppA1| BppA protein  P35|  -0.25 8.27E-01 1.01 1.07E-01 
BB_P36| bppB1| BppB protein  P36|  -0.58 2.78E-01 0.43 4.61E-01 
BB_P37| bppC1| site-specific recombinase phage integrase family  -0.44 4.05E-01 0.42 4.32E-01 
BB_P38| erpA| ErpA protein  P38|  0.95 9.26E-02 1.25 2.28E-02 
BB_P39| erpB1| ErpB1 protein  P39|  0.31 6.02E-01 1.45 1.25E-04 
BB_P40|      hypothetical protein  P40|  -0.83 3.78E-02 0.03 9.89E-01 
BB_P41| hypothetical protein  P41|  -0.25 7.57E-01 0.55 3.43E-01 
BB_P42| phage terminase    large subunit    pbsx family  P42|  -0.10 9.59E-01 0.27 7.85E-01 
BB_Q0091| hypothetical protein  Q0091|  0.00 9.98E-01 0.86 4.07E-01 
BB_Q03| outer membrane protein  Q03|  -1.28 6.03E-03 1.93 7.35E-06 
BB_Q05| antigen    P35          Q05|  -0.19 8.24E-01 0.13 9.22E-01 
BB_Q06| borrelia membrane protein P13  Q06|  -1.19 1.62E-02 -0.06 9.89E-01 
BB_Q07|      plasmid partition protein  Q07|  -0.03 9.68E-01 -0.05 9.89E-01 
BB_Q08| PF-32 protein  Q08|  -1.84 5.68E-01 0.14 9.89E-01 
BB_Q09| borrelia family of unknown function  Q09|  -1.88 1.34E-03 -0.19 9.03E-01 
BB_Q12| lyme disease proteins of unknown function  Q12|  -0.68 2.20E-01 0.35 6.03E-01 
BB_Q13|      hypothetical protein  Q13|  -0.40 5.26E-01 0.50 3.86E-01 
BB_Q14|      hypothetical protein  Q14|  -5.02 4.38E-02 -0.55 9.51E-01 
BB_Q15|      hypothetical protein  Q15|  -0.12 9.59E-01 0.59 5.36E-01 
BB_Q17|      hypothetical protein  Q17|  -0.38 7.45E-01 0.60 5.14E-01 
BB_Q18|      hypothetical protein  Q18|  -0.81 2.00E-01 0.29 7.64E-01 
BB_Q19|      hypothetical protein  Q19|  -0.43 7.15E-01 0.77 3.95E-01 
BB_Q20|      hypothetical protein  Q20|  -0.83 2.41E-01 0.33 7.30E-01 
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BB_Q21|      hypothetical protein  Q21|  0.42 8.80E-01 1.37 3.32E-01 
BB_Q22|      hypothetical protein  Q22|  -0.59 3.25E-01 0.27 7.39E-01 
BB_Q23|      hypothetical protein  Q23|  -1.23 3.68E-02 0.04 9.89E-01 
BB_Q24|      hypothetical protein  Q24|  -0.21 7.97E-01 0.25 7.26E-01 
BB_Q25|      hypothetical protein  Q25|  -0.23 8.14E-01 0.28 7.47E-01 
BB_Q26|      hypothetical protein  Q26|  -1.08 3.34E-03 0.57 2.07E-01 
BB_Q27|      hypothetical protein  Q27|  -1.42 1.01E-04 0.65 1.42E-01 
BB_Q28|      hypothetical protein  Q28|  -1.77 2.90E-05 0.27 7.14E-01 
BB_Q29|      hypothetical protein  Q29|  -2.40 2.53E-13 0.48 2.91E-01 
BB_Q30| holin    BlyA family  Q30|  -1.09 1.63E-02 0.67 1.98E-01 
BB_Q31| hemolysin accessory protein  Q31|  -1.24 1.98E-03 0.42 4.35E-01 
BB_Q32| 2.9-6 ORF-C  Q32|  -1.55 3.41E-05 0.04 9.89E-01 
BB_Q33| borrelia orf-D family  Q33|  -1.99 2.45E-10 0.08 9.63E-01 
BB_Q34| BdrW  Q34|  -0.31 4.97E-01 0.98 2.84E-03 
BB_Q35| MlpJ  Q35|  0.24 7.26E-01 0.77 9.17E-02 
BB_Q37| 2.9-5 36K%3B minus strand ORF  Q37|  0.03 NA -0.11 NA 
BB_Q38| BBC01  Q38|  -0.42 2.92E-01 -0.40 3.47E-01 
BB_Q39| borrelia family of unknown function  Q39|  -1.13 3.07E-04 -0.36 3.98E-01 
BB_Q40| PF-32 protein  Q40|  -2.72 3.41E-08 -0.44 5.85E-01 
BB_Q42| BdrV  Q42|  -0.92 4.00E-02 -0.48 3.94E-01 
BB_Q43| BppA  Q43|  -0.11 9.59E-01 1.12 6.16E-02 
BB_Q44| BppB  Q44|  -0.96 1.43E-01 0.79 2.34E-01 
BB_Q45| BppC  Q45|  -0.65 2.87E-01 0.25 7.81E-01 
BB_Q47| erpX| ErpX protein  Q47|  -0.30 8.10E-01 4.06 1.99E-13 
BB_Q48|      hypothetical protein  Q48|  -1.71 4.88E-05 0.04 9.89E-01 
BB_Q49| hypothetical protein  Q49|  -1.53 6.43E-04 -0.02 9.89E-01 
BB_Q50| phage terminase    large subunit    pbsx family  Q50|  -1.02 8.92E-02 0.12 9.72E-01 
BB_Q52|      hypothetical protein  Q52|  -0.12 9.59E-01 0.52 4.43E-01 
BB_Q53|      hypothetical protein  Q53|  -0.43 5.16E-01 0.50 4.03E-01 
BB_Q54|      hypothetical protein  Q54|  -0.33 6.15E-01 0.59 2.67E-01 
BB_Q62|      hypothetical protein  Q62|  -2.88 2.09E-05 -2.09 4.37E-03 
BB_Q67| adenine specific DNA methyltransferase  Q67|  -1.73 1.78E-03 -0.01 9.89E-01 
BB_Q85|      hypothetical protein  Q85|  0.76 6.46E-01 1.30 3.12E-01 
BB_Q88| CdsC  Q88|  0.15 9.59E-01 0.37 8.01E-01 
BB_Q89| hypothetical protein  Q89|  0.44 9.13E-01 1.91 2.01E-01 
BB_R01|      hypothetical protein  R01|  -0.20 8.14E-01 0.41 4.58E-01 
BB_R03| lyme disease proteins of unknown function  R03|  -0.56 3.34E-01 0.62 2.83E-01 
BB_R04| lyme disease proteins of unknown function  R04|  -0.38 5.62E-01 0.19 8.41E-01 
BB_R05| lyme disease proteins of unknown function  R05|  -1.03 4.08E-02 0.56 3.39E-01 
BB_R06|      hypothetical protein  R06|  -0.80 9.05E-02 0.39 5.21E-01 
BB_R07|      hypothetical protein  R07|  -0.44 4.53E-01 0.28 6.89E-01 
BB_R08|      hypothetical protein  R08|  -0.41 6.62E-01 0.50 5.42E-01 
BB_R09|      hypothetical protein  R09|  -0.33 6.82E-01 0.44 5.27E-01 
BB_R10|      hypothetical protein  R10|  -0.46 5.30E-01 0.12 9.60E-01 
BB_R11|      hypothetical protein  R11|  -0.45 5.38E-01 0.41 5.76E-01 
BB_R12|      hypothetical protein  R12|  -0.65 3.11E-01 0.61 3.52E-01 
BB_R13|      hypothetical protein  R13|  -0.88 1.84E-01 0.36 6.85E-01 
BB_R14|      hypothetical protein  R14|  -0.13 9.59E-01 0.59 6.99E-01 
BB_R15|      hypothetical protein  R15|  -0.37 5.80E-01 0.29 6.75E-01 
BB_R16|      hypothetical protein  R16|  -0.59 3.98E-01 0.13 9.53E-01 
BB_R17|      hypothetical protein  R17|  0.46 2.15E-01 0.13 8.62E-01 
BB_R18|      hypothetical protein  R18|  -0.54 4.74E-01 -0.02 9.89E-01 
BB_R19|      hypothetical protein  R19|  -0.93 1.24E-02 0.60 1.68E-01 
BB_R20|      hypothetical protein  R20|  -1.24 5.60E-04 0.63 1.45E-01 
BB_R21|      hypothetical protein  R21|  -1.41 4.76E-04 0.55 2.90E-01 
BB_R22|      hypothetical protein  R22|  -1.52 3.25E-06 0.34 4.59E-01 
BB_R23| holin    BlyA family  R23|  -1.12 1.52E-02 0.64 2.34E-01 
BB_R24| hemolysin accessory protein  R24|  -0.86 7.02E-02 0.14 9.20E-01 
BB_R25| 2.9-6 ORF-C  R25|  -1.50 6.35E-05 0.05 9.89E-01 
BB_R26| borrelia orf-D family  R26|  -1.41 4.85E-05 0.26 6.55E-01 
BB_R27| BdrH  R27|  1.19 4.93E-03 1.10 1.49E-02 
BB_R28| lipoprotein  R28|  1.43 2.82E-03 0.78 1.86E-01 
BB_R29| 2.9-5 36K%3B minus strand ORF  R29|  -0.47 5.08E-01 1.09 4.51E-02 
BB_R31| BBC01  R31|  0.33 4.59E-01 -0.68 5.77E-02 
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BB_R32| borrelia family of unknown function  R32|  -1.04 6.44E-03 -0.09 9.64E-01 
BB_R33| PF-32 protein  R33|  -1.58 6.65E-05 -0.29 6.55E-01 
BB_R34| PF-49 protein  R34|  -1.57 9.06E-04 -0.21 8.45E-01 
BB_R36| BppA  R36|  -0.07 9.59E-01 1.05 8.39E-02 
BB_R37| BppB  R37|  -0.23 8.65E-01 0.61 4.10E-01 
BB_R38| BppC  R38|  -0.01 9.92E-01 0.43 5.92E-01 
BB_R41| borrelia outer surface protein E  R41|  -0.08 9.59E-01 0.84 4.06E-02 
BB_R42| erpY| ErpY protein  R42|  0.09 9.59E-01 0.92 1.13E-02 
BB_R43|      hypothetical protein  R43|  0.06 9.59E-01 0.08 9.83E-01 
BB_R44| hypothetical protein  R44|  -0.20 8.07E-01 1.05 1.47E-02 
BB_R45| phage terminase    large subunit    pbsx family  R45|  -0.61 1.69E-01 0.48 3.39E-01 
BB_S01|      hypothetical protein  S01|  -0.05 9.59E-01 0.57 2.76E-01 
BB_S02|      hypothetical protein  S02|  -0.25 7.97E-01 0.61 3.40E-01 
BB_S03| lyme disease proteins of unknown function  S03|  -0.31 6.79E-01 0.55 3.52E-01 
BB_S04| lyme disease proteins of unknown function  S04|  0.01 9.92E-01 0.79 2.05E-01 
BB_S06|      hypothetical protein  S06|  -0.91 1.01E-01 0.54 4.09E-01 
BB_S07|      hypothetical protein  S07|  -0.30 6.62E-01 0.41 4.97E-01 
BB_S08|      hypothetical protein  S08|  -0.35 6.40E-01 0.31 6.80E-01 
BB_S09|      hypothetical protein  S09|  -0.14 9.35E-01 0.52 3.99E-01 
BB_S10|      hypothetical protein  S10|  -0.62 3.25E-01 0.33 6.75E-01 
BB_S11|      hypothetical protein  S11|  -0.65 2.81E-01 0.29 7.30E-01 
BB_S12|      hypothetical protein  S12|  -0.61 3.39E-01 0.52 4.37E-01 
BB_S13|      hypothetical protein  S13|  -0.77 2.20E-01 0.31 7.23E-01 
BB_S14|      hypothetical protein  S14|  -0.12 9.59E-01 0.39 7.51E-01 
BB_S15|      hypothetical protein  S15|  -0.37 5.92E-01 0.27 7.30E-01 
BB_S16|      hypothetical protein  S16|  -0.86 1.24E-01 0.12 9.51E-01 
BB_S17|      hypothetical protein  S17|  0.16 8.33E-01 0.24 6.85E-01 
BB_S18|      hypothetical protein  S18|  -0.39 6.31E-01 0.51 4.52E-01 
BB_S19|      hypothetical protein  S19|  -0.63 1.69E-01 0.55 2.62E-01 
BB_S20|      hypothetical protein  S20|  -1.42 1.13E-04 0.48 3.11E-01 
BB_S21|      hypothetical protein  S21|  -1.28 1.34E-03 0.30 6.26E-01 
BB_S23| holin    BlyA family  S23|  -0.47 2.77E-01 0.41 3.73E-01 
BB_S24| hemolysin accessory protein  S24|  -0.86 6.80E-02 0.14 9.19E-01 
BB_S25| 2.9-6 ORF-C  S25|  -1.50 5.82E-05 -0.09 9.58E-01 
BB_S26| borrelia orf-D family  S26|  -1.29 5.02E-04 0.02 9.89E-01 
BB_S27| Bbs27 protein  S27|  -0.70 6.20E-01 0.36 8.62E-01 
BB_S29| bdrF| KID repeat protein  S29|  0.82 5.11E-02 1.29 9.81E-04 
BB_S30| lipoprotein  S30|  0.97 1.41E-01 1.38 3.03E-02 
BB_S31| 2.9-5 36K%3B minus strand ORF  S31|  0.38 4.50E-01 1.05 6.05E-03 
BB_S33| BBC01  S33|  0.52 1.50E-01 -0.67 5.58E-02 
BB_S34| borrelia family of unknown function  S34|  -0.38 3.11E-01 -0.32 4.27E-01 
BB_S35| PF-32 protein  S35|  -0.19 7.69E-01 -0.48 2.74E-01 
BB_S37| BdrE  S37|  -0.27 6.29E-01 -0.50 2.76E-01 
BB_S38| BppA  S38|  0.10 9.59E-01 1.11 6.27E-02 
BB_S39| BppB  S39|  0.06 9.59E-01 0.87 1.94E-01 
BB_S40| BppC  S40|  0.08 9.59E-01 0.46 5.69E-01 
BB_S41| erpG| ErpG protein  S41|  0.70 1.23E-01 2.06 1.95E-08 
BB_S42| bapA| BapA protein  S42|  0.87 6.61E-02 2.34 2.54E-09 
BB_S44| hypothetical protein  S44|  0.33 7.69E-01 0.85 2.79E-01 
BB_S45| phage terminase    large subunit    pbsx family  S45|  -0.18 8.63E-01 0.58 3.11E-01 
BB_T0008| Borrelia ORF-A superfamily protein  T0008|  0.50 5.32E-01 0.51 5.14E-01 
BB_T01|      hypothetical protein  T01|  0.62 4.73E-01 0.52 5.67E-01 
BB_T02|      hypothetical protein  T02|  0.00 1.00E+00 1.01 9.77E-01 
BB_T03|      hypothetical protein  T03|  1.21 5.89E-01 0.53 8.97E-01 
BB_T06| Sua5/YciO/YrdC/YwlC family protein          T06|  -0.52 6.62E-01 -0.34 8.22E-01 
BB_T07| outer membrane protein  T07|  -0.13 9.59E-01 1.57 2.87E-01 
BB_U01|      hypothetical protein  U01|  0.69 3.39E-01 0.57 4.57E-01 
BB_U02|      hypothetical protein  U02|  0.94 7.45E-03 0.40 3.95E-01 
BB_U04| BBC01  U04|  0.49 5.13E-01 0.38 6.41E-01 
BB_U05| PF-32 protein  U05|  -0.21 8.35E-01 0.18 8.75E-01 
BB_U06|      plasmid partition protein  U06|  0.22 8.36E-01 1.19 3.20E-02 
BB_U07| BBC01  U07|  -0.08 9.59E-01 0.92 2.25E-02 
BB_U08| SUA5 domain subfamily  U08|  -0.42 7.39E-01 0.88 3.05E-01 
BB_U09| TM2 domain family  U09|  0.31 8.07E-01 0.59 5.11E-01 
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BB_U10| BBC01  U10|  -1.17 6.64E-01 -0.59 8.87E-01 
BB_U11| Sua5/YciO/YrdC/YwlC family protein          U11|  -0.49 6.81E-01 0.01 9.97E-01 
EBG00001182576| tRNA    G00001182576     0.54 7.11E-01 -0.80 5.59E-01 
EBG00001182577| tRNA    G00001182577     -0.02 9.88E-01 -0.13 9.37E-01 
EBG00001182578| tRNA    G00001182578     1.25 2.49E-01 0.78 5.59E-01 
EBG00001182579| 5_8S_rRNA| biotype=rRNA 0.18 9.59E-01 -0.57 8.66E-01 
EBG00001182580| tRNA    G00001182580     0.44 6.46E-01 -0.55 5.45E-01 
EBG00001182581| Bacteria_small_SRP| biotype=ncRNA -0.08 9.59E-01 -0.60 4.36E-01 
EBG00001182582| tRNA    G00001182582     0.00 9.98E-01 0.22 7.81E-01 
EBG00001182583| tRNA    G00001182583     -2.13 NA -2.45 NA 
EBG00001182584| tRNA    G00001182584     -1.12 1.70E-02 -0.14 9.14E-01 
EBG00001182585| tRNA    G00001182585     1.41 4.01E-02 -0.95 2.50E-01 
EBG00001182586| tRNA    G00001182586     0.33 7.11E-01 -1.71 4.75E-03 
EBG00001182587| 5_8S_rRNA| biotype=rRNA 0.18 9.59E-01 -0.57 8.66E-01 
EBG00001182588| tRNA    G00001182588     0.66 2.82E-01 -0.05 9.89E-01 
EBG00001182589| tRNA    G00001182589     0.13 9.59E-01 -1.44 2.92E-01 
EBG00001182590| tRNA    G00001182590     -0.32 9.59E-01 -0.28 9.73E-01 
EBG00001182591| 5S_rRNA| biotype=rRNA 0.15 9.59E-01 -0.56 6.76E-01 
EBG00001182592| PK-G12rRNA| biotype=rRNA 0.21 9.59E-01 0.28 9.83E-01 
EBG00001182593| PK-G12rRNA| biotype=rRNA 0.22 9.59E-01 0.05 9.89E-01 
EBG00001182594| LSU_rRNA_bacteria| biotype=rRNA 0.54 8.67E-01 1.65 3.53E-01 
EBG00001182595| LSU_rRNA_bacteria| biotype=rRNA 0.54 8.67E-01 1.66 3.52E-01 
EBG00001182596| tRNA    G00001182596     -0.07 9.59E-01 -0.30 7.56E-01 
EBG00001182597| tRNA    G00001182597     0.51 5.48E-01 -0.57 5.04E-01 
EBG00001182598| tRNA    G00001182598     -0.61 4.47E-01 -1.08 1.18E-01 
EBG00001182599| tRNA    G00001182599     3.11 1.20E-01 0.46 9.62E-01 
EBG00001182600| tRNA    G00001182600     0.66 2.56E-01 0.05 9.89E-01 
EBG00001182601| tRNA    G00001182601     1.14 4.23E-03 -1.18 4.87E-03 
EBG00001182602| tRNA    G00001182602     1.06 3.00E-01 0.19 9.68E-01 
EBG00001182603| tRNA    G00001182603     0.60 2.15E-01 0.62 2.25E-01 
EBG00001182604| tRNA    G00001182604     1.17 3.71E-02 -0.79 2.77E-01 
EBG00001182605| tRNA    G00001182605     1.03 3.81E-01 -0.37 8.78E-01 
EBG00001182606| tRNA    G00001182606     1.77 5.46E-03 -1.61 4.15E-02 
EBG00001182607| 5S_rRNA| biotype=rRNA 0.15 9.59E-01 -0.57 6.65E-01 
EBG00001182608| tRNA    G00001182608     0.94 4.29E-01 -0.29 9.19E-01 
EBG00001182609| tRNA    G00001182609     0.00 9.98E-01 -0.85 1.45E-01 
EBG00001182610| tRNA    G00001182610     1.10 7.64E-02 -0.42 6.58E-01 
EBG00001182611| SSU_rRNA_archaea| biotype=rRNA 2.73 1.09E-01 2.49 1.77E-01 
EBG00001182612| tRNA    G00001182612     0.53 3.89E-01 -0.05 9.89E-01 
EBG00001182613| tRNA    G00001182613     0.88 5.56E-01 -0.01 9.99E-01 
EBG00001182614| tRNA    G00001182614     -0.95 6.22E-01 1.34 3.94E-01 
EBG00001182615| tRNA    G00001182615     0.84 5.83E-01 0.25 9.55E-01 
EBG00001182616| tmRNA| biotype=ncRNA 0.00 9.98E-01 0.47 5.89E-01 
EBG00001182617| tRNA    G00001182617     0.64 6.29E-01 -0.61 6.74E-01 
EBG00001182618| RNaseP_bact_a| biotype=ribozyme 0.80 1.42E-01 0.56 3.76E-01 
EBG00001182619| tRNA    G00001182619     1.83 6.43E-04 0.17 9.20E-01 
EBG00001182620| tRNA    G00001182620     0.40 6.10E-01 0.54 4.18E-01 
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Figure A5.2 WT vs DspoVG and WT vs spoVG-ON sRNA Full table 
    Start Stop Strand 
WT v ∆ 
log2 
WT v ∆ 
padj 
WT vs 
ON log2 WT vs ON padj 
SR0001 chr 3151 3343 - -0.34 6.35E-01 1.36 2.24E-03 
SR0002 chr 3324 3454 + NA NA NA NA 
SR0003 chr 4262 4345 + 0.05 9.89E-01 0.21 9.59E-01 
SR0004 chr 4303 4430 - 0.33 5.18E-01 0.92 1.15E-02 
SR0005 chr 5053 5193 - -0.12 9.15E-01 0.07 9.59E-01 
SR0006 chr 7249 7383 + -1.16 4.61E-03 0.28 6.62E-01 
SR0007 chr 7600 7661 + -1.27 3.92E-02 0.37 6.82E-01 
SR0008 chr 8549 8625 - -0.53 5.27E-01 0.83 2.08E-01 
SR0009 chr 10915 11072 - -0.23 6.62E-01 -0.60 1.09E-01 
SR0010 chr 12319 12446 - 0.00 9.97E-01 -0.42 5.96E-01 
SR0011 chr 15804 15873 + -0.27 8.87E-01 0.21 9.42E-01 
SR0012 chr 17717 17775 - -0.08 9.89E-01 0.37 6.20E-01 
SR0013 chr 20453 20602 - -0.69 6.34E-02 0.80 1.73E-02 
SR0014 chr 25903 25952 - 0.19 8.30E-01 1.03 1.98E-02 
SR0015 chr 27083 27132 - -0.02 9.89E-01 -0.48 5.36E-01 
SR0016 chr 29143 29197 + 0.31 6.75E-01 -0.31 6.89E-01 
SR0017 chr 30909 31000 + 0.72 7.01E-01 0.47 8.65E-01 
SR0018 chr 32808 32854 + -1.30 1.19E-01 -0.55 6.19E-01 
SR0019 chr 34937 35008 - 0.05 9.89E-01 0.21 9.59E-01 
SR0020 chr 39004 39085 - 0.05 9.89E-01 0.21 9.59E-01 
SR0021 chr 39498 39674 - -1.64 4.96E-02 0.09 9.59E-01 
SR0022 chr 39746 39824 + 0.64 5.76E-01 -0.07 9.64E-01 
SR0023 chr 39916 40070 + -0.33 9.59E-01 0.03 9.92E-01 
SR0024 chr 40608 40692 + -0.48 7.34E-01 0.39 8.07E-01 
SR0025 chr 41076 41147 + -0.10 9.47E-01 0.86 3.88E-02 
SR0026 chr 41649 41800 - -0.67 9.55E-01 -0.56 9.59E-01 
SR0027 chr 45022 45127 + 0.07 9.83E-01 -0.07 9.59E-01 
SR0028 chr 45908 45970 - 0.37 6.58E-01 1.67 6.43E-04 
SR0029 chr 46530 46597 + 0.16 9.89E-01 1.82 3.39E-01 
SR0030 chr 47000 47049 - 0.52 6.26E-01 0.12 9.59E-01 
SR0031 chr 47902 48000 + -0.72 4.75E-01 0.10 9.59E-01 
SR0032 chr 48088 48201 - 0.17 7.95E-01 -0.25 6.49E-01 
SR0033 chr 49223 49324 - -1.11 1.74E-01 0.53 6.09E-01 
SR0034 chr 49815 49872 + 0.05 9.89E-01 0.21 9.59E-01 
SR0035 chr 49847 49975 - -0.58 1.73E-01 -0.16 8.25E-01 
SR0036 chr 57840 57973 - -0.30 5.82E-01 0.64 1.18E-01 
SR0037 chr 58602 58757 + 0.13 8.71E-01 0.69 6.19E-02 
SR0038 chr 60372 60439 - 0.05 9.89E-01 0.21 9.59E-01 
SR0039 chr 61365 61528 + 0.10 9.52E-01 0.99 1.21E-02 
SR0040 chr 61723 61807 - -0.02 9.89E-01 0.75 1.25E-01 
SR0041 chr 62800 63058 - 0.60 3.34E-01 0.99 5.26E-02 
SR0042 chr 62874 62965 + 0.56 4.00E-01 1.11 3.69E-02 
SR0043 chr 63122 63192 + 0.20 9.12E-01 -0.32 7.71E-01 
SR0044 chr 64058 64128 + 0.05 9.89E-01 0.21 9.59E-01 
SR0045 chr 67706 67810 - 0.77 9.17E-02 -0.85 7.05E-02 
SR0046 chr 68117 68241 - 0.37 3.99E-01 -0.18 7.74E-01 
SR0047 chr 69927 69997 - 0.33 5.39E-01 -0.71 9.44E-02 
SR0048 chr 70112 70208 + 0.48 3.92E-01 0.28 6.82E-01 
SR0049 chr 70662 70754 + 0.05 9.89E-01 0.80 7.53E-01 
SR0050 chr 72696 72745 - 1.01 2.64E-01 -0.94 3.81E-01 
SR0051 chr 73036 73111 + 0.05 9.89E-01 0.21 9.59E-01 
SR0052 chr 75960 76009 + 0.05 9.89E-01 0.21 9.59E-01 
SR0053 chr 80423 80539 - -1.81 1.50E-02 -0.95 2.56E-01 
SR0054 chr 82200 82258 + 0.05 9.89E-01 0.21 9.59E-01 
SR0055 chr 86020 86069 + -0.27 5.49E-01 -0.17 7.59E-01 
SR0056 chr 86743 86853 - 0.46 9.64E-01 0.64 9.22E-01 
SR0057 chr 88061 88228 - -0.18 7.33E-01 0.15 8.17E-01 
SR0058 chr 92262 92361 + -0.13 9.52E-01 -0.32 7.00E-01 
SR0059 chr 97554 97668 - 0.05 9.89E-01 0.21 9.59E-01 
SR0060 chr 99576 99625 - 0.02 9.89E-01 0.21 7.27E-01 
SR0061 chr 101607 101683 - 0.05 9.89E-01 0.21 9.59E-01 
206 
 
 
SR0062 chr 102785 102853 + 0.28 6.96E-01 0.29 7.00E-01 
SR0063 chr 104400 104491 + -0.49 2.39E-01 -0.80 1.84E-02 
SR0064 chr 104727 104792 + -0.62 2.77E-01 -0.67 2.10E-01 
SR0065 chr 107081 107150 - 0.05 9.89E-01 0.21 9.59E-01 
SR0066 chr 108374 108495 + 0.05 9.89E-01 0.21 9.59E-01 
SR0067 chr 109635 109750 + -0.23 8.38E-01 -1.27 2.13E-02 
SR0068 chr 111621 111713 - 1.76 7.32E-01 0.20 9.76E-01 
SR0069 chr 114070 114191 + 0.57 3.30E-01 0.14 9.34E-01 
SR0070 chr 114758 114830 + 0.10 9.89E-01 -0.03 9.89E-01 
SR0071 chr 114956 115046 + 0.05 9.89E-01 0.21 9.59E-01 
SR0072 chr 115524 115593 + -0.22 8.14E-01 -1.02 4.28E-02 
SR0073 chr 115545 115617 - 0.05 9.89E-01 0.21 9.59E-01 
SR0074 chr 117446 117496 + -0.61 4.01E-01 -0.40 6.48E-01 
SR0075 chr 117640 117725 - -0.91 9.91E-02 0.12 9.55E-01 
SR0076 chr 120029 120165 + 0.51 2.52E-01 0.70 6.84E-02 
SR0077 chr 122496 122678 - -0.22 9.35E-01 0.22 9.46E-01 
SR0078 chr 124199 124250 + 1.09 3.49E-02 0.68 2.25E-01 
SR0079 chr 124286 124448 - 11.04 NA 0.21 NA 
SR0080 chr 125149 125221 - 0.05 9.89E-01 -0.18 9.63E-01 
SR0081 chr 125198 125273 + -0.29 6.08E-01 -0.98 1.21E-02 
SR0082 chr 127478 127578 + -0.32 5.66E-01 -0.52 2.52E-01 
SR0083 chr 128171 128250 + -0.48 5.76E-01 -0.62 4.41E-01 
SR0084 chr 129662 129711 + -0.40 4.70E-01 -0.24 7.20E-01 
SR0085 chr 131268 131657 + -0.27 9.33E-01 -0.76 6.19E-01 
SR0086 chr 131278 131327 - -0.19 9.89E-01 0.76 6.54E-01 
SR0087 chr 133785 133890 - 0.33 5.55E-01 -0.04 9.61E-01 
SR0088 chr 135801 135867 - -0.12 9.60E-01 0.36 6.50E-01 
SR0089 chr 138320 138376 + 0.13 8.86E-01 -1.30 2.24E-04 
SR0090 chr 139474 139594 - -0.66 3.04E-02 -0.08 9.37E-01 
SR0091 chr 139700 139749 - -0.99 1.83E-04 0.18 6.79E-01 
SR0092 chr 141357 141457 + -0.67 6.26E-02 0.25 6.13E-01 
SR0093 chr 141905 141949 - -0.59 3.23E-01 -0.42 5.37E-01 
SR0094 chr 147733 147826 + -0.03 9.89E-01 0.37 6.15E-01 
SR0095 chr 150850 150898 + -0.12 9.89E-01 0.20 9.59E-01 
SR0096 chr 153045 153130 + -0.11 9.51E-01 -0.84 6.66E-02 
SR0097 chr 153203 153431 - -0.60 1.63E-01 -0.38 4.36E-01 
SR0098 chr 153604 153707 - -0.38 5.89E-01 -0.99 4.84E-02 
SR0099 chr 155117 155163 + -0.84 1.05E-02 0.16 7.82E-01 
SR0100 chr 155608 155772 - 0.36 9.74E-01 0.51 9.42E-01 
SR0101 chr 156491 156609 + 0.05 9.89E-01 0.21 9.59E-01 
SR0102 chr 156950 156999 - 0.58 4.49E-01 0.36 7.02E-01 
SR0103 chr 157426 157486 + -0.20 9.79E-01 -1.07 4.60E-01 
SR0104 chr 157520 157585 - 0.81 1.61E-01 -0.67 2.44E-01 
SR0105 chr 158500 158713 + 0.50 4.64E-01 0.96 7.71E-02 
SR0106 chr 159827 159877 - 0.45 5.25E-01 -0.64 3.03E-01 
SR0107 chr 161458 161509 + -0.35 5.44E-01 -0.13 9.22E-01 
SR0108 chr 162724 162773 + -0.63 3.73E-01 0.39 6.42E-01 
SR0109 chr 163509 163702 - 0.40 9.30E-01 0.71 7.68E-01 
SR0110 chr 163976 164109 - 0.05 9.89E-01 0.21 9.59E-01 
SR0111 chr 164373 164418 + 0.25 7.13E-01 1.34 4.16E-04 
SR0112 chr 164713 164837 - 0.63 4.25E-01 1.30 3.43E-02 
SR0113 chr 165045 165094 + -0.37 5.81E-01 -0.18 8.72E-01 
SR0114 chr 165969 166048 + -0.44 5.96E-01 -0.32 7.41E-01 
SR0115 chr 166396 166655 - -0.33 9.58E-01 0.21 9.59E-01 
SR0116 chr 166523 166587 + -0.86 2.17E-01 -0.54 4.96E-01 
SR0117 chr 169306 169359 - 0.05 9.89E-01 0.21 9.59E-01 
SR0118 chr 170467 170544 + 0.05 9.89E-01 0.21 9.59E-01 
SR0119 chr 172501 172571 + -0.70 2.71E-01 -0.32 7.02E-01 
SR0120 chr 172728 172781 + -1.07 1.37E-01 0.09 9.59E-01 
SR0121 chr 172735 172869 - 0.28 9.83E-01 0.43 9.42E-01 
SR0122 chr 174087 174144 - -5.90 3.01E-02 -0.57 9.59E-01 
SR0123 chr 174394 174446 - 0.05 9.89E-01 0.21 9.59E-01 
SR0124 chr 175079 175128 + -0.14 9.65E-01 0.02 9.91E-01 
SR0125 chr 175626 175675 - -0.59 2.05E-01 -0.02 9.86E-01 
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SR0126 chr 176642 176691 + -1.15 9.13E-02 -1.31 3.88E-02 
SR0127 chr 177497 177688 + -0.75 6.73E-02 -0.50 2.56E-01 
SR0128 chr 178637 178735 - 0.05 9.89E-01 0.21 9.59E-01 
SR0129 chr 180386 180435 + -0.80 4.61E-03 -0.41 1.98E-01 
SR0130 chr 180392 180485 - 0.05 9.89E-01 0.21 9.59E-01 
SR0131 chr 181560 181679 - -0.55 9.16E-01 -0.04 9.91E-01 
SR0132 chr 181625 181673 + -1.50 4.87E-03 -0.28 7.66E-01 
SR0133 chr 182747 182807 - -0.97 7.20E-01 0.02 9.97E-01 
SR0134 chr 185485 185535 - -0.09 9.73E-01 -0.78 1.29E-01 
SR0135 chr 188410 188493 + -0.04 9.89E-01 0.22 7.59E-01 
SR0136 chr 188520 188701 - -0.13 9.09E-01 0.40 4.47E-01 
SR0137 chr 190061 190170 + -0.53 3.12E-01 0.63 1.92E-01 
SR0138 chr 190996 191046 + 0.05 9.89E-01 0.21 9.59E-01 
SR0139 chr 191060 191137 - -0.24 9.55E-01 -0.34 9.05E-01 
SR0140 chr 191997 192046 + -0.49 2.03E-01 0.29 5.23E-01 
SR0141 chr 192094 192147 + -0.64 3.12E-01 0.23 8.20E-01 
SR0142 chr 193336 193454 - -0.22 9.83E-01 0.21 9.59E-01 
SR0143 chr 193545 193597 - -0.45 6.94E-01 1.23 1.12E-01 
SR0144 chr 193707 193829 + 0.15 8.93E-01 0.29 6.61E-01 
SR0145 chr 196151 196257 + 0.54 9.14E-01 -0.51 9.47E-01 
SR0146 chr 196508 196630 + -0.39 9.79E-01 0.20 9.59E-01 
SR0147 chr 198376 198426 + -0.78 4.67E-01 0.00 9.98E-01 
SR0148 chr 198383 198576 - -0.41 7.30E-01 0.80 3.72E-01 
SR0149 chr 198658 198723 + -1.30 3.87E-01 0.20 9.59E-01 
SR0150 chr 202693 202761 + -0.09 9.89E-01 -0.20 9.42E-01 
SR0151 chr 202719 202824 - 0.17 9.88E-01 0.76 6.03E-01 
SR0152 chr 202958 203156 - 0.16 8.76E-01 0.78 9.30E-02 
SR0153 chr 203288 203350 + 0.05 9.89E-01 0.21 9.59E-01 
SR0154 chr 203424 203534 + -0.06 9.89E-01 0.40 8.67E-01 
SR0155 chr 204592 204663 - -0.81 5.73E-02 -0.48 3.12E-01 
SR0156 chr 204893 205094 - -0.85 7.78E-02 -0.68 1.65E-01 
SR0157 chr 205092 205165 + 0.52 5.66E-01 -0.40 7.00E-01 
SR0158 chr 205346 205395 - 0.12 9.32E-01 -0.46 4.15E-01 
SR0159 chr 206320 206382 + 0.25 9.44E-01 0.92 4.48E-01 
SR0160 chr 206428 206477 + 0.09 9.89E-01 0.95 4.64E-01 
SR0161 chr 207461 207628 + -0.22 9.56E-01 -0.62 6.89E-01 
SR0162 chr 208143 208283 - 0.03 9.89E-01 0.71 6.67E-01 
SR0163 chr 210616 210744 - 0.33 7.84E-01 -0.52 6.19E-01 
SR0164 chr 210844 210892 - 1.01 5.27E-01 -0.16 9.59E-01 
SR0165 chr 211234 211296 + 0.84 2.40E-01 2.05 1.75E-04 
SR0166 chr 215154 215257 - 0.29 6.99E-01 -0.84 1.03E-01 
SR0167 chr 216448 216606 - 0.84 1.86E-02 -0.46 2.56E-01 
SR0168 chr 218334 218546 + -0.13 8.79E-01 1.31 7.14E-05 
SR0169 chr 219103 219154 - 0.05 9.89E-01 0.21 9.59E-01 
SR0170 chr 221344 221442 + 0.46 9.60E-01 1.21 6.89E-01 
SR0171 chr 221936 222147 - 0.05 9.89E-01 -0.80 3.41E-02 
SR0172 chr 222564 222703 + -0.96 7.74E-01 -0.05 9.91E-01 
SR0173 chr 223054 223124 - -0.10 9.39E-01 -1.36 1.97E-04 
SR0174 chr 223525 223661 + 0.05 9.89E-01 1.21 6.95E-01 
SR0175 chr 223659 223775 - -0.19 7.75E-01 -0.03 9.74E-01 
SR0176 chr 226905 227203 - -1.08 NA -0.94 NA 
SR0177 chr 229214 229308 + -0.69 8.84E-01 0.21 9.59E-01 
SR0178 chr 230033 230116 + 0.05 9.89E-01 0.21 9.59E-01 
SR0179 chr 230783 230894 + -0.70 2.79E-01 -0.63 3.23E-01 
SR0180 chr 231582 231652 + -0.59 5.82E-01 0.48 6.82E-01 
SR0181 chr 231828 231887 - -0.05 9.89E-01 0.62 2.92E-01 
SR0182 chr 232846 232933 + 0.05 9.89E-01 0.21 9.59E-01 
SR0183 chr 232863 232952 - -0.14 9.44E-01 -0.31 7.31E-01 
SR0184 chr 233547 233669 - -0.15 9.50E-01 -0.54 4.97E-01 
SR0185 chr 242397 242495 + -0.92 1.64E-01 -0.28 7.80E-01 
SR0186 chr 245945 246070 - -2.50 2.16E-21 2.64 5.11E-24 
SR0187 chr 246367 246464 - -3.15 3.01E-33 2.35 5.02E-21 
SR0188 chr 250167 250293 - -0.84 4.99E-01 -0.50 7.45E-01 
SR0189 chr 250385 250467 + -1.16 4.61E-03 -0.01 9.92E-01 
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SR0190 chr 253091 253141 + -0.09 9.89E-01 -0.44 6.58E-01 
SR0191 chr 254196 254320 - -0.44 2.85E-01 -0.77 2.27E-02 
SR0192 chr 254551 254701 - -0.55 4.07E-01 -0.83 1.47E-01 
SR0193 chr 255970 256097 - -0.01 9.93E-01 0.32 5.51E-01 
SR0194 chr 256281 256345 + 0.56 4.32E-01 0.16 9.42E-01 
SR0195 chr 257052 257123 + 0.05 9.89E-01 0.21 9.59E-01 
SR0196 chr 260581 260796 - 0.06 9.89E-01 -1.22 7.17E-03 
SR0197 chr 260769 260852 + -0.17 8.71E-01 -0.16 8.90E-01 
SR0198 chr 261078 261149 - -0.26 7.81E-01 0.18 8.95E-01 
SR0199 chr 263683 263729 - -0.04 9.89E-01 0.87 6.10E-01 
SR0200 chr 263804 263906 + -0.79 4.02E-01 -0.88 3.24E-01 
SR0201 chr 266747 266799 - -1.06 5.68E-02 -0.42 5.73E-01 
SR0202 chr 267703 267868 - 0.02 9.89E-01 -0.61 1.96E-01 
SR0203 chr 269511 269626 + -1.50 9.38E-03 -0.03 9.78E-01 
SR0204 chr 270114 270175 + -1.00 1.19E-01 -0.63 3.76E-01 
SR0205 chr 273744 273890 + 0.08 9.89E-01 0.21 8.67E-01 
SR0206 chr 274374 274472 - 0.31 6.51E-01 0.43 4.66E-01 
SR0207 chr 276164 276260 + -0.69 8.84E-01 0.21 9.59E-01 
SR0208 chr 276500 276617 + -0.59 2.45E-01 0.26 6.99E-01 
SR0209 chr 278453 278546 - 0.05 9.89E-01 0.21 9.59E-01 
SR0210 chr 280235 280355 - 0.33 9.80E-01 -0.51 9.48E-01 
SR0211 chr 282150 282250 - 0.05 9.89E-01 0.21 9.59E-01 
SR0212 chr 282439 282511 + -0.44 2.57E-01 -0.45 2.28E-01 
SR0213 chr 288401 288487 + -0.97 1.15E-01 -0.84 1.70E-01 
SR0214 chr 291828 291928 - 0.05 9.89E-01 0.21 9.59E-01 
SR0215 chr 295449 295594 - 0.01 9.99E-01 12.38 1.22E-09 
SR0216 chr 297224 297342 + 0.24 7.26E-01 -0.41 4.50E-01 
SR0217 chr 299204 299253 + 0.14 9.17E-01 -0.14 9.20E-01 
SR0218 chr 300174 300223 + -0.52 2.88E-01 -0.66 1.36E-01 
SR0219 chr 301612 301771 - -0.17 9.89E-01 0.20 9.59E-01 
SR0220 chr 308247 308372 - -0.71 8.75E-01 0.46 9.48E-01 
SR0221 chr 308446 308496 - 0.05 9.89E-01 0.21 9.59E-01 
SR0222 chr 311513 311609 + -0.67 9.45E-02 -0.32 5.19E-01 
SR0223 chr 311567 311681 - -0.64 4.57E-01 0.29 8.20E-01 
SR0224 chr 312010 312115 - 0.49 9.57E-01 0.64 9.22E-01 
SR0225 chr 317317 317439 - -0.09 9.89E-01 0.55 7.80E-01 
SR0226 chr 320204 320287 - 0.09 9.83E-01 0.68 2.19E-01 
SR0227 chr 320801 320869 - -0.30 7.30E-01 0.12 9.59E-01 
SR0228 chr 322977 323052 + -0.64 2.83E-01 -0.12 9.59E-01 
SR0229 chr 323316 323394 - 0.44 9.68E-01 0.21 9.59E-01 
SR0230 chr 324885 324951 + -0.93 1.21E-01 -0.38 6.38E-01 
SR0231 chr 327363 327412 - 0.05 9.89E-01 0.21 9.59E-01 
SR0232 chr 327661 327819 - 0.17 9.33E-01 0.50 5.59E-01 
SR0233 chr 327895 328102 + -0.36 4.95E-01 1.10 3.15E-03 
SR0234 chr 328956 329015 + 0.05 9.89E-01 0.21 9.59E-01 
SR0235 chr 330430 330515 - 0.05 9.89E-01 0.21 9.59E-01 
SR0236 chr 331681 331751 - 0.05 9.89E-01 0.21 9.59E-01 
SR0237 chr 331733 331782 + -0.96 1.63E-01 -1.01 1.18E-01 
SR0238 chr 331922 332039 + -0.85 9.45E-02 -0.77 1.19E-01 
SR0239 chr 333152 333242 - 0.05 9.89E-01 0.21 9.59E-01 
SR0240 chr 333808 333888 - -0.29 9.89E-01 0.21 9.59E-01 
SR0241 chr 334587 334654 - -0.90 8.92E-02 0.53 3.76E-01 
SR0242 chr 334785 334835 + -0.68 8.85E-02 0.83 1.78E-02 
SR0243 chr 335529 335578 - -0.64 1.86E-01 0.58 2.20E-01 
SR0244 chr 336511 336565 + -1.02 4.74E-02 0.81 1.18E-01 
SR0245 chr 338243 338293 + -1.59 1.49E-03 0.80 1.18E-01 
SR0246 chr 340302 340576 + -1.02 2.09E-03 5.23 1.10E-92 
SR0247 chr 340555 340650 - -1.01 1.07E-02 0.39 4.42E-01 
SR0248 chr 344861 344909 + -0.29 6.56E-01 0.89 4.12E-02 
SR0249 chr 344889 345010 - -0.21 7.74E-01 0.61 1.83E-01 
SR0250 chr 350380 350449 + -0.29 7.21E-01 -0.15 9.16E-01 
SR0251 chr 355027 355371 - -0.03 9.89E-01 1.19 1.81E-01 
SR0252 chr 356175 356224 - -1.03 2.03E-01 0.35 7.46E-01 
SR0253 chr 356987 357118 + 0.98 5.36E-02 -0.14 9.36E-01 
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SR0254 chr 358532 358589 - 1.36 1.12E-02 -0.78 2.15E-01 
SR0255 chr 361001 361145 - 0.02 9.89E-01 -0.22 7.96E-01 
SR0256 chr 361193 361301 + 2.43 2.70E-01 2.18 3.21E-01 
SR0257 chr 362663 362714 - 0.05 9.89E-01 0.21 9.59E-01 
SR0258 chr 365828 365879 - -0.41 5.87E-01 0.45 5.47E-01 
SR0259 chr 365936 365986 + -0.61 6.03E-01 -0.11 9.59E-01 
SR0260 chr 366768 366819 - 0.05 9.89E-01 0.21 9.59E-01 
SR0261 chr 367895 368055 - -0.98 6.99E-03 0.44 3.09E-01 
SR0262 chr 368492 368541 - -0.50 5.55E-01 -0.23 8.67E-01 
SR0263 chr 369675 369724 - -0.45 4.32E-01 -1.00 2.65E-02 
SR0264 chr 373474 373545 + -1.38 1.09E-01 -1.69 3.23E-02 
SR0265 chr 373995 374099 - 0.05 9.89E-01 0.21 9.59E-01 
SR0266 chr 376548 376623 - -0.35 9.89E-01 -0.18 9.63E-01 
SR0267 chr 376795 376859 - 0.05 9.89E-01 0.21 9.59E-01 
SR0268 chr 380045 380094 + -0.80 2.04E-01 -0.44 5.68E-01 
SR0269 chr 380332 380478 - 0.05 9.89E-01 0.21 9.59E-01 
SR0270 chr 384156 384208 - -1.10 2.92E-01 1.55 6.87E-02 
SR0271 chr 388256 388442 - -0.38 4.43E-01 0.83 3.07E-02 
SR0272 chr 389852 390012 + -0.61 1.29E-01 0.63 9.50E-02 
SR0273 chr 391800 391853 - -1.19 1.50E-02 0.35 6.12E-01 
SR0274 chr 392496 392605 - 0.05 9.89E-01 0.95 8.05E-01 
SR0275 chr 394443 394499 - 0.05 9.89E-01 0.21 9.59E-01 
SR0276 chr 394805 394853 + 0.44 1.49E-01 1.28 3.57E-08 
SR0277 chr 395312 395387 - -0.40 6.78E-01 1.76 2.89E-03 
SR0278 chr 396334 396428 + 0.34 7.33E-01 1.56 8.54E-03 
SR0279 chr 399917 400036 + -0.40 5.99E-01 -1.12 3.69E-02 
SR0280 chr 401309 401358 + -0.42 5.27E-01 -0.76 1.44E-01 
SR0281 chr 402480 402558 - -0.42 5.27E-01 -0.69 2.11E-01 
SR0282 chr 405124 405404 - 0.03 9.89E-01 -0.37 4.16E-01 
SR0283 chr 408120 408192 - -0.04 9.89E-01 0.87 2.80E-01 
SR0284 chr 408412 408480 - 0.37 6.06E-01 1.61 4.76E-04 
SR0285 chr 408662 408711 - 0.05 9.89E-01 0.21 9.59E-01 
SR0286 chr 408989 409048 - 0.05 9.89E-01 0.21 9.59E-01 
SR0287 chr 409131 409240 - -0.35 9.89E-01 -0.18 9.63E-01 
SR0288 chr 409907 409957 + -0.28 6.06E-01 -0.27 6.31E-01 
SR0289 chr 409907 409970 - 0.05 9.89E-01 0.21 9.59E-01 
SR0290 chr 410343 410463 - 0.20 9.55E-01 0.27 9.13E-01 
SR0291 chr 410714 410810 + -0.57 7.34E-01 -0.46 8.18E-01 
SR0292 chr 413076 413126 + -0.62 3.53E-01 0.08 9.59E-01 
SR0293 chr 413744 413790 - -0.49 6.62E-01 -0.20 9.42E-01 
SR0294 chr 413807 413899 + 0.05 9.89E-01 0.21 9.59E-01 
SR0295 chr 414168 414264 - -0.03 9.89E-01 -0.19 8.17E-01 
SR0296 chr 416521 416589 - -0.37 8.10E-01 0.35 8.27E-01 
SR0297 chr 416920 416986 + 0.05 9.89E-01 0.21 9.59E-01 
SR0298 chr 417750 417820 + 0.05 9.89E-01 0.21 9.59E-01 
SR0299 chr 418364 418432 - -1.29 3.43E-01 -0.95 5.30E-01 
SR0300 chr 418627 418694 + -0.52 5.57E-01 -0.18 9.35E-01 
SR0301 chr 419241 419465 - 0.05 9.89E-01 0.21 9.59E-01 
SR0302 chr 421545 421607 + -0.14 9.89E-01 0.23 9.59E-01 
SR0303 chr 421685 421769 - -0.95 2.10E-01 -1.37 3.91E-02 
SR0304 chr 423176 423275 + 0.05 9.89E-01 0.21 9.59E-01 
SR0305 chr 423518 423638 - -1.01 1.24E-01 -1.70 2.38E-03 
SR0306 chr 423712 423769 + 0.05 9.89E-01 0.21 9.59E-01 
SR0307 chr 424041 424108 - 0.05 9.89E-01 0.21 9.59E-01 
SR0308 chr 425565 425704 + 0.22 8.63E-01 0.02 9.89E-01 
SR0309 chr 428415 428516 - -0.39 5.41E-01 -1.28 3.34E-03 
SR0310 chr 428554 428603 + 0.64 8.79E-01 0.78 8.26E-01 
SR0311 chr 428764 428818 + 0.05 9.89E-01 0.21 9.59E-01 
SR0312 chr 428973 429036 + 0.05 9.89E-01 0.21 9.59E-01 
SR0313 chr 429728 429863 - 0.05 9.89E-01 -0.04 9.91E-01 
SR0314 chr 433843 433896 - 0.05 9.89E-01 0.21 9.59E-01 
SR0315 chr 434558 434622 + -0.24 8.73E-01 -0.44 6.62E-01 
SR0316 chr 435208 435431 - -0.36 8.02E-01 0.10 9.59E-01 
SR0317 chr 435602 435653 + 0.05 9.89E-01 0.21 9.59E-01 
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SR0318 chr 438217 438308 - 0.81 7.39E-01 1.15 5.92E-01 
SR0319 chr 438345 438393 - 0.46 8.27E-01 0.28 9.48E-01 
SR0320 chr 438439 438555 - -0.53 6.87E-01 0.09 9.59E-01 
SR0321 chr 441461 441555 - 0.81 7.38E-01 1.14 5.95E-01 
SR0322 chr 442772 442838 + -0.62 2.03E-01 -0.18 8.20E-01 
SR0323 chr 442926 443036 - 0.05 9.89E-01 0.21 9.59E-01 
SR0324 chr 443571 443751 + -1.58 9.88E-04 1.53 1.06E-03 
SR0325 chr 444341 444409 - -0.94 8.85E-02 0.71 2.08E-01 
SR0326 chr 444712 444783 + 10.48 3.57E-12 0.21 9.59E-01 
SR0327 chr 445010 445082 + 0.05 9.89E-01 0.21 9.59E-01 
SR0328 chr 445300 445350 + 0.05 9.89E-01 0.21 9.59E-01 
SR0329 chr 445765 445810 + 0.05 9.89E-01 0.21 9.59E-01 
SR0330 chr 446158 446220 - 1.02 2.34E-01 1.43 5.32E-02 
SR0331 chr 450390 450524 + -0.73 2.39E-01 0.01 9.91E-01 
SR0332 chr 451393 451459 + 1.47 1.66E-02 0.15 9.59E-01 
SR0333 chr 453539 453684 - 0.05 9.89E-01 0.21 9.59E-01 
SR0334 chr 454709 454759 - 0.05 9.89E-01 0.21 9.59E-01 
SR0335 chr 455085 455211 - 0.05 9.89E-01 0.21 9.59E-01 
SR0336 chr 456465 456514 - 0.33 9.60E-01 1.23 5.59E-01 
SR0337 chr 456784 456906 + 0.05 9.89E-01 0.21 9.59E-01 
SR0338 chr 457121 457196 - -0.22 6.89E-01 -0.49 2.41E-01 
SR0339 chr 457281 457455 + 0.05 9.89E-01 0.04 9.90E-01 
SR0340 chr 461704 461802 + -0.44 2.50E-01 -0.47 1.92E-01 
SR0341 chr 465040 465110 - 0.18 8.07E-01 1.08 2.99E-03 
SR0342 chr 466347 466447 + 0.30 5.27E-01 -0.82 1.83E-02 
SR0343 chr 466545 466608 + 0.16 8.07E-01 -0.55 1.69E-01 
SR0344 chr 466678 466756 + -0.02 9.89E-01 -0.95 8.69E-03 
SR0345 chr 467849 467895 + -0.53 4.97E-01 -1.89 5.06E-04 
SR0346 chr 469260 469381 - 0.04 9.89E-01 -0.12 9.76E-01 
SR0347 chr 472002 472086 + -0.47 6.89E-01 -1.82 1.40E-02 
SR0348 chr 472138 472210 - 0.05 9.89E-01 0.21 9.59E-01 
SR0349 chr 473672 473837 - 1.66 3.35E-01 -0.34 9.59E-01 
SR0350 chr 474517 474567 - 0.70 5.08E-01 1.14 1.83E-01 
SR0351 chr 475638 475711 + 0.05 9.89E-01 0.21 9.59E-01 
SR0352 chr 476272 476353 + -0.21 7.82E-01 -0.59 2.49E-01 
SR0353 chr 477474 477631 - -0.22 9.84E-01 0.20 9.59E-01 
SR0354 chr 477997 478112 - 0.31 7.19E-01 0.70 2.51E-01 
SR0355 chr 478971 479147 + -0.02 9.89E-01 -0.27 7.00E-01 
SR0356 chr 481083 481153 + -0.06 9.89E-01 -0.10 9.59E-01 
SR0357 chr 481228 481305 + 0.74 2.34E-01 0.51 4.66E-01 
SR0358 chr 481249 481318 - 0.66 4.68E-01 0.57 5.71E-01 
SR0359 chr 482082 482232 + -1.08 9.41E-02 1.29 2.56E-02 
SR0360 chr 482310 482392 + -1.07 6.67E-02 -0.96 9.61E-02 
SR0361 chr 483222 483283 - -0.62 4.32E-01 -0.89 2.02E-01 
SR0362 chr 484023 484080 + 0.05 9.89E-01 0.21 9.59E-01 
SR0363 chr 485379 485426 - -0.05 9.89E-01 0.41 7.20E-01 
SR0364 chr 486427 486520 - -0.35 5.48E-01 0.06 9.59E-01 
SR0365 chr 486555 486748 + 0.05 9.89E-01 -0.05 9.74E-01 
SR0366 chr 486834 486997 - 0.61 2.34E-01 0.43 4.48E-01 
SR0367 chr 487719 487810 + 1.11 6.59E-01 -0.51 9.47E-01 
SR0368 chr 487914 487967 + 0.05 9.89E-01 0.21 9.59E-01 
SR0369 chr 489099 489172 - -0.64 1.86E-01 -0.35 5.47E-01 
SR0370 chr 489870 489959 + 0.05 9.89E-01 0.21 9.59E-01 
SR0371 chr 489929 489976 - -0.56 5.21E-01 -0.72 3.58E-01 
SR0372 chr 490076 490126 - -0.69 3.97E-01 -0.30 7.97E-01 
SR0373 chr 490253 490308 - -0.74 1.28E-01 -0.27 6.91E-01 
SR0374 chr 490647 490735 + -0.39 9.80E-01 -0.22 9.59E-01 
SR0375 chr 493394 493458 + 0.05 9.89E-01 0.21 9.59E-01 
SR0376 chr 493684 493730 + 0.05 9.89E-01 0.21 9.59E-01 
SR0377 chr 494638 494724 - -0.24 9.84E-01 0.99 5.99E-01 
SR0378 chr 494853 494903 + -0.32 5.69E-01 -0.02 9.79E-01 
SR0379 chr 497126 497205 + -0.39 9.73E-01 0.78 8.33E-01 
SR0380 chr 498841 498951 + 0.05 9.89E-01 0.21 9.59E-01 
SR0381 chr 503510 503626 - 0.15 8.63E-01 -0.08 9.59E-01 
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SR0382 chr 503545 503643 + 0.02 9.95E-01 0.78 8.31E-01 
SR0383 chr 506700 506896 + 0.63 3.14E-01 0.44 5.45E-01 
SR0384 chr 507041 507097 + 0.05 9.89E-01 0.21 9.59E-01 
SR0385 chr 507280 507483 - 0.14 8.91E-01 0.27 6.62E-01 
SR0386 chr 507662 507809 + -0.58 1.38E-01 0.02 9.76E-01 
SR0387 chr 511358 511498 + 0.26 9.89E-01 0.21 9.59E-01 
SR0388 chr 513075 513177 - -0.31 7.26E-01 0.16 9.16E-01 
SR0389 chr 513193 513273 + -1.23 8.95E-04 -0.62 1.37E-01 
SR0390 chr 514927 514976 - -1.08 3.38E-02 -0.67 2.20E-01 
SR0391 chr 515495 515559 + 0.05 9.89E-01 0.21 9.59E-01 
SR0392 chr 515629 515807 + -0.83 1.21E-01 -2.18 2.70E-07 
SR0393 chr 518453 518590 + -0.24 9.89E-01 -0.37 9.59E-01 
SR0394 chr 521556 521775 + 0.05 9.89E-01 0.21 9.59E-01 
SR0395 chr 523418 523524 + -0.39 4.55E-01 -1.01 9.39E-03 
SR0396 chr 526293 526449 + -0.50 3.79E-01 -1.82 5.61E-06 
SR0397 chr 530238 530287 + -0.37 7.72E-01 -1.26 1.09E-01 
SR0398 chr 530686 530827 - 0.05 9.89E-01 0.21 9.59E-01 
SR0399 chr 531636 531704 - 0.04 9.89E-01 1.68 2.15E-02 
SR0400 chr 532157 532282 - 0.14 9.07E-01 0.69 1.29E-01 
SR0401 chr 534455 534504 - -0.41 6.33E-01 0.31 7.41E-01 
SR0402 chr 534793 534926 + -0.40 NA 4.05 NA 
SR0403 chr 542236 542328 + -0.34 6.58E-01 0.41 5.65E-01 
SR0404 chr 545088 545138 + 0.05 9.89E-01 0.21 9.59E-01 
SR0405 chr 547366 547581 + 0.15 9.57E-01 0.43 6.61E-01 
SR0406 chr 547385 547688 - 0.46 4.57E-01 0.71 1.83E-01 
SR0407 chr 547729 547797 - 0.34 8.79E-01 0.51 7.44E-01 
SR0408 chr 550265 550328 + -0.46 3.92E-01 -0.36 5.41E-01 
SR0409 chr 551645 551708 + -0.21 8.71E-01 0.15 9.50E-01 
SR0410 chr 551650 551769 - -0.46 6.30E-01 -0.17 9.48E-01 
SR0411 chr 551853 551903 - -0.41 8.09E-01 0.52 7.05E-01 
SR0412 chr 551933 552192 + 0.06 9.89E-01 2.41 2.68E-04 
SR0413 chr 552972 553062 - -0.10 9.52E-01 0.19 7.96E-01 
SR0414 chr 556204 556357 + 0.24 9.89E-01 -0.01 9.98E-01 
SR0415 chr 556404 556549 - 0.27 6.89E-01 0.01 9.92E-01 
SR0416 chr 559261 559321 + 0.47 4.54E-01 -1.30 6.82E-03 
SR0417 chr 561897 561958 - 1.31 4.40E-04 0.59 1.83E-01 
SR0418 chr 562185 562279 + 0.06 9.89E-01 -0.04 9.90E-01 
SR0419 chr 565644 565716 - 0.07 9.89E-01 0.02 9.89E-01 
SR0420 chr 565724 565773 + 0.75 5.27E-01 1.26 1.83E-01 
SR0421 chr 567939 568009 + 0.05 9.89E-01 0.21 9.59E-01 
SR0422 chr 568447 568633 + -0.43 5.59E-01 -0.27 7.69E-01 
SR0423 chr 568729 568781 + 0.05 9.89E-01 0.21 9.59E-01 
SR0424 chr 569067 569162 - -0.28 8.78E-01 0.69 5.03E-01 
SR0425 chr 570669 570777 + 0.33 9.80E-01 -0.51 9.48E-01 
SR0426 chr 571781 571854 + -0.30 9.33E-01 1.14 3.41E-01 
SR0427 chr 571797 571905 - -0.06 9.60E-01 0.59 4.24E-02 
SR0428 chr 572892 572943 + -0.05 9.89E-01 -0.37 6.46E-01 
SR0429 chr 577156 577205 + -1.83 1.13E-02 0.14 9.59E-01 
SR0430 chr 581323 581411 + 0.05 9.89E-01 0.21 9.59E-01 
SR0431 chr 581843 581933 - 0.11 9.19E-01 -0.17 7.97E-01 
SR0432 chr 584094 584193 - 0.08 9.89E-01 -0.13 9.59E-01 
SR0433 chr 585174 585253 - -0.20 7.36E-01 0.23 6.67E-01 
SR0434 chr 586204 586314 + -0.59 3.63E-01 -0.64 2.92E-01 
SR0435 chr 587261 587358 - -0.76 2.33E-01 0.43 5.61E-01 
SR0436 chr 589486 589627 + -0.18 9.89E-01 -0.01 9.98E-01 
SR0437 chr 589788 589912 - -1.78 NA -0.92 NA 
SR0438 chr 589932 589982 + -1.04 5.83E-02 0.11 9.59E-01 
SR0439 chr 590184 590242 - -1.30 3.08E-01 0.08 9.62E-01 
SR0440 chr 590903 590952 + 0.35 9.33E-01 0.59 8.01E-01 
SR0441 chr 592484 592635 + 0.44 8.23E-01 0.21 9.59E-01 
SR0442 chr 593038 593115 - 0.55 3.39E-01 -0.86 7.74E-02 
SR0443 chr 594023 594072 - 0.63 1.13E-01 0.05 9.59E-01 
SR0444 chr 596314 596485 + 0.29 9.26E-01 0.12 9.59E-01 
SR0445 chr 596343 596440 - 0.17 7.85E-01 -0.22 7.11E-01 
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SR0446 chr 596709 596787 - 0.42 5.27E-01 0.25 7.65E-01 
SR0447 chr 598507 598751 + -0.95 6.90E-02 -0.08 9.59E-01 
SR0448 chr 598753 598831 - 0.05 9.89E-01 0.21 9.59E-01 
SR0449 chr 600136 600203 + 0.05 9.89E-01 0.21 9.59E-01 
SR0450 chr 600593 600717 - -0.67 8.66E-02 0.60 1.15E-01 
SR0451 chr 600874 600966 + -1.24 3.51E-02 0.18 9.11E-01 
SR0452 chr 602840 602916 - 0.24 6.55E-01 0.38 4.01E-01 
SR0453 chr 603273 603343 - 0.78 2.10E-01 -0.55 4.36E-01 
SR0454 chr 604095 604190 + -0.16 9.72E-01 -1.09 2.61E-01 
SR0455 chr 604762 604807 - -0.12 9.89E-01 -0.51 7.41E-01 
SR0456 chr 604914 605000 - 0.05 9.89E-01 0.80 7.53E-01 
SR0457 chr 605915 605979 + -0.34 5.42E-01 -1.02 1.09E-02 
SR0458 chr 606945 607277 + 0.73 1.69E-01 0.97 3.58E-02 
SR0459 chr 607624 607706 - 1.05 2.94E-02 0.79 1.11E-01 
SR0460 chr 609985 610065 + 0.36 4.57E-01 0.23 7.00E-01 
SR0461 chr 610243 610352 + 0.04 9.89E-01 0.26 6.79E-01 
SR0462 chr 611309 611375 + 0.05 9.89E-01 0.21 9.59E-01 
SR0463 chr 613830 614008 + -0.17 9.35E-01 0.03 9.84E-01 
SR0464 chr 614003 614066 - 0.07 9.89E-01 -0.05 9.64E-01 
SR0465 chr 614136 614219 + 0.12 8.65E-01 -0.04 9.59E-01 
SR0466 chr 615492 615541 + -0.17 8.11E-01 0.23 6.84E-01 
SR0467 chr 618247 618551 - 0.26 9.57E-01 0.41 8.69E-01 
SR0468 chr 620161 620224 - -0.02 9.89E-01 0.32 9.22E-01 
SR0469 chr 620762 620844 - 0.66 2.19E-01 0.39 5.40E-01 
SR0470 chr 621047 621113 + 0.39 6.16E-01 0.28 7.68E-01 
SR0471 chr 621537 621624 - 0.05 9.89E-01 0.21 9.59E-01 
SR0472 chr 621854 621957 - 2.60 2.59E-02 -0.43 8.98E-01 
SR0473 chr 621952 622120 + -1.61 7.63E-02 0.47 7.27E-01 
SR0474 chr 623117 623203 + 0.11 9.89E-01 0.01 9.98E-01 
SR0475 chr 623333 623436 + 0.05 9.89E-01 0.21 9.59E-01 
SR0476 chr 623903 623952 - -0.98 1.84E-01 -0.50 5.89E-01 
SR0477 chr 627097 627398 - 0.05 9.89E-01 0.33 9.39E-01 
SR0478 chr 630426 630475 + -0.15 9.37E-01 -0.95 1.03E-01 
SR0479 chr 630577 630626 + -0.14 9.57E-01 -0.38 7.00E-01 
SR0480 chr 631726 631866 + 0.05 9.89E-01 0.21 9.59E-01 
SR0481 chr 631929 631984 - 0.02 9.89E-01 1.07 3.56E-04 
SR0482 chr 632527 632645 + 0.05 9.89E-01 0.21 9.59E-01 
SR0483 chr 633099 633148 - -0.82 4.08E-01 0.30 8.57E-01 
SR0484 chr 633827 633895 - -0.30 7.81E-01 -0.03 9.78E-01 
SR0485 chr 634371 634506 - -0.79 3.01E-01 -0.99 1.50E-01 
SR0486 chr 636099 636222 + -0.63 4.58E-01 0.75 3.09E-01 
SR0487 chr 636248 636296 + -0.23 9.67E-01 0.78 5.93E-01 
SR0488 chr 636396 636446 + 0.19 8.14E-01 0.56 2.26E-01 
SR0489 chr 636481 636548 + 0.20 8.72E-01 0.33 7.00E-01 
SR0490 chr 638067 638272 + 0.05 9.89E-01 0.43 9.42E-01 
SR0491 chr 638645 638847 - 0.36 3.28E-01 0.48 1.42E-01 
SR0492 chr 639796 639887 - -0.12 9.33E-01 -0.57 2.56E-01 
SR0493 chr 640167 640372 - -0.45 5.81E-01 -0.54 4.81E-01 
SR0494 chr 643117 643283 - 0.63 1.86E-01 0.64 1.55E-01 
SR0495 chr 645028 645102 + 0.05 9.89E-01 0.21 9.59E-01 
SR0496 chr 645285 645347 + -0.28 8.31E-01 -0.30 8.10E-01 
SR0497 chr 645584 645633 - -1.15 1.67E-01 0.92 2.65E-01 
SR0498 chr 645671 645817 + 0.54 3.91E-01 0.97 5.43E-02 
SR0499 chr 646212 646266 + 0.05 9.89E-01 0.21 9.59E-01 
SR0500 chr 646576 646662 - 0.70 2.42E-01 -0.31 7.04E-01 
SR0501 chr 647338 647424 + 0.23 8.38E-01 0.36 6.74E-01 
SR0502 chr 647833 647946 + 0.52 2.74E-01 0.17 8.23E-01 
SR0503 chr 648464 648534 + -0.10 9.89E-01 0.30 8.95E-01 
SR0504 chr 649059 649139 - -0.24 8.75E-01 -0.69 4.08E-01 
SR0505 chr 649984 650122 + -1.12 1.91E-01 -0.63 5.38E-01 
SR0506 chr 650666 650715 + -0.39 5.78E-01 0.19 8.67E-01 
SR0507 chr 651673 651718 - 0.05 9.89E-01 0.21 9.59E-01 
SR0508 chr 652809 652858 + -0.72 5.89E-01 -0.81 5.55E-01 
SR0509 chr 653384 653520 + -0.76 4.37E-01 -0.90 3.27E-01 
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SR0510 chr 656299 656348 + 0.05 9.89E-01 0.21 9.59E-01 
SR0511 chr 656942 657012 + -1.54 NA -1.63 NA 
SR0512 chr 656988 657108 - 0.86 5.32E-01 0.68 6.62E-01 
SR0513 chr 657818 657937 - 1.36 2.18E-02 1.02 9.32E-02 
SR0514 chr 658746 658855 - 1.45 4.57E-03 0.91 9.61E-02 
SR0515 chr 658876 658925 + 0.13 9.89E-01 -0.07 9.64E-01 
SR0516 chr 659033 659089 + 0.05 9.89E-01 0.21 9.59E-01 
SR0517 chr 659351 659545 + -0.02 9.89E-01 -0.54 7.97E-01 
SR0518 chr 661247 661377 - 0.30 9.83E-01 -0.35 9.59E-01 
SR0519 chr 661545 661641 + -0.52 8.30E-01 0.47 8.40E-01 
SR0520 chr 662542 662591 + -2.93 6.62E-06 -1.59 2.63E-02 
SR0521 chr 663063 663145 - -3.65 1.16E-08 0.93 2.70E-01 
SR0522 chr 664859 664908 + -0.77 2.42E-01 0.99 7.95E-02 
SR0523 chr 665387 665539 - -0.18 9.89E-01 -0.01 9.98E-01 
SR0524 chr 666067 666185 + -0.06 9.89E-01 -2.30 1.22E-05 
SR0525 chr 666439 666489 + 0.20 9.51E-01 -1.13 2.40E-01 
SR0526 chr 667291 667438 + 0.33 5.69E-01 -0.22 7.68E-01 
SR0527 chr 668891 668971 - 0.59 5.18E-01 -1.28 9.56E-02 
SR0528 chr 669766 669895 - -0.17 8.97E-01 -0.06 9.59E-01 
SR0529 chr 670619 670734 + -0.48 6.32E-01 -0.96 2.16E-01 
SR0530 chr 670942 670991 + -0.95 5.42E-01 -0.77 6.55E-01 
SR0531 chr 671334 671395 - 0.51 8.20E-01 -0.82 6.63E-01 
SR0532 chr 671661 671715 - -0.16 9.89E-01 -0.41 8.95E-01 
SR0533 chr 671922 672069 - 1.49 5.66E-01 0.63 9.13E-01 
SR0534 chr 672027 672174 + -0.48 4.39E-01 -0.20 8.42E-01 
SR0535 chr 673237 673391 + -0.68 7.00E-02 -0.43 2.85E-01 
SR0536 chr 674248 674349 + 0.05 9.89E-01 0.21 9.59E-01 
SR0537 chr 674835 674884 + -1.95 1.86E-06 -0.50 3.46E-01 
SR0538 chr 675672 675744 - -1.34 1.52E-04 0.19 7.69E-01 
SR0539 chr 676116 676165 - -0.52 4.70E-01 0.19 8.95E-01 
SR0540 chr 679320 679394 + -0.77 2.01E-01 -1.68 5.94E-04 
SR0541 chr 680433 680486 - 0.05 9.89E-01 0.21 9.59E-01 
SR0542 chr 681883 681994 + 0.96 6.42E-02 -0.06 9.59E-01 
SR0543 chr 681911 681991 - 0.05 9.89E-01 0.21 9.59E-01 
SR0544 chr 682376 682524 - 0.05 9.89E-01 0.78 5.37E-01 
SR0545 chr 684912 685001 + -1.59 8.58E-02 -1.07 2.77E-01 
SR0546 chr 686437 686562 - -0.02 9.89E-01 0.35 5.15E-01 
SR0547 chr 687870 687919 + 0.58 2.74E-01 -0.39 5.41E-01 
SR0548 chr 688222 688271 + -1.60 3.63E-01 0.17 9.59E-01 
SR0549 chr 688778 688888 - 1.06 4.64E-02 0.92 7.95E-02 
SR0550 chr 689567 689693 + 0.05 9.89E-01 0.21 9.59E-01 
SR0551 chr 689900 690151 + 0.60 2.31E-01 0.84 5.32E-02 
SR0552 chr 693165 693315 + 0.21 9.89E-01 0.37 9.46E-01 
SR0553 chr 693535 693613 - -0.58 2.30E-01 -0.13 9.11E-01 
SR0554 chr 693652 693717 + 0.05 9.89E-01 0.21 9.59E-01 
SR0555 chr 694649 694732 - -0.61 6.21E-01 -0.78 5.15E-01 
SR0556 chr 695610 695676 + 0.01 9.97E-01 1.06 7.45E-01 
SR0557 chr 696669 696840 + -1.46 5.26E-07 0.69 3.21E-02 
SR0558 chr 697843 697973 + -0.19 9.89E-01 0.56 8.61E-01 
SR0559 chr 699758 699987 - 7.80 2.03E-06 -0.36 9.59E-01 
SR0560 chr 700764 700817 + 0.22 7.12E-01 0.61 1.31E-01 
SR0561 chr 700871 700960 - 0.05 9.89E-01 0.11 9.59E-01 
SR0562 chr 702987 703052 + -0.39 8.40E-01 0.75 5.74E-01 
SR0563 chr 704005 704053 - -0.69 3.05E-01 0.48 5.19E-01 
SR0564 chr 706371 706618 + -0.40 7.82E-01 -0.08 9.59E-01 
SR0565 chr 708075 708215 - -0.46 3.19E-01 -1.18 7.76E-04 
SR0566 chr 708828 708901 + 0.05 9.89E-01 0.21 9.59E-01 
SR0567 chr 710037 710087 + 0.05 9.89E-01 0.21 9.59E-01 
SR0568 chr 711583 711679 - 0.23 7.79E-01 -1.15 1.17E-02 
SR0569 chr 712781 712830 + 1.08 1.16E-01 -0.05 9.69E-01 
SR0570 chr 713629 713680 + -0.75 2.31E-01 -0.76 2.02E-01 
SR0571 chr 713893 713942 - 0.05 9.89E-01 0.21 9.59E-01 
SR0572 chr 714601 714780 - 0.33 9.73E-01 0.92 7.33E-01 
SR0573 chr 714672 714720 + -0.90 1.73E-01 1.13 3.42E-02 
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SR0574 chr 715920 716128 + 0.38 9.74E-01 -0.20 9.59E-01 
SR0575 chr 719402 719450 - -0.11 9.27E-01 -0.98 1.30E-02 
SR0576 chr 719640 719782 + 0.05 9.89E-01 0.43 9.42E-01 
SR0577 chr 719819 719903 - -0.30 5.55E-01 -0.98 5.39E-03 
SR0578 chr 720645 720755 + 0.05 9.89E-01 0.21 9.59E-01 
SR0579 chr 722022 722071 - -0.36 4.57E-01 -1.01 3.78E-03 
SR0580 chr 722874 722936 + 0.05 9.89E-01 0.21 9.59E-01 
SR0581 chr 722994 723136 + -0.21 7.37E-01 -0.98 8.92E-03 
SR0582 chr 723012 723154 - -0.05 9.89E-01 -1.02 1.11E-03 
SR0583 chr 723986 724144 - 0.46 9.60E-01 1.20 7.00E-01 
SR0584 chr 724079 724129 + -0.15 9.88E-01 0.80 4.58E-01 
SR0585 chr 724200 724249 + 0.63 5.57E-01 -0.31 8.52E-01 
SR0586 chr 724342 724419 + 0.05 9.89E-01 0.21 9.59E-01 
SR0587 chr 727264 727353 - -0.23 8.07E-01 -0.81 1.50E-01 
SR0588 chr 729667 729792 - -0.90 2.25E-02 -0.09 9.56E-01 
SR0589 chr 730107 730159 + 0.05 9.89E-01 0.21 9.59E-01 
SR0590 chr 730515 730591 - 0.09 9.55E-01 0.00 9.98E-01 
SR0591 chr 731768 731852 + -0.23 9.14E-01 2.23 1.06E-03 
SR0592 chr 732148 732302 + 0.05 9.89E-01 -0.37 9.59E-01 
SR0593 chr 732568 732628 + 0.05 9.89E-01 0.21 9.59E-01 
SR0594 chr 732870 733019 + 0.04 9.89E-01 0.31 9.35E-01 
SR0595 chr 735317 735452 + 0.55 6.29E-01 0.21 9.47E-01 
SR0596 chr 735607 735720 + -0.23 9.89E-01 -0.04 9.91E-01 
SR0597 chr 737891 737969 - 0.23 6.69E-01 -0.36 4.29E-01 
SR0598 chr 738038 738268 + 0.40 3.91E-01 0.85 1.77E-02 
SR0599 chr 740426 740475 - 0.10 9.44E-01 -0.30 6.13E-01 
SR0600 chr 742120 742170 + 0.34 5.27E-01 0.21 7.68E-01 
SR0601 chr 742120 742223 - 0.01 9.97E-01 0.46 9.46E-01 
SR0602 chr 742438 742623 - -0.27 9.72E-01 0.22 9.59E-01 
SR0603 chr 742476 742541 + 0.14 9.28E-01 1.59 2.33E-04 
SR0604 chr 744349 744471 + 0.05 9.89E-01 0.21 9.59E-01 
SR0605 chr 744877 745005 + -1.14 6.14E-01 -0.25 9.59E-01 
SR0606 chr 745039 745097 + 1.19 2.73E-01 -0.70 6.18E-01 
SR0607 chr 745826 745919 - -0.92 5.29E-02 -1.05 1.70E-02 
SR0608 chr 747133 747384 + 0.16 8.23E-01 0.56 1.60E-01 
SR0609 chr 747667 747729 + -0.43 7.12E-01 0.00 9.98E-01 
SR0610 chr 747919 748025 + -0.03 9.89E-01 -0.69 5.26E-02 
SR0611 chr 749585 749708 + 0.18 9.89E-01 0.22 9.59E-01 
SR0612 chr 750582 750658 + 0.05 9.89E-01 0.21 9.59E-01 
SR0613 chr 750817 750901 + 0.57 3.44E-01 0.74 1.72E-01 
SR0614 chr 751120 751257 - -0.92 2.52E-01 0.30 8.07E-01 
SR0615 chr 751745 751794 - -0.87 1.20E-01 -0.14 9.35E-01 
SR0616 chr 754389 754503 - -1.58 1.37E-02 -0.18 9.34E-01 
SR0617 chr 756644 756712 - -1.01 8.32E-02 -0.37 6.48E-01 
SR0618 chr 757370 757432 - -0.98 2.94E-02 -0.77 9.33E-02 
SR0619 chr 760362 760423 - -0.73 3.28E-01 -1.13 7.44E-02 
SR0620 chr 760922 760971 - -0.77 2.23E-01 -1.29 1.50E-02 
SR0621 chr 761058 761177 - -0.78 2.85E-01 -1.11 8.08E-02 
SR0622 chr 761522 761598 + 0.05 9.89E-01 0.21 9.59E-01 
SR0623 chr 761559 761716 - 0.07 9.89E-01 0.47 5.38E-01 
SR0624 chr 763469 763518 + 0.42 2.32E-01 -0.12 8.53E-01 
SR0625 chr 763777 763827 - 0.43 1.90E-01 0.12 8.31E-01 
SR0626 chr 764001 764078 + 1.05 7.46E-01 0.64 9.14E-01 
SR0627 chr 768400 768450 + 0.33 4.32E-01 -0.57 1.06E-01 
SR0628 chr 768411 768575 - 0.19 9.89E-01 0.21 9.59E-01 
SR0629 chr 769231 769280 + 0.40 6.82E-01 0.05 9.63E-01 
SR0630 chr 769844 769938 + 0.36 5.35E-01 -1.14 5.39E-03 
SR0631 chr 769854 770014 - 0.05 9.89E-01 -0.05 9.90E-01 
SR0632 chr 770132 770181 + 0.01 9.90E-01 -1.05 6.07E-02 
SR0633 chr 773079 773177 - 0.44 9.68E-01 0.21 9.59E-01 
SR0634 chr 774200 774375 - 0.23 9.89E-01 -0.29 9.59E-01 
SR0635 chr 774458 774512 + 0.08 9.89E-01 1.89 1.22E-02 
SR0636 chr 776556 776696 - 0.05 9.89E-01 0.23 9.59E-01 
SR0637 chr 787035 787090 - 0.32 3.38E-01 0.77 2.37E-03 
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SR0638 chr 788994 789090 + -0.68 7.85E-01 0.60 8.07E-01 
SR0639 chr 789050 789119 - -0.47 6.51E-01 -0.01 9.92E-01 
SR0640 chr 789136 789249 - -0.86 4.59E-01 0.59 6.32E-01 
SR0641 chr 789321 789371 + 0.05 9.89E-01 0.21 9.59E-01 
SR0642 chr 789416 789475 - 0.28 8.24E-01 0.91 1.88E-01 
SR0643 chr 790233 790281 + -1.72 1.40E-03 -2.62 1.44E-07 
SR0644 chr 791442 791497 + -1.64 3.25E-02 -1.06 1.99E-01 
SR0645 chr 792168 792255 - -0.39 9.77E-01 0.52 9.45E-01 
SR0646 chr 792294 792361 + -0.73 8.73E-01 0.62 9.16E-01 
SR0647 chr 793731 793785 - 1.27 3.53E-01 1.34 3.07E-01 
SR0648 chr 796463 796547 + 0.21 6.76E-01 -1.02 7.25E-04 
SR0649 chr 797921 797971 + -0.05 9.89E-01 -1.16 1.92E-04 
SR0650 chr 800315 800428 - 0.39 6.23E-01 0.83 1.66E-01 
SR0651 chr 801846 801909 + -0.63 2.71E-01 0.43 4.98E-01 
SR0652 chr 803502 803604 - -1.60 2.09E-03 -0.04 9.69E-01 
SR0653 chr 804246 804295 + -0.04 9.89E-01 1.02 4.31E-01 
SR0654 chr 809919 810016 - 0.15 9.89E-01 0.13 9.59E-01 
SR0655 chr 810040 810190 + -0.68 2.21E-01 -1.78 3.41E-05 
SR0656 chr 811230 811403 - 0.05 9.89E-01 0.21 9.59E-01 
SR0657 chr 812265 812439 - -2.32 6.31E-05 -1.75 2.76E-03 
SR0658 chr 814185 814257 + 0.11 9.30E-01 0.01 9.90E-01 
SR0659 chr 814592 814727 - 0.20 9.89E-01 0.70 7.23E-01 
SR0660 chr 816639 816694 - 0.05 9.89E-01 0.21 9.59E-01 
SR0661 chr 819328 819400 - 0.97 6.75E-02 0.12 9.57E-01 
SR0662 chr 820365 820441 + 0.05 9.89E-01 0.21 9.59E-01 
SR0663 chr 821254 821321 - 0.06 9.89E-01 -1.07 1.15E-01 
SR0664 chr 821535 821667 + 0.34 9.39E-01 0.21 9.59E-01 
SR0665 chr 822408 822454 - -0.15 9.30E-01 -1.31 1.49E-02 
SR0666 chr 822940 822989 - -7.06 9.11E-76 4.59 4.62E-50 
SR0667 chr 823166 823231 + -1.18 1.18E-05 1.02 1.45E-04 
SR0668 chr 826299 826381 + 0.05 9.89E-01 0.21 9.59E-01 
SR0669 chr 827263 827335 + 0.07 9.89E-01 -0.09 9.82E-01 
SR0670 chr 829053 829114 + -1.45 4.07E-01 -1.14 5.59E-01 
SR0671 chr 830827 830943 - -0.37 9.85E-01 -0.20 9.59E-01 
SR0672 chr 831633 831683 + 0.58 4.66E-01 1.26 3.57E-02 
SR0673 chr 831982 832089 - -0.31 8.79E-01 0.58 6.46E-01 
SR0674 chr 832128 832190 + -0.63 5.39E-01 -0.01 9.95E-01 
SR0675 chr 834156 834226 - -0.54 3.94E-01 0.26 7.61E-01 
SR0676 chr 834779 834973 + -0.44 3.43E-01 -0.12 9.04E-01 
SR0677 chr 835511 835569 + 0.24 7.64E-01 0.06 9.59E-01 
SR0678 chr 835714 835866 + 0.38 5.66E-01 0.94 4.99E-02 
SR0679 chr 836154 836233 - -0.82 2.63E-01 0.85 2.16E-01 
SR0680 chr 839781 839903 + -0.55 9.12E-01 0.21 9.59E-01 
SR0681 chr 839800 839939 - -0.60 2.83E-01 -0.55 3.11E-01 
SR0682 chr 840916 841133 + 0.05 9.89E-01 0.21 9.59E-01 
SR0683 chr 841215 841350 - -0.64 1.94E-01 -0.93 2.64E-02 
SR0684 chr 842145 842196 - -1.07 1.17E-01 -0.78 2.74E-01 
SR0685 chr 842471 842538 + -0.05 9.89E-01 -0.03 9.88E-01 
SR0686 chr 843316 843362 - -0.30 7.13E-01 0.45 5.11E-01 
SR0687 chr 848259 848343 - 0.39 6.63E-01 -0.41 6.46E-01 
SR0688 chr 856162 856326 - -0.25 6.29E-01 -0.86 1.16E-02 
SR0689 chr 856710 856869 + 0.05 9.89E-01 0.63 8.42E-01 
SR0690 chr 856824 856960 - -0.44 4.32E-01 -0.97 2.74E-02 
SR0691 chr 858409 858487 + 0.05 9.89E-01 0.21 9.59E-01 
SR0692 chr 860131 860278 + -1.73 7.18E-03 0.48 6.11E-01 
SR0693 chr 860333 860544 - -1.73 9.58E-04 0.46 5.45E-01 
SR0694 chr 860872 860923 + 0.05 9.89E-01 0.21 9.59E-01 
SR0695 chr 862452 862516 + -0.95 3.23E-01 -0.81 4.15E-01 
SR0696 chr 862625 862675 + -0.68 2.27E-01 0.38 5.87E-01 
SR0697 chr 863477 863549 - -1.49 5.05E-03 -0.34 6.91E-01 
SR0698 chr 867463 867533 + 0.05 9.89E-01 0.21 9.59E-01 
SR0699 chr 868744 868895 - -0.56 1.72E-01 0.39 3.70E-01 
SR0700 chr 870007 870077 - 0.01 9.99E-01 0.18 9.60E-01 
SR0701 chr 871538 871606 + -0.23 7.52E-01 -1.24 2.60E-03 
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SR0702 chr 872610 872658 - 0.49 9.59E-01 0.21 9.59E-01 
SR0703 chr 873630 873717 + -0.18 8.79E-01 -0.66 2.63E-01 
SR0704 chr 873674 873728 - 0.05 9.89E-01 0.21 9.59E-01 
SR0705 chr 874159 874208 + -0.26 7.57E-01 0.44 5.24E-01 
SR0706 chr 875171 875261 + 0.23 9.39E-01 0.81 4.79E-01 
SR0707 chr 881310 881422 - 0.05 9.89E-01 1.20 7.11E-01 
SR0708 chr 881440 881553 + 0.01 9.89E-01 -1.70 5.82E-05 
SR0709 chr 881987 882036 + -0.18 9.27E-01 -1.62 6.44E-03 
SR0710 chr 883224 883285 + -0.38 5.48E-01 -1.09 1.46E-02 
SR0711 chr 884032 884142 - 0.05 9.89E-01 0.21 9.59E-01 
SR0712 chr 885800 885849 + -0.17 8.63E-01 0.21 8.07E-01 
SR0713 chr 886343 886497 - 0.25 9.23E-01 0.34 8.54E-01 
SR0714 chr 888242 888377 + -0.09 9.73E-01 -0.97 2.61E-02 
SR0715 chr 889701 889829 + 0.03 9.89E-01 -1.11 4.39E-03 
SR0716 chr 890350 890442 + 0.05 9.89E-01 0.21 9.59E-01 
SR0717 chr 891803 891890 + 0.05 9.89E-01 0.21 9.59E-01 
SR0718 chr 898930 898990 - 0.05 9.89E-01 0.21 9.59E-01 
SR0719 chr 899690 899766 + 0.05 9.89E-01 0.21 9.59E-01 
SR0720 chr 901558 901617 + 0.05 9.89E-01 0.21 9.59E-01 
SR0721 chr 902869 903038 + 0.47 9.17E-01 0.21 9.59E-01 
SR0722 chr 903124 903224 - -0.20 7.74E-01 0.96 1.03E-02 
SR0723 chr 905118 905186 + 0.39 8.38E-01 1.05 3.30E-01 
SR0724 chr 908448 908578 + -0.23 9.89E-01 0.21 9.59E-01 
SR0725    lp17 2883 2933 - 1.08 4.04E-01 1.70 1.13E-01 
SR0726    lp17 4269 4365 - 0.63 9.38E-01 1.53 6.56E-01 
SR0727    lp17 6593 6703 + 0.78 4.77E-02 1.12 1.34E-03 
SR0728    lp17 8155 8220 + 3.01 1.05E-13 1.24 1.11E-02 
SR0729    lp17 8211 8257 - 2.66 4.83E-05 1.11 1.66E-01 
SR0730    lp17 8407 8487 - 2.03 1.03E-09 1.54 1.04E-05 
SR0731    lp17 9414 9567 + 0.59 2.32E-01 1.01 1.21E-02 
SR0732    lp17 10026 10124 + -0.10 9.89E-01 -0.54 8.20E-01 
SR0733    lp17 10554 10615 - 1.57 2.99E-01 0.71 7.47E-01 
SR0734    lp17 10785 10832 + 0.77 4.20E-01 1.88 6.27E-03 
SR0735    lp17 10829 10901 - 0.25 9.30E-01 0.70 5.73E-01 
SR0736    lp17 11749 11833 + 4.18 1.41E-01 3.63 2.07E-01 
SR0737    lp17 12541 12594 - 0.23 9.65E-01 0.49 8.09E-01 
SR0738    lp17 12902 12951 + 1.74 2.20E-02 -0.04 9.79E-01 
SR0739    lp17 15175 15224 - 1.05 7.26E-01 -0.19 9.60E-01 
SR0740    lp17 15321 15448 + 0.88 4.36E-01 0.39 8.30E-01 
SR0741    lp17 16230 16279 + 1.34 5.65E-01 -0.50 9.48E-01 
SR0742    lp21 1290 1340 - 1.57 4.98E-01 0.97 7.45E-01 
SR0743    lp21 1488 1584 + 0.05 9.89E-01 0.21 9.59E-01 
SR0744    lp25 4544 4593 - -0.36 9.89E-01 -2.62 5.37E-01 
SR0745    lp25 5310 5359 - -0.89 4.01E-01 -4.78 7.40E-04 
SR0746    lp25 7036 7267 - -0.57 3.58E-01 -2.98 1.86E-11 
SR0747    lp25 9409 9553 - -0.62 2.17E-01 -2.73 6.04E-11 
SR0748    lp25 10412 10464 - 0.05 9.89E-01 0.21 9.59E-01 
SR0749    lp25 10817 10862 + -0.95 4.09E-01 -3.10 3.78E-03 
SR0750    lp25 11188 11252 - 0.34 9.73E-01 -1.80 5.41E-01 
SR0751    lp25 12423 12473 + -1.63 4.87E-03 -3.73 6.04E-12 
SR0752    lp25 13269 13417 - -2.30 5.23E-03 -4.70 3.23E-07 
SR0753    lp25 14404 14512 - -0.09 9.89E-01 -0.07 9.79E-01 
SR0754    lp25 15673 15944 - -0.78 1.73E-01 -4.54 2.92E-24 
SR0755    lp25 15951 16076 + -1.50 4.94E-03 -3.06 1.86E-09 
SR0756    lp25 18781 18830 - -0.12 9.89E-01 -3.12 8.26E-02 
SR0757    lp25 19502 19589 + -1.44 5.05E-01 -2.85 1.83E-01 
SR0758    lp25 20437 20486 - 1.53 8.51E-01 -0.75 9.59E-01 
SR0759    lp25 20980 21067 + 0.43 9.73E-01 -0.75 9.16E-01 
SR0760    lp25 21790 21834 + 0.88 9.83E-01 -0.75 9.59E-01 
SR0761    lp25 23037 23109 + 0.08 9.89E-01 -2.62 5.26E-01 
SR0762    lp25 23581 23630 + -1.58 3.69E-01 -2.13 2.05E-01 
SR0763    lp25 23946 23995 + -0.57 9.02E-01 -3.30 1.81E-01 
SR0764    lp28-1 2136 2233 + -0.74 5.27E-01 0.90 3.38E-01 
SR0765    lp28-1 5855 5904 - -0.81 9.22E-01 2.05 5.34E-01 
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SR0766    lp28-1 10442 10547 - -1.77 9.56E-04 -0.21 8.48E-01 
SR0767    lp28-1 12242 12293 - -0.42 9.44E-01 1.02 6.54E-01 
SR0768    lp28-1 13306 13355 + -2.62 1.25E-04 0.76 2.69E-01 
SR0769    lp28-1 16309 16358 - -0.75 8.07E-01 1.23 5.30E-01 
SR0770    lp28-2 2692 2761 - 2.02 7.70E-02 2.02 6.58E-02 
SR0771    lp28-2 4254 4359 + 0.76 2.99E-01 0.73 3.07E-01 
SR0772    lp28-2 7333 7420 - 0.53 8.07E-01 -1.30 4.45E-01 
SR0773    lp28-2 11054 11172 + 0.98 1.95E-01 -0.46 6.51E-01 
SR0774    lp28-2 18835 18885 + 1.27 1.45E-01 0.43 7.55E-01 
SR0775    lp28-2 24347 24396 + 1.82 9.52E-02 0.84 5.75E-01 
SR0776    lp28-2 24426 24490 - 1.76 5.81E-01 2.06 4.97E-01 
SR0777    lp28-2 24514 24650 + -1.62 5.56E-01 -1.45 6.19E-01 
SR0778    lp28-2 25074 25148 + 0.05 9.89E-01 0.21 9.59E-01 
SR0779    lp28-2 26424 26497 + 2.22 4.61E-03 0.13 9.59E-01 
SR0780    lp28-2 28015 28127 + -0.51 NA 0.29 NA 
SR0781    lp28-2 28532 28781 + -0.14 9.89E-01 -0.19 9.59E-01 
SR0782    lp28-2 29410 29532 - 0.04 9.89E-01 0.58 8.51E-01 
SR0783    lp28-2 29569 29618 - 0.05 9.89E-01 0.21 9.59E-01 
SR0784    lp28-3 1594 1643 + 0.76 8.71E-01 1.61 5.59E-01 
SR0785    lp28-3 2165 2244 - -0.10 9.89E-01 -0.56 6.34E-01 
SR0786    lp28-3 4412 4461 + 1.05 8.86E-01 -0.63 9.59E-01 
SR0787    lp28-3 8351 8432 - 0.58 6.91E-01 -0.51 7.81E-01 
SR0788    lp28-3 9510 9570 - -2.02 5.60E-05 0.80 1.66E-01 
SR0789    lp28-3 10436 10534 - 0.41 4.73E-01 0.61 2.08E-01 
SR0790    lp28-3 11446 11507 - 0.30 9.62E-01 -0.23 9.59E-01 
SR0791    lp28-3 16481 16565 + 0.44 7.45E-01 1.60 4.74E-02 
SR0792    lp28-3 18496 18579 + 0.07 9.89E-01 -0.50 9.51E-01 
SR0793    lp28-3 19459 19508 + 0.33 6.45E-01 1.02 2.95E-02 
SR0794    lp28-3 23090 23141 + -0.36 7.64E-01 -0.52 6.16E-01 
SR0795    lp28-3 24448 24549 + 0.65 6.65E-01 1.78 7.10E-02 
SR0796    lp28-3 25268 25327 - -0.61 8.71E-01 -0.19 9.59E-01 
SR0797    lp28-3 25656 25733 - 1.72 5.23E-01 0.21 9.59E-01 
SR0798    lp28-4 1403 1452 - -0.13 9.89E-01 -0.25 9.59E-01 
SR0799    lp28-4 2779 2828 - 0.57 5.25E-01 0.64 4.53E-01 
SR0800    lp28-4 4578 4627 + 1.06 3.19E-01 -0.02 9.92E-01 
SR0801    lp28-4 4780 4877 - 1.01 1.68E-01 -0.13 9.59E-01 
SR0802    lp28-4 4991 5056 + 0.31 7.64E-01 0.77 2.52E-01 
SR0803    lp28-4 6472 6626 - 0.35 5.87E-01 -0.32 6.35E-01 
SR0804    lp28-4 10785 10862 + -0.09 9.83E-01 1.29 4.68E-03 
SR0805    lp28-4 12723 12840 - -1.38 1.66E-02 -1.19 3.71E-02 
SR0806    lp28-4 13608 13734 + 0.05 9.89E-01 0.21 9.59E-01 
SR0807    lp28-4 14110 14171 + -0.97 5.12E-02 -0.38 5.68E-01 
SR0808    lp28-4 14738 14811 + 1.08 8.10E-01 0.84 8.96E-01 
SR0809    lp28-4 15656 15705 - -0.29 9.73E-01 0.63 8.10E-01 
SR0810    lp28-4 16622 16678 + 0.76 8.71E-01 0.21 9.59E-01 
SR0811    lp28-4 18054 18137 + 1.09 1.86E-01 2.10 1.25E-03 
SR0812    lp28-4 19115 19207 - 1.34 3.44E-02 0.50 5.68E-01 
SR0813    lp28-4 24157 24211 - -0.28 9.44E-01 0.04 9.88E-01 
SR0814    lp28-4 24601 24764 - 0.25 9.89E-01 -0.57 9.06E-01 
SR0815    lp28-4 26351 26421 + 2.70 4.87E-07 -1.02 1.42E-01 
SR0816    lp36 747 807 + 0.05 9.89E-01 0.21 9.59E-01 
SR0817    lp36 3097 3166 + 0.09 9.89E-01 1.12 7.73E-01 
SR0818    lp36 5132 5181 + -1.29 7.51E-01 -1.09 8.17E-01 
SR0819    lp36 6782 6860 + 1.80 2.76E-01 1.06 6.21E-01 
SR0820    lp36 8665 8903 - 0.03 9.89E-01 0.04 9.59E-01 
SR0821    lp36 9167 9245 + 0.04 9.89E-01 -0.05 9.63E-01 
SR0822    lp36 9642 9745 + -0.29 9.89E-01 -0.53 9.48E-01 
SR0823    lp36 11673 11748 + 0.44 9.68E-01 0.21 9.59E-01 
SR0824    lp36 12209 12260 - 0.44 6.55E-01 -1.36 4.55E-02 
SR0825    lp36 12718 12803 - 0.06 9.89E-01 0.48 5.59E-01 
SR0826    lp36 12999 13107 + 7.69 NA 6.13 NA 
SR0827    lp36 13278 13364 - 0.04 9.89E-01 0.47 9.56E-01 
SR0828    lp36 14171 14220 + 0.82 4.68E-01 0.30 9.04E-01 
SR0829    lp36 14207 14315 - -0.42 9.14E-01 -0.27 9.59E-01 
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SR0830    lp36 15735 15794 - 1.31 1.75E-02 1.00 7.95E-02 
SR0831    lp36 16054 16104 - 0.35 9.72E-01 1.07 6.85E-01 
SR0832    lp36 16149 16291 + 0.26 8.07E-01 1.31 1.44E-02 
SR0833    lp36 16937 16987 + 0.49 5.33E-01 0.93 1.20E-01 
SR0834    lp36 18792 18871 - 0.53 7.20E-01 -0.43 8.26E-01 
SR0835    lp36 21230 21314 + -0.70 7.34E-01 0.73 6.85E-01 
SR0836    lp36 22363 22451 + -0.51 8.19E-01 -6.33 4.91E-06 
SR0837    lp36 22421 22583 - -1.53 4.44E-04 0.26 7.33E-01 
SR0838    lp36 23166 23440 + -0.74 5.58E-02 -0.57 1.50E-01 
SR0839    lp36 25584 25675 - 0.25 8.09E-01 1.42 6.38E-03 
SR0840    lp36 25705 25783 + 0.20 9.60E-01 1.84 3.00E-02 
SR0841    lp36 26891 26940 - 1.27 1.35E-02 0.48 5.05E-01 
SR0842    lp36 27908 27995 + -0.64 1.32E-01 -0.34 4.98E-01 
SR0843    lp36 27966 28060 - 0.05 9.89E-01 0.21 9.59E-01 
SR0844    lp36 28345 28411 + 0.32 9.30E-01 0.69 7.00E-01 
SR0845    lp36 28602 28663 - 0.44 6.22E-01 -0.51 5.67E-01 
SR0846    lp36 30472 30528 - -1.36 6.01E-01 -0.45 9.47E-01 
SR0847    lp36 33046 33106 - 1.35 3.53E-01 -0.22 9.59E-01 
SR0848    lp36 35057 35217 + 1.18 2.18E-03 1.62 3.34E-06 
SR0849    lp36 36075 36145 + 0.05 9.89E-01 0.21 9.59E-01 
SR0850    lp38 4505 4881 + -1.16 1.96E-01 -1.21 1.50E-01 
SR0851    lp38 4820 4889 - -0.01 9.89E-01 -0.22 6.02E-01 
SR0852    lp38 6872 6947 + -1.35 4.51E-02 -0.63 4.47E-01 
SR0853    lp38 10402 10463 - 0.24 8.24E-01 3.30 5.87E-15 
SR0854    lp38 10511 10581 - 0.05 9.89E-01 0.21 9.59E-01 
SR0855    lp38 11938 12047 + 0.72 2.21E-01 0.39 5.95E-01 
SR0856    lp38 13386 13469 - 0.52 3.50E-01 2.07 7.63E-08 
SR0857    lp38 14313 14362 + 0.93 6.85E-01 0.65 8.31E-01 
SR0858    lp38 14513 14560 - -0.33 9.71E-01 0.69 8.07E-01 
SR0859    lp38 20309 20358 + 0.05 9.89E-01 0.21 9.59E-01 
SR0860    lp38 23054 23103 + 1.00 1.36E-01 0.87 1.98E-01 
SR0861    lp38 24109 24183 + 1.15 3.35E-01 0.22 9.59E-01 
SR0862    lp38 24736 24810 + 0.90 4.09E-01 1.03 3.16E-01 
SR0863    lp38 24777 24988 - 0.15 9.38E-01 0.66 2.92E-01 
SR0864    lp38 26035 26126 + -0.45 5.10E-01 -0.01 9.92E-01 
SR0865    lp38 26484 26597 + 1.66 2.94E-02 1.33 8.29E-02 
SR0866    lp38 26536 26600 - 1.64 4.05E-02 1.50 5.38E-02 
SR0867    lp38 28965 29014 + 1.26 6.94E-01 -1.63 6.68E-01 
SR0868    lp38 29116 29204 + 0.00 1.00E+00 -0.93 5.98E-01 
SR0869    lp38 29541 29610 + 0.99 4.36E-01 0.57 7.38E-01 
SR0870    lp38 29837 29893 - 0.01 9.92E-01 -0.23 9.06E-01 
SR0871    lp38 30642 30724 - 0.05 9.89E-01 0.21 9.59E-01 
SR0872    lp38 32186 32235 + 0.97 2.44E-01 0.68 4.75E-01 
SR0873    lp38 33225 33332 + 1.28 3.47E-01 0.47 8.42E-01 
SR0874    lp38 34706 34755 + 0.82 5.49E-01 0.83 5.56E-01 
SR0875    lp38 35143 35223 - 0.05 9.89E-01 0.21 9.59E-01 
SR0876    lp38 36354 36403 + 0.33 9.80E-01 -0.08 9.83E-01 
SR0877    lp38 37024 37117 + 0.10 9.89E-01 -0.38 9.59E-01 
SR0878    lp38 37312 37365 + -0.92 9.85E-01 -0.75 9.59E-01 
SR0879    lp38 38374 38508 - 3.41 2.67E-09 0.02 9.92E-01 
SR0880    lp54 2261 2354 - 0.05 9.89E-01 0.21 9.59E-01 
SR0881    lp54 3623 3672 - 0.05 9.89E-01 0.21 9.59E-01 
SR0882    lp54 4604 4715 - -0.66 5.55E-01 -0.05 9.78E-01 
SR0883    lp54 8022 8074 - 0.77 1.28E-01 0.17 8.69E-01 
SR0884    lp54 10502 10586 + 0.05 9.89E-01 0.21 9.59E-01 
SR0885    lp54 11249 11304 + -0.53 5.33E-01 -0.44 6.40E-01 
SR0886    lp54 11313 11372 - -0.97 1.77E-01 -0.82 2.50E-01 
SR0887    lp54 11430 11587 - -0.34 6.21E-01 0.22 7.97E-01 
SR0888    lp54 11715 11849 + 0.97 4.15E-02 1.97 4.28E-07 
SR0889    lp54 11974 12040 - 0.69 3.39E-01 1.19 4.38E-02 
SR0890    lp54 12814 13093 + 0.31 5.82E-01 0.11 9.47E-01 
SR0891    lp54 14845 15059 + 1.17 2.17E-01 1.15 2.08E-01 
SR0892    lp54 15329 15379 + 0.85 2.34E-01 0.35 7.15E-01 
SR0893    lp54 17585 17646 + 0.50 7.34E-01 -0.79 5.90E-01 
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SR0894    lp54 17624 17795 - 0.48 3.12E-01 -0.51 2.78E-01 
SR0895    lp54 18718 18780 - 0.19 9.73E-01 -0.09 9.59E-01 
SR0896    lp54 23118 23236 + 1.35 7.41E-04 0.16 8.73E-01 
SR0897    lp54 23475 23538 - 1.55 8.29E-01 0.21 9.78E-01 
SR0898    lp54 25104 25162 + 0.31 9.12E-01 1.37 2.03E-01 
SR0899    lp54 25131 25289 - -0.74 5.46E-01 1.30 1.81E-01 
SR0900    lp54 29365 29422 - 0.24 8.45E-01 -1.26 4.38E-02 
SR0901    lp54 29435 29515 + 0.05 9.89E-01 0.21 9.59E-01 
SR0902    lp54 39336 39435 - 1.50 3.74E-01 0.24 9.59E-01 
SR0903    lp54 39493 39539 - 1.37 3.92E-01 1.03 5.74E-01 
SR0904    lp54 41163 41261 + -0.19 9.32E-01 -0.07 9.59E-01 
SR0905    lp54 41173 41266 - 1.13 1.15E-01 -0.04 9.79E-01 
SR0906    lp54 41328 41380 - -0.77 2.51E-01 -0.24 8.24E-01 
SR0907    lp54 41530 41649 + -0.68 1.92E-01 -1.06 1.55E-02 
SR0908    lp54 42671 42743 - 0.05 9.89E-01 0.21 9.59E-01 
SR0909    lp54 44646 44713 - 1.60 2.94E-02 0.77 3.95E-01 
SR0910    lp54 44818 44870 - 0.05 9.89E-01 0.21 9.59E-01 
SR0911    lp54 45194 45286 + 1.73 7.71E-03 0.22 8.99E-01 
SR0912    lp54 46072 46181 - 0.52 7.09E-01 1.32 1.75E-01 
SR0913    lp54 46406 46458 - -0.61 7.70E-01 0.12 9.59E-01 
SR0914    lp54 47340 47433 + -0.93 6.29E-01 -0.38 9.25E-01 
SR0915    lp54 48337 48441 + 1.25 4.95E-01 1.20 5.28E-01 
SR0916    lp54 49370 49433 - -0.39 9.52E-01 0.53 8.89E-01 
SR0917    lp54 50265 50344 - -1.57 8.48E-02 0.70 5.41E-01 
SR0918    lp54 51191 51239 - -0.71 4.72E-01 0.28 8.67E-01 
SR0919    lp54 51485 51540 + -1.16 6.15E-01 -2.25 2.43E-01 
SR0920    lp56 1727 1773 - -0.05 9.89E-01 0.05 9.59E-01 
SR0921    lp56 4293 4342 - -1.43 1.24E-01 0.63 6.02E-01 
SR0922    lp56 19795 19847 - 0.25 7.01E-01 -2.13 8.22E-09 
SR0923    lp56 22612 22685 - 0.78 7.96E-01 0.44 9.49E-01 
SR0924    lp56 24875 24928 + 0.05 9.89E-01 0.21 9.59E-01 
SR0925    lp56 31737 31810 - -0.69 6.22E-01 -3.22 1.01E-02 
SR0926    lp56 37477 37590 - 0.79 4.48E-01 0.62 5.99E-01 
SR0927    lp56 41099 41203 - -0.56 9.21E-01 -0.79 8.44E-01 
SR0928    lp56 43488 43558 - 0.05 9.89E-01 0.21 9.59E-01 
SR0929    lp56 49567 49649 + 1.02 2.88E-01 0.23 9.39E-01 
SR0930     cp  9 133 283 + 0.00 1.00E+00 1.18 9.59E-01 
SR0931     cp  9 2128 2308 + 2.48 2.83E-01 13.29 4.36E-25 
SR0932     cp  9 2603 2653 + NA NA NA NA 
SR0933     cp  9 2697 2774 - NA NA NA NA 
SR0934     cp  9 2775 2915 + NA NA NA NA 
SR0935     cp  9 4067 4159 + NA NA NA NA 
SR0936     cp  9 5230 5289 + NA NA NA NA 
SR0937     cp  9 5823 5890 + NA NA NA NA 
SR0938     cp  9 5984 6034 - NA NA NA NA 
SR0939     cp  9 6308 6404 + NA NA NA NA 
SR0940     cp  9 6624 6722 - NA NA NA NA 
SR0941     cp  9 7132 7181 - NA NA NA NA 
SR0942     cp  9 7829 7897 + NA NA NA NA 
SR0943     cp  9 8366 8437 - NA NA NA NA 
SR0944     cp  9 9218 9267 + NA NA NA NA 
SR0945     cp  26 870 955 + -0.92 1.18E-02 1.78 3.07E-09 
SR0946     cp  26 1973 2066 + 0.12 9.55E-01 -0.30 7.26E-01 
SR0947     cp  26 2288 2338 + 0.28 9.60E-01 0.90 6.11E-01 
SR0948     cp  26 2376 2476 + -0.58 3.68E-01 1.93 1.48E-05 
SR0949     cp  26 2406 2475 - 0.43 7.69E-01 1.36 1.23E-01 
SR0950     cp  26 2604 2683 - 0.05 9.89E-01 0.21 9.59E-01 
SR0951     cp  26 3191 3257 + -0.22 7.54E-01 2.29 8.64E-11 
SR0952     cp  26 6558 6607 + -0.60 8.71E-01 0.24 9.59E-01 
SR0953     cp  26 7013 7135 - 1.80 1.76E-05 0.92 5.56E-02 
SR0954     cp  26 7267 7354 + 0.05 9.89E-01 0.21 9.59E-01 
SR0955     cp  26 7671 7782 - 0.18 9.60E-01 0.40 7.71E-01 
SR0956     cp  26 7673 7740 + 0.47 8.89E-01 0.05 9.87E-01 
SR0957     cp  26 7794 7856 + 0.75 3.45E-01 2.09 3.48E-04 
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SR0958     cp  26 8033 8111 - 1.18 1.77E-02 1.03 3.58E-02 
SR0959     cp  26 8638 8764 + 0.07 9.89E-01 -0.34 9.59E-01 
SR0960     cp  26 10223 10292 - 0.52 6.55E-01 -0.05 9.77E-01 
SR0961     cp  26 10732 10791 + 1.91 6.73E-02 1.80 7.91E-02 
SR0962     cp  26 10804 10884 - -1.05 6.69E-01 -1.25 6.05E-01 
SR0963     cp  26 11217 11342 + 0.43 3.73E-01 -0.03 9.64E-01 
SR0964     cp  26 11625 11690 - 0.13 9.89E-01 0.30 9.59E-01 
SR0965     cp  26 11977 12247 + 0.97 7.51E-02 0.66 2.51E-01 
SR0966     cp  26 12302 12351 - 0.27 7.49E-01 0.55 3.61E-01 
SR0967     cp  26 13617 13679 + 1.30 4.24E-01 0.02 9.96E-01 
SR0968     cp  26 13913 14140 + -0.43 3.95E-01 -0.10 9.54E-01 
SR0969     cp  26 16309 16407 - 0.80 8.62E-01 0.21 9.59E-01 
SR0970     cp  26 17917 18032 - 0.38 6.94E-01 -0.35 7.53E-01 
SR0971     cp  26 20105 20208 - 0.05 9.89E-01 0.21 9.59E-01 
SR0972     cp  26 20473 20664 - -1.65 NA -2.33 NA 
SR0973     cp  26 21021 21080 - 0.05 9.89E-01 0.21 9.59E-01 
SR0974     cp  26 21879 21987 + 0.72 7.47E-01 0.37 9.44E-01 
SR0975     cp  26 21903 21952 - 0.67 3.79E-01 0.83 2.27E-01 
SR0976     cp  26 23233 23305 + 0.68 8.92E-01 -0.77 8.99E-01 
SR0977     cp  32-1 16391 16498 + -0.14 9.89E-01 -0.44 8.31E-01 
SR0978     cp  32-1 17551 17705 + 0.66 5.67E-01 -0.03 9.86E-01 
SR0979     cp  32-1 18870 18932 - -0.21 9.84E-01 0.60 7.69E-01 
SR0980     cp  32-1 22671 22740 - -1.21 1.66E-02 -1.42 2.38E-03 
SR0981     cp  32-3 16665 16711 - 0.22 9.89E-01 0.72 7.55E-01 
SR0982     cp  32-3 19353 19421 - -0.36 9.44E-01 1.53 3.01E-01 
SR0983     cp  32-4 11486 11540 - -0.02 9.89E-01 0.08 9.59E-01 
SR0984     cp  32-4 18691 18778 - 0.90 6.48E-01 0.81 7.02E-01 
SR0985     cp  32-4 22381 22447 + -0.53 9.60E-01 0.96 8.17E-01 
SR0986     cp  32-4 27534 27583 + 0.52 6.55E-01 -1.53 9.44E-02 
SR0987     cp  32-4 28029 28167 - -0.45 5.81E-01 0.36 6.85E-01 
SR0988     cp  32-6 11520 11602 - 0.20 8.27E-01 0.14 9.34E-01 
SR0989     cp  32-6 17657 17711 + 0.28 9.88E-01 -0.04 9.91E-01 
SR0990     cp  32-6 18834 18884 - -1.12 3.35E-01 1.27 2.18E-01 
SR0991     cp  32-6 19451 19503 - 0.85 9.73E-02 0.72 1.69E-01 
SR0992     cp  32-6 21424 21518 + 0.17 9.57E-01 -1.22 1.23E-01 
SR0993     cp  32-6 27205 27254 - 0.43 9.12E-01 1.32 4.45E-01 
SR0994     cp  32-6 27219 27266 + 0.63 2.90E-01 1.18 1.34E-02 
SR0995     cp  32-7 12297 12411 + 0.44 9.68E-01 0.21 9.59E-01 
SR0996     cp  32-7 18868 18934 - -1.81 4.17E-02 1.31 1.07E-01 
SR0997     cp  32-7 28487 28536 - 1.17 1.95E-01 0.82 4.08E-01 
SR0998     cp  32-8 17578 17652 + -0.67 9.01E-01 -0.50 9.56E-01 
SR0999     cp  32-8 18849 18908 - -1.32 5.38E-01 1.76 2.24E-01 
SR1000     cp  32-8 20743 20904 + 0.42 9.24E-01 0.41 9.35E-01 
SR1001     cp  32-8 22556 22605 - -0.73 6.87E-02 -0.66 9.33E-02 
SR1002     cp  32-8 23033 23091 + 0.40 9.81E-01 0.56 9.48E-01 
SR1003     cp  32-9 17636 17737 + 0.65 8.81E-01 0.23 9.59E-01 
SR1004     cp  32-9 18914 18980 - 0.05 9.95E-01 1.15 9.44E-01 
SR1005     cp  32-9 27800 27896 + 0.40 8.64E-01 0.43 8.36E-01 
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included judging local science fairs, various festivals (both open-house, and 
at specific schools) with hands-on demonstrations and experiments, GEMS 
(girls in engineering and science) conference for elementary and middle 
school girls, food drives for the local food pantry, cooking meals at the 
Ronald McDonald House, and bingo nights at Hope Lodge for cancer-
affected families. 
2016-present Member. American Association for the Advancement of Science 
2015  Poster Judge, Annual Postdoctoral Poster session, University of Kentucky 
2015  Science Fair Judge, Morton Middle School, Lexington, KY 
2014-present Ad Hoc Reviewer, PLoS ONE  
